15 minutes to go! ⏳️
Women's Health Career Pathways: Jessica Badlam
📅 19 November 2026
🕓️ 16:00 GMT
Join Jessica Badlam for the inaugural Women's Health Career Pathways webinar and explore the experiences, opportunities, and lessons that shaped her career in women's health and PH research.
➡️ Register now: pvrinstitute.org/learning-hub/events/womens-health-career…
Pulmonary Vascular Research Institute
The Pulmonary Vascular Research Institute (PVRI) is a global medical research charity. It is registered Charity in the United Kingdom (Charity No: 1127115) and a private limited company by guarantee. The company registration number is 5780068. The PVRI is a professional membership organisation for doctors and scientists from around the world who have a special interest in pulmonary hypertension (PH) or pulmonary vascular diseases (PVD). More on Wikipedia
-
The Pulmonary Vascular Research Institute
@PVRI
-
The Pulmonary Vascular Research Institute
@PVRI
What can 4,000 patient voices tell us about PH? 💬
The PHGPS Dashboard helps you explore findings from nearly 4,000 patients and carers across 90 countries.
Use the dashboard to:
▪️explore results by region
▪️compare diagnosis classifications
▪️filter by respondent type and gender
❓️ Want to dive deeper?
You can also request access to the full PHGPS dataset to support:
✅️ research projects
✅️ advocacy initiatives
✅️ education programmes
✅️ service improvement
🔗 Explore the dashboard and request data access: pvrinstitute.org/learning-research/pulmonary-hypertension… -
The Pulmonary Vascular Research Institute
@PVRI
Missed this month's webinar on 'Blood Biomarkers in Pulmonary Arterial Hypertension – New Insights?'
Watch on demand! Featuring Christopher J. Rhodes, Anna Hemnes, Patricia A. Thistlethwaite, Mona Alotaibi, and Grazyna Kwapiszewska, the session explored the following:
▪️biomarker validation for clinical use
▪️plasma proteome risk stratification
▪️NOTCH3-ECD as a biomarker for PAH
▪️novel predictors of outcomes in PAH
▪️markers of vascular dysfunction
▶️ Watch the session now: pvrinstitute.org/learning-hub/material/blood-biomarkers-p…
#pulmonaryhypertension #pahresearch #biomarkers -
The Pulmonary Vascular Research Institute
@PVRI
⏰ Happening tomorrow!
Don't miss the first Women's Health Career Pathways webinar!
Women's Health Career Pathways: Jessica Badlam
📅 19 November 2026
🕓️ 16:00 GMT
Join us for an honest conversation about career decisions, challenges, collaborations, mentorship, and the lessons learned along the way.
➡️ Register now: pvrinstitute.org/learning-hub/events/womens-health-career… -
The Pulmonary Vascular Research Institute
@PVRI
Less than two weeks left to submit a late-breaking abstract ⏳
The latest discoveries often have the biggest impact.
If you have important new findings don't miss your opportunity to present them at PVRI 2027 Bangkok. Late-breaking abstracts are intended for highly impactful developments in:
✅ major clinical trials
✅ landmark registry analyses
✅ transformative translational discoveries
✅ emerging technologies with immediate clinical relevance
Join colleagues from around the world in Bangkok and contribute to the conversations shaping the future of PH.
➡️ Submit now: pvrinstitute.org/pvri2027/abstractsubmission -
The Pulmonary Vascular Research Institute
@PVRI
15 minutes to go ⏳️
Hear from Erik Swenson as he shares insights from a career spent studying high altitude medicine, respiratory physiology and how humans and animals respond to extreme environments.
Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise
📅 17 November 2026
🕐️ 13:00 GMT
➡️ Register and join: pvrinstitute.org/learning-hub/events/bleeding-ponies-bloa… -
The Pulmonary Vascular Research Institute
@PVRI
This #phawarenessmonth, we’re recognising the everyday pressures of living with pulmonary hypertension (#ph). We also want to remind you: you are not alone - and you are not powerless.
Empowerment means building the knowledge, skills and confidence to navigate life with PH - including feelings of anxiety, sadness or frustration.
What can empowerment look like?
It can mean:
• Understanding your disease and treatment options
• Reducing stress
• Feeling more in control by opening up to your healthcare team and family
• Making lifestyle adaptations
• Choosing to help others as a patient expert or advocate
🔗 Read more: pvrinstitute.org/PH-patient-resources/how-empower-yoursel…
➡️ Watch 'steps to build an empowerment plan' to help you, from setting personal health goals and creating an action plan to tracking your progress.
www.youtube.com/watch?v=9SN0bqEV40I
#livingunderpressure #pulmonaryhypertension @PHAssociation -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow ⏰
❓️ How do humans and animals adapt when oxygen levels fall?
Tomorrow, Erik Swenson will take us on a journey through high-altitude medicine, exercise physiology and environmental adaptation in our latest webinar.
Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise
🗓 17 November
🕐 13:00 GMT
➡️ Register now: pvrinstitute.org/learning-hub/events/bleeding-ponies-bloa… -
The Pulmonary Vascular Research Institute
@PVRI
🤝 Patients are helping shape the future of research.
People living with PH bring valuable lived experience that can help researchers better understand what matters most to patients.
In this video from our 'Understanding clinical trials' PH patient resource collection, Luke Howard discusses the important role patients can play as partners in research.
🎥 Watch the full series: pvrinstitute.org/PH-patient-resources/understanding-clini… -
The Pulmonary Vascular Research Institute
@PVRI
15 minutes to go! ⏳️
Blood Biomarkers in PAH – New Insights
📅 12 November 2026
🕓️ 16:00 GMT
Join us for cutting-edge PH research, expert discussion and audience Q&A covering the latest developments in PAH biomarkers.
➡️ Register and join now: pvrinstitute.org/learning-hub/events/blood-biomarkers-pul… -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow ⏰
Blood Biomarkers in Pulmonary Arterial Hypertension – New Insights
📅 12 November 2026
🕓️ 16:00 - 17:00 GMT
Join experts from across the PH community as they discuss emerging biomarkers, methodological challenges, risk stratification and new approaches to predicting outcomes in PAH.
➡️ Register now: pvrinstitute.org/learning-hub/events/blood-biomarkers-pul… -
The Pulmonary Vascular Research Institute
@PVRI
🌍 New for #pvri2027: Bayer is supporting new travel awards, offering a total of £10,000 (up to a max of £1,700 per person) to help more early-career delegates from across the world join us in Bangkok & applications are OPEN now.
These awards are in addition to PVRI’s previous round of travel awards.
Application deadline: 25 November 2026, 09:00 GMT
Applicants notified: 27 November 2026
Find out more & apply: pvrinstitute.org/pvri2027/travelawards -
The Pulmonary Vascular Research Institute
@PVRI
One week to go! 📣
Join Jessica Badlam for the first Women's Health Career Pathways webinar.
Women's Health Career Pathways: Jessica Badlam
📅 19 November 2026
🕓️ 16:00 GMT
Hear her personal career journey and gain practical advice on mentorship, collaboration, leadership, and building a career in women's health and PH research.
➡️ Register: pvrinstitute.org/learning-hub/events/womens-health-career… -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Effect of Incident Pulmonary Arterial Hypertension on Risk of Newly-Diagnosed Mental Health Conditions
📆 07 September 2026
🔢 16(3), e70398
👤 Anna Watzker, Oscar Patterson-Lomba, Cameron Fowler, Yan Song, Alejandro Victores, Alen Dezia, Jiayang Li, Azeem Banatwala, Qingyi Cai, Lana Melendres-Groves
➡️ Read the full research article: doi.org/10.1002/pul2.70398 -
The Pulmonary Vascular Research Institute
@PVRI
Speaker spotlight💡
PVRI 2027 Bangkok will explore some of the biggest clinical and scientific challenges facing the PH community today, from critical care and Group 2 PH to advanced imaging and right ventricular recovery.
Here’s a glimpse of what’s to come ⬇️
Preoperative Risk Assessment in PH: Assessing Hemodynamics, RV Function, & Surgical Risk
🎙 Monica Mukherjee, Johns Hopkins University
Novel Diagnostics for the Next Generation of Therapeutics
🎙 Bruno Thal, Justus Liebig University of Giessen
Multimodal AI Pipelines for PAH Detection: Bridging ECG, Chest Imaging and Clinical Translation
🎙 Wen-Hui Fang, Tri-Service General Hospital / National Defense Medical Center
The Distinct Pulmonary Vascular Phenotype of Group 3 PH
🎙 Franz Rischard, University of Arizona
The PVRI GoDeep Registry: Building the World's Largest Meta-Registry for Deep Phenotyping in PH
🎙 Athiththan Yogeswaran, Justus Liebig Universität Giessen
PVRI 2027 Bangkok
Bridging Science, Innovation & Care for the Next 20 Years
📅 27-31 January 2027
📍 Amari Bangkok Hotel & Conference Centre
🎟 Register now: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok -
The Pulmonary Vascular Research Institute
@PVRI
One week to go! 📢
Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise
📅 17 November 2026
🕐️ 13:00 GMT
From high-altitude expeditions to animal physiology, hypoxia can teach us a great deal about how the heart and lungs respond under stress.
➡️ Register now: pvrinstitute.org/learning-hub/events/bleeding-ponies-bloa… -
The Pulmonary Vascular Research Institute
@PVRI
#livingunderpressure: Empowering patients through knowledge 💜
Living with pulmonary hypertension (PH) can mean navigating uncertainty, complex medical information and difficult decisions about care. But patients should never feel under pressure to make decisions without the information and support they need.
Understanding clinical trials can help people living with PH feel informed, confident and empowered to take an active role in research and care.
PVRI's 'Understanding clinical trials' video series helps patients better understand clinical research and why their voices matter in shaping future research and treatment.
Explore the series here: pvrinstitute.org/PH-patient-resources/understanding-clini…
OR watch here: youtu.be/Op6wntPXSa4
#phawarenessmonth #pulmonaryhypertension #patientempowerment #clinicaltrials -
The Pulmonary Vascular Research Institute
@PVRI
Generated important new data?
Late-breaking abstract submissions are now open 📢
PVRI 2027 Bangkok is now accepting late-breaking abstracts showcasing highly impactful findings. We are particularly interested in:
🔬 major clinical trials
📊 landmark registry analyses
🧬 transformative translational discoveries
💡 emerging technologies with immediate clinical relevance
Late-breaking submissions provide an opportunity to share the very latest advances with the global PH community and help shape discussions at PVRI 2027 Bangkok.
📅 Deadline: 30 November 2026, 09:00 GMT
➡️ Submit your abstract: pvrinstitute.org/pvri2027/abstractsubmission -
The Pulmonary Vascular Research Institute
@PVRI
We're proud to support #phdayuk 2026 💜
Raising awareness is an important step towards earlier diagnosis, better understanding and improved outcomes for people living with PH.
That's why we're backing this year's #weneedtotalkaboutph campaign. Every conversation helps more people recognise the signs and symptoms of PH and understand the impact it can have on daily life.
Join us in supporting this year's campaign: phday.phauk.org/get-involved -
The Pulmonary Vascular Research Institute
@PVRI
✅ Is taking part in a clinical trial right for you?
There is no single right answer. Every person, situation, and clinical trial is different.
In this video from our 'Understanding clinical trials' PH patient collection, Huan Huang from PHA China explores some of the factors patients may wish to consider when making decisions about research participation.
🎥 Watch the full series: pvrinstitute.org/PH-patient-resources/understanding-clini… -
The Pulmonary Vascular Research Institute
@PVRI
One week to go! ⏳️
Blood Biomarkers in PAH – New Insights
📅 12 November 2026
🕓️ 16:00 - 17:00 GMT
You'll hear talks on:
▪️Validation of biomarkers for clinical use: methological challenges and the path forward - Anna Hemnes, Vanderbilt University
▪️Use of the plasma proteosome for risk stratifying patients with PAH
Christopher J. Rhodes, National Heart and Lung Institute, Imperial College
▪️NOTCH3-ECD as a Biomarker for PAH - Patricia A. Thistlethwaite, University of California
▪️Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in PAH - Mona Alotaibi, University of California San Diego
▪️Blood endostatin, a Collagen18a1 fragment, as markers of vascular dysfunction in PAH - Grazyna Kwapiszewska, University of Graz
➡️ Register now: pvrinstitute.org/learning-hub/events/blood-biomarkers-pul… -
The Pulmonary Vascular Research Institute
@PVRI
You may know the right clinician 💬
Global PH Consult gives clinicians the opportunity to bring anonymised complex PH cases to a tailored panel of PH specialists for discussion and shared learning.
Help us spread the word by sharing Global PH Consult with:
▪️colleagues managing complex PH cases
▪️regional PH centres
▪️clinical networks and professional societies
▪️clinicians working in low- and middle-income countries
A single recommendation could connect a clinician with valuable PH discussion, specialist perspectives, and a global learning community.
➡️ Find out more: pvrinstitute.org/learning-research/global-ph-consult -
The Pulmonary Vascular Research Institute
@PVRI
Thank you to everyone who submitted an abstract for PVRI 2027 Bangkok 👏
We're delighted by the quality and diversity of submissions received from across the global PH community, showcasing the latest advances in research, clinical care, innovation and collaboration.
Congratulations to all authors whose abstracts have been accepted for presentation in Bangkok. We look forward to showcasing your work!
➡️ View the programme and register: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok -
The Pulmonary Vascular Research Institute
@PVRI
🫁 🌏 This #phawarenessmonth, we’re sharing a video from the PH Association highlighting the real-life experiences of people living with pulmonary hypertension - from symptoms and diagnosis to treatment and daily life. Their stories remind us that no one has to navigate this journey alone. phassociation.org/get-involved/raise-awareness/faces-of-ph/
For anyone living with PH, explore PVRI's trusted resources to help you understand treatment options, navigate daily life, learn about clinical trials, and access emotional and peer support: pvrinstitute.org/PH-patient-resources
#pulmonaryhypertension #phcommunity @PHAssociation -
The Pulmonary Vascular Research Institute reposted
Wiley Clinical and Health
@WileyHealth
As the official journal of @PVRI #pulmonarycirculation journal features high-quality, peer-reviewed articles from leading experts in the field of pulmonary circulation, from pulmonary hypertension to lung transplantation #journalspotlight
Visit now: onlinelibrary.wiley.com/journal/20458940?SocialAccount=Wi… -
The Pulmonary Vascular Research Institute
@PVRI
In this state-of-the-art review, researchers from basic science, clinical research, and industry came together through the Pulmonary Vascular Research Institute (PVRI) Innovative Drug Discovery Initiative (IDDI) to discuss:
🔹 The biology of ASIs
🔹 The importance of specific BMP ligands
🔹 Efficacy and side effect profiles
🔹 Key considerations for developing next-generation ASIs
📖 Read the full review: onlinelibrary.wiley.com/doi/full/10.1002/pul2.70353
#pulmonaryhypertension #drugdiscovery #medicalresearch -
The Pulmonary Vascular Research Institute
@PVRI
❓️Planning to join us in Bangkok?
Only one month left to secure the special PVRI delegate hotel rate ⏳️
Stay at the Amari Bangkok Hotel & Conference Centre, and be steps away from the main scientific programme.
By staying at the venue, you'll be just moments away from:
✅ scientific sessions and satellite meetings
✅ Congress luncheons and networking events
✅ fundraising activities
✅ Gala Dinner & Awards Presentation Evening
January is a busy time to visit Bangkok, so we recommend booking your room early.
➡️ Book your hotel: pvrinstitute.org/pvri2027/accommodation
📅 Delegate rates available until 30 November 2026 -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Referral Patterns and Clinical Characteristics of Patients With Pulmonary Hypertension at a Comprehensive Care Center
📆 10 September 2026
🔢 16(3), e70399
👤 Nelson Villasmil Hernandez, Maria Jose Maestre, Meagan Chavarria, Pujita Munnangi, Neelam Lakhani, Laura Valecillos Loukidis, Sandeep Sahay
➡️ Read the full research article: doi.org/10.1002/pul2.70399 -
The Pulmonary Vascular Research Institute
@PVRI
🌏 We’re delighted to share that the PVRI Southeast Asia Task Force was relaunched in September 2026
The Task Force, co-led by Dr Suree Sompradeekul (Thailand) and Dr Ruan Wen (Singapore), aims to:
🔹 Strengthen collaboration and knowledge-sharing across Southeast Asia’s PH community
🔹 Identify regional priorities to improve PH diagnosis, treatment, and patient outcomes
🔹 Advance regional and national guidelines, registries, and data-sharing
🔹 Build a lasting regional network beyond PVRI 2027 in Bangkok
Learn more about the Task Force’s relaunch, activities, and future plans: pvrinstitute.org/learning-hub/news/understanding-ph-care-…
#pulmonaryhypertension #ph #southeastasia -
The Pulmonary Vascular Research Institute
@PVRI
Missed our October Community Call?
Our latest Community Call is now available on demand! Featuring Tyler Couch, Agustin Garcia and Olympia Bikou, the session explored the following:
🔹 Pulmonary artery dilation on chest CT Across the spectrum of chronic lung disease
🔹 CT imaging derived pulmonary vascular abnormalities associated with PH in chronic lung disease
🔹 MicroRNA-224 as a therapeutic target in preclinical pulmonary arterial hypertension
▶️ Watch the session now: pvrinstitute.org/learning-hub/material/pulmonary-hyperten…
#pulmonaryhypertension #phresearch -
The Pulmonary Vascular Research Institute
@PVRI
New webinar series launch! 🎉
Women's Health Career Pathways: Jessica Badlam
📅 19 November 2026
🕓️ 16:00 GMT
The Women's Health Task Force have launched their new series, 'Women's Health Career Pathways', that explores the personal and professional journeys of leaders working across women's health and PH.
Join Jessica Badlam for the inaugural webinar. Through an in-depth conversation, Jessica will share the experiences, decisions, collaborations, and lessons that have shaped her career in women's health and PH research.
➡️ Register today: pvrinstitute.org/learning-hub/events/womens-health-career… -
The Pulmonary Vascular Research Institute
@PVRI
Speaker spotlight💡
PVRI 2027 Bangkok will explore some of the biggest clinical and scientific challenges facing the PH community today, from critical care and Group 2 PH to advanced imaging and right ventricular recovery.
Here’s a glimpse of what’s to come ⬇️
Multiomics Profiling to Uncover Mechanisms of PVD
🎙 Anna Hemnes, Vanderbilt University Medical Center
Digital Twins in PAH: Integrating Multimodal Data for Precision Personalised Prognosis
🎙 Tiffany Baptiste, King's College London
Redefining the Hemodynamics of PAH in the Sotatercept Era
🎙 Yogesh Reddy, Mayo Clinic
Challenges in Classification, Evaluation, and Care of Pediatric Group 2 PH
🎙 Karin Tran-Lundmark, Lund University and Skåne University Hospital
Balancing Risk & Clinical Outcomes During Pregnancy with PH
🎙 Jenna Skowronski, University of North Carolina
PVRI 2027 Bangkok
Bridging Science, Innovation & Care for the Next 20 Years
📅 27-31 January 2027
📍 Amari Bangkok Hotel & Conference Centre
🎟 Register now: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok -
The Pulmonary Vascular Research Institute
@PVRI
Last chance to nominate 🚨
Nominations for the PVRI Achievement Awards 2026 and PVRI President 2028-30 close tomorrow.
❓️Who has inspired you?
❓️Who has made an exceptional contribution to PH research or patient care?
Now is your opportunity to recognise their impact.
➡️ Submit a nomination: pvrinstitute.org/learning-hub/news/nominations-now-open-p…
📅 Deadline: 28 October 2026 at 09:00 GMT -
The Pulmonary Vascular Research Institute
@PVRI
📊 What happens after a clinical trial ends?
Many people have questions about study results, follow-up care, and how their personal information is protected.
In this video from our 'Understanding clinical trials' PH patient resource collection, Luz Osorio from Sociedad Latina de Hipertensión Pulmonar discusses what patients can expect once a trial is complete.
🎥 Watch now: pvrinstitute.org/PH-patient-resources/understanding-clini… -
The Pulmonary Vascular Research Institute
@PVRI
Nominations for PVRI President 2028-30 and PVRI Achievement Awards 2026 close next week ⏳️
PVRI members can:
▪️recognise outstanding contributions to PH research, care, collaboration
▪️shape the future leadership of PVRI
We particularly encourage nominations that reflect the diversity and international nature of our community.
📅 Nominations close 28 October 2026 at 09:00 GMT
➡️ Submit a nomination: pvrinstitute.org/learning-hub/news/nominations-now-open-p… -
The Pulmonary Vascular Research Institute
@PVRI
Upcoming webinar 💻️
Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise
📅 17 November 2026
🕐️ 13:00 GMT
In this webinar, Erik Swenson will explore how humans and animals respond to the challenges of hypoxia and exercise, drawing on decades of research in high-altitude medicine, respiratory physiology and extreme environments.
➡️ Register now: pvrinstitute.org/learning-hub/events/bleeding-ponies-bloa… -
The Pulmonary Vascular Research Institute
@PVRI
Supporting early-career professionals and colleagues from LMICs 🌍🤝
We're committed to making the global PH community more accessible, inclusive and connected.
PVRI 2027 Bangkok includes more support than ever for early-career professionals and colleagues from low- and middle-income countries (LMICs), including:
✅ reduced PVRI membership fees from just $15 per year
✅ reduced Congress registration rates
✅ travel awards helping early-career and LMIC delegates attend PVRI 2027 Bangkok
✅ seven Early Career Abstract Awards worth £2,000 each
✅ Career Catalyst PH Luncheon, providing mentoring from PH experts
✅ World Café PH Luncheon, to discuss challenges, and solutions for improving PH care globally
➡️ Find out more about PVRI 2027 Bangkok: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok -
The Pulmonary Vascular Research Institute
@PVRI
What can 4,000 patient voices tell us about PH? 💬
The PHGPS Dashboard helps you explore findings from nearly 4,000 patients and carers across 90 countries.
Use the dashboard to:
▪️explore results by region
▪️compare diagnosis classifications
▪️filter by respondent type and gender
❓️ Want to dive deeper?
You can also request access to the full PHGPS dataset to support:
✅️ research projects
✅️ advocacy initiatives
✅️ education programmes
✅️ service improvement
🔗 Explore the dashboard and request data access: pvrinstitute.org/learning-research/pulmonary-hypertension… -
The Pulmonary Vascular Research Institute
@PVRI
📢 Join tomorrow's PH Community Call, 22 October 2026, 15:00 BST, to discuss:
🔹 Pulmonary artery dilation across chronic lung disease with Tyler Couch
🔹 CT imaging-derived pulmonary vascular abnormalities associated with PH with Agustin Garcia
🔹 A promising new therapeutic target in preclinical PAH involving microRNA-224 with Olympia Bikou
Free and open to all. Register today pvrinstitute.org/learning-hub/events/october-ph-community…
#pulmonaryhypertension #phresearch #pvri -
The Pulmonary Vascular Research Institute
@PVRI
📅 What is it really like to take part in a clinical trial?
From study visits and appointments to monitoring and health checks, participation can look different from person to person.
In this video from our 'Understanding clinical trials' PH patient resource collection, Colleen Brunetti, explores some of the practical aspects of taking part in a clinical trial.
🎥 Watch now: pvrinstitute.org/PH-patient-resources/understanding-clini… -
The Pulmonary Vascular Research Institute
@PVRI
A major milestone for #pulmonaryhypertension (PH) care in Sri Lanka. 🇱🇰
The country’s first Joint Clinical Statement on the medical management of #ph has been published and presented at the Sri Lanka College of Cardiology Annual Academic Sessions 2026.
It was a collaborative effort between PVRI members of the Sri Lanka College of Cardiology, the Sri Lanka College of Pulmonology, and experts from the UK. The initiative reflects the growing commitment of clinicians, researchers and healthcare leaders in Sri Lanka and beyond to improving the diagnosis, management and long-term care of people living with PH in the country.
Congratulations to everyone who contributed to this landmark achievement.
🔗 Read the Joint Clinical Statement and learn more about our Sri Lanka Task Force: pvrinstitute.org/srilanka
#srilanka #globalhealth #cardiology -
The Pulmonary Vascular Research Institute
@PVRI
Every breakthrough in PH starts with people coming together globally to make progress possible 🌍🤝
Your donation helps PVRI:
▪️advance PH research worldwide
▪️support education and knowledge sharing
▪️connect researchers, clinicians and patients
▪️improve outcomes for people living with PH
Together, we're building a future with better treatments, earlier diagnosis and improved care.
💜 Donate today: pvrinstitute.org/support-us -
The Pulmonary Vascular Research Institute
@PVRI
📢 Join the next PVRI PH Community Call on 🗓 22 October 2026, 15:00 BST 📢
Every month, researchers from around the world present their papers, and we discuss the latest advances in pulmonary hypertension. This month we explore:
🔹 Pulmonary artery dilation across chronic lung disease
🔹 CT imaging-derived pulmonary vascular abnormalities associated with PH
🔹 A promising new therapeutic target in preclinical PAH involving microRNA-224
Calls are free and open to all. Register today pvrinstitute.org/learning-hub/events/october-ph-community…
#pulmonaryhypertension #phresearch #medicalresearch #respiratorymedicine #pvri #scientificcommunity #cardiopulmonaryresearch -
The Pulmonary Vascular Research Institute
@PVRI
📢 Just one week to go!
8th International Leh Symposium 2026
📍 McLeod Ganj, Dharamshala, India
🗓 23-27 October 2026
Join the global PH community to explore the latest research on therapeutic targets and molecular mechanisms for pulmonary diseases in hypoxia.
Highlights include:
▪️cutting-edge science in hypoxia and pulmonary disease
▪️international experts in research and clinical care
▪️opportunities for collaboration and scientific exchange
▪️discussions on advancing prevention and treatment strategies
➡️ Register here: lehsymposium.in -
The Pulmonary Vascular Research Institute
@PVRI
⚙️ Randomisation? Placebos? Study design?
Clinical trials use carefully designed methods to help researchers generate reliable results and understand whether new treatments are safe and effective.
In this video from our 'Understanding clinical trials' collection, Jamie Myrah from PHA Canada explains some of the key concepts behind clinical trial design in an easy-to-understand way.
🎥 Watch the full series: pvrinstitute.org/PH-patient-resources/understanding-clini… -
The Pulmonary Vascular Research Institute
@PVRI
Who do you think would make an excellent PVRI President? 🏆💡 Nominations are open for two more weeks for PVRI President 2028-30 and for PVRI Achievement Awards 2026.
Help us celebrate the people shaping PH research, care & collaboration around the world. ➡️ Nominate: pvrinstitute.org/learning-hub/news/nominations-now-open-p…
Nominations close: 28 October, 09:00 GMT -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Validation of Tricuspid Annular Displacement by Tissue Doppler in Pulmonary Hypertension
📆 11 September 2026
🔢 16(3), e70372
👤 Rongrong Chen, Shadi P. Bagherzadeh, Neev Patel, Patrick Khoury, Bettia E. Celestin, Frida N. Hermansson, Jennifer P. Woo, Francois Haddad
➡️ Read the full research article: doi.org/10.1002/pul2.70372 -
The Pulmonary Vascular Research Institute
@PVRI
What can blood biomarkers tell us about PAH? 🩸
Blood Biomarkers in Pulmonary Arterial Hypertension – New Insights
📅 12 November 2026
🕓️ 16:00 - 17:00 GMT
You'll hear the latest research on:
▪️biomarker validation for clinical use
▪️plasma proteome risk stratification
▪️NOTCH3-ECD as a biomarker for PAH
▪️novel predictors of outcomes in PAH
▪️markers of vascular dysfunction
➡️ Register now: pvrinstitute.org/learning-hub/events/blood-biomarkers-pul… -
The Pulmonary Vascular Research Institute
@PVRI
📢⏰️ Time is running out...abstract submissions close tomorrow!
Don't miss your final opportunity to submit your research to PVRI 2027 Bangkok.
🗓️ Deadline: 12 October 2026, 09:00 BST
➡️ Submit your abstract: pvrinstitute.org/pvri2027/abstractsubmission -
The Pulmonary Vascular Research Institute
@PVRI
Abstract submissions close on Monday! ⏳
This is your final weekend to submit your abstract for PVRI 2027 Bangkok.
Submit under one of the five themes:
1️⃣ Basic & Translational Science
2️⃣ Clinical Science
3️⃣ International & Global Health
4️⃣ Mind the Gap: Cases that Highlight Gaps in Evidence
5️⃣ Next-Generation Diagnostics, AI & Therapeutics
Your opportunity to present your work to the global PH Community, and be considered for awards.
🗓️ Deadline: 12 October 2026, 09:00 BST
➡️ Submit today: pvrinstitute.org/pvri2027/abstractsubmission -
The Pulmonary Vascular Research Institute
@PVRI
📋 Did you know you have rights when taking part in a clinical trial?
Before joining a clinical trial, you should receive clear information about the study, have the opportunity to ask questions, and take time to decide whether participation is right for you.
In this video from our 'Understanding clinical trials' PH patient resource collection, Anca Berendea from PH Romania explains informed consent and the rights every participant should understand.
🎥 Watch the full series: pvrinstitute.org/PH-patient-resources/understanding-clini… -
The Pulmonary Vascular Research Institute
@PVRI
🩺 Do you have a current or past PH case that would benefit from wider discussion?
Global PH Consult gives clinicians the opportunity to bring anonymised complex PH cases to a tailored panel of PH specialists for discussion and shared learning.
The service is free and open to clinicians worldwide, with a particular focus on supporting those in low- and middle-income countries.
You don't need to have all the answers.
The purpose is to create space for discussion, different perspectives, and learning.
➡️ Submit your case: pvrinstitute.org/learning-research/global-ph-consult -
The Pulmonary Vascular Research Institute
@PVRI
Speaker spotlight💡
PVRI 2027 Bangkok will explore some of the biggest clinical and scientific challenges facing the PH community today, from critical care and Group 2 PH to advanced imaging and right ventricular recovery.
Here’s a glimpse of what’s to come ⬇️
PVRI 2027 Bangkok
Bridging Science, Innovation & Care for the Next 20 Years
📅 27-31 January 2027
📍 Amari Bangkok Hotel & Conference Centre
🎟 Register now: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok -
The Pulmonary Vascular Research Institute
@PVRI
Now available on demand: Global PH Consult Case #1 🎥
Watch the first Global PH Consult case discussion webinar, featuring an anonymised complex PH case from Vietnam.
▪️Case submitter: Minh Ly Nguyen
▪️Specialist: Tomas Pulido
▪️Moderator: Sandeep Sahay
The session explores the challenges of managing severe pulmonary arterial hypertension in a setting with limited access to PH therapies and specialist interventions.
➡️ Watch the recording: pvrinstitute.org/learning-hub/material/global-ph-consult-… -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Association Between Serum Uric Acid and Pulmonary Hypertension in Takayasu Arteritis With Pulmonary Artery Involvement: A Cross-Sectional Study
📆 15 September 2026
🔢 16(3), e70393
👤 Jinzhi Wang, Shuwen Zheng, Ruzetuoheti Yiminniyaze, Hanyu Zheng, Shuai Zhang, Han Tian, Yanhua Kong, Wanmu Xie, Qiang Huang, Zhenguo Zhai
➡️ Read the full research article: doi.org/10.1002/pul2.70393 -
The Pulmonary Vascular Research Institute
@PVRI
Abstract deadline has been extended! 📢
Due to popular demand, abstract submissions for PVRI 2027 Bangkok have been extended until:
🗓️ 12 October 2026 at 09:00 BST
Don't miss your opportunity to:
✅️ present your work
✅️ compete for prestigious awards
✅️ share your research with the global PH community
➡️ Submit now: pvrinstitute.org/pvri2027/abstractsubmission -
The Pulmonary Vascular Research Institute
@PVRI
Speaker spotlight 💡
PVRI 2027 Bangkok will explore some of the biggest clinical and scientific challenges facing the PH community today, from critical care and Group 2 PH to advanced imaging and right ventricular recovery.
Here’s a glimpse of what’s to come ⬇️
PVRI 2027 Bangkok
Bridging Science, Innovation amp; Care for the Next 20 Years.
📅 27-31 January 2027
📍 Amari Bangkok Hotel & Conference Centre
🎟 Register now: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok -
The Pulmonary Vascular Research Institute
@PVRI
📢 Nominations are now open for...PVRI President 2028-30 and PVRI Achievement Awards 2026
These nominations provide an opportunity for PVRI members to:
▪️recognise outstanding contributions to PH research
▪️help shape the future leadership of PVRI
🗓️ Nominations close 28 October 2026, 09:00 GMT
➡️ Submit a nomination: pvrinstitute.org/learning-hub/news/nominations-now-open-p…
❓️ Not a member? Become a member today: pvrinstitute.org/member-area/become-member -
The Pulmonary Vascular Research Institute
@PVRI
⚖️ What are the potential benefits and risks of taking part in a clinical trial?
Clinical trials can offer opportunities, but they also involve uncertainty.
Understanding the potential benefits, risks, and expectations can help patients make informed decisions about participation.
In this video from our 'Understanding clinical trials' PH patient resource collection, Alicia Gracia from HPE-ORG explores what patients should know before joining a clinical trial.
🎥 Watch the full series: pvrinstitute.org/PH-patient-resources/understanding-clini… -
The Pulmonary Vascular Research Institute
@PVRI
Just one week left to submit your abstract for PVRI 2027 Bangkok! 📢
Share your latest research, clinical insights and innovations with the global PH community.
✅️ present your work in Bangkok
✅️ be considered for prestigious awards, including seven Early Career Abstract Awards worth £2,000 each
✅️ opportunity to be selected for an oral presentation
🗓️ Deadline: 09:00 BST, 5 October 2026
➡️ Submit your abstract: pvrinstitute.org/pvri2027/abstractsubmission -
The Pulmonary Vascular Research Institute
@PVRI
15 mins to go ⏳️
Global PH Consult Case #1
📅 29 September
🕓️ 16:00 BST
Join us for the first-ever Global PH Consult webinar, a new PVRI Access to Care Workstream initiative connecting clinicians and PH specialists through real-world case discussions.
Today's case explores a challenging PAH case from Vietnam. Bring your questions and hear specialist perspectives on diagnosis, treatment decisions and managing PH in complex healthcare settings.
➡️ Register and join: pvrinstitute.org/learning-hub/events/global-ph-consult-ca… -
The Pulmonary Vascular Research Institute
@PVRI
World Heart Day ❤️
PH doesn't only affect the lungs. It can place significant strain on the heart, making timely diagnosis and access to appropriate care essential.
This #worldheartday, we're supporting the theme "Don't Miss a Beat" by raising awareness of PH and encouraging people to learn more about the condition.
Whether you're newly diagnosed, supporting a loved one, or looking for trusted information, our PH resources can help.
📚 Learn about PH: pvrinstitute.org/living-ph/what-pulmonary-hypertension-ph
🤝 Explore patient resources: pvrinstitute.org/PH-patient-resources
🌍 Find support locally: pvrinstitute.org/living-ph/find-support-locally -
The Pulmonary Vascular Research Institute
@PVRI
Join us tomorrow for the first Global PH Consult webinar!
🗓️ 29 September 2026
🕓️ 16:00 BST
In our first case discussion, we'll explore a complex real-world anonymised case of PAH.
Together, we'll discuss:
▪️what further diagnostic workup is needed?
▪️what treatment options should be considered next?
▪️what factors may influence prognosis?
▪️how can complex PH be managed when treatment options are limited?
Whether you're a PH specialist, clinician, trainee or healthcare professional, this is an opportunity to hear different perspectives and take part in a global discussion focused on improving PH care.
➡️ Register now: pvrinstitute.org/learning-hub/events/global-ph-consult-ca… -
The Pulmonary Vascular Research Institute
@PVRI
Millions of people worldwide are affected by PH, yet access to expertise, diagnosis and treatment varies significantly across regions.
At PVRI, we work to reduce these inequalities through advocacy, education and collaboration, helping connect healthcare professionals and advance knowledge across the global PH community.
Your donation can help make this work possible.
💜 Donate today: pvrinstitute.org/support-us -
The Pulmonary Vascular Research Institute reposted
Wiley Clinical and Health
@WileyHealth
PVRI 2027 is heading to Bangkok, and the theme of our annual Congress is Bridging Science, Innovation & Care for the Next 20 Years.
27–31 January 2027 Amari Hotel & Conference Centre, registration is now open!
#journalspotlight @PVRI
For more info: teams.public.onecdn.static.microsoft/evergreen-assets/saf… -
The Pulmonary Vascular Research Institute
@PVRI
World Lung Day 🫁
Lung health matters throughout our lives.
Pulmonary hypertension (PH) is a serious condition that affects the blood vessels of the lungs and can have a significant impact on both lung and heart health.
Early diagnosis is important, but many people wait years for the correct diagnosis.
This #worldlungday, we're highlighting the importance of understanding PH, recognising symptoms, and helping people access the information and support they need.
📚 Learn about PH: pvrinstitute.org/living-ph/what-pulmonary-hypertension-ph
🤝 Explore patient resources: pvrinstitute.org/PH-patient-resources
🌍 Find support locally: pvrinstitute.org/living-ph/find-support-locally
#worldlungday2026 -
The Pulmonary Vascular Research Institute reposted
PHAEUROPE
@EuropePHA
📢 Understanding Clinical Trials: Episodes 3 & 4
💬 Why consider taking part? Angele Belliveau, PHA Canada, explores potential benefits of trial participation and contributing to medical progress.
🔎 Understanding risks & expectations: Alicia Garcia, HPE-ORG, Spain,...⤵️ -
The Pulmonary Vascular Research Institute
@PVRI
We're live in 15 minutes!
Today's PH Community Call will explore:
▪️The Paediatric PH International Risk Score: A Prediction Model for Outcomes Using Machine Learning by Megan Griffiths
▪️Placental growth factor promotes endothelial activation and inflammatory remodelling in PH by My Ngoc Ha
➡️ Register and join: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
❓️Attending PVRI 2027 Bangkok?
Don't forget to book your hotel!
We've secured a special delegate rate at the Amari Bangkok, the venue for PVRI 2027, so you can stay where the Congress is taking place.
✅ stay on-site with easy access to sessions and networking
✅ breakfast, Wi-Fi, VAT and service charges included
✅ available for stays between 22 January and 3 February 2027
✅ share a twin room with a colleague to reduce costs
⏳ The delegate rate is available until 30 November 2026, and January is a busy time in Bangkok, so we recommend booking early.
➡️ Book now: pvrinstitute.org/pvri2027/accommodation -
The Pulmonary Vascular Research Institute
@PVRI
One month to go! 📢
6th Paediatric & 3rd Adult LATAM PH Symposium
📅 25 September 2026 - 26 September 2026
📌 Lima, Peru
Hosted by the PVRI Latin America Task Force, this two-day meeting will bring together the PH community from across Latin America and beyond to share knowledge, strengthen collaborations, and discuss the latest developments in PH care.
Highlights include:
▪️clinical and physiological foundations of PH
▪️diagnostic challenges and emerging approaches
▪️PH and congenital heart disease
▪️critical care and treatment strategies
▪️imaging and biomarkers
▪️PH at high altitude
▪️current challenges and future directions for PH care in Latin America
➡️ Register today: sopecard.org/vi-simposio-latinoamericano/ -
The Pulmonary Vascular Research Institute
@PVRI
Looking for an informal way to stay up to date with the latest PH research?
Join tomorrow's...PH Community Call
📅 24 September 2026
🕒 15:00-16:00 BST
We're discussing:
▪️The Pediatric PH International Risk Score: A Prediction Model for Outcomes Using Machine Learning by Megan Griffiths
▪️Placental growth factor promotes endothelial activation and inflammatory remodelling in PH by My Ngoc Ha
Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
👤 Why do people choose to take part in clinical trials?
Taking part in a clinical trial is always a personal choice.
For some people, it can be an opportunity to access new treatments, receive additional monitoring, or contribute to future advances in PH care.
In the third video of our 'Understanding clinical trials' PH patient resource collection, Angèle Belliveau from PHA Canada explores some of the reasons people consider taking part and the questions they may wish to discuss with their healthcare team.
🎥 Watch the full series: pvrinstitute.org/PH-patient-resources/understanding-clini…
Developed by PVRI's Patient Engagement & Empowerment Workstream. -
The Pulmonary Vascular Research Institute
@PVRI
🎥 Why attend the first Global PH Consult webinar?
In the video below, Sandeep Sahay, explain what makes this anonymised PH case particularly interesting and why the discussion will be valuable for clinicians working across different healthcare settings.
Global PH Consult: Case #1
🗓️ 29 September
🕓 16:00 BST
Join us as we explore the management of severe pulmonary arterial hypertension in a resource-limited setting.
➡️ Register now: pvrinstitute.org/learning-hub/events/global-ph-consult-ca… -
The Pulmonary Vascular Research Institute
@PVRI
📢 There's still time to submit your abstract for ISHLT 2027.
The International Society for Heart and Lung Transplantation is accepting abstracts for presentation at its 47th Annual Meeting & Scientific Sessions, taking place in Sydney, Australia, from 14-17 April 2027.
Whether you're working in basic, translational or clinical PH research, this is an opportunity to share your work with a global audience.
➡️ Submit your abstract: www.ishlt.org/annual-meeting/science-collaboration/progra…
⏳ Abstract submission deadline: 30 September 2026 (03:59 UTC) -
The Pulmonary Vascular Research Institute
@PVRI
📢 Registration is now open for our next Living Legends in PH webinar.
Living Legends: Werner Seeger, Justus-Liebig-Universität Gießen
🗓️ 15 October 2026
🕓️ 16:00-17:30 GMT
This October, we're delighted to welcome Werner Seeger, one of the most influential figures in PH research and care.
Over a career spanning decades, Werner has helped drive major advances in our understanding of PH, including research collaborations that contributed to several globally approved PH therapies. Today, he continues to lead major international initiatives, including the GoDeep PH Meta Registry.
Join us for an opportunity to hear both the science and the personal story behind a remarkable career dedicated to advancing PH.
➡️ Register now: pvrinstitute.org/learning-hub/events/living-legends-werne…
Facilitated by Ghazwan Butrous & Vasile Foris. -
The Pulmonary Vascular Research Institute
@PVRI
❓️ Why do clinical trials matter for patients?
Clinical trials help improve treatments, advance research, and improve care for people living with PH.
In the second video of our 'Understanding clinical trials' PH patient resource collection, Louise Bouman from Alliance for PH explains why clinical trials matter and how research helps shape the future of PH care.
🎥 Watch the full series: pvrinstitute.org/PH-patient-resources/understanding-clini…
Developed by PVRI's Patient Engagement & Empowerment Workstream. -
The Pulmonary Vascular Research Institute
@PVRI
Join Team PVRI 🌍
We're recruiting a Project Coordinator (Maternity Cover) to support our global community of PH experts.
If you're an organised, proactive communicator with a passion for bringing people together and making things happen, we'd love to hear from you.
▪️£31,720-£33,280 pa
▪️Full-time, 35 hours per week
▪️London (fully remote considered)
🗓️ Apply by 17 September 2026: pvrinstitute.org/about-us/careers-opportunities -
The Pulmonary Vascular Research Institute
@PVRI
Nominations are now open! 📢
PVRI members can now nominate for both PVRI President 2028-30 and the PVRI Achievement Awards 2026.
🗳️ PVRI President 2028-30
Nominate a proactive PVRI member with a strong scientific reputation who can help lead and represent our global PH community.
🗳️ PVRI Achievement Awards 2026
Help us recognise the individuals who are shaping the future of PH. You can nominate for:
▪️PVRI Lifetime Achievement Award
▪️PVRI Achievement Award
▪️PVRI Special Recognition Award
➡️ Submit your nomination today: pvrinstitute.org/learning-hub/news/nominations-now-open-p…
Not a member? Become a member today: pvrinstitute.org/member-area/become-member -
The Pulmonary Vascular Research Institute
@PVRI
Join us for our...
September PH Community Call
📅 24 September 2026
🕒 15:00-16:00 BST
Our free monthly PH Community Calls bring the global PH community together to discuss the latest developments in research and care.
This month, we'll be exploring:
▪️The Pediatric PH International Risk Score: A Prediction Model for Outcomes Using Machine Learning with Megan Griffiths
▪️Placental growth factor promotes endothelial activation and inflammatory remodelling in PH with My Ngoc Ha
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Supporting the next generation of PH leaders 🤝
At PVRI 2027 Bangkok, we're investing in the next generation of PH leaders and helping make our global community more accessible and inclusive.
Highlights include:
✅ Seven Early Career Abstract Awards worth £2,000 each
✅ Career Catalyst PH Luncheon, connecting early-career professionals with globally renowned PH experts
✅ Dedicated networking and mentoring opportunities throughout the Congress
✅ World Café PH Luncheon, supporting collaboration and knowledge-sharing with colleagues working in low- and middle-income countries (LMICs)
✅ Reduced PVRI membership fees, starting from just $15 per year for early-career professionals living and working in LMICs
Because the future of PH depends on supporting the people who will lead it.
➡️ Join us in Bangkok: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok -
The Pulmonary Vascular Research Institute
@PVRI
Still time to join...⏰️
Spatial and Molecular Profiling of Tissue-Derived Soluble and Matrix-Bound Extracellular Vesicles in PH by Sushil Kumar, University of Colorado
📅 15 September 2026
🕐️ 13:00 BST
➡️ Register and join: pvrinstitute.org/learning-hub/events/spatial-and-molecula…
Moderated by Silvia Ulrich and Aastha Mishra. -
The Pulmonary Vascular Research Institute
@PVRI
📢 Join tomorrow's webinar...
Spatial and Molecular Profiling of Tissue-Derived Soluble and Matrix-Bound Extracellular Vesicles in PH
📅 15 September
🕐️ 13:00 BST
Featuring:
▪️Sushil Kumar, University of Colorado
▪️Silvia Ulrich, University of Zurich
▪️Aastha Mishra, CSIR-Institute of Genomics and Integrative Biology
➡️ Register now: pvrinstitute.org/learning-hub/events/spatial-and-molecula…
Part of the Hypoxia in Pulmonary Vascular Research – Altitude and Beyond webinar series. -
The Pulmonary Vascular Research Institute
@PVRI
❓️What can we learn from nearly 4,000 people affected by PH?
The PHGPS Dashboard gives you an accessible way to explore findings from nearly 4,000 patients and carers across 90 countries.
You can filter results:
▪️region
▪️diagnosis classification
▪️respondent type
▪️gender
📊 Want to go further? You can also request access to the full PHGPS dataset to support research, advocacy, education and service improvement.
Whether you're identifying gaps in care, exploring patient experiences or informing future projects, the data is available to help you turn insight into action.
🔗 Explore the dashboard and access the data: pvrinstitute.org/learning-research/pulmonary-hypertension… -
The Pulmonary Vascular Research Institute
@PVRI
We're hiring 📢
Want to use your organisational skills to make a global impact?
This is a fantastic opportunity for a highly organised communicator who enjoys coordinating projects, webinars and international collaborations.
Project Coordinator (Maternity Cover)
📍 Bermondsey, London (hybrid working preferred, but fully remote will be considered)
💷 £31,720-£33,280
⏰ Full-time, 35 hours/week
📅 Apply by 17 September 2026, 09:00
➡️ Learn more and apply today: pvrinstitute.org/about-us/careers-opportunities -
The Pulmonary Vascular Research Institute
@PVRI
15 mins to go! ⏰️
There's still time to join today's webinar...Imaging of Pulmonary Arterial Hypertension.
Join us and explore the role of radiographs, CT, MRI, and echocardiography in PAH, and hear from experts from leading institutions around the world.
➡️ Register and join: pvrinstitute.org/learning-hub/events/imaging-pulmonary-ar… -
The Pulmonary Vascular Research Institute
@PVRI
We've launched the first Global PH Consult case discussion webinar 📢🎉
Global PH Consult: Case #1
🗓️ 29 September
🕓 16:00 BST
Join us to discuss a real-world anonymised complex PH case from Vietnam. This session will focus on the management of severe PAH when access to specialist therapies and interventions is limited.
➡️ Register now: pvrinstitute.org/learning-hub/events/global-ph-consult-ca… -
The Pulmonary Vascular Research Institute
@PVRI
Only one day to go! ⏳️
Imaging of Pulmonary Arterial Hypertension
📅 10 September 2026
🕓️ 16:00 - 17:30 BST
Join us and explore the latest imaging approaches in PAH, including radiographs, CT, MRI, echocardiography, and the assessment of suspected PAH.
➡️ Register now: -
The Pulmonary Vascular Research Institute
@PVRI
The first topic in our new 'Understanding clinical trials' PH patient resource collection is...
🧪 What is a clinical trial?
Clinical trials are medical studies that help researchers develop new treatments, improve care, and can deepen our understanding of PH.
Learn what clinical trials are, why they matter, and the different types of research studies patients may be invited to take part in.
Watch the video below ⬇️📽️
➡️ Explore the full collection: pvrinstitute.org/PH-patient-resources/understanding-clini…
Developed by PVRI's Patient Engagement & Empowerment Workstream. -
The Pulmonary Vascular Research Institute
@PVRI
Join the latest webinar in our 'Hypoxia in Pulmonary Vascular Research: Altitude and Beyond' series.
Spatial and Molecular Profiling of Tissue-Derived Soluble and Matrix-Bound Extracellular Vesicles in Pulmonary Hypertension
📅 15 September 2026
🕐️ 13:00 BST
Hear from Sushil Kumar, University of Colorado, as he shares insights into emerging research on extracellular vesicles in PH, moderated by Silvia Ulrich, University of Zurich and Aastha Mishra, CSIR-Institute of Genomics and Integrative Biology.
➡️ Register now: pvrinstitute.org/learning-hub/events/spatial-and-molecula… -
The Pulmonary Vascular Research Institute
@PVRI
Just one month left to submit your abstract for PVRI 2027 Bangkok! 📢
Share your latest research, clinical insights and innovations with the global PH community.
Submit under one of five themes:
▪️Basic & Translational Science
▪️Clinical Science
▪️International & Global Health
▪️Mind the Gap: Cases that Highlight Gaps in Evidence
▪️Next-Generation Diagnostics, AI & Therapeutics
You could be considered for a range of awards, including:
🏆the Rupert Swift Award
🏆the Butrous Foundation Young Investigator Award
🏆one of seven Early Career Abstract Awards worth £2,000 each
🔗 Submit your abstract: pvrinstitute.org/pvri2027/abstractsubmission
📅 Main abstract portal will close 5 October 2026
📅 Late-breaking abstract portal will open 6 November 2026 -
The Pulmonary Vascular Research Institute
@PVRI
Applications closing in just 3 days! 🚨
We're looking for a Marketing & Events Officer to help grow PVRI's global reach and support our mission to improve understanding, research and care in pulmonary hypertension (PH).
💷 £32,000 - £35,000
📍 London hybrid (remote considered)
⏰ Full-time
You'll be creating engaging content, supporting webinars and scientific events, and helping to raise awareness of a condition that affects millions worldwide.
Application close 09:00, Monday 7 September 2026. Don't miss this opportunity to build your marketing career while making a real difference.
🔗 pvrinstitute.org/about-us/careers-opportunities -
The Pulmonary Vascular Research Institute
@PVRI
And we're back! 👋
Our first PH Community Call since the Summer break.
📅 24 September 2026
🕒️ 15:00 - 16:00 BST
Join our free online discussion bringing together experts from across the global PH community to explore the latest developments in PH.
This month, we're discussing:
📄 The Pediatric PH International Risk Score: A Prediction Model for Outcomes Using Machine Learning by Megan Griffiths
📄 Placental growth factor promotes endothelial activation and inflammatory remodelling in pulmonary hypertension by My Ngoc Ha
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Abstract submissions are open 📢
Share your research, clinical cases and innovations with the global PH community at PVRI 2027 Bangkok.
Submit under one of five themes:
▪️Basic & Translational Science
▪️Clinical Science
▪️International & Global Health
▪️Mind the Gap: Cases that Highlight Gaps in Evidence
▪️Next-Generation Diagnostics, AI & Therapeutics
Submit and you could win one of seven Early Career Abstract Awards, the Rupert Swift Award, or the Butrous Foundation Young Investigator Award 🏆️
🔗 Submit your abstract: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok
🗓️ Main abstract deadline: 5 October 2026 -
The Pulmonary Vascular Research Institute
@PVRI
Next week...
Imaging of Pulmonary Arterial Hypertension
🗓 10 September 2026
⏰ 16:00-17:30 BST
Imaging plays a vital role in the diagnosis and assessment of PAH, but how do the different modalities work together in clinical practice?
You'll hear from experts covering:
▪️radiographs
▪️computed tomography (CT)
▪️magnetic resonance imaging (MRI)
▪️echocardiography
▪️imaging approaches for patients with suspected PAH
➡️ Register today: pvrinstitute.org/learning-hub/events/imaging-pulmonary-ar… -
The Pulmonary Vascular Research Institute
@PVRI
❓️ Could you explain a clinical trial in a few minutes?
For many people living with PH, clinical research can feel difficult to navigate.
In this introduction to our new 'Understanding Clinical Trials' PH patient resource collection, Hall Skaara gives an accessible overview and sets the scene for the full collection.
Watch below 🎥⬇️
Thank you to PVRI's IDDI Patient Engagement & Empowerment Workstream for developing this collection. -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
The Causal Role of Gut Microbiota in Pulmonary Embolism and the Mediating Effects of Circulating Metabolites: A Mendelian Randomization Study
📆 03 August 2026
🔢 16(3), e70376
👤 Yidan Gao, Xuehan Jiang, Yanshuang Lyu, Huiyuan Hu, Shuang Wang, Yufei Hu, Hong Zhang, Zhenguo Zhai, Wanlu Song, Peiran Yang
➡️ Read the full research article: onlinelibrary.wiley.com/doi/10.1002/pul2.70376 -
The Pulmonary Vascular Research Institute
@PVRI
We're hiring! 📢
Want to use your marketing and events skills to support a global community working to improve the lives of people affected by PH?
We're looking for a Marketing & Events Officer to join our small team.
You'll help promote our webinars, events, membership activities, and educational initiatives, while supporting our mission to advance research, education, and care in PH.
📍 Bermondsey, London (hybrid preferred, remote considered)
💰 £32,000-£35,000
⏰ Full time, 35 hours per week
📅 Apply by 7 September 2026, 09:00
If you're organised, creative, and enjoy working with people from around the world, we'd love to hear from you.
🔗 pvrinstitute.org/about-us/careers-opportunities -
The Pulmonary Vascular Research Institute
@PVRI
We're working towards better treatments and better care for people living with PH.
PVRI brings together experts from around the world to share knowledge, drive collaboration, and advance understanding of PH.
Donations help make that work possible 💜
Support PH research today: -
The Pulmonary Vascular Research Institute
@PVRI
💬 "It's useful sometimes to step back and think about where it all came from and how it happened."
In the latest Living Legends in PH: History & Personal Perspectives webinar, Nick Morrell reflects on the discoveries, collaborations, and mentors that shaped his career and helped advance our understanding of PAH.
Highlights from the discussion:
▪️the early days of PH research and what inspired his scientific journey
▪️the discovery of BMPR2 mutations and their impact on the field
▪️decades of research into BMP signalling and novel therapies
▪️turning research discoveries into potential treatments
▪️lessons from academia, biotech, and entrepreneurship
▪️advice for young investigators entering the field
Alongside the science, Nick shares personal stories about the mentors, collaborators, and conversations that influenced his career and helped drive progress in PH.
A special thank you to our facilitators, Gregory Elliott, University of Utah and Shreya Sangam, Massachusetts General Hospital, for leading this engaging discussion.
🎥 Watch the recording now: pvrinstitute.org/learning-hub/material/living-legend-nick… -
The Pulmonary Vascular Research Institute
@PVRI
New PH patient resource collection 📢🎉
Understanding clinical trials 🔬
Clinical trials play a vital role in improving care and advancing treatment options for people living with pulmonary hypertension (PH).
Yet many patients and families find clinical research difficult to understand and may feel uncertain about what participation involves.
To help address this, PVRI's IDDI Patient Engagement & Empowerment Workstream has developed a new collection of PH patient resources focused on clinical trials.
The collection includes:
🧪 A 13-part video series on YouTube
📋 A patient information flyer (plus large-font version)
🤝 A flyer for sponsors and research teams
🎨 Co-brandable resources for patient associations
The resources cover:
▪️What clinical trials are
▪️How clinical trials work
▪️Benefits and risks
▪️Informed consent and patient rights
▪️What participation involves
▪️How patients can help shape research and trial design
➡️ Explore the collection: pvrinstitute.org/PH-patient-resources/understanding-clini… -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2027 Travel Award applications close tomorrow ⏰
If you would like to join us at PVRI 2027 Bangkok but would otherwise face financial barriers to attending, this is your final reminder to apply.
We’re offering £20,000 in travel funding, alongside free PVRI memberships, to help more PH professionals take part in the Congress.
Awards are available for:
✅ Early-career professionals living and working in LMICs
✅ Professionals actively working in PH from Southeast Asia and Sri Lanka
➡️ Apply now: pvrinstitute.org/pvri2027/travelawards -
The Pulmonary Vascular Research Institute
@PVRI
🏨 Heading to PVRI 2027 Bangkok?
Don't forget to book your accommodation at the Amari Bangkok Hotel & Conference Centre, the official Congress venue.
✅ THB 4,410 per room, per night
✅ breakfast included
✅ stay at the Congress venue
✅ option to share a Deluxe Twin room and split the cost
January is a busy time to visit Bangkok, and our special delegate rate is only available until 30 November 2026. Book early to avoid missing out!
➡️ Book your hotel: pvrinstitute.org/pvri2027/accommodation -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Activin Signalling Inhibitors in Pulmonary Hypertension: A State-of-the-Art Review
📆 14 July 2026
🔢 16(3), e70353
👤 Sudarshan Rajagopal, Joseph Abueg, Kevin M. Hart, Edmund Lau, Eliana C. Martinez, Nicholas W. Morrell, Ioana R. Preston, Sandeep Sahay, Namita Sood, Paul B. Yu, Nayeli G. Zayas-Hernández
This review brings together experts from across the PVRI Innovative Drug Discovery Initiative (IDDI) to explore one of the most promising new areas in PH treatment.
By combining insights from researchers, clinicians and industry scientists, the authors examine what we've learned so far, what challenges remain, and what could come next for people living with PH.
➡️ Read the full research article: doi.org/10.1002/pul2.70353 -
The Pulmonary Vascular Research Institute
@PVRI
We're live in 15 minutes! 🔔
There's still time to join Living Legends in PH with Nick Morrell!
Hear reflections on a career spanning major discoveries in PAH research, the journey towards new PH treatments, and how the field has evolved over the years
➡️ Register and join now: pvrinstitute.org/learning-hub/events/living-legends-nick-… -
The Pulmonary Vascular Research Institute
@PVRI
Just a few days left to apply for a PVRI 2027 Travel Award ⏳
❓️ Would you like to join us in Bangkok, but would otherwise face financial barriers to attending?
We're offering £20,000 in travel funding, alongside free PVRI memberships, to help more PH professionals take part.
▪️Global Early Career LMIC Travel Awards
▪️Southeast Asia & Sri Lanka Capacity Building Travel Awards
➡️ Apply now: pvrinstitute.org/pvri2027/travelawards
🗓️ Applications close 25 August 2026 at 12:00 BST -
The Pulmonary Vascular Research Institute
@PVRI
1 day to go! ⏳️
Living Legends: Nick Morrell, Cambridge Heart and Lung Research Institute
🗓️ 20 August 2026
⏰ 16:00-17:30 BST
Join us for a conversation with Nick Morrell, whose work has helped shape our understanding of PAH and the development of new treatments for PH.
Hear Nick reflect on:
▪️his career at the forefront of PAH research
▪️the discoveries that have shaped his work
▪️taking research from the laboratory towards new treatments for PH
▪️how the field has changed, and where it could go next
➡️ Register now: pvrinstitute.org/learning-hub/events/living-legends-nick-…
Don't miss the opportunity to hear directly from one of the leading voices in PH research. -
The Pulmonary Vascular Research Institute
@PVRI
🖥️ Coming up this September...
Spatial and Molecular Profiling of Tissue-Derived Soluble and Matrix-Bound Extracellular Vesicles in Pulmonary Hypertension
🗓️ 15 September 2026
🕓 13:00 BST
Join Sushil Kumar, University of Colorado, for a focused session exploring spatial and molecular profiling of tissue-derived soluble and matrix-bound extracellular vesicles in PH.
➡️ Register now: pvrinstitute.org/learning-hub/events/spatial-and-molecula…
This webinar is part of the Hypoxia in pulmonary vascular research – altitude and beyond series from the High Altitude Task Force. -
The Pulmonary Vascular Research Institute
@PVRI
Webinar recording now available 🎥
Watch, From Data to Action: Exploring the PHGPS Data Dashboard for Patient Associations, and discover how our PHGPS Data Dashboard can help turn patient insights into local action.
Nearly 4,000 patients and carers across 90 countries shared their experiences through the Pulmonary Hypertension Global Patient Survey (PHGPS).
With the dashboard, you can:
🌍 explore findings by region and group
🔎 identify gaps and shared challenges
📣 support advocacy, education, research, and planning
💜 better understand the lived experience of PH
In the webinar recording, the PVRI PHGPS Task Force, PHA USA, and PHA Europe explore:
▪️how to navigate the dashboard
▪️practical ways to use the findings locally
▪️the impact of PHGPS so far
▪️opportunities to support PHGPS Phase 2
▶️ Watch the recording: pvrinstitute.org/learning-hub/material/data-action-explor…
📊 Explore our PHGPS Data Dashboard: pvrinstitute.org/learning-research/pulmonary-hypertension… -
The Pulmonary Vascular Research Institute
@PVRI
We're hiring! 📢
We're looking for a Marketing & Events Officer to join our small, friendly team and support our global community through marketing, webinars and events.
📍 Bermondsey, London (hybrid working preferred, fully remote considered)
💷 £32,000-£35,000 per annum
📅 Applications close 7 September 2026, 09:00 BST
➡️ Find out more and apply: www.linkedin.com/jobs/view/4455249977/
Know someone who'd be a great fit? Please help us spread the word 💬 -
The Pulmonary Vascular Research Institute
@PVRI
New webinar announcement 🎉
Imaging of Pulmonary Arterial Hypertension
🗓️ 10 September 2026
🕓 16:00 - 17:30 BST
Our speakers will explore:
▪️Imaging of PAH: Radiographs - David Levin
▪️Imaging of PAH: Computed Tomography - Lilian Meijboom
▪️Imaging of PAH: Magnetic Resonance Imaging - Christopher Francois
▪️Imaging of PAH: Echocardiography - Athanasios Charalampopoulos
▪️Imaging Approach to the Patient with Suspected PAH - Martine Remy Jardin
➡️ Register now: pvrinstitute.org/learning-hub/events/imaging-pulmonary-ar… -
The Pulmonary Vascular Research Institute
@PVRI
We’re live in 15 minutes! ⏰
Join us for...
From Data to Action: Exploring the PHGPS Data Dashboard for Patient Associations
📅 13 August 2026
🕓️ 16:00 BST
We’ll show how to navigate our PHGPS Data Dashboard, use the findings locally, and support the next phase of PHGPS.
➡️ Register and join: pvrinstitute.org/learning-hub/events/data-action-explorin… -
The Pulmonary Vascular Research Institute
@PVRI
1 day to go! ⏳️
From Data to Action: Exploring the PHGPS Data Dashboard for Patient Associations
📅 13 August 2026
🕓 16:00 BST
Tomorrow, join the PVRI PHGPS Task Force, PHA USA, and PHA Europe and learn how to:
▪️navigate our PHGPS Data Dashboard
▪️use the findings for advocacy, education, and planning
▪️explore the impact of PHGPS so far
▪️support PHGPS Phase 2
➡️ Register for free: pvrinstitute.org/learning-hub/events/data-action-explorin… -
The Pulmonary Vascular Research Institute
@PVRI
One week to go! ⌛
❓What sparked Nick Morrell’s interest in PH?
❓Which career moments surprised him most?
❓And how did he keep going when the science didn’t follow the plan?
Join our next Living Legends in PH webinar to find out.
Living Legends: Nick Morrell, Cambridge Heart and Lung Research Institute
📅 20 August 2026
🕟 16:30 – 18:00 BST
Nick will be joined by Gregory Elliott and Shreya Sangam. Make sure to bring your questions!
➡️ Register now: pvrinstitute.org/learning-hub/events/living-legends-nick-… -
The Pulmonary Vascular Research Institute
@PVRI
Registration is now open! 🎉
Join our global PH community for five days of science, collaboration, and connection.
PVRI 2027 Bangkok
📌 Amari Bangkok Hotel & Conference Centre
🗓️ 27 – 31 January 2027
And...🥁
For the first time ever, we're giving away free PVRI merchandise!
Register early and you could receive one of our limited-edition PVRI 2027 Bangkok caps.
Make the most of PVRI 2027 Bangkok with:
▪️satellite meetings led by PVRI IDDI Workstreams and Task Forces
▪️the World Café PH Luncheon
▪️the Advancing Women in PH Luncheon
▪️the Career Catalyst PH Luncheon
▪️the Gala Dinner & Awards Presentation
▪️A Toast to Southeast Asia wine tasting
▪️Sunrise Serenity Tai Chi
Don't forget abstract submissions and travel award applications are still open too.
➡️ Register now: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok
P.S. PVRI members receive a 20% discount! 🎟️
We can’t wait to welcome you to Bangkok! 💜 -
The Pulmonary Vascular Research Institute
@PVRI
Help us spread the word about Global PH Consult 🌍
Global PH Consult gives clinicians around the world a space to bring anonymised complex PH cases for discussion with a tailored panel of PH specialists.
Reaching the clinicians who may benefit most will depend on word of mouth.
Please use our free promotional pack to share the service with:
✅️ colleagues managing complex PH cases
✅️ regional PH centres and teaching hospitals
✅️ professional and clinical networks
✅️ contacts in low- and middle-income countries
Your share could connect a clinician with valuable specialist discussion around a complex case.
➡️ Download the promotional pack: pvrinstitute.org/learning-hub/news/launching-global-ph-co… -
The Pulmonary Vascular Research Institute
@PVRI
📢 Meet our next Living Legend...Nick Morrell
Join us for stories, science, and a look back at a career that has helped shape PH research.
Living Legends: Nick Morrell, Cambridge Heart and Lung Research Institute
📅 20 August 2026
🕟 16:30 – 18:00 BST
Nick will be joined by Gregory Elliott and Shreya Sangam for a lively conversation about the breakthroughs, challenges, and moments that mattered along the way.
➡️ Signup now: pvrinstitute.org/learning-hub/events/living-legends-nick-… -
The Pulmonary Vascular Research Institute
@PVRI
Share your research at PVRI 2027 Bangkok 📣
Abstract submissions are still open for the opportunity to present your work to our global PH community and contribute to the scientific programme.
Submit under one of five themes:
▪️Basic & Translational Science
▪️Clinical Science
▪️International & Global Health
▪️Mind the Gap: Cases that Highlight Gaps in Evidence
▪️Next-Generation Diagnostics, AI & Therapeutics
Eligible abstracts may also be considered for:
🏆️ the Rupert Swift Award
🏆️the Butrous Foundation Young Investigator Award
🏆️one of seven Early Career Abstract Awards worth £2,000 each
➡️ Submit your abstract: pvrinstitute.org/pvri2027/abstractsubmission
📅 Deadline: 12 October 2026, 23:59 BST -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
How do poverty and social deprivation shape the experiences and outcomes of people living with pulmonary arterial hypertension (PAH)?
Poverty and Social Deprivation in Patients With Pulmonary Arterial Hypertension — A PHAR Analysis
📆 19 July 2026
🔢 16(3), e70373
👤 Roberto J. Bernardo, Di Lu, Haley Hedlin, Daniel Grinnan, Roberto F. Machado, Lana Melendres-Groves, Jean M. Elwing, Sandeep Sahay, Steven M. Kawut, Jeffrey C. Robinson, Vinicio A. de Jesus Perez, Roham T. Zamanian, PHAR Investigators
➡️ Read the full research article: onlinelibrary.wiley.com/doi/10.1002/pul2.70373 -
The Pulmonary Vascular Research Institute
@PVRI
📊 Want more guidance on using the new PHGPS Data Dashboard?
Join the PVRI PHGPS Task Force, PHA USA, and PHA Europe next week for a practical webinar designed to help patient associations turn global patient insights into local action.
From Data to Action: Exploring the PHGPS Data Dashboard for Patient Associations
📅 13 August 2026
🕓 16:00 BST
We’ll explore:
▪️how to access and navigate the dashboard
▪️practical ways to use the data for advocacy, education, and planning
▪️the impact of PHGPS so far, including the 10 calls to action
▪️opportunities to shape and support PHGPS Phase 2
➡️ Register now: pvrinstitute.org/learning-hub/events/data-action-explorin… -
The Pulmonary Vascular Research Institute
@PVRI
Help us share Global PH Consult 🌍
We’ve created a free promotional pack to help you introduce Global PH Consult to clinicians and clinical networks.
The pack includes ready-to-use:
▪️social media copy and graphics
▪️email template
▪️PowerPoint slide template
▪️printable flyer
Please share these resources through your networks, especially with clinicians in low- and middle-income countries who may benefit from discussing a complex PH case with a tailored panel of specialists.
➡️ Download the promotional pack: pvrinstitute.org/learning-research/global-ph-consult
Your share could help connect a clinician with valuable support and bring a complex case into global discussion 🗺️🤝 -
The Pulmonary Vascular Research Institute
@PVRI
The #ishlt2027 call for abstracts opens soon! 📣
From 3 August, you’ll be able to submit your work for the ISHLT Annual Meeting & Scientific Sessions in Sydney and share it with an international audience of experts.
Submissions will be welcomed as:
✅️ Research abstracts
✅️ Clinical case reports
✅️ Late-Breaking clinical science
✅️ ePosters
📅 Submissions open: 3 August
⏰ Deadline: 29 September at 23:59 ET / 30 September at 03:59 UTC
➡️ Find out more: www.ishlt.org/ishlt2027 -
The Pulmonary Vascular Research Institute
@PVRI
Your support can help turn shared knowledge into meaningful progress for people affected by PH around the world 💜
Donations help PVRI:
▪️deliver expert-led PVRI Digital webinars
▪️bring the global PH community together at our Annual Congress
▪️amplify patient voices through PHGPS
▪️strengthen global research through GoDeep
▪️connect clinicians through Global PH Consult
Together, we can make a difference.
➡️ Please consider making a donation: pvrinstitute.org/support-us -
The Pulmonary Vascular Research Institute
@PVRI
Why does the right ventricle adapt differently in women and men?
Now available to watch on demand...
🎥 Sex Differences in Right Heart Remodelling: Oestrogenic Angiogenesis and RV Adaptation to Pressure Overload
Ketul Chaudhary and Jiajun Li explore:
▪️estradiol and right ventricular adaptation
▪️angiogenesis in pressure overload
▪️ the role of oestrogen receptor α in preserving endothelial integrity
Discover emerging insights into sex differences in right heart remodelling and what they could mean for PH research and care.
➡️ Watch on demand: pvrinstitute.org/learning-hub/material/sex-differences-ri… -
The Pulmonary Vascular Research Institute
@PVRI
Explore the new PHGPS Data Dashboard 🌍
Nearly 4,000 patients and carers across 90 countries shared their experiences through the Pulmonary Hypertension Global Patient Survey.
You can now explore key findings from Phase 1 through an interactive dashboard!
Use the filters to:
▪️explore findings by region and group
▪️identify gaps and shared challenges
▪️support advocacy, education, research, and planning
▪️better understand the lived experience of PH
➡️ Explore the dashboard: pvri.s.gy/phgps -
The Pulmonary Vascular Research Institute
@PVRI
Four weeks left to apply for a PVRI 2027 Travel Award ✈️
We’re offering £20,000 in travel awards, alongside free PVRI memberships, to help more PH professionals join us in Bangkok.
You can apply for:
🌍 Global Early Career LMIC Travel Awards
Five awards of up to £2,000 each for early-career PH professionals living and working in low- or low-middle-income countries
🌏 Southeast Asia & Sri Lanka Capacity Building Travel Awards
A total of £10,000 for PH professionals supporting research, care, and capacity building across Southeast Asia and Sri Lanka
➡️ Apply for a travel award: pvrinstitute.org/pvri2027/travelawards
📅 Applications close in four weeks: 25 August 2026, 12:00 BST -
The Pulmonary Vascular Research Institute
@PVRI
We’re live in 10 minutes! ⏰
Join the PVRI Women’s Health Task Force to explore how sex differences, oestrogen signalling, angiogenesis, and endothelial integrity influence right heart remodelling in PH.
Hear from Ketul Chaudhary and Jiajun Li, with hosts Daria Kostyunina, and Sue Gu.
➡️ Register and join: pvrinstitute.org/learning-hub/events/sex-differences-righ… -
The Pulmonary Vascular Research Institute
@PVRI
How do sex differences shape the right heart’s response to pressure overload in PH? Join our webinar to find out...
Sex Differences in Right Heart Remodelling: Oestrogenic Angiogenesis and RV Adaptation to Pressure Overload
📅 27 July 2026
🕓 16:00 BST
➡️ Register now: -
The Pulmonary Vascular Research Institute
@PVRI
❓️ Have a complex PH case that would benefit from wider discussion?
Global PH Consult gives clinicians around the world a space to submit anonymised PH cases for discussion with a tailored panel of specialists.
If your case is selected, you’ll:
▪️meet the panel before the webinar
▪️join a live 60-minute case discussion
▪️hear specialist perspectives relevant to your case
▪️contribute to shared learning across the global PH community
The service is free and open to clinicians globally 🌍
➡️ Submit your case: pvrinstitute.org/global-ph-consult -
The Pulmonary Vascular Research Institute
@PVRI
Join the next Living Legends in PH webinar 🫁
Nick Morrell has helped shape PH research for decades – from advancing our understanding of bone morphogenetic protein biology to developing new approaches to treatment.
In this special session, he’ll share the science, stories, and experiences behind his career, with discussion led by Gregory Elliott and Shreya Sangam.
Living Legends: Nick Morrell, Cambridge Heart and Lung Research Institute
📅 20 August 2026
🕟 16:30 – 18:00 BST
Hear personal reflections from one of the field’s leading figures, explore key developments in PH, and join the live discussion.
➡️ Register now: pvrinstitute.org/learning-hub/events/living-legends-nick-… -
The Pulmonary Vascular Research Institute
@PVRI
Submit your abstract 📣
Share your research with the global PH community and contribute to the scientific programme at PVRI 2027 Bangkok.
You can submit under one of five themes:
📄 Basic & Translational Science
📄 Clinical Science
📄 International & Global Health
📄 Mind the Gap: Cases that Highlight Gaps in Evidence
📄 Next-Generation Diagnostics, AI & Therapeutics
Accepted abstracts may be selected for poster or oral presentation, and eligible early-career authors can be considered for abstract awards.
📅 Main abstract deadline: 5 October 2026
➡️ Submit your abstract: pvrinstitute.org/pvri2027/abstractsubmission -
The Pulmonary Vascular Research Institute
@PVRI
From Data to Action: Exploring the PHGPS Data Dashboard for Patient Associations
📅 13 August 2026
🕓 16:00 BST
Join the PVRI PHGPS Task Force, PHA USA, and PHA Europe for a practical webinar on how patient associations can use PHGPS data to support local advocacy, education, and planning.
We’ll cover:
▪️how to access and explore the new PHGPS Data Dashboard
▪️practical ways to use the data in your own setting
▪️the impact of PHGPS so far, including publications and the 10 calls to action
▪️opportunities to shape and support PHGPS Phase 2
The session is designed mainly for patient associations, but everyone interested in PHGPS is welcome.
➡️ Register now: pvrinstitute.org/learning-hub/events/data-action-explorin… -
The Pulmonary Vascular Research Institute
@PVRI
Looking to explore the PH Global Patient Survey (PHGPS) data in more depth? 📊
Nearly 4,000 patients & carers took part in Phase 1, sharing insights into:
▪️diagnosis & treatment
▪️quality of life
▪️financial impact
▪️research participation
▪️patient support
Researchers, collaborators, and partners can apply to access the full anonymised dataset through PVRI’s data access process.
➡️ Find out more and request data access: pvrinstitute.org/learning-research/pulmonary-hypertension… -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Patient Perspectives on Palliative Care in Pulmonary Arterial Hypertension in the United States
📆 24 June 2026
🔢 16(2), e70330
👤 Karim El-Kersh, Rebecca Crawford, Hilary DuBrock, Peter Classi, Phuong Phan, Lori McLeod, Benjamin Wu, Denise Sese
➡️ Read the full research article: onlinelibrary.wiley.com/doi/10.1002/pul2.70330 -
The Pulmonary Vascular Research Institute
@PVRI
Book your stay for PVRI 2027 Bangkok 🏨
PVRI 2027 Bangkok
27 – 31 January 2027📅
📌 Amari Bangkok Hotel & Conference Centre
We’ve secured a special delegate rate of THB 4,410 per room. January is a busy time to visit Bangkok, and the delegate rate is only available until 30 November 2026, so we recommend booking early.
➡️ Book your hotel: pvrinstitute.org/pvri2027/accommodation
P.S. Congress registration will open in early August! 🎟️ -
The Pulmonary Vascular Research Institute
@PVRI
The PHGPS Data Dashboard is now live 🌍🎉
Nearly 4,000 patients and carers across 90 countries took part in the first Pulmonary Hypertension Global Patient Survey (PHGPS), sharing their experiences of diagnosis, treatment, access to care, daily life, work, and emotional wellbeing.
You can now explore key findings through the new interactive PHGPS Data Dashboard!
The dashboard can help patient associations, clinicians, researchers, advocates, and decision-makers:
✅️ identify gaps in care
✅️ recognise shared challenges
✅️ support local advocacy and education
✅️ inform research, planning, and service improvement
➡️ Explore the PHGPS Data Dashboard: pvri.s.gy/phgps -
The Pulmonary Vascular Research Institute
@PVRI
❓ Have a current or past complex PH case that would benefit from wider discussion?
Today we’re launching Global PH Consult 🌍🎉
This new, free online service from PVRI’s Access to Care Workstream gives clinicians around the world a space to bring anonymised complex PH cases for discussion with a tailored panel of PH specialists.
If your case is selected, you’ll:
▪️meet with a tailored PH panel before the webinar
▪️join a live 60-minute case discussion
▪️hear specialist perspectives relevant to your case
▪️contribute to shared learning across the global PH community
Global PH Consult is open to clinicians everywhere, with a primary focus on supporting those in low and middle-income countries (LMICs).
➡️ Find out more and submit your case: pvrinstitute.org/global-ph-consult -
The Pulmonary Vascular Research Institute
@PVRI
Join us now for...
Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise
📅 14 July 2026
🕐 13:00 BST
Hear from Erik Swenson, VA Puget Sound Health Care System, as he explores how hearts and lungs respond to hypoxia and exercise across humans and animals in extreme environments.
➡️ Register and join: pvrinstitute.org/learning-hub/events/bleeding-ponies-bloa… -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2027 Travel Award applications are open! 📢
We’re offering £20,000 in travel awards and free PVRI memberships to help more colleagues join us in Bangkok.
Support is available through:
▪️Global Early Career LMIC Travel Awards — for early-career PH professionals living and working in low- and middle-income countries
▪️Southeast Asia and Sri Lanka Capacity Building Travel Awards — for colleagues working in PH, or actively supporting PH capacity-building, in the region
Travel award applications close on 25 August 2026, 12:00 BST.
➡️ Apply for a travel award: pvrinstitute.org/pvri2027/travelawards -
The Pulmonary Vascular Research Institute
@PVRI
Join us tomorrow for the next 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar...
Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise
📅 14 July 2026
🕐️ 13:00 BST
Hear from Erik Swenson, VA Puget Sound Health Care System, as he explores how hearts and lungs respond to the combined stresses of hypoxia and exercise across humans and animals in extreme environments.
➡️ Register now: pvrinstitute.org/learning-hub/events/bleeding-ponies-bloa… -
The Pulmonary Vascular Research Institute
@PVRI
Join us now...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 BST
Hear from leading experts as they explore the latest in CTEPH genomics, balloon angioplasty, distal pulmonary endarterectomy, and lung transplantation.
➡️ Register and join: -
The Pulmonary Vascular Research Institute
@PVRI
We want more early-career PH professionals and colleagues from LMICs to be part of PVRI 2027 Bangkok.
We're doing this through:
▪️£20,000 in travel awards, including support for early-career professionals in LMICs and colleagues working in or supporting PH capacity-building in Southeast Asia and Sri Lanka
▪️£16,000 in abstract awards, including seven Best Early-Career Abstract Awards of £2,000 each, the £2,000 Rupert Swift Award, and the Butrous Foundation Young Investigator Award
▪️reduced membership fees for early-career professionals in LMICs — now $15 a year, down from $50
Abstract submissions and travel award applications are open now!
➡️ Submit your abstract: pvrinstitute.org/pvri2027/abstractsubmission
➡️ Apply for a travel award: pvrinstitute.org/pvri2027/travelawards -
The Pulmonary Vascular Research Institute
@PVRI
Still time to register! ⏳️
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 BST
We'll hear from:
▪️Shared and Distinct Genomics of CTEPH and Pulmonary Embolism - James Liley, Durham University
▪️Balloon Angioplasty for CTEPH: Indications, Results, and Treatment Considerations - Irene Lang, Medical University of Vienna
▪️Distal Pulmonary Endarterectomy: When, How, Why? - Victor Pretorius, Emory University
▪️Lung transplantation for CTEPH - Brett Cronin, University of California, San Diego
➡️ Register now: pvrinstitute.org/learning-hub/events/hot-topics-cteph-and… -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
HIV-Associated Pulmonary Arterial Hypertension in Resource-Limited Settings: A “Forgotten” Diagnosis, a Great Imitator, and a Multi-Hit Pulmonary Vasculopathy
📆 19 June 2026
🔢 16(2), e70341
👤 Emmanuel Eroume A Egom, Mfopa Adamou, Ibrahima Djouldé, Njimona Ibrahim, Mountchissi Célestin, Lum Abenwi Ambe, Medou Mba Fabrice, Moustapha, René Kamgang
➡️ Read the full research article: doi.org/10.1002/pul2.70341 -
The Pulmonary Vascular Research Institute
@PVRI
❓️ What happens to the heart and lungs under the combined stress of hypoxia and exercise?
Join us next week for the High Altitude Task Force’s next webinar in their Hypoxia in pulmonary vascular research – altitude and beyond series.
Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise
📅 14 July 2026
🕐️ 13:00 BST
➡️ Register now: pvrinstitute.org/learning-hub/events/bleeding-ponies-bloa… -
The Pulmonary Vascular Research Institute
@PVRI
Join the latest Women's Health Task Force webinar...
Sex Differences in Right Heart Remodeling: Oestrogenic Angiogenesis and RV Adaptation to Pressure Overload
📅 27 July 2026
🕓 16:00 BST
Hear talks on:
▪️Sexual dimorphism in right ventricular adaptation to pressure overload: Role of estradiol and angiogenesis - Ketul Chaudhary, Dalhousie University
▪️Sexually dimorphic role of estrogen receptor α (ERα) in preserving right ventricular endothelial integrity - Jiajun Li, University of Colorado
➡️ Register now: pvrinstitute.org/learning-hub/events/sex-differences-righ… -
The Pulmonary Vascular Research Institute
@PVRI
Still time to join today's Latin America Task Force webinar...
Chronic Thromboembolic Pulmonary Hypertension
📅 2 July 2026
🕔️ 17:00 BST
🗨️ Spanish with translated subtitles
➡️ Register now: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute
@PVRI
One day to go! ⏳️
Don’t miss tomorrow’s Latin America Task Force webinar...
Chronic Thromboembolic Pulmonary Hypertension
📅 2 July 2026
🕔️ 17:00 BST
🗨️ Spanish with translated subtitles
You’ll hear from PH experts on:
• identifying and assessing chronic thrombosis
• recognising CTEPH, including forms without manifest PH
• using imaging, haemodynamics, and risk stratification to guide care
• selecting the most appropriate treatment approach
➡️ Save your place: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute
@PVRI
We are proud to announce £36,000 in abstract & travel awards for PVRI 2027 Bangkok! 🤝
This fund is to help early-career professionals and colleagues from low- and middle-income countries (LMICs) join us at our next Annual Congress.
The awards include:
▪️£10,000 for Global Early Career LMIC Travel Awards (New)
For early-career professionals living and working in LMICs
▪️£10,000 for Southeast Asia & Sri Lanka Capacity Building Travel Awards (New)
For professionals actively working in PVD from Sri Lanka and Southeast Asia
▪️£16,000 for Best Early-Career Abstract Travel Awards (Expanded)
Awarded to the lead authors of the best submitted abstracts to PVRI 2027. As well as the £2,000 Rupert Swift Award, and the Butrous Foundation Young Investigator Award.
➡️ Find out more: pvrinstitute.org/learning-hub/news/ps36000-abstract-trave… -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2027 abstract submissions are now open! 📢
Share your work at PVRI 2027 Bangkok and contribute to the scientific programme.
You can submit your abstract under one of five themes:
▪️Basic and translational science
▪️Clinical science
▪️International and global health
▪️Mind the gap: cases that highlight gaps in evidence
▪️Next-generation diagnostics, AI, and therapeutics
➡️ Submit your abstract: pvrinstitute.org/pvri2027/abstractsubmission
📆 Main abstract submissions close: 5 October 2026
📆 Late-breaking abstract submissions will open on 6 November 2026 -
The Pulmonary Vascular Research Institute
@PVRI
❓️ Missed our June PH Community Call?
You can now watch it on demand.
Stuti Sunil Kumar Agarwal and Madelyn Blake discussed two recent studies exploring metabolic dysfunction, endothelial injury, ferroptosis, and organ involvement in PH.
The session covered:
▪️CES1 deficiency and metabolic reprogramming in pulmonary arterial hypertension
▪️impaired lung BCAA metabolism, ferroptosis, and PH-associated hepatopathy
▪️how these pathways may shape pulmonary vascular remodelling and right heart stress
➡️ Watch the recording now: pvrinstitute.org/learning-hub/material/pulmonary-hyperten… -
The Pulmonary Vascular Research Institute
@PVRI
Next up in our 'Cutting Edge Innovation in Clinical & Experimental PH' series...
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓️ 16:00 - 17:30 BST
We'll be hearing talks on :
▪️Shared and Distinct Genomics of CTEPH and Pulmonary Embolism - James Liley, Durham University
▪️Balloon Angioplasty for CTEPH: Indications, Results, and Treatment Considerations - Irene Lang, Medical University of Vienna
▪️Distal Pulmonary Endarterectomy: When, How, Why? - Victor Pretorius, Emory University
▪️Lung transplantation for CTEPH - Brett Cronin, University of California, San Diego
➡️ Register here: pvrinstitute.org/learning-hub/events/hot-topics-cteph-and… -
The Pulmonary Vascular Research Institute
@PVRI
Heading to PVRI 2027 Bangkok? ✈️
You can now book your stay at Amari Bangkok Hotel & Conference Centre, the official Congress venue!
Stay where the Congress is taking place, with more time to connect with colleagues, attend sessions, and make the most of your time in Bangkok.
January is a busy time to visit the city, and the special delegate rate is only available until 30 November 2026, so we recommend booking your room early.
➡️ Book your hotel: pvrinstitute.org/pvri2027/accommodation -
The Pulmonary Vascular Research Institute
@PVRI
Help guide future PH collaboration in Southeast Asia 🗺️
We've launched a survey to better understand PH care and research across Southeast Asia.
With the PVRI Annual Congress coming to Bangkok in 2027, we want this work to be shaped by people in the region.
Do you know anyone connected to PH in Southeast Asia? Please share the survey and help us reach the right people.
➡️ Share the survey: www.surveymonkey.com/r/KPXLY8V
❓ Want to know more about why we're doing this? Read here: pvrinstitute.org/learning-hub/news/pvri-launches-survey-u… -
The Pulmonary Vascular Research Institute
@PVRI
❓️ What do bleeding ponies, bloated cattle, and breathless mountaineers have in common?
Join our next webinar in our 'Hypoxia in pulmonary vascular research – altitude and beyond' series, led by the PVRI High Altitude Task Force to find out.
Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise
📅 14 July 2026
🕐️ 13:00 BST
👤 Erik Swenson, VA Puget Sound Health Care System
➡️ Signup for free: pvrinstitute.org/learning-hub/events/bleeding-ponies-bloa… -
The Pulmonary Vascular Research Institute
@PVRI
❔️ What can patient experiences teach us about the future of PH care?
The Pulmonary Hypertension Global Patient Survey (PHGPS) brings together almost 4,000 responses from patients and carers across 90 countries, offering vital insight into what it’s like to live with PH globally.
The PHGPS data cover:
▪️diagnosis and treatment
▪️quality of life
▪️financial pressures
▪️hospital visits
▪️research participation
▪️telemedicine and digital tools
These insights can help shape better care, guide future research, and address unmet needs across the global PH community.
➡️ Find out more and access the data: pvrinstitute.org/learning-research/pulmonary-hypertension… -
The Pulmonary Vascular Research Institute
@PVRI
Join us now for our final Community Call before the summer break!
Pulmonary Hypertension Community Call
📅 25 June 2026
🕒️ 15:00 - 16:00 BST
We’re discussing new research on metabolic reprogramming, endothelial dysfunction, BCAA metabolism and PAH-associated hepatopathy.
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Join us tomorrow for...
Pulmonary Hypertension Community Call
📅 25 June 2026
🕒️ 15:00 - 16:00 BST
This month, we’ll discuss:
▪️CES1 Deficiency is Associated With Metabolic Reprograming and Endothelial Dysfunction in PAH — Stuti Sunil Kumar Agarwal
▪️Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant PAH-Associated Hepatopathy — Madelyn Blake
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Factors Influencing Physical Activity Engagement Amongst Those Living With Pulmonary Hypertension in the UK
📆 11 June 2026
🔢 16(2), e70332
👤 Sarah J. Hardcastle, Zachary Wells, Carol Keen, Robin Condliffe, David G. Kiely, Ciara McCormack
➡️ Read the full research article: onlinelibrary.wiley.com/doi/10.1002/pul2.70332 -
The Pulmonary Vascular Research Institute
@PVRI
Únase a nuestro próximo seminario web del Grupo de Trabajo de América Latina...
Hipertensión Pulmonar por Tromboembolia Pulmonar Crónica
📅 2 de julio de 2026
🕔️ 17:00 BST
🗨️ Sesión impartida en español, con subtítulos traducidos
Exploraremos:
• la identificación de la trombosis crónica con o sin PH manifiesta
• el papel de las pruebas de imagen, el cateterismo derecho y la estratificación del riesgo
• opciones de tratamiento, incluidas la tromboendarterectomía, la angioplastia, la terapia médica y los abordajes híbridos
➡️ Regístrese ahora: pvrinstitute.org/learning-hub/events/hipertension-pulmona…
The Pulmonary Vascular Research Institute
@PVRI
Join our next Latin America Task Force webinar...
Chronic Thromboembolic Pulmonary Hypertension
📅 2 July 2026
🕔️ 17:00 BST
🗨️ Deliver in Spanish, with translated subtitles
We’ll explore:
▪️identifying chronic thrombosis with or without manifest PH
▪️the role of imaging, right heart catheterisation, and risk stratification
▪️treatment options including thromboendarterectomy, angioplasty, medical therapy, and hybrid approaches
➡️ Register now: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute
@PVRI
Last chance to help us reach PH colleagues across Southeast Asia ⏳️
As we look ahead to our Annual Congress, PVRI 2027 Bangkok, we’re gathering local insight to help shape meaningful...
✅️ collaboration
✅️ education
✅️ research
✅️ support
Please share this short survey with any colleagues, organisations, or contacts in Southeast Asia who may want to contribute.
➡️ www.surveymonkey.com/r/KPXLY8V -
The Pulmonary Vascular Research Institute
@PVRI
We’re delighted to welcome Joan Z.hang to the PVRI Innovative Drug Development Initiative (IDDI) leadership team, as Sidra Hoffman steps down from the role.
Joan brings over 30 years of experience across PH, cardiology, medical affairs, clinical practice, and biopharmaceutical leadership.
She joins Luke Howard, Gil Golden, and Sandeep Sahay as the IDDI continues to bring people together across disciplines, sectors, and regions to advance PH research and improve care for patients worldwide.
We’re deeply grateful to Sidra for her leadership, insight, and commitment to the IDDI.
📄 Read the full article to learn more: pvrinstitute.org/learning-hub/news/pvri-welcomes-joan-zha… -
The Pulmonary Vascular Research Institute
@PVRI
❓ Missed last week’s Living Legends in PH webinar?
PVRI members can now watch the recording on demand.
In this session, Marlene Rabinovitch, Stanford University, reflects on her “voyage into the deep sea of PH”, including:
▪️the early mentors and moments that shaped her path
▪️her work on paediatric lung vascular development
▪️the long journey from discovery to clinical translation
▪️the role of elastase activity and BMPR2 in PH research
▪️the persistence needed when papers are rejected, grants are turned down, and experiments don’t go to plan
▪️her advice for the next generation: learn from many mentors, and ask for help when you’re stuck
➡️ Watch now: pvrinstitute.org/learning-hub/material/living-legend-marl…
Thank you to Kurt Stenmark, University of Colorado, and Clare Prohaska, University of Indiana for facilitating. -
The Pulmonary Vascular Research Institute
@PVRI
Do you know PH colleagues, organisations, or contacts in Southeast Asia? 🌏️
PVRI is gathering insight from people in the region to help shape future collaboration, education, research, and support around PH care.
Please help us reach the right people by sharing this short survey with anyone in your network who lives, works, or has strong professional links in Southeast Asia.
➡️ www.surveymonkey.com/r/KPXLY8V
Thank you for helping us make sure this work is driven by local needs 🤝 -
The Pulmonary Vascular Research Institute
@PVRI
Starting in 15 minutes! ⏰️
Our Living Legend webinar with Marlene Rabinovitch, Stanford University, begins at 16:00 BST.
Join us to hear from one of the leading voices in PH, with discussion led by Kurt Stenmark and Andrea Frump.
➡️ There’s still time to join: -
The Pulmonary Vascular Research Institute
@PVRI
1 day to go ⏳️
Living Legend with Marlene Rabinovitch
📅 18 June
🕓️ 16:00–17:30 BST
Marlene will share insights from her pioneering work in pulmonary vascular disease, alongside personal reflections from her career in PH.
➡️ Signup now: pvrinstitute.org/learning-hub/events/living-legend-marlen…
Thank you to Kurt Stenmark, University of Colorado, and Andrea Frump, University of Indiana for facilitating. -
The Pulmonary Vascular Research Institute
@PVRI
Join us for our final PH Community Call before the summer break.
📅 25 June 2026
🕒 15:00 – 16:00 BST
🌍 Free and online
This month, we'll be discussing:
▪️CES1 Deficiency is Associated With Metabolic Reprograming and Endothelial Dysfunction in PAH
▪️Impaired Lung BCAA Metabolism Promotes Ferroptosis and Resultant PAH Hepatopathy
Come along, ask questions, and connect with the global PH community.
➡️ Signup now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Your support changes lives 🫁
PH can be difficult to diagnose, and many people wait too long for answers. Your donation helps PVRI bring people together across the world to improve understanding, diagnosis, treatment, and care for people living with PH.
Every gift helps us support research, share knowledge, and keep working towards better outcomes for patients.
➡️ Donate today: www.justgiving.com/charity/pvrinstitute -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2027 Bangkok is taking shape 🚀
We’re delighted to announce the Scientific Organising Committee, chaired by Jane Leopold and co-chaired by Khodr Tello.
The committee will help shape a programme that looks ahead to the next 20 years of progress in PH, bringing together science, innovation, clinical insight, and global collaboration.
Meet the Scientific Organising Committee:
▪️Jane Leopold
▪️Khodr Tello
▪️Aleksandra Babicheva
▪️Valentina Mercurio
▪️Shahin Moledina
▪️Steven Niederer
▪️Peter Nyasulu
▪️Sasha Prisco
▪️Rogerio Souza
▪️Suree Sompradeekul
▪️Ryan Tedford
▪️Athiththan Yogeswaran
▪️Dingyi Wang
📄 Learn more about the committee: pvrinstitute.org/learning-hub/news/pvri-2027-bangkok-scie… -
The Pulmonary Vascular Research Institute
@PVRI
PVRI Annual Congress is coming to Bangkok in 2027 🌏
We want to help build a lasting legacy for PH care, research, and education across Southeast Asia.
Do you live, work, or have strong professional links in the region? 💬
Share your insight through our short survey and help shape future PH collaboration in Southeast Asia.
➡️ www.surveymonkey.com/r/KPXLY8V -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Balancing Risk and Hope: Insights Into Pregnancy Outcomes in Pulmonary Arterial Hypertension
📆 24 May 2026
🔢 16(2), e70327
👤 Teresa Segura de la Cal, Carmen Pérez-Olivares, Raquel Luna-López, Irene Martín de Miguel, Alejandro Cruz-Utrilla, Olga Villar, Fernando Sarnago, Pedro Muñoz, Marina Santiago Sánchez, María Jesús López Gude, Maite Velázquez, Laura Forcén, Juan F. Delgado, Fernando Arribas Ynsaurriaga, Pilar Escribano-Subias
➡️ Read the full research article: doi.org/10.1002/pul2.70327 -
The Pulmonary Vascular Research Institute
@PVRI
📢 Únete al cuarto y último seminario web del ciclo del Grupo de Trabajo de América Latina
Hipertensión pulmonar por tromboembolia pulmonar crónica
📅 2 de julio de 2026
🕔 17:00 BST
🗣️ Sesión en español, con subtítulos traducidos disponibles
Charlas:
▪️Revisión general, epidemiología y presentación de caso de HPTEC
▪️Identificación y evaluación de trombosis crónica con o sin PH
▪️Tromboendarterectomía y angioplastia como terapias en HPTEC
▪️Abordaje a la terapia híbrida y multimodal
➡️ Regístrate ahora: pvrinstitute.org/learning-hub/events/hipertension-pulmona…
The Pulmonary Vascular Research Institute
@PVRI
📢 Join us for the fourth and final webinar in the Latin America Task Force series
Chronic thromboembolic pulmonary hypertension
📅 2 July 2026
🕔 17:00 BST
🗣️ Delivered in Spanish, with translated subtitles available
Talks:
▪️Overview, epidemiology, and CTEPH case presentation
▪️Identification and assessment of chronic thrombosis with or without PH
▪️Pulmonary thromboendarterectomy and angioplasty as therapies in CTEPH
▪️Hybrid and multimodal therapy approaches
➡️ Register now: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute
@PVRI
What can the history of PH teach us about its future?
Join us next week for the next Living Legends in PH: History & Personal Perspectives session.
Living Legend: Marlene Rabinovitch, Stanford University
📅 18 June 2026
🕓 16:00 – 17:30 BST
💻 Free and open to everyone
➡️ Register: pvrinstitute.org/learning-hub/events/living-legend-marlen… -
The Pulmonary Vascular Research Institute
@PVRI
New in Pulmonary Circulation 🫁
Meeting abstracts from PVRI 2026 Dublin
📆 5 June 2026
🔢 16(2), e70315
This special meeting abstract issue brings together the research shared at PVRI 2026 Dublin, capturing the breadth of science, collaboration, and discussion from our Annual Congress earlier this year.
From basic science and translational research to clinical care and global perspectives on PH, these abstracts reflect the ideas and investigations helping to shape the future of the field.
Thank you to everyone who submitted their work and contributed to another inspiring PVRI Congress 👏
➡️ Explore the full abstract collection: onlinelibrary.wiley.com/doi/10.1002/pul2.70315 -
The Pulmonary Vascular Research Institute
@PVRI
Join us for the next "Cutting Edge Innovation in Clinical & Experimental PH" session!
Hot Topics in CTEPH and Pulmonary Endarterectomy
📅 9 July 2026
🕓 16:00 - 17:30 BST
Talks include:
▪️Shared and Distinct Genomics of CTEPH and Pulmonary Embolism
▪️Balloon Angioplasty for CTEPH: Indications, Results, and Treatment Considerations
▪️Distal Pulmonary Endarterectomy: When, How, Why?
▪️Lung transplantation for CTEPH
➡️ Register now: pvrinstitute.org/learning-hub/events/hot-topics-cteph-and… -
The Pulmonary Vascular Research Institute
@PVRI
The PHGPS brings together almost 4,000 patient and carer voices from 90 countries.
This global dataset is an opportunity to keep improving PH care and research, using real-world insights from every stage of the patient journey, including:
▪️diagnosis and testing
▪️treatment and genetic testing
▪️hospital visits and financial pressures
▪️quality of life
▪️research participation
▪️telemedicine, PROMs, and digital tools
Interested in accessing the data?
➡️ Find out how: pvrinstitute.org/learning-and-research/pulmonary-hyperten… -
The Pulmonary Vascular Research Institute
@PVRI
Help guide future PH collaboration in Southeast Asia 🗺️
We've launched a short survey to better understand PH care, research, and education across Southeast Asia.
With the PVRI Annual Congress coming to Bangkok in 2027, we want this work to be shaped by people in the region.
Do you know colleagues, organisations, or contacts connected to PH in Southeast Asia? Please share the survey with your network and help us reach the right people.
➡️ Share the survey: www.surveymonkey.com/r/KPXLY8V
❓ Want to know more about why we're doing this? Read here: pvrinstitute.org/learning-hub/news/pvri-launches-survey-u… -
The Pulmonary Vascular Research Institute
@PVRI
Time to continue the conversation at the Royal College of Physicians 🗨️
The networking reception is underway, bringing our community together after a full day exploring genetics-inspired therapeutics for PH.
Thank you to everyone joining us for discussion, connection, and collaboration.
#pvrisymposium -
The Pulmonary Vascular Research Institute
@PVRI
What information should we be collecting from clinical trials to better inform drug development in this space?
That’s the question our PH community explored to close out the Symposium.
Looking at how the right data can help us understand whether new treatments are working, who they may help most, and how they could shape future PH therapies.
#pvrisymposium -
The Pulmonary Vascular Research Institute
@PVRI
Our final scientific session looked beyond the TGF-β/BMP pathway to other genetically validated pathways.
We had talks on:
▪️ Targeting ZIP12
▪️ Sox17
A strong close to the scientific programme, looking at how today’s genetic discoveries could help shape tomorrow’s PH therapies.
#pvrisymposium -
The Pulmonary Vascular Research Institute
@PVRI
Our Therapeutic agents targeting TGF-b/BMP pathway session continued.
Speakers explored different ways this pathway could be targeted, including:
▪️ Sotatercept - what can we learn from the biological
response
▪️Inhibiting BMP9
▪️LTP001 study
▪️Alk1:BMPRII agonism via bispecific clustering antibody
for the treatment of HHT & PАН
▪️Modulating TGF-beta signalling for pulmonary
hypertension and HНТ
A focused look at a fast-moving area of therapeutic development.
#pvrisymposium -
The Pulmonary Vascular Research Institute
@PVRI
This morning, attention turned to the TGF-β/BMP pathway — a key signalling pathway involved in how cells grow, repair, and communicate.
We had talks on:
▪️Overview of TGF-β/BMP pathway
▪️Biology behind the PAH - HHT overlap
▪️Sotatercept - a case study
▪️Sotatercept - overview of clinical experience
▪️Sotatercept - deep phenotyping the cardiac response
#pvrisymposium -
The Pulmonary Vascular Research Institute
@PVRI
A strong scientific opening this morning ☀️
Our Genetic insights into pulmonary vascular disease session explored:
▪️ Overview of genetics in PH & hereditary haemorrhagic telangiectasia
▪️ Genetics of the right ventricle
A thoughtful start to the day, and an important reminder of how genetic discovery can open new directions for research and care.
#pvrisymposium -
The Pulmonary Vascular Research Institute
@PVRI
Welcome to Genetics-inspired Therapeutics for PH!
Today we’re celebrating it being 25 years since the identification and publication of mutations in BMPR2 in PAH. A discovery that transformed how we understand the genetics of PH.
Today we’ll explore what that means now, and where the field goes next, including:
▪️ Genetic insights into pulmonary vascular disease
▪️ Therapeutic agents targeting the TGF-β/BMP pathway
▪️ Developing therapeutic agents to target other genetically validated pathways
We’re delighted to begin with leadership from Brad Maron, setting the tone for a focused day of science and collaboration.
#pvrisymposium -
The Pulmonary Vascular Research Institute
@PVRI
The registration desk is now open 🎟️
Come collect your badge this morning and grab some refreshments and take a moment to settle in before the Symposium begins.
#pvrisymposium -
The Pulmonary Vascular Research Institute
@PVRI
The PVRI team has arrived at the Royal College of Physicians!
We’re setting up and excited to welcome our global PH community — with colleagues travelling from 13 countries around the world — as we set to explore how genetic discovery is shaping future therapeutic development.
Doors open soon and we can’t wait to welcome you 🤝
#pvrisymposium -
The Pulmonary Vascular Research Institute
@PVRI
Only one day to go!
Genetics-inspired Therapeutics for Pulmonary Hypertension (PH)
📅 2 June 2026
📌 Royal College of Physicians, London
We’re excited to see the PH community come together in London tomorrow for a packed day of science, discussion, and connection.
🎟️ Still time to register: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
❓ Do you support, treat, or work with people living with PH?
This anonymous survey on PH and climate is closing soon. Please share it with your patient networks while there’s still time to take part.
Led by Hospital del Mar Barcelona and Universitätsspital Zürich, the survey explores how extreme heat, extreme cold, and pollution may affect symptoms, physical activity, and access to care.
➡️ Access and share the survey: de.surveymonkey.com/r/ph-climate -
The Pulmonary Vascular Research Institute
@PVRI
Didn't make our latest PH Community Call?
The full webinar recording is now available! 🎥
This month we discussed two Sotatercept papers:
▪️Sotatercept in Pulmonary Arterial Hypertension: Central, Hematologic, and Peripheral Mechanisms of Benefit by Yogesh Reddy
▪️Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension by Hooman Poor
➡️ Watch here: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Challenges and Strategies in Managing PAH Within the Indian Healthcare System: A Consensus Statement From the PVRI India Taskforce
📆 11 May 2026
🔢 16(2), e70311
👤 Prashant Bobhate, Neeraj Awasthy, Abraham Samuel Babu, Shatabdi Giri, Arun Gopalakrishnan, Sivadasanpillai Harikrishnan, Niharikar Karandikar, Basha J. Khan, Snehal Kulkarni, Shine Kumar, Rahul Mehrotra, Smrutiranjan Mohanty, S. Ramakrishnan, Anita Saxena, Padmanabha Shenoy, B. K. Srinivasa Sastry, T. Sunder
This article looks at how PAH care can be improved across India, from earlier diagnosis to better access to treatment and support.
Guidelines help steer advocacy from intention to action, and action to impact. This work reflects the PVRI India Task Force’s efforts to help more people receive consistent, high-quality care.
➡️ Read the full research article: onlinelibrary.wiley.com/doi/10.1002/pul2.70311 -
The Pulmonary Vascular Research Institute
@PVRI
Join now...🖥️
Our monthly PH Community Call is starting in 5 minutes! And this month we're discussing...
▪️Sotatercept in Pulmonary Arterial Hypertension: Central, Hematologic, and Peripheral Mechanisms of Benefit by Yogesh Reddy
▪️Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension by Hooman Poor
➡️ Register and join: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Abstract submission closes soon!
8th International Leh Symposium 2026 - Therapeutic targets & molecular mechanisms for pulmonary diseases in hypoxia
📅 23 - 27 October 2026
📌 McLeod Ganj, Dharamshala, Himachal Pradesh, India
Share your research with an international scientific community exploring pulmonary diseases in hypoxia, PH, and altitude-related pulmonary vascular research.
➡️ Submit your abstract by 30 May 2026: pvrinstitute.org/learning-hub/events/8th-international-le… -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! ⏰
Join our free, informal global discussion on the latest PH research.
PH Community Call May
📅 27 May 2026
🕒 15:00–16:00 BST
💻 Online | Free
This month, we're discussing:
▪️Sotatercept in PAH: Central, Hematologic, and Peripheral Mechanisms of Benefit — Yogesh Reddy
▪️Sotatercept improves small airway disease and hyperinflation in patients with PH — Hooman Poor
➡️ Register here: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Only one week to go! 🎉
Genetics-inspired Therapeutics for PH
📅 2 June 2026
🕗️ 08:00 - 18:30
📍 Royal College of Physicians, London
This one-day Symposium will explore how discoveries in genetics are helping researchers better understand PH. Join us to:
🧬 learn how genetics is changing our understanding of PH
🔬 explore what this could mean for future treatments
💬 hear from leading voices across research, clinical care, and industry
There’s still time to join us!
➡️ Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
What can we learn from the people who helped shape the field of PH?
Living Legend: Marlene Rabinovitch, Stanford University
📅 18 June 2026
🕓 16:00 - 17:30 BST
Join us and hear Marlene reflect on:
▪️the discoveries that shaped her career
▪️how our understanding of PH has changed over time
▪️the people, ideas, and collaborations that influenced her work
➡️ Signup for free: pvrinstitute.org/learning-hub/events/living-legend-marlen…
Thank you to our moderators Kurt Stenmark and Andrea Frump! -
The Pulmonary Vascular Research Institute
@PVRI
Next week...
PH Community Call — May
🗓️ 27 May 2026
🕒 15:00 - 16:00 BST
This month, we’ll be focusing on two papers exploring sotatercept in PH:
▪️Sotatercept in PAH: Central, Hematologic, and Peripheral Mechanisms of Benefit by Yogesh Reddy
▪️Sotatercept improves small airway disease and hyperinflation in patients with PH by Hooman Poor
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
This editorial looks back at PVRI 2026 Dublin, our 20th anniversary Annual Congress and our largest Congress yet.
Highlights of the 2026 Pulmonary Vascular Research Institute Conference: Celebrating 20 Years of Progress and Innovation
📆 8 May 2026
🔢 16(2), e70275
👤 Laura Price, Katarina Zeder, Sasha Prisco
➡️ Read the full research article: onlinelibrary.wiley.com/doi/10.1002/pul2.70275
The Pulmonary Vascular Research Institute
@PVRI
And the conversation continues at PVRI 2027 Bangkok 🗨️
From 27–31 January 2027, our global PH community will come together at the Amari Hotel & Conference Centre for five days of science, collaboration, and connection under the theme Bridging Science, Innovation & Care for the Next 20 Years.
➡️ Find out more and save the date: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok -
The Pulmonary Vascular Research Institute
@PVRI
Over the past eight weeks, we've shared nine key insights from the three recently published Pulmonary Hypertension Global Patient Survey (PHGPS) papers.
Together, these papers highlight the #invisibleimpactofph.
The daily physical and emotional challenges the those with PH and their families face everyday.
Like:
▪️54% of female respondents worrying about pregnancy
▪️83% of those in work with Group 2 PH having their work affected
▪️36% feeling misunderstood, often wanting to discuss emotional symptoms but experiencing a lack of empathy
▪️40% of caregivers providing constant care, with many leaving or changing jobs
➡️ Explore the data further: pvrinstitute.org/phgps
The Pulmonary Vascular Research Institute
@PVRI
Read the papers:
The PHGPS: Groups 2 and 3 PH: onlinelibrary.wiley.com/doi/10.1002/pul2.70256
The PHGPS: Understanding the Invisible Burden of Paediatric PH: onlinelibrary.wiley.com/doi/10.1002/pul2.70269
The PHGPS: Physical and Psychosocial Impacts on Health-Related QoL: onlinelibrary.wiley.com/doi/10.1002/pul2.70264 -
The Pulmonary Vascular Research Institute
@PVRI
❓️ How can we support informed conversations about clinical trials?
For #clinicaltrialsday, we’re sharing the clinical trials video from our PH Patient Engagement and Empowerment series, created by our IDDI Patient Engagement and Empowerment Workstream.
The video is designed for people living with PH, families, and carers, and can help support conversations around:
▪️what clinical trials involve
▪️what questions patients may want to ask
▪️how safety is protected
▪️how people can decide what feels right for them
It’s part of an 11-part series covering topics from understanding PH and self-care to shared decision-making, peer support, advocacy, and building an empowerment plan.
Watch the video and share it with anyone who may find it helpful.
➡️ Explore the full series: pvrinstitute.org/PHpatients -
The Pulmonary Vascular Research Institute
@PVRI
One week to go!
I Brasillinois Symposium on infection and PVD
📅 26 May 2026
🕣️ 08.30 - 15:00 CT (13:30 - 18:00 BST)
📌 UIC COMRB Moss Auditorium 1020, Chicago & virtually via Zoom
This free one-day, hybrid mini-symposium will explore how microorganisms contribute to inflammatory PVD, the clinical challenges this creates, and where new, druggable targets may lie.
➡️ Register now: pvrinstitute.org/learning-hub/events/i-brasillinois-sympo… -
The Pulmonary Vascular Research Institute
@PVRI
Only two weeks to go!
Genetics-inspired Therapeutics for Pulmonary Hypertension (PH)
📅 2 June 2026
🕣️ 8:00 - 18:30 BST
Join us for our celebration of it being 25 years since the identification and publication of mutations in BMPR2 in PAH. And hear from experts...
▪️Patrick Andre, Diagonal Therapeutics
▪️Ardeschir Ghofrani, Justus-Liebig-Universität Gießen/ University Clinic Giessen
▪️Simon Gibbs, Imperial College London
▪️Marie-Jose Goumans, Leiden University
▪️Rachel Gurrell, Apollo Therapeutics
▪️Lars Harbaum, Universitätsklinikum Hamburg-Eppendorf
▪️Kevin Hart, Pfizer
▪️Wei Li, VPD-Heart and Lung Research Institute, University Of Cambridge
▪️Nick Morrell, Interact Bio
▪️Chris Rhodes, Imperial College London
▪️Alex Rothman, The University of Sheffield & Sheffield Teaching Hospitals NHS Foundation Trust
▪️Ana-Maria Tanase, Novartis
▪️Khodr Tello, Justus Liebig University Giessen
▪️Richard Trembath, King's College London
▪️Paul Yu, Mass General Brigham
➡️ Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
📢 PVRI 2027 Bangkok is underway!
🗓️ 27–31 January 2027
📍 Amari Hotel & Conference Centre, Bangkok
We’re delighted to announce that Jane Leopold, Brigham and Women's Hospital, will lead the PVRI 2027 Scientific Organising Committee, with Khodr Tello, Universitätsklinikum Gießen und Marburg GmbH (UKGM), as Co-Chair.
The theme for 2027, Bridging Science, Innovation & Care for the Next 20 Years, builds on the momentum and great science discussed in Dublin and reflects our continued commitment to advancing collaboration, accelerating innovation, and improving patient care worldwide.This media couldn't be displayed. See it on the original post.
The Pulmonary Vascular Research Institute
@PVRI
Abstract submission dates have also now been announced!
This is your opportunity to present your work in the poster sessions and be considered for the main scientific programme.
➡️ Find them here: pvrinstitute.org/learning-hub/events/pvri-2027-bangkok -
The Pulmonary Vascular Research Institute
@PVRI
Last Thursday, we brought together a brilliant group of people who care deeply about the same rare condition.
Our webinar, TBX4 syndrome, bench and bedside, explored TBX4 syndrome from the family perspective through to early lung development, clinical care, research models, and future therapies.
It was a lovely example of collaboration in action, with speakers who have worked together, learned from each other, and helped grow TBX4 research 🤝
A huge thank you to everyone who joined us live, and to our brilliant speakers for sharing their insight so generously.
➡️ Watch the recording: pvrinstitute.org/learning-hub/material/tbx4-syndrome-benc… -
The Pulmonary Vascular Research Institute
@PVRI
New insights from the PH Global Patient Survey (PHGPS) highlights the diagnosis delay for children with PH.
The PHGPS: Understanding the Invisible Burden of Paediatric PH: doi.org/10.1002/pul2.70269
📊 41% of families waited more than 6 months for diagnosis
This underlines the need to improve early recognition of PH symptoms in children and support faster referral to specialist care.
➡️ Explore the PHGPS data: pvrinstitute.org/PHpatients
💬 Support families navigating these challenges: pvrinstitute.org/learning-and-research/pulmonary-hyperten…
#invisibleimpactofph -
The Pulmonary Vascular Research Institute
@PVRI
Still time to join...
TBX4 syndrome, bench and bedside
📅 14 May 2026
🕓️ 16:00 - 17:30 BST
The next webinar in our 'Cutting Edge Innovation in Clinical & Experimental PH' series, giving early career professionals the chance to share their research.
➡️ Register and watch now: pvrinstitute.org/learning-hub/events/tbx4-syndrome-bench-… -
The Pulmonary Vascular Research Institute
@PVRI
1 day to go ⏳
TBX4 syndrome, bench and bedside
📅 14 May 2026
🕓 16:00 - 17:30 BST
Join us and hear..
▪️TBX4 biology: role in fetal lung development
▪️Clinical manifestations & management of TBX4 syndrome
▪️Mouse models of TBX4-PH
▪️Towards therapy for developmental lung disease
➡️ Register now: pvrinstitute.org/learning-hub/events/tbx4-syndrome-bench-… -
The Pulmonary Vascular Research Institute
@PVRI
Speaker teaser...👀
Genetics-inspired Therapeutics for PH: A PVRI Symposium
📅 2 June 2026
🕘 09:00 - 18:30 BST
📍 Royal College of Physicians, London
LTP001 study
👤 Alex Rothman, The University of Sheffield and Ana Maria Tanase, Novartis
👉 Register now: -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Flexible, Accessible, Effective: Patient Perceptions of the Pulmonary Hypertension and Home-Based (PHAHB) Physical Activity Intervention
📆 29 April 2026
🔢 16(2), e70309
👤 Ciara McCormack, Sarah J. Hardcastle, Niall M. Moyna, Emer Morahan, Sarah Cullivan, Sean Gaine, Brian McCullagh, Brona Kehoe
➡️ Read the full research article: onlinelibrary.wiley.com/doi/10.1002/pul2.70309 -
The Pulmonary Vascular Research Institute
@PVRI
❓️ Missed the live session?
Recording now available!
Watch our latest 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar...
🖥️ Early changes in the pulmonary vasculature in response to high altitude: mechanisms and potential treatments
Cheng-Jun Hu, University of Colorado
➡️ Watch now: pvrinstitute.org/learning-hub/material/early-changes-pulm… -
The Pulmonary Vascular Research Institute
@PVRI
The impact of PH isn’t always visible, especially for Groups 2 and 3.
New insights from the PH Global Patient Survey (PHGPS) highlight the burden PH can place on work life.
The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3: onlinelibrary.wiley.com/doi/10.1002/pul2.70256
📊 83% say PH has affected their work (Group 2)
📊 88% say PH has affected their work (Group 3)
These findings highlight that PH symptoms can affect all aspects of life.
➡️ Explore the PHGPS data:
pvrinstitute.org/learning-and-research/pulmonary-hyperten…
💬 Support patients to start conversations about emotional wellbeing:
pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
Your support changes lives 🫁
It helps drive progress in PH research, education, and care, supporting earlier diagnosis and better treatment for people living with PH.
Our work brings together researchers, clinicians, industry partners, and patient representatives across the globe. By connecting people with different expertise and experiences, we help share knowledge, spark collaboration, and turn research insights into better care.
And your donation can help us keep this work going.
➡️ Donate today: donate.justgiving.com/charity/pvrinstitute -
The Pulmonary Vascular Research Institute
@PVRI
Join our next 'Cutting Edge Innovation in Clinical & Experimental PH' webinar...
TBX4 syndrome, bench and bedside
📅 14 May 2026
🕓 16:00 - 17:30 BST
We're joined by:
▪️Anton Morkin, CEO - TBX4Life
▪️Ripla Arora, Michigan State University
▪️Matina Prapa, St George's & Royal Brompton Hospital
▪️James West, University
▪️Micheala Aldred, Indiana University
▪️Vlad Kalinichenko, Phoenix Children's Research Institute
➡️ Register here: pvrinstitute.org/learning-hub/events/tbx4-syndrome-bench-… -
The Pulmonary Vascular Research Institute
@PVRI
Less than a month to go! ⏳
Join our celebration of it being 25 years since the identification and publication of mutations in BMPR2 in PAH.
Genetics-inspired Therapeutics for Pulmonary Hypertension
🗓️ 2 June 2026
🕐 09:00 - 18:30 BST
📌 Royal College of Physicians, London
➡️ Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
Starting in 15 mins...
Early changes in the pulmonary vasculature in response to high altitude: mechanisms and potential treatments
📅 5 May 2026
🕐 13:00 BST
The next in our 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar series led by our High Altitude Task Force.
Today we're joined by Cheng Jun Hu, Associate Professor at University of Colorado.
➡️ Still time to join: pvrinstitute.org/learning-hub/events/epigenetic-strategie… -
The Pulmonary Vascular Research Institute
@PVRI
It's #worldphday 🫁
A day for the global community to come together and raise awareness of #pulmonaryhypertension.
Today, we're saying thank you to our global PH community. For your dedication to improving diagnosis, treatment and care for all those with PH.
From our Board of Trustees and Scientific and Medical Advisory Council, to our Workstream and Task Force Leaders, our PVRI Digital Scientific Organising Committee, and Community Call Hosts, your commitment drives everything we do.
We’re proud to be part of a community working towards a world without pulmonary vascular disease.
🗨️ "PVRI has been instrumental in helping me build international collaborations to move the field of PVD forward scientifically, particularly in understudied aspects of PH"
It's quotes like this that show the strength of our global community.
Thank you 💜 -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow...🖥️
Early changes in the pulmonary vasculature in response to high altitude: mechanisms and potential treatments
📅 5 May 2026
🕐 13:00 BST
The next in our 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar series led by our High Altitude Task Force.
This month we're joined by Cheng Jun Hu, Associate Professor at University of Colorado.
➡️ Register now: pvrinstitute.org/learning-hub/events/epigenetic-strategie… -
The Pulmonary Vascular Research Institute
@PVRI
Speaker teaser...👀
Genetics-inspired Therapeutics for PH: A PVRI Symposium
📅 2 June 2026
🕘 09:00 - 18:30 BST
📍 Royal College of Physicians, London
Inhibiting BMP9
👤 Kevin Hart, Pfizer
👉 Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
There is an invisible emotional impact to living with PH.
New insights from the PH Global Patient Survey (PHGPS) highlight the emotional impact on those living with PH:
The PHGPS: Physical & Psychosocial Impacts on Health-Related QoL
onlinelibrary.wiley.com/doi/10.1002/pul2.70264
📊 36% feel misunderstood, often wanting to discuss emotional symptoms but experiencing a lack of empathy
This finding highlights the importance for free, or at least affordable, psychological care as a mandatory part of PH treatment.
Explore the PHGPS data: pvrinstitute.org/learning-and-research/pulmonary-hyperten…
Support patients to start conversations about these topics: pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Schistosomiasis-Associated PAH in Brazil: A Call to Action for Enhanced Diagnostic Recognition
📆 16 April 2026
🔢 16(2), e70302
👤 Camila M. C. Loureiro, Ricardo A. Correa, Roberto José de Carvalho Filho, Brian Graham, Ghazwan Butrous, Rudolf Oliveira
This review article has been published by PVRI's Infection in Pulmonary Vascular Disease (iPVD) Consortium.
During PVRI 2025 Rio, the annual iPVD symposium addressed the most relevant aspects of the epidemiology, diagnosis, and prevention of Sch-PAH in Brazil. This review summarises the main discussed topics and serves as a call to increase efforts to understand the disease burden better and enhance diagnostic proficiency.
This reinforces the power of global collaboration, turning discussions at a PVRI annual congress into research that drives change in PH.
➡️ Read the full review article: onlinelibrary.wiley.com/doi/10.1002/pul2.70302 -
The Pulmonary Vascular Research Institute
@PVRI
Speaker teaser...👀
Genetics-inspired Therapeutics for PH: A PVRI Symposium
📅 2 June 2026
🕘 09:00 - 18:30 BST
📍 Royal College of Physicians, London
Targeting ZIP12
👤 Rachel Gurrell, Apollo Therapeutics
👉 Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
Less than one month to go!
I Brasillinois Symposium on infection and PVD
📅 Tuesday 26 May 2026
🕣️ 08.30 - 15:00 CT (13:30 - 18:00 BST)
📌 UIC COMRB Moss Auditorium 1020, Chicago & virtually via Zoom
Infectious cardiopulmonary diseases remain among the top ten causes of death worldwide. Yet the mechanisms linking infection, inflammation, and chronic PVD are still underexplored.
This Symposium aims to explore how microorganisms contribute to inflammatory PVD, the clinical challenges this creates, and where new, druggable targets may lie.
➡️ Register for free: pvrinstitute.org/learning-hub/events/i-brasillinois-sympo… -
The Pulmonary Vascular Research Institute
@PVRI
The next in our 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar series...
Epigenetic Strategies to Mitigate Acute Altitude-Induced Lung Injury
🗓️ 5 May 2026
🕒 13:00 BST
This month we're hearing from Cheng Jun Hu on their talk:
💬 Epigenetic Strategies to Mitigate Acute Altitude-Induced Lung Injury
➡️ Register now: pvrinstitute.org/learning-hub/events/epigenetic-strategie… -
The Pulmonary Vascular Research Institute
@PVRI
Learn the latest PH research 🧬
Our latest PH Community Call webinar recording is now available!
Last week, we discussed:
▪️C–C Motif chemokine receptor-2 blockade ameliorates PH in rats and synergizes with a pulmonary vasodilator by Yoshihide Mitani
▪️Deep-learning networks accurately detect PH in patients with idiopathic pulmonary fibrosis by Alexandra Arvanitaki, Laura Price, John Wort and Gerhard-Paul Diller
▪️Assessing the feasibility of using smartphone data to identify risk of idiopathic PAH by Juan Delgado San Martin, and Allan Lawrie
➡️ Watch now: pvrinstitute.org/learning-hub/material/pulmonary-hyperten… -
The Pulmonary Vascular Research Institute
@PVRI
Speaker teaser...👀
Genetics-inspired Therapeutics for PH: A PVRI Symposium
📅 2 June 2026
🕘 09:00 - 18:30 BST
📍 Royal College of Physicians, London
Join us and hear from Simons Gibbs, Imperial College London, for his talk...
💬 Restoring Right‑Ventricular Function Through Activin Modulation
Sotatercept, a first‑in‑class activin signaling inhibitor targeting the TGF‑β/BMP pathway, demonstrated consistent and favorable effects on right ventricular (RV) structure and function across the Phase 3 STELLAR, ZENITH, and HYPERION studies. In post hoc echocardiographic analyses through Week 24, sotatercept was associated with improvements in right heart dimensions, RV performance, RV–pulmonary artery coupling, and reductions in tricuspid regurgitation severity. These benefits were observed across diverse patient populations, including both recently diagnosed and prevalent PAH, and across baseline risk strata. Collectively, the findings support the concept that modulation of dysregulated TGF‑β/BMP signaling not only improves pulmonary vascular hemodynamics but also contributes to reverse right heart remodeling in PAH.
👉 Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
Starting in 15 mins! Still time to join!
PH Community Call
📅 23 April 2026
🕒️ 15:00 - 16:00 BST
Our monthly informal discussions on the latest research in PH. Join us to stay informed, share ideas, and hear directly from your peers.
➡️ Register and join now: -
The Pulmonary Vascular Research Institute
@PVRI
Webinar recording now available 📽️
🖥️ Sex Matters: Translational Advances in Respiratory and PAH Research
Exploring how biological sex influences pulmonary arterial hypertension (PAH) and respiratory disease.
Hear talks:
▪️Intermittent hypoxia modulates in a sex-specific manner the transcriptional profile of endothelial cell in pulmonary arterial hypertension by SANDA PREDESCU
▪️The role of Sex as a biological variable in the developing lung endothelium by Krithika Lingappan
➡️ Watch now: pvrinstitute.org/learning-hub/material/sex-matters-transl… -
The Pulmonary Vascular Research Institute
@PVRI
One day to go! ⏳
PH Community Call
📅 23 April 2026
🕒 15:00 - 16:00 BST
This month, we're discussing:
▪️C–C Motif chemokine receptor-2 blockade ameliorates PH in rats and synergizes with a pulmonary vasodilator by Yoshihide Mitani
▪️Deep-learning networks accurately detect PH in patients with idiopathic pulmonary fibrosis by Alexandra Arvanitaki, Laura Price, John Wort and Gerhard-Paul Diller
▪️Assessing the feasibility of using smartphone data to identify risk of idiopathic PAH by Juan Delgado San Martin and Allan Lawrie
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Speaker teaser...👀
Genetics-inspired Therapeutics for PH: A PVRI Symposium
📅 2 June 2026
🕘 09:00 - 18:30 BST
📍 Royal College of Physicians, London
Overview of genetics in PH & hereditary haemorrhagic telangectasia
👤 Richard Trembath, King's College London
👉 Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
Launching the next webinar is in our Cutting Edge Innovation in Clinical & Experimental PH series...
TBX4 syndrome, bench and bedside
📅 14 May 2026
🕓️ 16:00 - 17:30 BST
Presentations:
▪️ The family perspective - Anton Morkin
▪️ TBX4 biology: role in fetal lung development - Ripla Arora
▪️ Clinical manifestations & management of TBX4 syndrome - Matina Prapa
▪️ Mouse models of TBX4-PH - James West & Micheala Aldred
▪️ Towards therapy for developmental lung disease - Vlad Kalinichenko
➡️ Register now: pvrinstitute.org/learning-hub/events/tbx4-syndrome-bench-… -
The Pulmonary Vascular Research Institute
@PVRI
Starting in 15 mins...⏳
Sex Matters: Translational Advances in Respiratory and PAH Research
🗓️ 20 April 2026
🕓 16:00 BST
We'll be exploring how biological sex influences PAH and respiratory disease.
Presentations:
▪️Intermittent hypoxia modulates in a sex-specific manner the transcriptional profile of endothelial cell in PAH by Sanda Predescu
▪️The role of Sex as a biological variable in the developing lung endothelium by Krithika Lingappan
➡️ Register and join now: pvrinstitute.org/learning-hub/events/sex-matters-translat… -
The Pulmonary Vascular Research Institute
@PVRI
The impact of PH can be daily, especially for Groups 2 and 3.
New insights from the PH Global Patient Survey (PHGPS) highlight the daily physical toll experienced by patients.
The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3: onlinelibrary.wiley.com/doi/10.1002/pul2.70256
📊 63% struggle with walking short distances or climbing stairs (Group 2)
📊 66% struggle with household chores (Group 3)
These findings highlight the importance of recognising the physical limitations that effect daily life.
Explore the PHGPS data:
pvrinstitute.org/learning-and-research/pulmonary-hyperten…
Support patients to start conversations about emotional wellbeing:
pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
Join next week's Women's Health Task Force webinar!
Sex Matters: Translational Advances in Respiratory and PAH Research
🗓️ 20 April 2026
🕓 16:00 BST
We'll be exploring how biological sex influences pulmonary arterial hypertension (PAH) and respiratory disease.
Presentations:
▪️The role of Sex as a biological variable in the developing lung endothelium
▪️Intermittent hypoxia modulates in a sex-specific manner the transcriptional profile of endothelial cell in PAH
➡️ Register now: pvrinstitute.org/learning-hub/events/sex-matters-translat… -
The Pulmonary Vascular Research Institute
@PVRI
Join our PH Community Call next week!
Pulmonary Hypertension Community Call — April
📅 23 April 2026
🕒 15:00 BST
Our monthly, informal discussions on the latest developments and research in PH.
➡️ Register here: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Speaker teaser...👀
Genetics-inspired Therapeutics for PH: A PVRI Symposium
📅 2 June 2026
🕘 09:00 - 18:30 BST
📍 Royal College of Physicians, London
Biology behind the PAH – HHT overlap
👤 Wei Li, University of Cambridge
👉 Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
When a child lives with PH, the burden is not just on the child but the whole family.
New insights from the PH Global Patient Survey (PHGPS) highlight the impact on families:
The PHGPS: Understanding the Invisible Burden of Paediatric PH: onlinelibrary.wiley.com/doi/10.1002/pul2.70269
📊 40% of caregivers provide constant care, with some leaving work altogether, reducing hours, or changing careers
Explore the PHGPS data: pvrinstitute.org/learning-and-research/pulmonary-hyperten…
Support families navigating these challenges: pvrinstitute.org/PHpatients
#invisibleimpactofph -
The Pulmonary Vascular Research Institute
@PVRI
We are absolutely thrilled to introduce our friends and colleagues to...🥁
Vidhya Sasitharan, PVRI's newest team member!
Vidhya started with us recently as our new Advocacy & Engagement Lead and, working with Elvia Carvalho Silva, will work on scoping areas of need and develop and implement plans for new PH services.
Please join us in welcoming Vidhya to the PVRI team! 👋 -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Lifesaving Compassionate-Use of Sotatercept in a 12-Year-old With Idiopathic Pulmonary Arterial Hypertension
📆 02 April 2026
🔢 16(2), e70293
👤 Weronika Pelczar-Płachta, Rafał Surmacz, Waldemar Bobkowski
➡️ Read the full research article: onlinelibrary.wiley.com/doi/10.1002/pul2.70293 -
The Pulmonary Vascular Research Institute
@PVRI
I Brasillinois Symposium on infection and PVD
🗓️ Tuesday 26 May 2026
🕣 08.30 - 15:00 CT (13:30 - 18:00 BST)
📌 University of Illinois Chicago & virtually via Zoom
Supported by PVRI's iPVD consortium, join this one-day hybrid symposium to explore how microorganisms contribute to inflammatory PVD, the clinical challenges this creates, and where new, druggable targets may lie.
Hear talks on:
▪️Pulmonary Microbiome and Endothelial Cell Death in preclinical Schistosomiasis-PAH - Suellen Darc Oliveira
▪️Global Clinical Efforts against Schistosomiasis-PAH - Rudolf Oliveira
▪️Novel findings on S. mansoni and japonicum-associated PAH - Brian Graham
▪️Evolving Therapeutic Approach to kill S. mansoni - David Williams
➡️ Register for free: pvrinstitute.org/learning-hub/events/i-brasillinois-sympo… -
The Pulmonary Vascular Research Institute
@PVRI
Speaker teaser...👀
Genetics-inspired Therapeutics for PH: A PVRI Symposium
📅 2 June 2026
🕘 09:00 - 18:30 BST
📍 Royal College of Physicians, London
Sotatercept – what can we learn from the biological response
👤Paul Yu, Mass General Brigham
👉 Register now: -
The Pulmonary Vascular Research Institute
@PVRI
Recording now available 🎥
Last week, Paul Corris, joined us for our latest webinar in our Living Legends in PH: History & Personal Perspectives series.
Watch and hear his perspective on:
▪️Work/life balance
▪️Teams and working relationships
▪️His best moments and his worst
▪️Balancing research with clinician work
▪️Advice for those considering a career in PVD
➡️ Watch now: pvrinstitute.org/learning-hub/material/living-legends-pau… -
The Pulmonary Vascular Research Institute
@PVRI
Join the first Women's Health Task Force webinar of the year!
Sex Matters: Translational Advances in Respiratory and PAH Research
🗓️ 20 April 2026
🕓 16:00 BST
Hosted by our Task Force Leaders, Jessica Badlam and Daria Kostyunina, we'll be exploring how biological sex influences pulmonary arterial hypertension (PAH) and respiratory disease.
We'll be discussing two talks:
▪️The role of Sex as a biological variable in the developing lung endothelium
▪️Intermittent hypoxia modulates in a sex-specific manner the transcriptional profile of endothelial cell in PAH
Join this webinar and be part of a global effort to advance knowledge, research, and care for women affected by PH.
➡️ Register now: pvrinstitute.org/learning-hub/events/sex-matters-translat… -
The Pulmonary Vascular Research Institute
@PVRI
Speaker teaser...👀
Genetics-inspired Therapeutics for PH: A PVRI Symposium
📅 2 June 2026
🕘 09:00 - 18:30 BST
📍 Royal College of Physicians, London
Join us and hear from Nick Morrell, CSO and co-Founder of Interact Bio to here his talk...
Modulating TGF-beta signalling for pulmonary hypertension and HHT
👤 Nick Morrell, Interact Bio
👉 Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
Starting in 10 minutes ⏳️
Living Legends: Paul Corris, Newcastle University
📅 9 April 2026
🕓️ 16:00 BST
Hear Paul's career journey in PH, including both the breakthroughs and the failures. From developing clinical lung transplantation globally to establishing the UK National Service for patients with PH.
And get the opportunity to ask questions directly to a Living Legend in PH.
➡️ Register and join now: pvrinstitute.org/learning-hub/events/living-legends-paul-… -
The Pulmonary Vascular Research Institute
@PVRI
Next up in 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar series...
Epigenetic Strategies to Mitigate Acute Altitude-Induced Lung Injury
📅 5 May 2026
🕐️ 13:00 BST
We're joined by Cheng-Jun Hu, University of Colorado, whose research focuses on gene expression and hypoxia-driven disease mechanisms.
➡️ Register now: pvrinstitute.org/learning-hub/events/epigenetic-strategie…
Thank you to the High Altitude Task Force for organising! -
The Pulmonary Vascular Research Institute
@PVRI
Speaker teaser...👀
Genetics-inspired Therapeutics for PH: A PVRI Symposium
📅 2 June 2026
🕘 09:00 - 18:30 BST
📍 Royal College of Physicians, London
Join us and hear from Marie-Jose Goumans, Professor of Cardiovascular Cell Biology, for her talk exploring the TGFb-BMP pathway.
Overview of TGFb-BMP pathway
👤 Marie-Jose Goumans, Leiden University
👉 Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
We’re live tomorrow...
Living Legends: Paul Corris, Newcastle University
📅 9 April 2026
🕓️ 16:00 BST
From shaping lung transplantation globally to establishing the UK National PH Service, Paul’s impact on the field is hard to overstate.
Hear the story behind the science – the milestones, the challenges, and the lessons learned along the way.
➡️ Register now: pvrinstitute.org/learning-hub/events/living-legends-paul-… -
The Pulmonary Vascular Research Institute
@PVRI
PH can affect life decisions in ways that aren’t always visible.
New insights from the PH Global Patient Survey (PHGPS) highlight the impact on women living with PH:
The PHGPS: Physical & Psychosocial Impacts on Health-Related QoL
onlinelibrary.wiley.com/doi/10.1002/pul2.70264
📊 54% of female respondents worry about pregnancy
This finding highlights the importance of addressing reproductive health, future planning, and emotional wellbeing as part of holistic PH care.
Explore the PHGPS data:
pvrinstitute.org/learning-and-research/pulmonary-hyperten…
Support patients to start conversations about these topics:
pvrinstitute.org/phpatients -
The Pulmonary Vascular Research Institute
@PVRI
It's #worldhealthday 🗺️
This year's theme is: Together for health. Stand with science.
For those working in PH, this isn’t new.
It’s how progress happens.
Every advance in PH – from earlier diagnosis to new therapies – is built on collaboration. No single centre, no single study, can solve this alone.
At PVRI, we bring that collaboration into practice:
▪️Annual Congresses connect the global PH community
▪️IDDI Workstream and Task Forces drive focused research
▪️initiatives like Go Deep create space for deeper scientific exchange
▪️the PH Global Patient Survey (PHGPS) brings patient experience into the evidence base
Together, these efforts help turn evidence into action. Standing with science means working together to improve outcomes in PH. -
The Pulmonary Vascular Research Institute
@PVRI
PH Community Call
📅 23 April 2026
🕒️ 15:00 BST
Papers we're discussing this month are:
▪️C–C Motif chemokine receptor-2 blockade ameliorates PH in rats and synergizes with a pulmonary vasodilator
▪️Deep-learning networks accurately detect PH in patients with idiopathic pulmonary fibrosis
▪️Assessing the feasibility of using smartphone data to identify risk of idiopathic PAH
Join us for our free online, informal discussion on the latest developments in PH.
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
The impact of PH isn’t always visible, especially for Groups 2 and 3.
New insights from the PH Global Patient Survey (PHGPS) highlight the emotional burden experienced by patients:
The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3: onlinelibrary.wiley.com/doi/10.1002/pul2.70256
📊 27% feel misunderstood
📊 37% experience anger and frustration
These findings highlight the importance of recognising the emotional impact of PH, alongside physical symptoms, in patient care.
Explore the PHGPS data:
pvrinstitute.org/learning-and-research/pulmonary-hyperten…
Support patients to start conversations about emotional wellbeing:
pvrinstitute.org/phpatients -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Pregnancy Outcomes Following Macitentan or Bosentan Exposure Before or During Pregnancy: Review of Cases Reported to the Manufacturer's Global Safety Database
📆 20 March 2026
🔢 16(1), e70286
👤 Karen M. Olsson, Maria Solonets, Yan Yu, Anna Neild, Cécile Valette, Anna R. Hemnes
➡️ Read the full research article: onlinelibrary.wiley.com/doi/10.1002/pul2.70286 -
The Pulmonary Vascular Research Institute
@PVRI
Genetics-inspired Therapeutics for Pulmonary Hypertension (PH): A PVRI Symposium
📅 2 June 2026
📍 Royal College of Physicians, London
What makes a great scientific meeting?
At a recent PVRI event:
📊 93% of attendees rated the programme as good or excellent
📊 99% rated the overall experience as good or excellent
That’s what we’re aiming for again.
Join us for a day of thoughtful discussion, new ideas, and practical insight into genetics-driven therapies in PH.
➡️ Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
A life that helped shape modern PH care.
Living Legends: Paul Corris, Newcastle University
📅 9 April 2026
🕓 16:00 - 17:30 BST
Join us for the next session in our Living Legends in PH series.
So, what’s it about?
▪️the story behind developing lung transplantation on a global scale
▪️how the UK National PH Service came to life
▪️lessons from decades of clinical leadership, research, and mentorship
It’s a rare chance to hear directly from someone who’s helped shape the PH field
➡️ Register now: pvrinstitute.org/learning-hub/events/living-legends-paul-… -
The Pulmonary Vascular Research Institute
@PVRI
Infectious cardiopulmonary diseases remain among the top ten causes of death worldwide. But the link between infection, inflammation, and PVD is still not fully understood.
That’s exactly what this hybrid one-day symposium sets out to explore...
I Brasillinois Symposium on Infection and PVD
📅 Tuesday 26 May 2026
🕒 08:30–15:00 CT (13:30–18:00 BST)
📍 UIC COMRB Moss Auditorium, Chicago & online
🎟️ Free to attend
The programme covers:
▪️schistosomiasis-associated PAH
▪️new research on S. mansoni and japonicum
▪️emerging therapeutic approaches
▪️the pulmonary microbiome and endothelial cell death
Part of the wider Brasillinois Initiative, this symposium is all about collaboration across borders — and advancing our understanding of PH.
👉 Register now: pvrinstitute.org/learning-hub/events/i-brasillinois-sympo… -
The Pulmonary Vascular Research Institute
@PVRI
Genetics-inspired Therapeutics for Pulmonary Hypertension (PH): A PVRI Symposium
📅 2 June 2026
📍 Royal College of Physicians, London
What have we learned so far from sotatercept in clinical practice?
At our upcoming PVRI Symposium, Ardeschir Ghofrani will share an overview of the clinical experience with sotatercept – exploring what it’s teaching us about treatment response and future therapeutic potential in PH.
Sotatercept – overview of clinical experience
👤 Ardeschir Ghofrani, Justus Liebig University Giessen
👉 Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
PH Community Call - April
📅 23 April 2026
🕒️ 15:00 BST
We’ll be discussing:
▪️C–C Motif chemokine receptor-2 blockade ameliorates pulmonary hypertension in rats and synergizes with a pulmonary vasodilator by Yoshihide Mitain
Join our free online, informal discussion on the latest developments in PH.
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
When a child lives with PH, care often comes with an invisible burden.
New insights from the PH Global Patient Survey (PHGPS) highlight the impact on families:
The Pulmonary Hypertension Global Patient Survey: Understanding the Invisible Burden of Paediatric Pulmonary Hypertension: onlinelibrary.wiley.com/doi/10.1002/pul2.70269
📊 35% travel more than two hours for appointments
📊 28% receive no cost reimbursement
Explore the PHGPS data: pvrinstitute.org/learning-and-research/pulmonary-hyperten…
Support families navigating these challenges: pvrinstitute.org/phpatients
#invisibleimpactofph -
The Pulmonary Vascular Research Institute
@PVRI
March's PH Community Call is now available 🎥
In our March session, we discussed three of the latest PH papers:
▪️Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension
▪️Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia
▪️Acute Hemodynamic Effects of Sotatercept
Catch up on the insights, discussion, and emerging research shaping the future of PH.
➡️ Watch here: pvrinstitute.org/learning-hub/material/pulmonary-hyperten… -
The Pulmonary Vascular Research Institute
@PVRI
Genetics-inspired Therapeutics for Pulmonary Hypertension (PH): A PVRI Symposium
📅 2 June 2026
📍 Royal College of Physicians, London
What happens to the heart when we target disease pathways in PH?
At our upcoming PVRI Symposium, Khodr Tello will explore how sotatercept is shaping the cardiac response in PH – and what deep phenotyping can reveal about treatment impact.
Sotatercept – deep phenotyping the cardiac response
👤 Khodr Tello, Justus-Liebig-Universität Gießen
👉 Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet… -
The Pulmonary Vascular Research Institute
@PVRI
Living with PH isn’t just about clinical results.
New insights from the PH Global Patient Survey (PHGPS) highlight the invisible impact of PH. in one of the latest papers:
The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of Life: onlinelibrary.wiley.com/doi/10.1002/pul2.70264
📊 79% of patients report physical limitations
📊 42% experience poor sleep quality
Explore the PHGPS data: pvrinstitute.org/learning-and-research/pulmonary-hyperten…
Support patients to start conversations about quality of life: pvrinstitute.org/phpatients
#insivibleimpactofph -
The Pulmonary Vascular Research Institute
@PVRI
We’re live in 10 minutes 📢
Join us now for our March PH Community Call.
Discuss the latest PH research, including:
▪️Breast Cancer Reveals Latent BMPR2-Related Susceptibility to PH
▪️Predicting PH in infants with bronchopulmonary dysplasia
▪️Acute Hemodynamic Effects of Sotatercept
➡️ Join now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Don't miss tomorrow's PH Community Call 💬🖥️
The papers we'll be discussing this month are:
▪️Breast Cancer Reveals Latent BMPR2-Related Susceptibility to PH by Francois Potus and Manon Mougin
▪️Predicting PH in infants with bronchopulmonary dysplasia by Henry Foote
▪️Acute Hemodynamic Effects of Sotatercept by Nils Kremer and Khodr Tello
Your chance to dive into the latest research and be part of the conversation!
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Children with PH still face major barriers to accessing approved treatments.
At PVRI 2026 Dublin, Megan Griffiths and Sidra Hoffman shared why better paediatric clinical trials are key to changing that.
From paediatric-specific endpoints to regulatory flexibility, their interviews explore what it will take to improve access to therapies for young patients.
🎥 Watch the full interview: youtu.be/wYwYl-T4_dc -
The Pulmonary Vascular Research Institute
@PVRI
⏳ Pasando mañana
Hipertensión pulmonar del Grupo 3: asociada con EPOC y EPI
📅 18 de marzo de 2026
🕒️ 15:00 GMT
🗣️ Sesión en español
Acompáñenos en el próximo webinar del Latin America Task Force, donde expertos líderes explorarán la HP del Grupo 3 asociada con la EPOC y la EPID.
Agenda:
▪️Presentación y discusión de caso – Rafael Conde; Colombia
▪️Abordaje y evaluación inicial en HP asociada a grupo 3 – Oscar Aguirre; Perú
▪️Interpretación de estudios en HP-EPOC y HP-EPID – Jorge Caneva; Argentina
▪️Tratamiento PH en HP-EPOC y HP-EPID – Guillermo Montes; México
Moderado por Rodolfo A. Estrada, Nayeli Zayas y Veronica Franco.
➡️ Regístrese ahora: pvrinstitute.org/learning-hub/events/hipertension-pulmona…
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow ⏳
Group 3 Pulmonary Hypertension: Associated with COPD and ILD
📅 18 March 2026
🕒️ 15:00 GMT
🗣️ Delivered in Spanish
Join us for the next Latin America Task Force webinar, where leading experts will explore Group 3 PH linked to COPD and ILD.
Agenda:
▪️Case presentation and discussion – Rafael Conde; Colombia
▪️Approach and initial evaluation in Group 3 PH – Oscar Aguirre; Peru
▪️Interpretation of investigations in PH-COPD and PH-ILD – Jorge Caneva; Argentina
▪️Treatment of PH in PH-COPD and PH-ILD – Guillermo Montes; Mexico
Moderated by Rodolfo A. Estrada, Nayeli Zayas, and Veronica Franco.
➡️ Register now: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute
@PVRI
🧬 New webinar recording now available
In this PVRI Digital Webinar, researchers explore how metabolism, muscle, adipose tissue, and the microbiome may influence PH.
In this session:
▪️Exercise physiology and training in PH - Michael Risbano, University of Pittsburgh, USA
▪️Skeletal muscle secretome in PH-HFpEF - Charly Lai, Indiana University School of Medicine, Indianapolis, USA
▪️Adipose stores in PH - Nadine Al-Naamani, University of Pennsylvania, Philadelphia, USA
▪️The altered microbiome as a therapeutic target in PAH - Thenappan Thenappan, University of Minnesota, USA
🎥 Watch the recording: pvrinstitute.org/learning-hub/material/advances-understan…
Part of the ‘Cutting Edge Innovation in Clinical & Experimental PH’ webinar series. -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Plasma GDF-15 and PSP-D Predict the Development of Pulmonary Arterial Hypertension in Systemic Sclerosis
📆 19 February 2026
🔢 16(1), e70251
👤 Adam Engel Sällberg, Salaheldin Ahmed, Abdulla Ahmed, Kriss Kania, Jørn Carlsen, Roger Hesselstrand, Kristofer Andréasson, Göran Rådegran
➡️ Read the full research article: doi.org/10.1002/pul2.70251 -
The Pulmonary Vascular Research Institute
@PVRI
New webinar recording now available 📢
What happens to blood pressure when we travel to high altitude?
And should travellers be concerned?
Linda Keyes explores the latest thinking on blood pressure responses at altitude. You’ll learn about:
▪️how altitude affects blood pressure
▪️what this means for travellers and clinicians
▪️key questions still shaping research in this area
➡️ Watch now: pvrinstitute.org/learning-hub/material/do-travelers-high-…
This talk is part of the ‘Hypoxia in pulmonary vascular research – altitude and beyond’ webinar series from the PVRI High Altitude Task Force. -
The Pulmonary Vascular Research Institute
@PVRI
New PHGPS publications 📢
Nearly 4,000 patients and carers from 90 countries contributed to the PH Global Patient Survey (PHGPS), creating one of the most comprehensive global datasets on the lived experience of PH.
Together with our Workstreams and Task Forces, we have now published three new peer-reviewed papers in Pulmonary Circulation:
▪️The PHGPS: Physical & Psychosocial Impacts on Health-Related QoL
▪️The PHGPS: Understanding the Invisible Burden of Paediatric PH
▪️The PHGPS: Groups 2 and 3
Together, these papers highlight the invisible impact of PH. The daily physical, emotional, and practical challenges experienced by patients and families are not always reflected in clinical tests.
➡️ Explore the papers: pvrinstitute.org/phgps
#phgps #theinvisibleimpactofph -
The Pulmonary Vascular Research Institute
@PVRI
Starting in 15 minutes 📢
💻️ Advances in Understanding of Body Composition in PH
Hear expert insights on exercise physiology, skeletal muscle, adipose tissue, insulin sensitivity, and the microbiome in PH.
➡️ Still time to register: pvrinstitute.org/learning-hub/events/advances-understandi… -
The Pulmonary Vascular Research Institute
@PVRI
Join us for the next session in our Living Legends in PH: History & Personal Perspectives...
Living Legends in PH: Paul Corris
📅 9 April 2026
🕓 16:00 BST
Paul Corris, one of the leading figures in the development of lung transplantation and PH care in the UK and beyond.
In this special session, he will reflect on the science, milestones, and personal experiences that have shaped the field of PH. From establishing the UK National Service for PH to advancing lung transplantation globally, his work has influenced generations of clinicians and researchers.
Facilitated by Patricia Thistlethwaite and Nolan Winicki.
➡️ Register now: pvrinstitute.org/learning-hub/events/living-legends-paul-… -
Post not available here, view on X
The Pulmonary Vascular Research Institute
@PVRI
One week to go! ⏳️
Group 3 Pulmonary Hypertension: Associated with COPD and ILD
📅 18 March 2026
🕒️ 15:00 GMT
🗣️ Delivered in Spanish
Join us next week for our upcoming Latin America Task Force webinar exploring Group 3 PH associated with COPD and ILD.
You’ll hear expert perspectives on:
▪️Clinical phenotypes of PH in COPD and ILD
▪️Diagnostic approaches and interpretation of investigations
▪️Evidence-based treatment strategies
➡️ Register now: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute
@PVRI
1 day to go ⏳
Advances in Understanding of Body Composition in PH
🗓️ 12 March 2026
🕓 16:00 GMT
You’ll hear expert insights on:
▪️ Exercise physiology and training in PH
▪️ Skeletal muscle secretome in PH-HFpEF
▪️ Adipose stores in PH
▪️ Insulin sensitivity in PH
▪️ The altered microbiome as a therapeutic target in PAH
➡️ Register now: pvrinstitute.org/learning-hub/events/advances-understandi… -
The Pulmonary Vascular Research Institute
@PVRI
One week to go ⏳
📚 PH Community Call
🗓️ 19 March 2026
🕒 15:00–16:00 GMT
In just one week, we’ll come together for our next informal PH Community Call — a focused, interactive discussion on two thought-provoking new papers:
▪️Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension – Francois Potus
▪️Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia – Henry Foote
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
We’re live in 10 minutes ⏰️
Do Travelers to High Altitude Need to Worry about their Blood Pressure?
🕐 Starting at 13:00 GMT
Join Linda Keyes as we explore how high altitude affects blood pressure and what it means for patient care. This session is free and open to all as part of our High Altitude Task Force webinar series.
➡️ Still time to join us, register now: pvrinstitute.org/learning-hub/events/do-travelers-high-al… -
The Pulmonary Vascular Research Institute
@PVRI
Are you advising patients who travel to high altitude?
Do Travelers to High Altitude Need to Worry about their Blood Pressure?
📅 10 March 2026
🕐 13:00 GMT
Tomorrow, we’re joined by Linda Keyes for an expert-led discussion on altitude, hypoxia, and cardiovascular risk. This free webinar will explore:
▪️What happens to blood pressure at altitude
▪️Who may be at greater risk
▪️What this means for clinical advice and patient safety
If your patients live at, travel to, or work at high altitude, register now: pvrinstitute.org/learning-hub/events/do-travelers-high-al… -
The Pulmonary Vascular Research Institute reposted
Team PHenomenal Hope
@teamphhope
Thank you to the Pulmonary Vascular Research Institute (@PVRI) for their generous donation to The Lucilla Piccari PH-ILD Research Award fund. Learn more here: giving.gofundme.com/campaign/750843/donate
#pulmonaryhypertension #phresearch #phenomenalhope #pvri -
The Pulmonary Vascular Research Institute
@PVRI
❓️ Did you know?
83%* of women of childbearing age who are living with pulmonary hypertension (PH) worry about pregnancy, with the majority being told not to get pregnant due to the risk to their health.
"I was told years ago that pregnancy was absolutely discouraged by several doctors." 💬
These insights come from one of the latest PHGPS papers, The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of Life.
The data highlights the complex challenges many women with PH still face.
➡️ Read the full paper: onlinelibrary.wiley.com/doi/10.1002/pul2.70264
#iwd #internationalwomensday
*Of 793 female respondents of child-bearing age, 53.6% (n = 425) worry about pregnancy at least “sometimes” and 29.1% (n = 231) worry “very often” -
The Pulmonary Vascular Research Institute
@PVRI
Registration is now open! 📢
Genetics-inspired Therapeutics for Pulmonary Hypertension
🗓️ 2 June 2026
🕐 09:00 - 18:30 GMT
📌 Royal College of Physicians, London
Join us for a one-day Symposium exploring how advances in genetics are shaping the future of PH therapies. We'll be bringing together global experts to examine what that means in practice – for biology, clinical trials, and future therapies.
➡️ Register now: pvrinstitute.org/learning-hub/events/pvri-symposium-genet…
If you're a PVRI member, you’ll receive a 10% discount. Access it here: pvrinstitute.org/genetics-inspired-therapeutics-ph-member… -
The Pulmonary Vascular Research Institute
@PVRI
What can breast cancer teach us about latent BMPR2-related susceptibility to PH? And how can we better predict PH in infants with bronchopulmonary dysplasia?
Pulmonary Hypertension Community Call
🗓️ 19 March 2026
🕒 15:00–16:00 GMT
Join us for this month’s informal, interactive PH Community Call as we discuss two important new papers:
▪️Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension – Francois Potus
▪️Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia – Henry Foote
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2026 Dublin Report 📄
The report captures the science, collaboration, mentorship, and global engagement that defined our landmark Congress.
Inside, you’ll explore:
✔️ How our global PH community came together
✔️ The breadth of scientific discussion
✔️ The role of early-career professionals
✔️ Key feedback insights from delegates
✔️ How PVRI continues to evolve as a global charity
Whether you attended or followed from afar, the report offers a clear picture of where we are and where we’re heading.
📖 Read the report: pvrinstitute.org/learning-hub/news/pvri-2026-dublin-report -
The Pulmonary Vascular Research Institute
@PVRI
What does body composition really mean for people living with PH?
Advances in Understanding of Body Composition in PH
📅 12 March 2026
⏰ 16:00 GMT
Join us next week to explore how muscle, adipose tissue, insulin sensitivity, exercise physiology, and the microbiome are reshaping how we understand and manage PH.
You’ll hear from:
▪️Michael Risbano, University of Pittsburgh
▪️Charly LaiIndiana, University School of Medicine
▪️Nadine Al-Naamani, University of Pennsylvania
▪️Roham Zamanian, Stanford University
▪️Thenappan Thenappan, University of Minnesota
Moderated by Sudar Rajagopal, Duke Department of Medicine
➡️ Register now: pvrinstitute.org/learning-hub/events/advances-understandi… -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2027 Bangkok
🗓️ 27–31 January 2027
📌 Amari Hotel & Conference Centre, Bangkok
The global PH community will come together once again for five days of world-class science, collaboration, and connection.
More details on the programme, registration, and abstract submissions will follow.
For now, save the date! 📅 -
The Pulmonary Vascular Research Institute
@PVRI
Have you explored the full PH Patient Engagement & Empowerment series? 💜
PVRI’s Patient Engagement & Empowerment Initiative brings together practical, patient-focused resources designed to support people living with PH and their families.
The complete toolkit includes:
▪️11 short, themed videos
▪️A printable guide
▪️A foldable leaflet
▪️Editable Canva templates for patient organisations
From understanding PH and accessing psychological support to finding practical assistance and becoming an advocate, the series offers clear, supportive guidance at every stage of the journey.
If you haven’t explored it yet — or shared it with your patients and networks — now is the perfect time.
👉 Access the full toolkit & watch the series: pvrinstitute.org/PHpatients
And a sincere thank you to the PVRI IDDI Patient Engagement and Empowerment Workstream, and everyone that made this initiative possible.
Together, we continue building a stronger, more informed PH community. -
The Pulmonary Vascular Research Institute
@PVRI
❓ How do we improve treatment access for children with PH?
At PVRI 2026 Dublin, we spoke separately with:
Megan Griffiths of University of Texas Southwestern Medical Center and Sidra Hoffman, Senior Director, Clinical Development – Pulmonary Vascular Disease, Gossamer Bio.
Following Megan’s talk, “If you had it all: designing the ideal paediatric PH clinical trial,” she explored what better paediatric trial design could mean for drug approvals.
Sidra shared the industry perspective — and what it takes to move therapies forward.
Better endpoints.
Smarter regulatory pathways.
Real-world data.
Improved access.
🎥 Watch the full interview: youtu.be/wYwYl-T4_dc
➡️ Watch Megan's talk: pvrinstitute.org/learning-hub/material/if-you-had-it-all-… -
The Pulmonary Vascular Research Institute
@PVRI
❓️ Are you recognising Group 3 PH in COPD and ILD early enough?
Group 3 Pulmonary Hypertension: Associated with COPD and ILD
📅 18 March 2026
🕒️ 15:00 GMT
We’ll explore the updated haemodynamic definition (mPAP >20 mmHg, PVR >2), what it means for detection, and how to apply evidence-based strategies in clinical practice.
Delivered in Spanish, with subtitles available.
➡️ Register now: pvrinstitute.org/learning-hub/events/hipertension-pulmona…
The Pulmonary Vascular Research Institute
@PVRI
❓️¿Está reconociendo a tiempo la HP del Grupo 3 en pacientes con EPOC y EPID?
Hipertensión Pulmonar del Grupo 3: Asociada a EPOC y EPID
📅 18 de marzo de 2026
🕒️ 09:00 CST
Exploraremos la redefinición hemodinámica actualizada (PAPm >20 mmHg, RVP >2), su impacto en la detección y cómo aplicar estrategias basadas en la evidencia en la práctica clínica.
Sesión impartida en español, con subtítulos disponibles.
➡️ Regístrese ahora: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute reposted
touchRESPIRATORY
@tmmRESPIRATORY
🌍 From ambition to action: PVRI’s Innovative Drug Discovery Initiative
Progress in pulmonary hypertension (PH) depends on coordinated global effort. The Innovative Drug Discovery Initiative (IDDI), led by the Pulmonary Vascular Research Institute @PVRI, brings together academia, clinicians and industry to accelerate meaningful change.
Through focused workstreams, IDDI is addressing key barriers in PH research and care — from improving access and redesigning clinical trials to advancing paediatric frameworks, integrating real-world data and exploring new therapeutic modalities.
Read more: touchrespiratory.com/insight/from-ambition-to-action-insi…
#pulmonaryhypertension #clinicaltrials #drugdevelopment #medicalresearch -
The Pulmonary Vascular Research Institute
@PVRI
❓ How has the genetics of PAH informed present & future therapeutics?
A PVRI Symposium: Genetics-inspired Therapeutics for Pulmonary Hypertension
🗓️ 2 June 2026
🕘 09:00 - 18:30 GMT
📌 Royal College of Physicians, London
This one-day meeting will bring together geneticists, clinicians, translational scientists, and industry leaders to explore how advances in genetics are reshaping drug development — and where the next therapeutic breakthroughs may lie.
Registration opens soon, so make sure to save the date.
➡️ Explore the programme: pvrinstitute.org/learning-hub/events/pvri-symposium-genet…
Hear more from Martin Wilkins in the short video below 👇 -
The Pulmonary Vascular Research Institute
@PVRI
Do Travelers to High Altitude Need to Worry about their Blood Pressure?
📅 10 March 2026
🕐️ 13:00 GMT
We’re bringing together global expertise to explore what happens to blood pressure at altitude, what the risks really are, and what clinicians need to know.
Speakers & moderators
▪️Linda Keyes, University of Colorado & International Society for Mountain Medicine
▪️Aastha Mishra, CSIR-Institute of Genomics & Integrative Biology
▪️Silvia Ulrich, University Hospital Zurich
If you’re working in PH, travel medicine, emergency care, or simply curious about how altitude affects cardiovascular health, this session is for you.
➡️ Register now: pvrinstitute.org/learning-hub/events/do-travelers-high-al… -
The Pulmonary Vascular Research Institute
@PVRI
On Rare Disease Day, we stand with everyone affected by rare conditions — including PH.
PH is a serious, life-limiting condition. Some forms are so rare they’re often diagnosed late and poorly understood. Behind every diagnosis is a person waiting for answers, specialist care, and better treatment options.
At PVRI, we’re bringing the global PH community together to:
▪️drive earlier diagnosis
▪️advance research and innovation
▪️improve care worldwide
Together, we can move closer to a world where no one with PH is overlooked.
#rarediseaseday -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2026 Dublin Report is now live! 📈
Capturing the scale, impact, and momentum of a landmark year for our global PH community.
Inside the report, you’ll discover:
▪️The global reach of PVRI 2026
▪️How early-career professionals shaped the programme
▪️Delegate feedback and engagement insights
▪️Scientific programme highlights
If you joined us in Dublin, relive the impact.
If you couldn’t attend, explore what defined this milestone Congress.
📖 Read the PVRI 2026 Dublin Report: pvrinstitute.org/learning-hub/news/pvri-2026-dublin-report -
The Pulmonary Vascular Research Institute
@PVRI
Our 2025–26 IDDI Workstream & Task Forces Report is out now.
This report highlights the global collaboration driving progress in PH research, care, and innovation. Across 2025–2026, our Innovative Drug Development Initiative (IDDI) Workstreams and regional, disease, and specialty Task Forces have:
✅️ published peer-reviewed research
✅️delivered webinars and scientific meetings
✅️laid the groundwork for new consensus and guidance
✅️strengthened education, early diagnosis, and capacity building worldwide
➡️ Read the full report: pvrinstitute.org/learning-hub/news/2025-26-iddi-workstrea… -
The Pulmonary Vascular Research Institute
@PVRI
💜 PVRI’s Patient Engagement & Empowerment Series
No one should PH alone. Access to the right information and support networks can make a meaningful difference at every stage of the PH journey.
🔎 Theme 10: Resources and support networks
This theme highlights where patients and families can turn for trusted guidance and community support, including:
▪️patient organisations offering information, connection, and advocacy
▪️awareness campaigns such as World PH Day
▪️trusted websites including PHA Europe, PHA US, AfPH, and PVRI
▪️educational resources such as books, webinars, and courses
Strong networks provide more than information — they offer reassurance, shared experience, and the opportunity to help shape the future of PH care.
🎥 Explore now: pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
Our Pulmonary Circulation Gateway Programme is now accepting expressions of interest from Early Career Professionals in PH.
This 12-month mentoring pilot offers:
▪️Hands-on peer-review experience
▪️Personalised feedback from senior mentors
▪️Insight into journal editorial decision-making
▪️Formal training to strengthen your academic profile
You’ll learn directly from Anna Hemnes, Sandeep Sahay, and Vinicio de Jesus Perez.
Only three mentees will be selected — apply by Friday 13 March 2026.
➡️ Register your interest: pvrinstitute.org/learning-and-research/pulmonary-circulat… -
The Pulmonary Vascular Research Institute
@PVRI
🎥 Don’t forget #pvri2026 Dublin recordings are available to rewatch!
Revisit key sessions shaping the future of PH, including:
▪️The next 20 years in PH – what can we expect for our patients? – Paul Hassoun
▪️What is the real global burden of PH? – Sandeep Sahay
▪️Mitochondrial & metabolic modulators for PH: opportunities & challenges – Anna Hemnes
Catch up on the science and continue the conversation.
🔎 Watch now: pvrinstitute.org/learning-and-research?field_publication_… -
The Pulmonary Vascular Research Institute
@PVRI
PVRI Insights Survey – share your feedback & win a free year’s membership 🗨️
We’d love you to take 10–15 minutes today to complete our Insights Survey. Your input will help guide PVRI’s future priorities.
➡️ Take the survey today: www.surveymonkey.com/r/XRC6NWG -
The Pulmonary Vascular Research Institute
@PVRI
This paper shaped key conversations at PVRI 2026 Dublin 🫁
Published in Pulmonary Circulation, "Global Resource Disparities Between Pulmonary Hypertension Centers" shares findings from an international survey led by the PVRI IDDI Access to Care Workstream.
Referenced across multiple Congress sessions, the study highlights:
▪️Major differences in PH centre resources worldwide
▪️Gaps in diagnostics, infrastructure, and access to therapies
▪️The urgent need for equity-driven solutions in PH care
This article captures that challenge and the opportunity ahead.
➡️ Read the full research article: doi.org/10.1002/pul2.70229 -
The Pulmonary Vascular Research Institute
@PVRI
🎥 Satellite session recordings from #pvri2026 Dublin are now available!
You can now access all satellite sessions from this year’s Congress, including:
▪️IDDI
▪️Latin America Task Force
▪️Imaging Task Force
▪️Paediatric & Congenital Task Force
▪️iPVD Consortium
▪️High Altitude Task Force
▪️PAH-icon
These sessions reflect the global collaboration, regional leadership, and specialist expertise advancing PH research and care worldwide.
🔎 Watch now: pvrinstitute.org/learning-and-research?field_publication_… -
The Pulmonary Vascular Research Institute
@PVRI
National Pulmonary Hypertension Symposium 2026
📅 28 February – 01 March 2026
📍 The Oterra Hotel, Bengaluru
This two-day meeting will explore the latest evidence, practical approaches, and future directions in PH care — from risk stratification and imaging to advanced therapies and transplantation.
A valuable opportunity to strengthen collaboration and advance PH care across India.
➡️ Learn more and register: pvrinstitute.org/learning-hub/events/national-pulmonary-h… -
The Pulmonary Vascular Research Institute
@PVRI
Starting in 10 minutes ⏳️
Our Pulmonary Hypertension Community Call begins soon and you can still join us!
This month, we’re diving into:
▪️Subcutaneous treprostinil in PH associated with left heart or chronic lung disease
▪️Ferroportin inhibition in hypoxic sickle cell disease mice
▪️AI-based echocardiography in pulmonary arterial hypertension
Expect thoughtful discussion and open conversation with colleagues from across the global PH community.
➡️ Join us now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
💜 PVRI’s Patient Engagement & Empowerment Series
For some people living with PH, empowerment grows into something more — a desire to help shape care, research, and awareness beyond their own journey.
🔎 Theme 9: Become a patient expert & advocate
This theme explores how lived experience can influence real change, including opportunities to:
▪️join advisory boards or steering groups
▪️advise pharmaceutical companies
▪️speak at conferences
▪️collaborate with researchers, regulators, and healthcare teams
Becoming a patient expert takes time. But when the time feels right, lived experience brings a perspective no professional training can replace.
🎥 Watch now: pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
Join us tomorrow!
Pulmonary Hypertension Community Call - February
📅 19 February 2026
🕒️ 15:00–16:00 GMT
This month, we’ll be discussing:
▪️Subcutaneous Treprostinil in PH Associated With Left Heart Disease or Chronic Lung Disease – Irene Lang and Roela Sadushi-Koliçi
▪️Ferroportin Inhibition Attenuates PH in Hypoxic Sickle Cell Disease Mice – Melissa J Lucero, David C Irwin and Paul W Buehler
▪️Artificial Intelligence-Based Echocardiography in Pulmonary Arterial Hypertension – Bettia Edith Celestin and Francois Hadda
These free, informal online discussions are your chance to connect with the global PH community and unpack the latest research together.
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
A new chapter for PVRI starts now 📖
Brad Maron begins his term as PVRI President for 2026–28 with a clear vision: strengthen our global PH community, expand opportunity, and ensure research translates into real impact for patients — wherever they live.
In his first interview as President, Brad shares:
▪️Why community is PVRI’s greatest strength
▪️How we’ll break silos across disciplines
▪️Why access to care must be a global priority
▪️His commitment to early career members and under-represented regions
🎥 Watch the full interview now: pvrinstitute.org/learning-hub/news/brad-maron-begins-term… -
The Pulmonary Vascular Research Institute
@PVRI
❓️ Have you completed the PVRI Insights Survey yet?
This short survey is your opportunity to tell us:
▪️what’s working well
▪️where we can improve
▪️what you want to see more of in PH education, collaboration, and opportunities
Your feedback will directly shape our priorities across events, communications, advocacy, and membership — so we can better support you and your work in PH.
➡️ Complete the survey: pvrinstitute.org/learning-hub/news/pvri-insights-survey -
The Pulmonary Vascular Research Institute reposted
touchRESPIRATORY
@tmmRESPIRATORY
📢 Celebrating 20 years of progress in pulmonary hypertension: Reflections from PVRI 2026
The @PVRI 2026 Congress in Dublin marked a major milestone — 20 years of the Pulmonary Vascular Research Institute (PVRI) — bringing the global PH community together to reflect on progress and future priorities.
Over two decades, pulmonary hypertension (PH) has been transformed by advances in:
🧬 Genetics, biomarkers & molecular science
🩻 Imaging, epidemiology & risk stratification
💊 New therapies and more personalised care
🌍 Global collaboration and stronger patient focus
PVRI 2026 also highlighted what’s next: precision medicine, better trial design, improved access to care worldwide, and continued support for early-career professionals.
🔗 Read more: touchrespiratory.com/insight/celebrating-20-years-of-prog…
#pvri2026 #pulmonaryhypertension #respiratorymedicine #globalhealth #medicaleducation -
The Pulmonary Vascular Research Institute
@PVRI
PVRI's Central Asia Task Force is back 🌍
Re-established to strengthen PH care, research, and collaboration across Central Asia, this Task Force is focused on what matters most:
✅️ building clinical capacity and expertise
✅️ developing and expanding regional PH registries
✅️ adapting evidence-based PH guidelines for LMIC contexts
✅️ supporting equitable access to essential PH medicines
✅️ advancing practical, non-invasive diagnostic pathways
Looking ahead they're expanding collaboration with global experts, aligning more closely with PVRI’s global strategy, and deepening cross-regional partnerships.
➡️ Get involved: pvrinstitute.org/iddi-workstreams-task-forces/central-asi… -
The Pulmonary Vascular Research Institute
@PVRI
Now available on demand 🎥
Watch the latest Living Legends in PH session featuring Stuart Rich, who reflects on a career that helped shape modern PH care.
From leading the first NIH Registry on Primary Pulmonary Hypertension to advancing life-changing therapies, this is a powerful look at the science, milestones, and personal insights behind decades of progress in PH.
▶️ Watch now: pvrinstitute.org/learning-hub/material/living-legends-stu… -
The Pulmonary Vascular Research Institute
@PVRI
Applications are now open 🚀
We’ve launched the Pulmonary Circulation Gateway Programme!
A new 12-month peer-review mentoring pilot for Early Career Professionals in PH.
Gain hands-on reviewing experience and personalised feedback from anna hemnes, Sandeep Sahay, and Vinicio de Jesus Perez.
As a mentee, you’ll:
▪️Write structured peer reviews for real manuscripts
▪️Receive one-to-one mentor feedback
▪️Learn how editorial decisions are made
▪️Strengthen your CV with formal peer-review training
Only three mentees will be selected — apply by Friday 13 March 2026.
➡️ Register your interest: pvrinstitute.org/learning-and-research/pulmonary-circulat… -
The Pulmonary Vascular Research Institute
@PVRI
Advances in Understanding of Body Composition in PH
🗓️ 12 March 2026
⏰ 16:00–17:30 GMT
This webinar will examine how body composition influences disease progression, physiology, and potential therapeutic targets in PH.
You’ll hear from:
▪️Michael Risbano – Exercise physiology and training in PH
▪️Charly Lai – Skeletal muscle secretome in PH-HFpEF
▪️Nadine Al-Naamani – Adipose stores in PH
▪️Roham Zamanian – Insulin sensitivity in PH
▪️Thenappan Thenappan – The altered microbiome as a therapeutic target in PAH
➡️ Register now: pvrinstitute.org/learning-hub/events/advances-understandi… -
The Pulmonary Vascular Research Institute
@PVRI
PH Community Call — February
🗓️ 19 February 2026
⏰ 15:00–16:00 GMT
Join us for our next free, informal PH Community Call — your monthly space to explore the latest developments in PH and share perspectives with colleagues around the world.
This month, we’re discussing:
▪️Subcutaneous Treprostinil in PH Associated With Left Heart Disease or Chronic Lung Disease – Irene Lang & Roela Sadushi-Koliçi
▪️Ferroportin Inhibition Attenuates Pulmonary Hypertension in Hypoxic Sickle Cell Disease Mice – Melissa J Lucero, David C Irwin & Paul W Buehler
▪️Artificial Intelligence-Based Echocardiography in Pulmonary Arterial Hypertension – Bettia Edith Celestin & Francois Hadda
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Starting in 10 minutes ⏰
🖥️ Living Legends: Stuart Rich, Northwestern University Feinberg School of Medicine
We’re about to go live with one of the pioneers of modern PH research. Join us for an inspiring conversation on the science, the milestones, and the personal journey behind decades of progress in PH.
There’s still time to join us.
➡️ Register now: pvrinstitute.org/learning-hub/events/living-legends-stuar… -
The Pulmonary Vascular Research Institute
@PVRI
❓️ Missed a plenary at #pvri2026 Dublin?
All plenary talk recordings are now available on our website!
Revisit key sessions, catch up on what you missed, and continue the conversation across our global PH community.
🎥 Watch now: pvrinstitute.org/learning-and-research?field_publication_…
Some recordings are exclusive to PVRI members. So why not become a member for full access and year-round opportunities to connect, learn, and collaborate?
➡️ Become a member: pvrinstitute.org/membership/become-member -
The Pulmonary Vascular Research Institute
@PVRI
2025–26 IDDI Workstream & Task Forces Report now live 📃
Our latest report highlights the global collaboration driving progress in PH research, care, and innovation.
From access to care and lung transplantation to paediatric trial design, new technologies, real world evidence, and PH associated with chronic lung disease – our IDDI Workstreams and Task Forces are advancing shared knowledge worldwide.
➡️ Read the report: pvrinstitute.org/learning-hub/news/2025-26-iddi-workstrea… -
The Pulmonary Vascular Research Institute
@PVRI
⏳️ 1 day to go!
Living Legends in PH: Stuart Rich
🗓️ 12 February 2026
⏰ 16:00–17:30 GMT
Join us for the next session in our Living Legends in PH series, where we bring you the science and the stories behind the progress in PH.
Stuart Rich has shaped the modern understanding and treatment of PH for more than four decades. From leading the first NIH Registry on Primary Pulmonary Hypertension to pioneering research that transformed clinical care.
🔗 Register now: pvrinstitute.org/learning-hub/events/living-legends-stuar… -
The Pulmonary Vascular Research Institute
@PVRI
Do Travelers to High Altitude Need to Worry about their Blood Pressure?
📆 10 March 2026
🕐️ 13:00 GMT
Join us for a free webinar exploring how high altitude affects blood pressure and what this means for people living with PH and those caring for them.
Part of the 'Hypoxia in pulmonary vascular research – altitude and beyond' series from the High Altitude Task Force, this session brings together global experts in altitude and PH research.
➡️ Register now: pvrinstitute.org/learning-hub/events/do-travelers-high-al… -
The Pulmonary Vascular Research Institute
@PVRI
💜 PVRI’s Patient Engagement & Empowerment Series
Living with PH often comes with practical and financial challenges that can affect stability, wellbeing, and quality of life. Our Patient Engagement & Empowerment Series recognises that practical support is an essential part of care.
🔎 Theme 8: Find financial & practical support
This theme focuses on helping patients understand and access the support available to them, including:
▪️asking about insurance, benefits, and financial aid
▪️understanding workplace rights, such as flexible schedules, accommodations, or medical leave
▪️adjusting expectations and pacing activities to protect health
▪️exploring programmes that support medication access, travel, or home adaptations
Seeking support isn’t a weakness — it’s a proactive step that helps protect health and stability.
🎥 Watch now: pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
Launching the China Task Force 🌏️🎉
We’re delighted to launch the China Task Force, bringing together clinicians, researchers, and institutions to advance pulmonary vascular medicine across China and the Asia-Pacific region.
The Task Force is working to:
▪️ strengthen national PH, PE, and CTEPH registries
▪️ advance diagnosis and treatment of pulmonary vascular disease
▪️ support education and training for healthcare professionals
▪️ integrate innovation, including AI and interventional techniques, into clinical practice
With major registry growth and international collaboration already underway, 2026 will see new education initiatives, webinars, and the next annual Task Force meeting.
➡️ Want to be involved? Get in touch to join the China Task Force: pvrinstitute.org/iddi-workstreams-task-forces/china-task-… -
The Pulmonary Vascular Research Institute
@PVRI
Help us support you better 🤝
Your feedback in the PVRI Insights Survey directly informs how we develop education, opportunities, and communication for the global PH community.
➡️ Share your insight: www.surveymonkey.com/r/XRC6NWG -
The Pulmonary Vascular Research Institute
@PVRI
New case report in Pulmonary Circulation 🫁
Refractory Peripheral Pulmonary Stenosis and Severe Pulmonary Arterial Hypertension Associated With a De Novo Loss-of-Function Variant in FGD5
📆 21 January 2026
👤 Lea C. Steffes, Gregory T. Adamson, Kyla E. Dunn, Jeffrey A. Feinstein
Published in Pulmonary Circulation — PVRI’s open-access, peer-reviewed journal — this case report describes a rare genetic variant linked to refractory peripheral pulmonary stenosis and severe PAH.
➡️ Read now: onlinelibrary.wiley.com/doi/10.1002/pul2.70250 -
The Pulmonary Vascular Research Institute
@PVRI
Launching the Sri Lanka Task Force 🌏️🎉
We’re pleased to launch the Sri Lanka Task Force, a regional initiative focused on improving recognition, diagnosis, and management of PH in Sri Lanka.
Key priorities include:
▪️ establishing PH hubs across national and teaching hospitals
▪️ strengthening referral pathways to specialist care
▪️ delivering education in complex echocardiography
▪️ supporting national PH data to inform policy and service development
By working closely with local clinicians and stakeholders, the Task Force aims to support better outcomes for people living with PH.
🤝 Interested in supporting this work? Find out more here: pvrinstitute.org/iddi-workstreams-task-forces/sri-lanka-t… -
The Pulmonary Vascular Research Institute
@PVRI
💜 PVRI’s Patient Engagement & Empowerment Series
Living with PH doesn’t just affect patients, it also impacts the families and carers who support them every day.
That’s why our Patient Engagement & Empowerment Series includes a theme dedicated to recognising and supporting carers.
🔎 Theme 7: Support and empower carers & family members
This theme highlights the vital role carers play and how supporting them strengthens care for everyone, including:
▪️involving carers in care conversations and shared decision-making
▪️helping carers access reliable resources through patient associations
▪️encouraging carers to look after their own health and wellbeing
▪️recognising carers as key partners in the PH journey
When carers feel informed, supported, and included, everyone is better equipped to cope with the challenges of PH.
🎥 Watch now: pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
A final thank you from all of us at PVRI 💜
Now that we’ve all had time to travel home and reflect, we want to say a heartfelt thank you to everyone who joined us in Dublin for PVRI 2026.We hope you returned home safely and that the conversations, collaborations, and ideas from the week are continuing beyond the congress.
Session recordings will be released soon, and we’ll share more details as they become available 🎥
Go raibh míle maith agaibh for being part of our global PH community.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Pulmonary Hypertension Community Call — February
🗓️ 19 February 2026
🕒️ 15:00 –16:00 GMT
Our monthly online space bringing the PH community together to share updates, ask questions, and discuss what’s shaping the field right now — openly and collaboratively.
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi…
🗣 Thank you to our hosts: Katrina Barry, Joel James, Tatiana Kudryashova, Katarina Zeder, Rodolfo Estrada, and Sandeep Sahay -
The Pulmonary Vascular Research Institute
@PVRI
One week to go!
Living Legends: Stuart Rich, Northwestern University Feinberg School of Medicine
📆 12 February 2026
🕔 16:00 GMT - 17:30 GMT
Join us next week for Living Legends in PH, featuring Stuart Rich — a pioneer whose work has shaped modern PH care.
➡️ Register here: -
The Pulmonary Vascular Research Institute
@PVRI
That’s a wrap on the main scientific programme at PVRI 2026 Dublin 🎬
On behalf of the whole PVRI team, Karen, Debs, Elvia, Rachel, Katie, and Catherine. Thank you to everyone who joined us in Dublin — our speakers, chairs, poster presenters, partners, and delegates — for sharing your science, your time, and your energy throughout the week.
P.S. The Congress isn’t quite over yet — we still have one final satellite meeting tomorrow with PAH-ICON.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
A powerful close to the main scientific programme at PVRI 2026 Dublin 💪
The final sessions brought our Congress to a powerful close, looking firmly toward the future of PH. Together, they explored:
▪️ Precision medicine and artificial intelligence in PH
▪️ Sharks Den pitches spotlighting bold new targets, biomarkers, and devices
▪️ Innovative concepts shaping future research and care
▪️ What it truly means to live life to the full with PH
From cutting-edge science to patient-centred perspectives, these sessions captured both innovation and humanity — at the heart of PVRI.
Thank you to all speakers, chairs, and delegates for an inspiring main programme 👏
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
As PVRI 2026 comes to a close, we want to extend our heartfelt thanks to Anna Hemnes for her leadership over the past two years as PVRI President.
During her term, Anna has guided PVRI with clarity, dedication, and a deep commitment to advancing PH research, collaboration, and community worldwide.
Her leadership has helped strengthen connections across our global network at a pivotal time for PVRI.
Thank you, Anna, for your time, energy, and unwavering support of the PH community 🤝
Go raibh míle maith agat.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
The Women in PH Luncheon brings colleagues together to celebrate inclusion, mentorship, and shared leadership.
A space to connect, support one another, and amplify women’s voices across the PH community 🤝
With thanks to United Therapeutics Corporation for supporting this important event.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Today marks the start of Brad Maron’s two-year term as PVRI President.
As Brad begins his presidency at this milestone moment for our community, his focus over the next two years will centre on:
▪️ Supporting career development across all stages
▪️ Strengthening equity and inclusion across global PH care
▪️ Expanding multidisciplinary collaboration, including AI, data science, and emerging research methods
▪️ Ensuring sustainable growth and transparency, while protecting access for early-career and global members
▪️ Addressing emerging global challenges shaping the future of PH
We’re grateful for Brad’s leadership and look forward to working together to advance research, care, and collaboration for our global PH community.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Poster discussions continue this morning.
So many excellent projects on display — don’t forget to vote for your favourite poster: www.surveymonkey.com/r/SG2N7SL
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Last night was about celebration and recognition ✨🏆️
The PVRI 2026 Gala Dinner honoured outstanding contributions across PH research, mentorship, and service — a powerful reminder of how far we’ve come together as a community.
Congratulations to our 2026 award recipients:
▪️Stephen Archer — PVRI Lifetime Achievement Award
▪️Daniel Colon Hidalgo — Butrous Foundation Young Investigator Award
▪️Sebastien Bonnet & Steeve Provencher — PVRI Achievement Award
▪️Gabor Kovacs — PVRI Achievement Award
▪️Katarina Zeder — PVRI Special Recognition Award
▪️Will Oldham — PVRI Special Recognition Award
▪️Abdullah Aldalaan — PVRI Special Recognition Award
▪️Sylvia Nikkho — Certificate of Recognition
Go raibh míle maith agaibh to all our awardees — and to everyone who makes the global PH community so special 👏 -
The Pulmonary Vascular Research Institute
@PVRI
Good morning from Dublin ☕
Lá 3 de PVRI 2026 looks firmly to the future, with sessions on:
▪️ Precision medicine
▪️ Artificial intelligence in PH
▪️ Living life fully with PH
We’re excited to hear future-focused keynotes from Bradley Maron, Raymond Benza, and Paul Hassoun as we look ahead to the next 20 years.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Fáilte chuig an nDinnéar Gala ✨
Tonight, we celebrate 20 years of PH innovation, recognise outstanding contributions through the PVRI Awards, and come together as a global community.
Enjoy a very special night at the iconic Guinness Storehouse.
#pvri2026
❗️Reminder: This is a ticketed event — guests are kindly asked to arrive at 19:00 to allow time to enjoy the venue ahead of the evening’s programme. -
The Pulmonary Vascular Research Institute
@PVRI
Another busy poster session this afternoon.
If you haven’t yet, take a moment to explore the posters — and remember to cast your vote: www.surveymonkey.com/r/SG2N7SL
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
The Career Catalyst Luncheon brings early-career professionals and established leaders together for focused, informal mentoring.
Short conversations, shared experiences, and practical advice — all designed to support the next generation of PH researchers and clinicians.
With thanks to United Therapeutics for supporting this important session — a real highlight of the week.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Lá 2 de PVRI 2026 is underway.
Today’s programme focuses on all-cause PH, including:
▪️ PH associated with lung diseases
▪️ Global burden, registries, and equity in care
▪️ Two decades of progress in CTEPH
We’re looking forward to keynote perspectives from Sandeep Sahay and Oksana Shlobin as we tackle global challenges and opportunities in PH.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Poster sessions are underway 🖼️
Take time to explore new data, meet the researchers behind the work, and don’t forget — you can vote for your favourite poster now: www.surveymonkey.com/r/SG2N7SL
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
It’s so good to see our Scientific Organising Committee all together in person at PVRI 2026 Dublin 🍀
Thank you for the vision, leadership, and hard work that went into shaping such an outstanding scientific programme. From cutting-edge sessions to thoughtful discussion, this Congress reflects your commitment to advancing PH research worldwide.
Go raibh míle maith agaibh — and thank you for everything you’ve done 👏
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
All are welcome at today's Women’s Health Task Force meet & greet 👋
An open invitation to meet the Task Force leaders, including Jessica Badlam and Meghan Cirulis, and connect with colleagues working to advance women’s health in PH.
Find us in the phoenix boardroom on the upper ground floor.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
A strong scientific opening this morning ☀️
Sessions 1 & 2 explored:
▪️ Clinical and real-world experience with sotatercept
▪️ Vascular remodelling and novel signalling pathways
▪️ Promising therapeutic targets shaping future PAH care
Insightful talks, lively discussion, and plenty to reflect on.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Fáilte go Lá 1 de PVRI 2026 🎉
We’re opening the main Congress with a focus on 20 years of progress in PAH, bringing together colleagues from 37 countries worldwide to share science, ideas, and collaboration.
Today’s programme includes:
▪️ Sotatercept — from trials to real-world insights
▪️ Translational targets and pathways
▪️ The right ventricle–lung alliance
We’re delighted to begin with leadership from Anna Hemnes, setting the tone for an exciting few days of science and collaboration.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Our satellite meetings have now come to a close after a full day of discussion.
From trial design and imaging standards to paediatric PH, infection, altitude, and regional challenges, today’s conversations laid important groundwork for the days ahead.
Tomorrow, we start the main scientific programme.
Slán go fóill 👋
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Great to see the IDDI leadership team come together in-person!
The Innovative Drug Development Initiative (IDDI) brings together academia, pharma, biotech, regulators, and patient voices to rethink how PH trials are designed — always with patient needs front and centre.
▪️ Sidra Hoffman
▪️ Luke Howard
▪️ Gil Golden
▪️ Sandeep Sahay
Together, the IDDI Workstreams are shaping the future of PH drug development.
Go raibh maith agaibh for leading the way.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Welcome to today’s satellite meetings 👋
Today, PVRI’s IDDI Workstreams, Specialty & Regional Task Forces are coming together to tackle key challenges in PH, including:
▪️Innovative Drug Development Initiative (IDDI)
▪️Latin America Task Force
▪️Imaging Task Force
▪️Paediatric & Congenital Task Force
▪️Infection in Pulmonary Vascular Disease (iPVD) Consortium
▪️High Altitude Task Force
A strong, collaborative start — rooted in science and shared purpose.
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2026 Dublin starts today 🎉
We’re looking forward to three days of discussion, discovery, and collaboration with colleagues from around the world.
Don’t forget to download the event app for the programme, live updates, and everything you need during the Congress.
Follow and share updates using #pvri2026 📲 -
The Pulmonary Vascular Research Institute
@PVRI
Fáilte go Baile Átha Cliath 🍀
The PVRI team has arrived in Dublin!
We’re setting up and excited to welcome our global PH community — with colleagues travelling from 37 countries around the world — as we mark 20 years of PVRI together.
We can’t wait to welcome you 🤝
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
PVRI’s Patient Engagement & Empowerment Series 💜
Research drives progress in PH — and patients play a vital role.
Our Patient Engagement & Empowerment Series helps you understand how research and clinical trials fit into PH care, so you can make informed choices with confidence.
🔎 Theme 6: Explore clinical trials & research participation
This theme focuses on understanding research opportunities, including how to:
▪️ ask your doctor about clinical trials
▪️ learn what participation involves, including potential benefits and risks
▪️ understand your rights and how your safety is protected
The message is clear: taking part in research is always a personal choice — and being informed puts you in control.
➡️ Explore the full series: pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
See you there! 👋🍀
It’s the final countdown — PVRI 2026 Dublin begins this week!
We’re looking forward to welcoming our global PH community as we come together to celebrate 20 years of PVRI.
If you’re joining us, safe travels and see you soon in Dublin! 🚂✈️⛴️ -
The Pulmonary Vascular Research Institute
@PVRI
The countdown is on for PVRI 2026 Dublin ⏳
❓ Have you downloaded the event app yet?
It’s the easiest way to:
▪️ plan your schedule
▪️find rooms & sessions
▪️ stay up to date during the week
➡️ Still time to register: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
PVRI’s Patient Engagement & Empowerment Series 💜
Living with PH can feel isolating at times — but connection makes a real difference. Our Patient Engagement & Empowerment Series highlights how community and shared experience can strengthen resilience and confidence.
🔎 Theme 5: Connect with peer-to-peer support and community engagement
This theme focuses on the power of connecting with others, including how to:
▪️ join patient associations or local support groups
▪️ share experiences, practical tips, and encouragement
▪️ create a group or online space if none exist in your area
▪️ become a peer mentor when you feel ready
The message is simple and powerful: you are not alone — and together, we can help each other feel stronger.
➡️ Explore the full series: pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
One week to go until PVRI 2026 Dublin! 🍀⌛
In just seven days, the global PH community comes together in Dublin for a week of science, collaboration, and shared purpose.
What to look forward to:
▪️cutting-edge PH research
▪️cross-disciplinary discussion
▪️opportunities to connect
Make sure to download the PVRI 2026 Congress app 📱
➡️ Still time to register: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
Huge thank you to MSD for their generous support at PVRI Dublin 2026! 💜
They’re a Platinum Exhibitor at this year’s Congress — and we’re incredibly grateful to have them with us. Their long-standing commitment to scientific innovation and global health aligns deeply with our mission to advance understanding and care in pulmonary hypertension.
MSD (known as Merck & Co., Inc., Rahway, NJ, USA in the US and Canada) uses leading-edge science to save and improve lives worldwide. With more than 130 years of innovation in medicines and vaccines, they continue to shape the future of healthcare through research leadership, a diverse and inclusive workforce, and a commitment to a healthy, sustainable future for all.
Make sure to visit MSD at Stand 2 in the Exhibition Hall at PVRI Dublin 2026 (28 January – 1 February 2026).
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors -
The Pulmonary Vascular Research Institute
@PVRI
❔What should PVRI do more of?
❔Less of?
❔Better?
The PVRI Insights Survey gives you the chance to shape how PVRI supports you and your work in PH.
Your feedback will directly inform our future priorities.
➡️ Take it now: www.surveymonkey.com/r/XRC6NWG -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Global Resource Disparities Between Pulmonary Hypertension Centers: Results From the International Survey
📆 06 January 2026
👤Sasha Prisco, Alex Kantorovich, Yan Liu, Sandeep Sahay, Roberto Bernardo, Vijay Balasubramanian, J. Usha Raj, Gil Golden, Franz Rischard
Led by the PVRI IDDI Access to Care Workstream, the study underscores critical gaps in infrastructure, diagnostics, and care delivery, and reinforces the importance of equity-driven solutions in PH worldwide.
➡️ Read the full research article: onlinelibrary.wiley.com/doi/full/10.1002/pul2.70229?campa…
Published in Pulmonary Circulation — PVRI’s open-access, peer-reviewed journal. -
The Pulmonary Vascular Research Institute
@PVRI
Fill out our insights survey 💡
Your insight helps us improve how PVRI supports you and the global PH community. By taking a few minutes to complete our insights survey, you’ll help shape what comes next.
❓ Why take part?
Your feedback will help us:
▪️strengthen the services and opportunities that matter most to you
▪️improve how we communicate, engage, and share opportunities with you
▪️shape future PVRI initiatives around real clinical and research priorities
It will take around 10–15 minutes and you'll be in with a chance to win a free year of PVRI membership!
👉 Take the survey: www.surveymonkey.com/r/XRC6NWG -
The Pulmonary Vascular Research Institute
@PVRI
Speaker spotlight 💡
PVRI 2026 Dublin
🗓️ 28 January 2026 - 1 February 2026
We’re celebrating our 20th anniversary with an exceptional line-up of global PH leaders — each bringing fresh insight, innovation, and forward-looking science to the PVRI 2026 stage.
Here’s a first look at four standout speakers shaping this year’s programme:
Is the basement membrane a novel therapeutic target in PAH?
👤 Grazyna Kwapiszewska, Medizinische Universität Graz
What can we learn from the right ventricle in congenital heart disease?
👤 Beatrijs Bartelds, Erasmus MC
Carving new pathways: translating PDGFRß or SGLT2 inhibition into PAH therapy
👤 Lisa Mielniczuk, University of Ottawa
AI-enhanced risk models for PH survival
👤 Andy Swift, University of Sheffield
This is just a glimpse of what awaits you in Dublin — a Congress built on two decades of collaboration, discovery, and shared purpose.
➡️ Register now: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
We’re delighted to launch the next webinar in our Living Legends in PH series...
Living Legends: Stuart Rich, Northwestern University Feinberg School of Medicine
🗓️ 12 February 2026
⏰ 16:00 GMT
This session offers a rare opportunity to hear directly from one of the pioneers of PH research.
What you can expect:
▪️ personal perspectives from a true Living Legend in PH
▪️ reflections on landmark discoveries and clinical advances
▪️ an interactive discussion with the global PH community
➡️ Register now: pvrinstitute.org/learning-hub/events/living-legends-stuar…
Thank you to our facilitators, Serpil Erzurum and Saad Kubba. -
The Pulmonary Vascular Research Institute
@PVRI
PVRI’s Patient Engagement & Empowerment Series 💜
Having pulmonary hypertension means you’re an important part of your healthcare team. Our Patient Engagement & Empowerment Series offers practical guidance to help you take an active, confident role in your care.
🔎 Theme 4: Engage in shared decision-making in healthcare
This theme focuses on working in partnership with your healthcare professionals, including how to:
▪️ prepare for appointments and raise what matters to you
▪️ ask questions and understand your options
▪️ use tools like EmPHasis-10 to explain how you’re really feeling
▪️ feel confident about your rights and choices as a patient
The message is clear: when patients and healthcare teams work together, care becomes more personal and effective.
➡️ Explore the full series: pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2026 Dublin event app is live 📣📱
We’re just two weeks away from coming together in Dublin with the global PH community. The countdown is on, and now you can start planning your Congress experience.
Use the event app to:
▪️explore the full scientific programme
▪️connect with colleagues from across the global PH community
▪️stay up to date with live Congress updates
Whether you’re finalising your travel plans or shaping your schedule, everything you need is now in one place.
➡️ Tickets are still available here: pvrinstitute.org/learning-hub/events/pvri-2026-dublin
📩 If you’ve already registered, your app access details have been sent by email. -
The Pulmonary Vascular Research Institute
@PVRI
We’re delighted to congratulate Bradley Maron, PVRI’s soon-to-be President, on his new role as Editor-in-Chief (Elect) of Circulation at the American Heart Association.
This is a hugely significant appointment, reflecting Bradley’s leadership, vision, and long-standing commitment to advancing cardiovascular and translational science. We’re proud to see his influence extend to one of the world’s leading journals — and excited for what this means for the global research community.
Congratulations, Bradley 👏 -
The Pulmonary Vascular Research Institute
@PVRI
Huge thank you to @ChiesiGroup for their generous support at PVRI Dublin 2026! 💜
They’re joining us as a Gold Sponsor — and we’re incredibly grateful for their partnership.
Chiesi is supporting the main programme by sponsoring the ‘Translating innovation into PH therapies’ session on 30 January, helping our global community explore how scientific breakthroughs can move closer to meaningful therapies for people living with PH.
Who they are:
Chiesi is a research-oriented international biopharmaceutical group developing innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. Their mission is to improve people’s quality of life while acting responsibly towards the community and the environment.
We’re proud to recognise their leadership, innovation, and long-standing dedication to patient care.
➡️ Explore the full list of our 2026 exhibitors and sponsors: pvrinstitute.org/pvri-2026-exhibitors-sponsors -
The Pulmonary Vascular Research Institute
@PVRI
Webinar recording now available! 🎥
Missed our recent webinar on Bioengineering and bioprinting advances in PH research?
You can now watch the full recording.
This session explored how bioengineering and bioprinting technologies are reshaping experimental approaches in PH research.
Featuring expert presentations from Brenda Ogle, Dan Shiwarski, Beata Wojciak-Stothard, and Taslim A. Al-Hilal, and moderated by Paul Yu and Sasha Prisco.
👉 Watch the recording and catch up on the discussion: pvrinstitute.org/learning-hub/material/bioengineering-and… -
The Pulmonary Vascular Research Institute
@PVRI
🎉 PVRI 2026 Dublin Fundraising Events
Join us for two special fundraising events that bring our global PH community together.
Morning run & walk
📅 Friday 30 January
⏰ 06:00–07:00 GMT
Start the day with a guided run or walk through Dublin before sessions begin.
PVRI Pub Social
📅 Saturday 31 January
⏰ 17:00–19:00 GMT
Unwind with colleagues across two iconic Dublin pubs.
👉 Take part and register: pvrinstitute.org/learning-hub/events/pvri-2026-dublin-fun… -
The Pulmonary Vascular Research Institute
@PVRI
🚀 We’re hiring: Advocacy & Engagement Lead
We’ve created a new role at PVRI to help drive real change in PH diagnosis and treatment in underserved regions worldwide.
This role will:
▪️ lead a two-year pilot project focused on improving PH diagnosis and treatment
▪️ work with local PH professionals and regional stakeholders
▪️ identify gaps in care and co-develop practical, context-specific solutions
▪️ draw on expertise from PVRI’s global membership and 20 workgroups
If you’re motivated by advocacy, collaboration, and making a meaningful global impact — this could be the role for you.
👉 Find out more and apply today: pvrinstitute.org/about-us/pvri-careers-and-opportunities -
The Pulmonary Vascular Research Institute
@PVRI
🎟️ Don't forget to register for the...
PVRI 2026 Gala Dinner & Awards Presentation Evening 🏆
Celebrate 20 years of PH innovation at the iconic Guinness Storehouse in Dublin, with awards, fine food, drinks, and live entertainment alongside colleagues from around the world.
➡️ Register here: pvrinstitute.org/learning-hub/events/pvri-2026-dublin
❗Tickets must be purchased in advance and will not be available to buy at the congress. -
The Pulmonary Vascular Research Institute
@PVRI
Congratulations to our PVRI President, Anna Hemnes, on her appointment as Chair of the Department of Medicine and System Physician-in-Chief at Vanderbilt Health! 🎉
This is a remarkable achievement and a testament to Anna’s vision, leadership, and long-standing commitment to advancing care and research in pulmonary hypertension.
We’re incredibly proud to see her take on this pivotal role and know she’ll make a lasting impact across clinical care, research, and training.
Congratulations, Anna — from all of us at PVRI 👏 -
The Pulmonary Vascular Research Institute
@PVRI
Starting now...🖥️
Bioengineering and bioprinting advances in PH research
The first PVRI webinar of 2026 explores how innovative technologies are shaping the future of PH research.
This live session will cover:
▪️Engineered muscle pump systems using iPSC-derived cardiomyocytes
▪️3D bioprinting of vasculature
▪️PAH organ-on-a-chip models
▪️Microfluidic platforms to study pulmonary vascular stiffness
➡️ Join now: pvrinstitute.org/learning-hub/events/bioengineering-and-b… -
The Pulmonary Vascular Research Institute
@PVRI
Huge thank you to United Therapeutics for their generous support at PVRI Dublin 2026! 💜
They’re joining us as a Premium Sponsor at this year’s Congress — and we’re incredibly grateful for their leadership and partnership.
United Therapeutics is powering two key community events:
▪️ the Career Catalyst Luncheon on 30 January
▪️ the Women in Pulmonary Hypertension Luncheon on 31 January
These sessions help elevate diverse voices in medicine and create space for mentorship, connection, and progress.
United Therapeutics partners with patients and healthcare providers to fight PH and other lung diseases. Their research spans pioneering pulmonary therapies and an ambitious long-term goal: enabling an unlimited supply of transplantable organs. As the first publicly traded biotech company organised as a sustainable Public Benefit Corporation, they are deeply committed to safety, innovation, access, compliance, ethics, and environmental responsibility.
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors -
The Pulmonary Vascular Research Institute
@PVRI
Still time to register!
Bioengineering and bioprinting advances in PH research
📆 8 January 2026
🕓 16:00 GMT
This session brings together international experts to discuss:
▪️ Engineered muscle pump systems using iPSC-derived cardiomyocytes
▪️ 3D bioprinting of vasculature
▪️ PAH organ-on-a-chip models
▪️ Microfluidic platforms to study pulmonary vascular stiffness
➡️ Signup now: pvrinstitute.org/learning-hub/events/bioengineering-and-b… -
The Pulmonary Vascular Research Institute
@PVRI
Huge thank you to @Insmed for their generous support at PVRI Dublin 2026! 💜
They’re a Platinum Exhibitor at this year’s Congress — and we’re incredibly grateful for their partnership. Insmed brings vital energy to our global PH community through their commitment to advancing science, strengthening collaboration, and improving care for people with rare and serious diseases.
@Insmed is a biopharmaceutical company driven by a mission to transform the lives of patients with serious and rare diseases. With a rich pipeline spanning rare pulmonary diseases, genetic conditions, neutrophil-driven inflammation, MAC lung disease, and pre-clinical research, they’re dedicated to delivering life-altering therapies with urgency, compassion, and scientific excellence.
Make sure to visit Insmed at Stand 1 in the Exhibition Hall at PVRI Dublin 2026 (28 January – 1 February 2026).
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors -
The Pulmonary Vascular Research Institute
@PVRI
PVRI’s Patient Engagement & Empowerment Series 💜
Everyday actions can play a powerful role in living well with pulmonary hypertension. Our Patient Engagement & Empowerment Series offers practical guidance to help patients care for themselves with confidence.
🔎 Theme 3: Practice self-care & make lifestyle adaptations
This theme focuses on realistic, manageable ways to support daily wellbeing, including:
▪️pacing activities and conserving energy
▪️incorporating gentle movement where appropriate
▪️tracking symptoms and medications
▪️building rest and recovery into daily routines
The message is simple but important: self-care isn’t selfish — it’s essential.
➡️ Explore the full series: pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
Only 3 weeks to go! ⏳
In just three weeks, the global PH community will come together in Dublin as we celebrate 20 years of progress, collaboration, and innovation.
PVRI 2026 Dublin
📆 28 January 2026 - 1 February 2026
📍 Dublin
From cutting-edge science and pro–con debates to satellite meetings, mentoring, and community events, this year’s Congress looks firmly to the future of PH.
➡️ Register now: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
Exploring the Impact of Platelet-Derived Growth Factor D in Pulmonary Hypertension Development
📆29 November 2025
👤Philip Tannenberg, Karin Tran-Lundmark, Ya-Ting Chang, Hanna Gladh, Frank Chenfei Ning, Christian Westöö, Christian Norvik, Azra Alajbegovic, Sebastian Albinsson, Hans Brunnström, Ulf Hedin, Erika Folestad
Published in Pulmonary Circulation — PVRI’s open-access, peer-reviewed journal — this article contributes to ongoing global discussion on optimising care in PH.
➡️ Read the full research article: pvrinstitute.org/learning-hub/material/exploring-impact-p… -
The Pulmonary Vascular Research Institute
@PVRI
Join PVRI's first webinar of 2026!
Bioengineering and bioprinting advances in PH research
📆 8 January 2026
🕓 16:00 GMT
We'll be discussing:
▪️Engineered muscle pump systems using iPSC-derived cardiomyocytes - Brenda Ogle, University of Minnesota, USA
▪️3D bioprinting vasculature - Dan Shiwarski, University of Pittsburgh, USA
▪️PAH organ on a chip - Beata Wojciak-Stothard, Imperial College London, UK
▪️Microfluidic platforms to study pulmonary vascular stiffness - Taslim A. Al-Hilal, The University of Utah
➡️ Register for free now: pvrinstitute.org/learning-hub/events/bioengineering-and-b… -
The Pulmonary Vascular Research Institute
@PVRI
💜 PVRI’s Patient Engagement & Empowerment Series
Living with PH affects more than the body — it can also take a toll on emotional and mental wellbeing.
That’s why theme two of our Patient Engagement & Empowerment Series focuses on psychological support and mental wellbeing.
🔎 Access psychological support & mental wellbeing resources
This video highlights why mental wellbeing matters in PH care and how patients can seek support when they need it, including:
▪️recognising feelings of anxiety, stress, or low mood
▪️understanding when professional support may help
▪️opening up conversations with healthcare teams, family, and carers
▪️connecting with peer support and patient communities
➡️ Explore the full series: pvrinstitute.org/pulmonary-hypertension/how-empower-yours… -
The Pulmonary Vascular Research Institute
@PVRI
Happy New Year from the PVRI team! 🎆
As we welcome 2026, we’re also celebrating 20 years of progress driven by our global PH community. Together, we’ve advanced research, strengthened collaboration and expanded knowledge.
Here’s to new ideas, shared ambition and even greater impact for people living with PH in the years ahead. 🚀 -
The Pulmonary Vascular Research Institute
@PVRI
Season’s greetings from the PVRI team 🎄✨
As the year comes to a close, the entire PVRI team sends our global PH community warm wishes for a peaceful and joyful holiday season — wherever you are in the world, and however you choose to celebrate.
Thank you for being part of our community and for the expertise, energy and generosity you bring to PVRI throughout the year.
We’re grateful for all you do, and we look forward to everything we’ll achieve together in 2026 🚀 -
The Pulmonary Vascular Research Institute
@PVRI
New research in Pulmonary Circulation 🫁
A Systematic Literature Review Exploring the Efficacy and Safety of Tadalafil and Sildenafil in Pulmonary Arterial Hypertension
📆27 November 2025
👤Rajan Saggar, Nora Rahhali, Assunta Senatore, Marinella Sandros, David Lopez, Gabriela Gomez Rendon, Ambar Khan, Ellie Boulton, Anna Bobrowska, Sandeep Sahay
Published in Pulmonary Circulation — PVRI’s open-access, peer-reviewed journal — this article contributes to ongoing global discussion on optimising care in PH.
➡️ Read the full research article: pvrinstitute.org/learning-hub/material/systematic-literat… -
The Pulmonary Vascular Research Institute
@PVRI
Looking ahead to Dublin…🍀
As the festive season approaches, we’re already getting excited about welcoming you to Dublin for PVRI 2026 this January.
If it’s your first time — or even if it isn’t — here are three Dublin experiences to try:
🎶 enjoy live Irish music and warm hospitality at Gogarty’s, right in the heart of the city
🍞 try a comforting bowl of Irish seafood chowder, served with freshly baked soda bread — perfect for winter evenings
🥃 discover the stories and craft behind Ireland’s most famous export with a whiskey distillery tour
In just a few weeks, Dublin will be the backdrop for five days of science, collaboration, and connection — as we begin celebrating 20 years of PVRI together.
➡️ Don't forget to register: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
❓ Missed it live?
Our December PH Community Call is now available on demand 🎥
Catch up on expert-led discussion exploring new insights into hypoxic pulmonary hypertension and the impact of exercise interventions in PAH, with perspectives from across the global PH community.
▶️ Watch the recording now: pvrinstitute.org/learning-hub/material/pulmonary-hyperten… -
The Pulmonary Vascular Research Institute
@PVRI
Huge thank you to @GossamerBio and Interact Bio for their fantastic support at PVRI Dublin 2026! 💜
We’re proud to recognise Interact Bio as a Gold Sponsor and Gossamer Bio as a Gold Exhibitor at next year’s Congress — and we’re incredibly grateful for their partnership.
Together, they help create a vibrant, forward-looking scientific environment at the meeting:
▪️ Interact Bio is sponsoring all three moderated poster sessions on 29, 30, and 31 January
▪️ Gossamer Bio joins our Exhibition Hall, find them at Stand 4
Make sure to meet both exhibitors in the Exhibition Hall at PVRI Dublin 2026 (28 January – 1 February 2026).
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors
The Pulmonary Vascular Research Institute
@PVRI
About Interact Bio
Interact Bio is a biotechnology company developing novel agents for rare cardiovascular diseases. Their work focuses on cutting-edge antibody discovery to target genetically and clinically validated pathways in PAH and hereditary haemorrhagic telangiectasia (HHT). Founded in 2023, they draw on world-leading expertise in PAH/HHT pathobiology from their base in Cambridge, UK.
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors
The Pulmonary Vascular Research Institute
@PVRI
About @GossamerBio
Gossamer Bio is a clinical-stage biopharmaceutical company developing seralutinib for PAH and PH-ILD. Their work is rooted in strengthening the “gossamer thread” — the vital connections between patients, researchers, providers, and partners — reflecting their commitment to improving the lives of people living with rare pulmonary diseases.
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors -
The Pulmonary Vascular Research Institute
@PVRI
¿No pudiste asistir en directo?
Ahora disponible a demanda 🎥
Nuestro seminario web de PVRI sobre hipertensión pulmonar del Grupo 2, parte del ciclo del Grupo de Trabajo de América Latina, ya está disponible para ver.
En esta sesión dirigida por expertos se abordan el diagnóstico, la clasificación actualizada según la 7.ª Conferencia Mundial sobre Hipertensión Pulmonar, y las estrategias de tratamiento — incluido el manejo de la CpcPH — a través de presentaciones clínicas y discusión de casos.
▶️ Ver la grabación: pvrinstitute.org/learning-hub/material/hipertension-pulmo…
The Pulmonary Vascular Research Institute
@PVRI
Missed it live?
Now available on demand 🎥
Our PVRI webinar on Group 2 pulmonary hypertension, part of the Latin America Task Force series, is now available to watch.
This expert-led session explores diagnosis, updated classification from the 7th World Symposium on Pulmonary Hypertension, and treatment strategies — including management of CpcPH — through clinical presentations and case discussion.
▶️ Watch the recording: pvrinstitute.org/learning-hub/material/hipertension-pulmo… -
The Pulmonary Vascular Research Institute
@PVRI
Starting in 15 minutes ⏰
Join us for the final PH Community Call of 2025.
In this final session of the year, we’ll cover:
▪️ monocytes and interstitial macrophages in hypoxic PH
▪️ kettlebell exercise training in pulmonary arterial hypertension
➡️ Register here: -
The Pulmonary Vascular Research Institute
@PVRI
Huge thank you to @Bayer and Pulmovant for their generous support at PVRI Dublin 2026! 💜
They’re both Gold Sponsors at next year’s Congress — and we’re incredibly grateful for their partnership.
Together, their contributions help strengthen our global community:
▪️Bayer is supporting seamless connectivity as our exclusive Wi-Fi Sponsor, helping every delegate stay connected, engaged, and fully present throughout the meeting.
▪️Pulmovant is generously sponsoring the PVRI 2026 Congress lanyards, ensuring every attendee begins the week with their support quite literally in hand.
We’re grateful for their commitment to innovation, patient impact, and global collaboration.
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors
The Pulmonary Vascular Research Institute
@PVRI
About @Bayer
Bayer has been a leader in pulmonary hypertension innovation since 1997 — from pioneering inhaled iloprost to developing the first-in-class sGC stimulator riociguat. Their commitment continues today with new advances driven by collaboration across academia, regulators, patient groups, and PVRI.
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors
The Pulmonary Vascular Research Institute
@PVRI
About Pulmovant
Pulmovant is a clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases. Pulmovant’s first investigational candidate, mosliciguat, is designed to provide a novel, once-daily, inhaled treatment option for patients with pulmonary hypertension associated with Interstitial Lung Disease (PH-ILD). Mosliciguat is a potential first-in-class soluble guanylate cyclase activator with a differentiated mechanism of action currently being evaluated in the Phase 2 PHocus global clinical trial in PH-ILD.
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors -
The Pulmonary Vascular Research Institute
@PVRI
Join us tomorrow for the final PH Community Call of 2025! 📣
PH Community Call December
🗓️ 18 December 2025
🕒 15:00 GMT
Our monthly PH Community Calls are free, informal online discussions bringing the global PH community together to share insights and explore the latest research.
In this final session of the year, we’ll discuss:
▪️ the role of monocytes and interstitial macrophages in hypoxic PH
▪️ kettlebell exercise training and functional outcomes in pulmonary arterial hypertension
➡️ Register here: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Now available for PVRI members 🎬
The full recording of our Living Legends in PH session with Rubin Tuder is now available to watch on demand.
Rubin Tuder reflects on the discoveries, questions, and collaborations that have shaped modern PH research — from foundational models to mentorship and scientific curiosity.
➡️ Watch the full recording: pvrinstitute.org/learning-hub/material/living-legend-rubi… -
The Pulmonary Vascular Research Institute
@PVRI
¡Comenzamos en 15 minutos! ⌛
La hipertensión pulmonar del grupo 2 es la forma más frecuente de HP — y una de las más complejas de manejar.
Únase en vivo mientras expertos internacionales analizan:
▪️ diagnóstico y clasificación (7.ª Conferencia Mundial sobre HP)
▪️ insuficiencia cardiaca, retención de líquidos y CpcPH
▪️ estudios de imagen, hemodinámica y discusión de casos clínicos reales
💬 Participe en la discusión: pvrinstitute.org/learning-hub/events/hipertension-pulmona…
The Pulmonary Vascular Research Institute
@PVRI
Starting in 15 minutes! ⌛
Group 2 pulmonary hypertension is the most common form of PH — and one of the most complex to manage.
Join us live as international experts explore:
▪️ diagnosis and classification (7th WSPH)
▪️ heart failure, fluid retention, and CpcPH
▪️ imaging, haemodynamics, and real-world case discussion
💬 Take part in the discussion: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute
@PVRI
The PVRI 2026 Dublin IDDI programme has now been released 📢
The Innovative Drug Development Initiative (IDDI) sessions take place during the satellite meetings on Wednesday 28 January, bringing together academia, industry, regulators and patient perspectives
The sessions will focus on:
▪️innovation in PH drug development
▪️future directions for clinical trials
▪️collaboration across sectors and disciplines
➡️ Explore the full programme: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
Speaker spotlight 💡
PVRI 2026 Dublin
🗓️ 28 January 2026 - 1 February 2026
We’re celebrating our 20th anniversary with an exceptional line-up of global PH leaders — each bringing fresh insight, innovation, and forward-looking science to the PVRI 2026 stage.
Here’s a first look at four standout speakers shaping this year’s programme:
The promise of AI
👤 Bradley Maron, University of Maryland
Precision medicine in PH: the emerging promise of molecular techniques
👤Jane Leopold, Harvard University
BPA - techniques, outcomes & future directions
👤Hiromi Matsubara, Okayama Medical Center
Global burden of paediatric PH
👤Mary Mullen, Boston Children Hospital
This is just a glimpse of what awaits you in Dublin — a Congress built on two decades of collaboration, discovery, and shared purpose.
➡️ Register now: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
¡Queda 1 día! ⌛
Acompáñanos para un análisis centrado en la HP del Grupo 2 — asociada a insuficiencia cardíaca y retención de líquidos — junto a expertos internacionales que explorarán diagnóstico, clasificación (7.ª CMHP), imagen, hemodinámica, estrategias de tratamiento y un caso clínico en vivo.
Hipertensión Pulmonar Grupo 2: asociada a insuficiencia cardiaca y retención de fluido
🗓 16 de diciembre de 2025
🕒 15:00 GMT
💬 Sesión impartida en español, con subtítulos disponibles.
👉 Inscríbete ahora: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute
@PVRI
❓ Did you know?
#phgps found that only 34% of adults with PAH, who were eligible under current guidelines, have had genetic testing.
Genetic insights can help clinicians understand inherited risk, guide family discussions, and support more personalised care. These findings highlight a clear opportunity to improve access and ensure more people benefit from the information genetic testing can provide.
➡️ Read the full #phgps paper to explore the key findings: doi.org/10.1183/23120541.00297-2025 -
The Pulmonary Vascular Research Institute
@PVRI
Don’t miss our final PH Community Call of 2025!
📅 18 December
⏰ 15:00–16:00 GMT
This month we’re exploring:
▪️How monocytes and interstitial macrophages contribute to hypoxic PH by Rahul Kumar
▪️The impact of kettlebell exercise training on daily function in people with PAH by Pinar Merc
PVRI’s Community Calls are free, informal spaces where we learn together, reflect together, and strengthen the global PH community.
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
We’re live now 👉
Join today’s Living Legends in PH session with Rubin Tuder.
He’s sharing the science and personal journey behind some of the most influential discoveries in PH — with Paul Hassoun and Jason Hong guiding the discussion.
➡️ You can still join us: -
The Pulmonary Vascular Research Institute
@PVRI
Celebrate 20 years of PVRI 🎉
Join us in marking this milestone by joining our two fundraising events that bring our community together.
Get Active — Morning Run/Walk
📆 30 January, 06:00–07:00 GMT
PVRI Pub Social
📆 31 January, 17:00–19:00 GMT
Your donation — at any level — directly supports PVRI’s mission and our 20th anniversary year.
➡️ Find out more here: pvrinstitute.org/learning-hub/events/pvri-2026-dublin-fun… -
The Pulmonary Vascular Research Institute
@PVRI
New in Pulmonary Circulation 🔬
Exploring the Impact of Platelet-Derived Growth Factor D in Pulmonary Hypertension Development
📆 29 November 2025
The findings highlight PDGF-D as a potentially unique therapeutic target, adding important depth to our understanding of PH biology.
➡️ Read the full article: pvrinstitute.org/learning-hub/material/exploring-impact-p…
Published in Pulmonary Circulation — PVRI’s global, open-access journal for cutting-edge PH research. -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow 👇
Living Legend: Rubin Tuder, University of Colorado
🗓️ 11 December
⏰ 16:00 – 17:30 GMT
We’re looking forward to welcoming Rubin Tuder to our Living Legends in PH series — where we spotlight remarkable people who’ve shaped the field of PH, sharing the science and the personal stories behind decades of progress.
Featuring:
▪️Rubin Tuder, University of Colorado
▪️Paul Hassoun, senior facilitator
▪️Jason Hong, junior facilitator
➡️ Register for free here: pvrinstitute.org/learning-hub/events/living-legend-rubin-… -
The Pulmonary Vascular Research Institute
@PVRI
First PVRI webinar of 2026! 📣
Bioengineering and bioprinting advances in PH research
📆 8 January 2026
🕓 16:00 GMT
Cutting-edge bioengineering is reshaping how we understand, model, and ultimately treat PH. This session brings together global experts who are pushing the boundaries of what’s possible in experimental and translational research.
You’ll hear fresh insights on:
▪️Engineered muscle pump systems using iPSC-derived cardiomyocytes — Brenda Ogle
▪️3D bioprinting vasculature — Dan Shiwarski
▪️PAH organ-on-a-chip platforms — Beata Wojciak-Stothard
▪️Microfluidic systems to study pulmonary vascular stiffness — Taslim A. Al-Hilal
➡️ Register for free now: pvrinstitute.org/learning-hub/events/bioengineering-and-b… -
The Pulmonary Vascular Research Institute
@PVRI
Huge thank you to @Liquidia_Corp for their generous support at PVRI Dublin 2026! 💜
They’re both a Premium Sponsor and a Gold Exhibitor at next year’s Congress — and we’re incredibly grateful for their partnership.
Liquidia's support helps bring our global community together, advancing scientific dialogue by sponsoring the 'PH associated with lung diseases: hope or hype?' session on January 30 at 08:00.
Liquidia is dedicated to developing and commercialising best-in-class therapies that improve the standard of care for people with rare cardiopulmonary diseases. Their mission is simple and powerful: to help patients breathe easier and live longer by enhancing drug delivery to the lungs and making every breath count.
Make sure to visit Liquidia at Stand 3 at PVRI Dublin 2026 (28 January – 1 February 2026).
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors -
The Pulmonary Vascular Research Institute
@PVRI
PVRI’s Patient Engagement & Empowerment Series 💜
We’ve launched a new resource designed to help people living with PH feel more informed, confident, and supported in their care. The series explores 11 key themes through short, patient-friendly videos featuring insights from clinicians, patients, and carers.
🔎 Theme 1: Understand the disease & treatment
Sandeep Sahay explains what PH is, how it affects the body, and why early diagnosis and personalised treatment are essential.
Clear knowledge is the foundation of empowerment — and it helps patients feel more prepared for conversations with their healthcare team.
➡️ Explore the series: pvrinstitute.org/PHpatients -
The Pulmonary Vascular Research Institute
@PVRI
La hipertensión pulmonar del Grupo 2 es la forma más común de HP — y la próxima semana profundizaremos en ella.
Hipertensión pulmonar Grupo 2: asociada a insuficiencia cardíaca y retención de líquidos
📆 16 de diciembre de 2025
🕒 15:00 GMT
💬 Sesión en español con subtítulos disponibles
Acompáñanos para explorar el diagnóstico, la clasificación de la 7.ª WSPH, las estrategias de tratamiento —incluido el manejo de la CpcPH— y participa en una discusión de caso en vivo dirigida por expertos internacionales.
🩺 Ponentes: Victor Moles, Adriano Tonelli, Guillermo Bortman, Veronica Franco
🎙 Moderadores: Rodolfo A. Estrada, Nayeli Zayas, Vinicio de Jesus Perez
👉 Reserva tu lugar: pvrinstitute.org/learning-hub/events/hipertension-pulmona…
The Pulmonary Vascular Research Institute
@PVRI
Group 2 pulmonary hypertension is the most common form of PH — and next week we’re taking a deep dive into it.
Group 2 Pulmonary Hypertension: associated with heart failure and fluid retention
📆 16 December 2025
🕒 15:00 GMT
💬 Spanish with subtitles available
Join us to explore diagnosis, the 7th WSPH classification, treatment strategies including CpcPH management, and take part in a live case discussion led by international experts.
🩺 Speakers: Victor Moles, Adriano Tonelli, Guillermo Bortman, Veronica Franco
🎙 Moderators: Rodolfo A. Estrada, Nayeli Zayas, Vinicio de Jesus Perez
👉 Save your place: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2026 Dublin — Speaker Spotlight 💡
From molecular mechanisms to major milestones — the conversations in Dublin will dive deep into the science shaping the future of pulmonary vascular disease.
Join us in Dublin as we celebrate 20 years of PVRI and explore the frontiers of discovery.
📅 28 January – 1 February 2026
📍 Dublin Royal Convention Centre
🎟 Register now: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
Living with PH can be overwhelming — but patients are not powerless 💜
Our new Patient Engagement & Empowerment Toolkit brings together everything needed to support people living with PH, including:
▪️11 short empowerment videos
▪️A printable leaflet
▪️A foldable patient guide
▪️Editable Canva templates for patient organisations
These resources are designed to help patients feel more informed, confident, and supported — and to give organisations practical tools they can use straight away.
➡️ Explore the full toolkit: pvrinstitute.org/PHpatients -
The Pulmonary Vascular Research Institute
@PVRI
Huge thank you to the Alliance for Pulmonary Hypertension and @pha_ireland
for their invaluable support at PVRI Dublin 2026! 💜
We’re honoured to have both organisations joining us as exhibitors — bringing patient voices, trusted information, and lived experience to the heart of the Congress.
Together, they help strengthen our global commitment to patient-centred care:
▪️ The Alliance for PH, founded in Brussels in 2020, empowers patients through knowledge-sharing, with a centralised hub of 800+ resources, webinars, and educational tools to inform and support families worldwide.
▪️ PH Ireland, a patient charity under the Mater Hospital Foundation, supports people living with PH across Ireland through awareness, trusted information, community connection, and collaboration with healthcare professionals to advance education, research, and care.
Their work ensures that the needs, voices, and insights of people living with PH remain at the centre of progress — and we’re grateful for the vital perspective they bring to PVRI Dublin 2026.
➡️ Explore the full list of our 2026 exhibitors and sponsors here: pvrinstitute.org/pvri-2026-exhibitors-sponsors -
The Pulmonary Vascular Research Institute
@PVRI
❓ Did you know?
PHGPS findings show that about half of adult patients (54.8%) are connected to a national PH patient organisation.
Those who are say the most valuable support includes:
▪️trusted information and education
▪️patient meetings and support groups
▪️helpful, informative websites
▪️national awareness activities
These networks make a real difference — helping people feel informed, supported, and less alone.
➡️ Read the full #phgps paper to explore the key findings: doi.org/10.1183/23120541.00297-2025 -
The Pulmonary Vascular Research Institute
@PVRI
Join our PVRI 2026 Dublin fundraising events and help us celebrate 20 years of PVRI!
Simple ways to come together as a community while supporting our mission to improve awareness, diagnosis, and research in PH.
❓ What’s happening?
▪️ Morning Run/Walk
▪️ PVRI Pub Social
➡️ Find out more and signup: pvrinstitute.org/learning-hub/events/pvri-2026-dublin-fun… -
The Pulmonary Vascular Research Institute
@PVRI
What an incredible month it’s been! 💜🌍
35 participants across 13 countries have taken part in our first-ever #breathbeyondborders challenge...
🏃 running
🚶♀️ walking
🚴 cycling
🚣♀️ rowing
⛸️ skating
...covering over 3,500km (2,200 miles) together.
We’ve even seen extraordinary moments like Paul Hassoun’s 9-hour piano performance in one go, and patients discovering they can walk farther than they ever imagined while living with PH.
This challenge has shown the power of community and the strength of our global PVRI family. Every step, mile and note has been a reminder of why PH awareness matters — and what we can achieve together.
We’re now at £1,272 raised, and we’d love to reach our goal of £1,500. If you can, please support our amazing participants as we cross the finish line.
➡️ Donate today: www.justgiving.com/campaign/breathbeyondborders
Thank you to all our participants! 👏 -
The Pulmonary Vascular Research Institute
@PVRI
Upcoming webinar 🖥️
Living Legend: Rubin Tuder, University of Colorado
🗓️ 11 December 2025
🕓 16:00 GMT - 17:30 GMT
Join us for our next Living Legends in PH session featuring RUBIN TUDER, a pioneer in PH whose work — including the SU-Hx model — has shaped the field for decades.
With Paul Hassoun and Jason Hong, as facilitators, we’ll explore his scientific impact and personal reflections.
➡️ Register for free: pvrinstitute.org/learning-hub/events/living-legend-rubin-… -
The Pulmonary Vascular Research Institute
@PVRI
Last chance — PVRI Awards 2026 nominations close at midnight tonight! ⏰
There’s still time to recognise the people who’ve gone above and beyond for our global PH community.
We’re closing nominations at 00:00 GMT, so if someone’s leadership, collaboration, or scientific impact has made a real difference this year, we’d love to hear from you.
You can nominate for:
▪️PVRI Lifetime Achievement Award
▪️PVRI Achievement Award
▪️PVRI Special Recognition Award
If you’re a PVRI member, this is your moment to shine a light on your colleagues’ achievements.
👉 Submit your nomination: pvrinstitute.org/learning-hub/news/nominations-now-open-p… -
The Pulmonary Vascular Research Institute
@PVRI
We did it — we’ve raised over £1,000 for Breath Beyond Borders! 🎉💜
A huge thank you to every single participant who’s been running, walking, cycling, swimming, rowing, and skating. Your dedication has been inspiring.
And today, we’re excited to share something special — a clip of Paul Hassoun completing his incredible 9-hour piano challenge. 🎹
But we’re not done yet. Breath Beyond Borders ends this Sunday, and we’d love to give our incredible team one final boost.
Can we reach £1,500 before the finish line? 🏃
➡️ Support our participants today: www.justgiving.com/campaign/breathbeyondborders
#breathbeyondborders #phawarenessmonth -
The Pulmonary Vascular Research Institute
@PVRI
We’re delighted to launch...🥁
PVRI’s PH Patient Engagement & Empowerment Series 🤝
A new evidence-based resource designed to help people living with PH — and the families & carers who support them — feel more informed, confident, and empowered.
➡️ Explore the series: pvrinstitute.org/PHpatients
The Pulmonary Vascular Research Institute
@PVRI
Developed by PVRI's IDDI Patient Engagement & Empowerment Workstream, the series explores 11 core themes, including:
▪️understanding PH
▪️accessing psychological support,
▪️shared decision-making,
▪️clinical trials
and more!
The Pulmonary Vascular Research Institute
@PVRI
We invite PH professionals to:
▪️explore the full series
▪️share the materials with your patients
▪️use the co-brandable leaflet & guide in your clinics and networks
Together, we can help patients take an active role in their care 🤝
➡️ Explore the series: pvrinstitute.org/PHpatients -
The Pulmonary Vascular Research Institute
@PVRI
❓Missed yesterday’s iPVD Virtual Symposium session?
The full session, Microbes/Parasites and Sex Differences in PVDs, is now ready to watch! 🎥
Hear expert insights from Imad Al Ghouleh on microbiome–metabolite interactions in pulmonary hypertension, and Tim Lahm on the mechanisms behind sexual dimorphisms in the cardiopulmonary vascular system.
Catch up on the discussion and stay connected to the latest advances in inflammatory and infectious PVD 💬
➡️ Watch here: pvrinstitute.org/learning-hub/material/microbesparasites-… -
The Pulmonary Vascular Research Institute
@PVRI
We’re live! 🎥
Join now for Microbes/Parasites and Sex Differences in PVDs — part of our iPVD Virtual Symposium Series.
Hear from:
▪️ Imad Al Ghouleh, Brown University
▪️ Tim Lahm, University of Colorado Anschutz / National Jewish Health
▪️ Suellen D'Arc Oliveira, University of Illinois Chicago
We’re exploring how infection, inflammation, and sex-specific biology shape pulmonary vascular disease — and what this means for future diagnosis and care.
👉 Join the webinar now: pvrinstitute.org/learning-hub/events/microbesparasites-an… -
The Pulmonary Vascular Research Institute
@PVRI
Get ready for three standout events at PVRI 2026 Dublin 🎉
We’re bringing our community together with functions designed to inspire, connect, and celebrate everything we’re achieving in PH research and care.
📆 Career Catalyst Luncheon – Friday 30 January
📆 Women in PH Luncheon – Saturday 31 January
📆 PVRI 2026 Gala Dinner & Awards Evening – Friday 30 January
We can’t wait to welcome you in Dublin and create moments that spark new ideas, stronger networks, and lasting collaborations.
➡️ Register here: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
What do microbes, parasites, and sex differences mean for PVD? 🦠
Join us this Wednesday, 26 November at 15:00 GMT, for our next iPVD Virtual Symposium as we unpack the latest insights in inflammation and infectious PVD.
You’ll hear from leading voices in the field:
▪️Imad Al Ghouleh, Brown University
▪️Tim Lahm, University of Colorado Anschutz / National Jewish Health
▪️Moderated by Suellen D'Arc Oliveira, University of Illinois Chicago
Together, we’ll explore how infection, inflammation, and sex-specific biology shape pulmonary vascular disease — and what this means for future diagnosis and care.
➡️ Register for free here: pvrinstitute.org/learning-hub/events/microbesparasites-an… -
The Pulmonary Vascular Research Institute
@PVRI
We’re proud to share a brand-new Pulmonary Circulation submission from our Latin America Task Force!
Why Wait for Sick People to Get Sicker? The Paradox of the Treatment of Patients With Pulmonary Arterial Hypertension
👤Mauricio Orozco-Levi, Vinicio A. de Jesús Pérez, Tomas Pulido, Angie Pabón-Quezada, Philip Morisky, Rafael Conde-Camacho, Alba Ramírez-Sarmiento
This important article tackles a critical question in PAH care:
❓Why do we still wait for symptoms before starting treatment?
The authors highlight:
▪️ The ongoing challenge of late clinical intervention — most patients receive treatment only once they reach NYHA class II or higher
▪️Why earlier recognition and action could significantly improve long-term outcomes
▪️The need for a shift in how we think about disease progression, risk, and timely therapy
This is exactly the kind of work Pulmonary Circulation exists to amplify — rigorous research, bold thinking, and regional expertise that help move our field forward.
And we’re delighted to see our LATAM Task Force continue championing research that reflects the realities and needs across Latin America.
📄 Read the full article: pvrinstitute.org/learning-hub/material/why-wait-sick-peop…
#pulmonarycirculation -
The Pulmonary Vascular Research Institute
@PVRI
❓ Heading to #pvri2026 Dublin?
Most of our reserved hotel rooms (70%) will be released to the public at the end of November.
If you haven’t booked your stay yet, do it soon so you don’t miss out on our special rates next to the venue.
➡️ Secure your room: -
The Pulmonary Vascular Research Institute
@PVRI
Here’s a first look 🎥👀
Every month, our PH Community Calls bring our global network together for open, thoughtful discussions.
Our November PH Community Call sparked an important conversation on methamphetamine-associated PAH with Cole Uhland, and Franz Rischard.
Watch the teaser below — then dive into the full recording to hear the latest insights shaping PH research and care.
➡️ Watch here: pvrinstitute.org/learning-hub/material/november-2025-pvri… -
The Pulmonary Vascular Research Institute
@PVRI
We’re so close! 💜
Together, we’ve raised £970 for Breath Beyond Borders — just £30 away from £1,000.
We’ve put together this little video to celebrate the incredible people taking on challenges around the world — from long runs and tough cycles to beautiful walks and even a nine-hour piano performance. Their energy and spirit are what make this campaign so special.
If you can, please show your support and help us reach this milestone today.
➡️ Donate: www.justgiving.com/campaign/breathbeyondborders
#phawarenessmonth -
The Pulmonary Vascular Research Institute
@PVRI
We’re digging deeper into the biology behind PVD 🔎
Join us for the next webinar in the global iPVD Virtual Symposium Series:
Microbes/Parasites and Sex Differences in PVDs
🗓️ 26 November 2025
🕒 15:00 GMT
You’ll hear fresh perspectives, new data, and the latest thinking in inflammation and infectious PVD from Imad Al Ghouleh and Tim Lahm, moderated by Suellen D’Arc Oliveira.
➡️ Register for free now: pvrinstitute.org/learning-hub/events/microbesparasites-an… -
The Pulmonary Vascular Research Institute
@PVRI
New in Pulmonary Circulation 🔎
A real-world comparison of PH-ILD patients starting inhaled treprostinil vs. those who remain untreated.
📆 10 November 2025
This study compares outcomes in patients with PH-ILD receiving inhaled treprostinil with those who remain untreated—adding valuable evidence to support clinical decision-making in an area where data remain limited.
➡️ Read the article: pvrinstitute.org/learning-hub/material/real-world-compari… -
The Pulmonary Vascular Research Institute
@PVRI
We’re live now!
Join our November PH Community Call 🤝
Today we’re discussing treatment response and survival in methamphetamine-associated PAH with Cole Uhland and Franz P Rischard.
➡️ Join now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Did you know? 💜
The Pulmonary Hypertension Global Patient Survey (PHGPS) found that about half of adult patients (54.8%) are part of a national PH patient organisation.
Patients told us that the most valuable support comes from:
▪️clear information and education
▪️patient meetings and support groups
▪️reliable online resources
▪️national awareness activities
These organisations play a vital role in helping people navigate life with PH — and in strengthening the global patient voice.
➡️ Read the full #phgps paper to explore the key findings: doi.org/10.1183/23120541.00297-2025 -
The Pulmonary Vascular Research Institute
@PVRI
Join our next PH Community Call 🤝
Your monthly space for open, global discussion on the latest in PH.
This month, we’ll explore treatment response and survival in methamphetamine-associated PAH, with insights from Cole Uhland and Franz P Rischard.
🗓️ 20 November 2025
🕒 15:00–16:00 GMT
💻 Free and open to all
Moderated by: Katarina Zeder, Rodolfo Estrada, Joel James, Sandeep Sahay, Katrina Barry, and Tatiana Kudryashova.
➡️ Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Un hito para PVRI — ¡nuestro primer seminario web impartido completamente en español! 🎉🇪🇸
Acompáñanos en esta sesión del Grupo de Trabajo de América Latina:
Hipertensión Pulmonar Grupo 2: asociada a insuficiencia cardiaca y retención de fluido
🗓️ 16 de diciembre de 2025
🕒 15:00 GMT
🌎 Sesión impartida íntegramente en español, con subtítulos disponibles
Exploraremos la forma más común de HP junto a expertos internacionales, revisando el diagnóstico, la clasificación actualizada de la 7.ª CMHP, las estrategias de tratamiento y un análisis de caso en vivo con aplicaciones prácticas reales.
➡️ Regístrate gratis: pvrinstitute.org/learning-hub/events/hipertension-pulmona…
______________________________
A first for PVRI — a full webinar delivered in Spanish! 💬
Join us for this landmark Latin America Task Force session:
Group 2 Pulmonary Hypertension: associated with heart failure and fluid retention
🗓️ 16 December 2025
🕒 15:00 GMT
🌎 Delivered entirely in Spanish, with subtitles available
We’ll explore the most common form of PH with international experts, covering diagnosis, the updated 7th WSPH classification, treatment strategies, and a live case discussion designed for real-world practice.
➡️ Register for free: pvrinstitute.org/learning-hub/events/hipertension-pulmona… -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2026 Dublin - Speaker spotlight 👀
At PVRI 2026, we’ll be asking the big questions shaping the next 20 years of pulmonary vascular medicine — from transformative targets to everyday living with PH.
Here’s a glimpse of what’s to come ⬇️
Join us in Dublin as we celebrate 20 years of PVRI and look ahead to the discoveries still to come.
📅 28 January – 1 February 2026
📍 Dublin Royal Convention Centre
🎟 Register now: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
Recording now live! 📽️
Unpack the challenges of developing new therapies for BPD-PH and hear from:
▪️A brief introduction to clinical features of PH in BPD — Steven Abman
▪️BPD-associated PH: Current evaluation and therapies — Anne Hilgendorff
▪️BPD-PH: Understudied and undertreated – the need for novel interventions — Bernard Thébaud
▪️Challenges in designing and implementing multicenter trials: A real-world perspective on studies of preterm infants — Victoria Niklas
A huge thank you to Sylvia Nikkho and Steven Abman for moderating!
➡️ Watch the recording here: pvrinstitute.org/learning-hub/material/challenges-develop…
#pvridigital -
The Pulmonary Vascular Research Institute
@PVRI
More findings from the Pulmonary Hypertension Global Patient Survey (PHGPS)...🔎
❓ Did you know?
73% of people living with PH have never taken part in clinical research.
But here’s the good news — of those who have, 73% said it was a positive experience, and 83% would do it again. Most importantly, 72% of those who haven’t would be willing to take part if invited.
There’s clear enthusiasm among patients to help advance research — we just need to make it more accessible.
➡️ Read the full #phgps paper to explore the key findings: doi.org/10.1183/23120541.00297-2025 -
The Pulmonary Vascular Research Institute
@PVRI
New research in #pulmonarycirculation 🩺
The Predictive Value of Quantitative Analysis of SPECT V/Q Imaging for Postoperative Persistent/Recurrent Pulmonary Hypertension in Patients With CTEPH After Pulmonary Endarterectomy
👤 Pingping Han, Rongzheng Ma, Wanmu Xie, Huan Li, Zhu Zhang, Zhenguo Zhai, Liping Fu
📖 Read the full open-access article in Pulmonary Circulation: onlinelibrary.wiley.com/doi/10.1002/pul2.70195 -
The Pulmonary Vascular Research Institute
@PVRI
And we’re live!
Join today’s webinar, Challenges of Developing Novel Therapies for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension, now.
Hear from leading experts as they explore the latest insights and real-world challenges in developing new treatments for BPD-associated PH:
▪️Steve Abman
▪️Anne Hilgendorff
▪️Bernard Thébaud
▪️Victoria Niklas
👉 Join live: pvrinstitute.org/learning-hub/events/challenges-developin… -
The Pulmonary Vascular Research Institute
@PVRI
1 day to go! ⌛
Still time to join our next cutting edge innovation webinar...
Challenges of Developing Novel Therapies for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
📆 13 November 2025
🕓 16:00 GMT
Hear from leading experts Steve Abman, Anne Hilgendorff, Bernard Thébaud, and Victoria Niklas as they explore new approaches, emerging therapies, and the complexities of clinical trials in preterm infants.
➡️ Register for free: pvrinstitute.org/learning-hub/events/challenges-developin… -
The Pulmonary Vascular Research Institute
@PVRI
What an incredible start! 💜
Together, our Breath Beyond Borders participants have raised over £700 so far — and we’re only halfway through #phawarenessmonth!
From mountain trails to coastal walks, their miles are already making a global impact. Every contribution helps fund PH research, training, and awareness.
Let’s keep going — every step counts! 🌍
👉 Donate today: www.justgiving.com/campaign/breathbeyondborders -
The Pulmonary Vascular Research Institute
@PVRI
Join our next monthly PH Community Call 📣
Pulmonary Hypertension Community Call — November
🗓️ 20 November 2025
🕒 15:00–16:00 GMT
💻 Online & Free
This month, we’ll explore treatment response and survival in methamphetamine-associated pulmonary arterial hypertension with Cole Uhland and Franz P Rischard.
➡️ Register for free: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi…
Thank you to our Community Call hosts Katarina Zeder, Rodolfo Estrada, Joel James, Sandeep Sahay, Katrina Barry and Tatiana Kudryashova. 👏 -
The Pulmonary Vascular Research Institute
@PVRI
🏆 Don't forget to nominate!
There’s still time to nominate for the PVRI Awards 2026, celebrating excellence, collaboration, and leadership in the global PH community.
Recognise those shaping the future of pulmonary hypertension research and care — nominate today for:
▪️Lifetime Achievement Award 2026
▪️Achievement Award 2026
▪️Special Recognition Award 2026 (new this year!)
🗓️ Deadline: 1 December 2025
➡️ Nominate here: pvrinstitute.org/learning-hub/news/nominations-now-open-p… -
The Pulmonary Vascular Research Institute
@PVRI
History shapes the future of pulmonary vascular medicine 🩺
The latest historical vignette in #pulmonarycirculation.
Birth of the Modern Era of CTEPH Diagnosis and Care
👤 William R. Auger
It takes us back to 1986 — when a Sunday morning case review sparked a turning point in understanding and treating chronic thromboembolic pulmonary hypertension (CTEPH).
📖 Read the full vignette: onlinelibrary.wiley.com/doi/10.1002/pul2.70187 -
The Pulmonary Vascular Research Institute
@PVRI
Today is PH Day UK 💜
This year’s theme — #breathlessnotvoiceless — reminds us that while pulmonary hypertension (PH) can take your breath away, it can never silence your voice.
PH is a rare lung disease that also affects the heart, and it has a huge impact on those who live with it. We’re standing with everyone living with PH, raising our voices to demand awareness, research, and hope.
Remember – not all disabilities are visible!
#phdayuk #phawareness -
The Pulmonary Vascular Research Institute
@PVRI
📣 Join us next week...
Challenges of Developing Novel Therapies for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
🗓️ 13 November 2025
🕓 16:00 GMT
Part of our Cutting Edge Innovation in Clinical & Experimental PH series — exploring the latest advances and real-world challenges in BPD-associated PH.
➡️ Register for free now: pvrinstitute.org/learning-hub/events/challenges-developin… -
The Pulmonary Vascular Research Institute
@PVRI
❓Did you know?
More than half of adult patients living with PH — 54% — are officially registered as disabled due to their condition.
This finding highlights the significant impact PH can have on daily life and the importance of continued research and support for patients worldwide.
🔍 Read the full PHGPS paper to explore more insights: doi.org/10.1183/23120541.00297-2025 -
The Pulmonary Vascular Research Institute
@PVRI
❓ Missed yesterday’s webinar?
Our High Altitude Task Force continued the series “Hypoxia in pulmonary vascular research – altitude and beyond”
We heard a fascinating talk from Professor Martina Muckenthaler, University Hospital Heidelberg on Iron and High Altitude.
Discover how iron metabolism adapts under hypoxic conditions and why these mechanisms matter for pulmonary hypertension and life at altitude.
🎥 Watch the full recording: pvrinstitute.org/learning-hub/material/iron-and-high-alti… -
The Pulmonary Vascular Research Institute
@PVRI
Incredible views coming in from around the world! 🌍
Our #breathbeyondborders participants are walking, running, cycling, rowing — to raise awareness and funds for PH research this #phawarenessmonth.
United by one mission: to advance understanding, improve care, and give hope to those living with PH 💜
➡️ Support the cause: justgiving.com/campaign/breathbeyondborders -
The Pulmonary Vascular Research Institute
@PVRI
PVRI 2026 Dublin - Speaker spotlight 👀
At PVRI 2026, we’ll be asking the big questions shaping the next 20 years of pulmonary vascular medicine — from transformative targets to everyday living with PH.
Here’s a glimpse of what’s to come ⬇️
Join us in Dublin as we celebrate 20 years of PVRI and look ahead to the discoveries still to come.
📅 28 January – 1 February 2026
📍 Dublin Royal Convention Centre
🎟 Register now: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
Happening soon! ⌛
Join us today for our next Hypoxia in Pulmonary Vascular Research – Altitude and Beyond webinar.
Iron and High Altitude
🕐 13:00 GMT
This session features Professor Martina Muckenthaler, University Hospital Heidelberg, whose pioneering work explores how iron metabolism adapts to hypoxic conditions at high altitude.
➡️ Register now: pvrinstitute.org/learning-hub/events/iron-and-high-altitude -
The Pulmonary Vascular Research Institute
@PVRI
❓How does iron respond when oxygen is scarce?
Join us tomorrow to find out.
Iron and High Altitude
📅 4 November 2025
🕐 13:00 GMT
Professor Martina Muckenthaler will explore how iron metabolism adapts to low-oxygen environments and what this means for pulmonary vascular research.
💻 Free and open to all — register now: pvrinstitute.org/learning-hub/events/iron-and-high-altitude -
The Pulmonary Vascular Research Institute
@PVRI
A heart under pressure beats stronger when we move together 💜
It's Pulmonary Hypertension Awareness Month.
This year’s theme, Heart Under Pressure, reminds us of the strength and resilience of everyone living with PH.
To mark it, we’ve launched our first-ever global fitness fundraiser — Breath Beyond Borders 🌍
From walking and running to cycling, rowing, skating, and even an 8-hour piano session(!), PVRI members and friends worldwide are pushing their limits to raise funds and awareness for PH research and innovation.
➡️ Donate today: justgiving.com/campaign/breathbeyondborders
#phawarenessmonth #heartunderpressure #breathebeyondborders -
The Pulmonary Vascular Research Institute
@PVRI
Breath Beyond Borders starts tomorrow! 📣
This November, PVRI members and friends around the world are taking on personal challenges to raise awareness for PH research.
From cycling to swimming, walking to piano-playing, our participants are taking on personal challenges that push their limits. 🚶
🎥 Hear from Alena Adarbehova in Austria, one of our participants, on what inspired her to take part in #breathbeyondborders.
➡️ Support the cause and help advance global PH research - donate here: justgiving.com/campaign/breathbeyondbordersThis media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
Most-downloaded paper of 2025 👏
Congratulations to the PVRI Lung Transplantation in Pulmonary Hypertension Workstream — their landmark Delphi consensus on lung transplantation in PAH tops this year’s Pulmonary Circulation downloads!
Open-access & authored by experts from across our global network, it’s already informing practice and inspiring collaboration.
🔗 Read the paper here: onlinelibrary.wiley.com/doi/10.1002/pul2.70088 -
The Pulmonary Vascular Research Institute
@PVRI
🏆 Nominations are open for the PVRI Awards 2026!
We’re celebrating excellence across the global PH community — recognising those whose dedication, collaboration, and leadership continue to drive progress in pulmonary vascular research and care.
PVRI members can now nominate for:
▪️Lifetime Achievement Award
▪️Achievement Award
▪️Special Recognition Award
🗓️ Deadline: 1 December 2025
🌍➡️ Who inspires you? pvrinstitute.org/learning-hub/news/nominations-now-open-p… -
The Pulmonary Vascular Research Institute
@PVRI
Webinar recording now available 🎥
Yesterday, our Latin America Task Force kicked off its new Pulmonary Hypertension in Latin America webinar series.
A PVRI first with sessions delivered in Spanish and English! 🎉
The first session in English explored PH diagnosis and phenotype differences between LATAM and the USA/Europe — with experts from across the region.
➡️ Watch the recording: pvrinstitute.org/learning-hub/material/pulmonary-hyperten…
The next three sessions will be in Spanish, with English subtitles available — part of PVRI’s commitment to sharing regional expertise and strengthening global collaboration in PH research and care. -
The Pulmonary Vascular Research Institute
@PVRI
Happening next week! 📣
Iron and High Altitude
📅 4 November 2025
🕐 13:00 GMT
How does iron metabolism adapt to life at high altitude?
Join Professor Martina Muckenthaler next week as she explores the connection between iron and hypoxia in our 'Hypoxia in Pulmonary Vascular Research – Altitude and Beyond' webinar series.
➡️ Free and open to all — register today: pvrinstitute.org/learning-hub/events/iron-and-high-altitude -
The Pulmonary Vascular Research Institute
@PVRI
❓ Did you know?
Only 21% of patients reported ever completing a Patient Reported Outcome Measure (PROM) — even though clinical guidelines recommend their regular use to understand how PH affects quality of life.
These tools can help ensure that patient voices are heard and care is truly person-centred.
🔍 Read the full PHGPS paper to explore more insights: doi.org/10.1183/23120541.00297-2025 -
The Pulmonary Vascular Research Institute
@PVRI
Last chance to register! ⌛
Pulmonary Hypertension in Latin America
📅 Today, 28 October 2025
🕒 15:00 GMT
Don’t miss this important discussion on how pulmonary hypertension presents across Latin America, the USA, and Europe — from diagnosis and phenotype to treatment and registry updates.
Join experts from across the region and be part of a global conversation shaping the future of PH care.
💻 Free and open to all — register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
✈️ Heading to PVRI 2026 Dublin?
January is one of Dublin’s busiest months — make sure you’ve got your accommodation sorted!
We’ve reserved rooms at two hotels right next to the Dublin Royal Convention Centre with exclusive PVRI rates — but availability is limited.
👉 Book your stay early to secure your room: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! 🚨
Join us for the first session in our new Latin America Task Force webinar series.
Pulmonary Hypertension in Latin America
🗓️ 28 October 2025
🕒 15:00 GMT
Leading experts from across Latin America and the USA will discuss how PH diagnosis, treatment, and patient phenotypes differ between regions — and what this means for clinical care and research.
➡️ Free and open to all – register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
❓ Missed yesterday’s PH Community Call?
You can now rewatch the full October session for free!
Our hosts and guests — including Clara Hjalmarsson and Helen Christou — discussed new insights on:
▪️Risk assessment models and event-free survival in pulmonary arterial hypertension
▪️PINK1/Parkin deficiency and vascular remodelling
Catch up on the conversation and stay up to date with the latest in PH research.
🎥 Watch now: pvrinstitute.org/learning-hub/material/october-2025-pvri-… -
The Pulmonary Vascular Research Institute
@PVRI
We’re live! 📣
Join our October PH Community Call now.
Today’s session features guest authors Clara Hjalmarsson and Helen Christou, exploring:
▪️ Risk Assessment Models and Event-Free Survival in Pulmonary Arterial Hypertension
▪️PINK1/Parkin Deficiency Enhances Vascular Remodeling and Aggravates Hypoxia-induced Pulmonary Hypertension
➡️ Join live now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
❔Did you know?
47% of adults on PH medication reported side effects, but only 32% spoke to their doctor about changing treatment.
This highlights the importance of open conversations between patients and clinicians about side effects and care options.
🔍 Read the full #phgps paper to explore key findings: doi.org/10.1183/23120541.00297-2025 -
The Pulmonary Vascular Research Institute
@PVRI
Join our October PH Community Call tomorrow 🌍
An open, informal discussion on the latest in PH research.
🗓️ 23 October 2025
🕒 15:00 BST
Featuring guest authors Clara Hjalmarsson and Helen Christou, discussing:
▪️ Risk Assessment Models and Event-Free Survival in PAH
▪️ PINK1/Parkin Deficiency and Hypoxia-induced PH
Our monthly calls are free and open to all — a space to connect, question, and learn.
➡️ pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Join leading experts from across Latin America and the USA as we explore how PH presents differently across regions — from diagnostic approaches to treatment options and registry insights.
Pulmonary Hypertension in Latin America
🗓️ 28 October 2025
🕒 15:00 GMT
This free PVRI webinar will discuss how Latin American patients often show distinct phenotypes, with younger age and fewer comorbidities, and what that means for clinical care and research.
➡️ Register for free: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Nominations are now open for the PVRI 2026 Dublin awards! 🏆
We’re celebrating excellence in PH at our 20th anniversary Congress in Dublin.
PVRI members can now nominate colleagues for:
▪️Lifetime Achievement Award
▪️Achievement Award
▪️Special Recognition Award
Help us honour those shaping the future of PH research and care.
Nominations close 1 December 2025 📆
➡️ Make your nomination here: pvrinstitute.org/learning-hub/news/nominations-now-open-p… -
The Pulmonary Vascular Research Institute
@PVRI
❔ How does iron influence our body’s response to high altitude — and what might that mean for pulmonary hypertension?
Join the next session in our Hypoxia in pulmonary vascular research – altitude and beyond series.
Iron and High Altitude
🗓 4 November 2025, 13:00 GMT
🎙 Martina Muckenthaler, University Hospital Heidelberg
👉 Register for free here: pvrinstitute.org/learning-hub/events/iron-and-high-altitude -
The Pulmonary Vascular Research Institute
@PVRI
Join our October PH Community Call 🫁
Thursday 23 October, 15:00 BST
This month, Clara Hjalmarsson and Helen Christou, will lead conversations on:
▪️Risk Assessment Models and Event-Free Survival in Pulmonary Arterial Hypertension
▪️PINK1/Parkin Deficiency Enhances Vascular Remodeling and Aggravates Hypoxia-induced Pulmonary Hypertension
Let’s come together to explore, question, and learn — as one global PH community.
➡️ Register for free: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Meet Elvia Carvalho Silva 👋
One of the incredible participants taking on our Breath Beyond Borders challenge this November for PH Awareness Month.
Elvia is walking 160 km / 100 miles to raise awareness of pulmonary hypertension (PH) and support PVRI’s work funding global research, training, and early-career scientists.
🎥 Watch Elvia’s message below ⬇️
💜 Donate today: pvrinstitute.org/breathbeyondborders
#breathbeyondborders #phawarenessmonthThis media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
Pulmonary arterial hypertension (PAH) is often described as a disease of younger adults without comorbidities — but is that true everywhere?
Join our upcoming webinar as we explore how regional differences shape diagnosis, patient presentation, and treatment approaches in Latin America vs. USA/Europe.
Pulmonary Hypertension in Latin America
📅 28 October 2025
🕓 15:00 GMT
💻 Free and open to all
👉 Register now: pvrinstitute.org/learning-hub/events/pulmonary-hypertensi… -
The Pulmonary Vascular Research Institute
@PVRI
Now available to rewatch 🎥
Our Living Legend session with Lewis Rubin — one of the pioneers who shaped modern pulmonary hypertension care — is now available!
Lewis reflects on:
▪️the early days of pulmonary hypertension research
▪️breakthroughs that changed how the disease is treated
▪️the collaborations that continue to drive innovation worldwide
A fascinating look at the science, the stories, and the people behind decades of progress in our field.
▶️ Watch the full recording on our website: pvrinstitute.org/learning-hub/material/living-legend-lewi…
Part of PVRI’s Living Legends in PH: History & Personal Perspectives series. Discover more here: pvrinstitute.org/PVRIDigitalThis media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
☘️ Dublin awaits!
Hear from Seán Gaine, Scientific Organising Committee Lead for PVRI 2026, as he shares why next year’s Congress in Dublin will be one to remember — celebrating 20 years of PVRI and the incredible progress in pulmonary vascular science and care.
PVRI 2026 Dublin
📆 28 January – 1 February 2026
📍 Dublin Royal Convention Centre
🎟️ Secure your place today and be part of this milestone event: pvrinstitute.org/learning-hub/events/pvri-2026-dublin
Already registered? Don’t forget to book your hotel early — our special PVRI rates
are filling fast.
▪️ Radisson Blu Royal Hotel: www.radissonhotels.com/en-us/booking/room-display?hotelCo…
▪️ The Chancery Hotel: bookings.thechanceryhotel.ie/offer/pvrconference
#pvri2026 #pvri20years #pulmonaryhypertensionThis media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
1 hour to go! ⏰
We’re going live soon with Living Legend Lewis Rubin, University of California San Diego — don’t miss the chance to hear his incredible journey in pulmonary hypertension.
Join us as he shares:
▪️ How it all began
▪️ Career highs and challenges
▪️ The impact of his work on patients and research
➡️ Last chance to register: us02web.zoom.us/webinar/register/WN_SCjAR3RxTZ-JHWdfJKa7rQ -
The Pulmonary Vascular Research Institute
@PVRI
1 day to go! ⌛
Meet the Living Legend: Lewis Rubin, University of California San Diego
📆 Thursday 9th October
🕓 16:00 BST
Join us as we sit down with Lewis Rubin to hear his story — from how it all began to the impact his work has had on the pulmonary hypertension field.
We'll discuss:
▪️What sparked your interest in pulmonary hypertension
▪️Key moments, breakthroughs, and challenges along the way
▪️How your work has advanced research or improved patients’ lives
➡️ Register here: pvrinstitute.org/learning-hub/events/living-legend-lewis-…
#pvriwebinar -
The Pulmonary Vascular Research Institute
@PVRI
We are absolutely thrilled to introduce our friends and colleagues to...🥁
Catherine Wynn, PVRI's newest team member! Catherine started with us yesterday as our Marketing Officer and, working with Debs, will oversee:
▪️Digital marketing
▪️Events & webinars
▪️Website management
▪️Branding
▪️Communications
Please join us in welcoming Catherine to the PVRI team! 👋 -
The Pulmonary Vascular Research Institute
@PVRI
Final call for abstracts for PVRI 2026 📣
Deadline: 8 Oct 2025, 23:59 BST
Don’t miss the opportunity to present your work. A £200 cash award will be presented for the best poster in each session.
➡️ Submit your abstract now: pvrinstitute.org/pvri2026
#pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
We want to extend our deepest thanks to Jason Weatherald, who has been a truly tremendous Host for the PVRI monthly #pulmonaryhypertension Community Calls over the years. His dedication and leadership have shaped the #communitycalls into a space of collaboration and inspiration. 🙏💙 Jason will be stepping down, but his contribution will always be a big part of our journey.
At the same time, we’re delighted to welcome Katarina Zeder and Rodolfo Estrada as our new Hosts! 🎉 Their energy, expertise and passion will help us continue growing and connecting as a global #ph community.
Please join us in welcoming Katarina and Rodolfo — and in celebrating Jason’s incredible impact! ✨ Find out more about Community Calls and our Hosts pvrinstitute.org/about-us/what-we-do -
The Pulmonary Vascular Research Institute
@PVRI
🫁 New in #pulmonarycirculation 🫁 “Porto-Pulmonary Hypertension in Children: Insights From a National Registry ” by Sadia Quyam et al. 👉
onlinelibrary.wiley.com/doi/10.1002/pul2.70133
🔗 Explore more from #pvri premier international, peer-reviewed #medicalresearch journal dedicated exclusively to pulmonary circulation and #pulmonaryvasculardisease 👉 pvrinstitute.org/learning-and-research/pulmonary-circulation
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
Meet Gil Golden, a real friend of PVRI. Gil, Chief Medical Officer for United Therapeutics, will be cycling 400km for #breathbeyondborders. In Gil's words, 'I think there are very bright things to look forward to in the future of #pulmonaryhypertension'. Watch the full interview:
The Pulmonary Vascular Research Institute
@PVRI
As well as raising awareness, Gil and the other participants are raising vital funds for PVRI’s educational programmes and to help us foster global research. Please show your support – donate to: www.justgiving.com/campaign/breathbeyondborders
-
The Pulmonary Vascular Research Institute
@PVRI
We are absolutely delighted to introduce you to Louise Bouman, who will be taking part in our #breathbeyondborders challenge in November. youtu.be/-BlXfwcQdrc
The Pulmonary Vascular Research Institute
@PVRI
Louise was diagnosed with #pah class 4 in 2008 and is now a #ph patient advocate. Please show your support for Louise and the many miles she will be walking to help raise awareness of #pulmonaryhypertension >> www.justgiving.com/campaign/breathbeyondborders
-
The Pulmonary Vascular Research Institute
@PVRI
📢 Great news! We’ve extended the abstract submission deadline for #pvri2026 Dublin to 8 October 2025, 23:59 BST.
If you haven’t yet submitted, this is your chance to be part of the scientific programme. Abstract themes include:
🌍 Basic & Translational Science
🌍 Clinical Science
🌍 International & Global Health
🌍 Mind the Gap: Cases that Highlight Gaps in Evidence
Highlights:
💡 Moderated poster sessions with £200 cash prizes
💡 Prestigious abstract awards (including The Butrous Foundation Young Investigator Award & The Rupert Swift Award)
💡 Winners invited to present in the main programme
Don’t miss this opportunity to connect with peers worldwide and shape the future of pulmonary vascular research.
👉 Submit your abstract by 8 October 2025, 23:59 BST: pvrinstitute.org/pvri2026
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
It’s a gorgeous morning in Amsterdam today. Wishing everyone attending the #erscongress a fabulous day. We can’t wait to get going!
-
The Pulmonary Vascular Research Institute
@PVRI
Our #paediatric Task Force is embarking on an update to the ‘Paediatric Classification of Pulmonary Vascular Disease’. It was first introduced and agreed upon at the #pvri2011 Panama meeting and published that same year in #pulmonarycirculation, alongside the first functional classification of PH for children and infants. These tools are now used by paediatricians worldwide!
Be among the first to learn about this exciting project at the kick-off meeting, to be held at the Paediatric Task Force Satellite Meeting during #pvri2026 Dublin on 28 January 2026 — free and open to all Congress attendees.
Book your place here -> pvrinstitute.org/pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Today on 🫁 #worldlungday 🫁 and beyond, we’re reminded that healthy lungs are vital for every breath we take. #pulmonaryhypertension is a serious condition affecting people regardless of where they live or their age, and with your help, we can drive research forward, improve treatments, and bring hope to patients worldwide.
So today, we take great pride in introducing you to Suzanne Lea, who received a double-lung transplant 10 years ago. She will be joining our #breathbeyondborders challenge this November, walking a formidable 100km / 62 miles in the Italian Alps. Find out what inspired Suzanne to take part, learn more about her story of living with #ph, and how you can support her to help her achieve her goal (snow or no snow...). 👉 youtu.be/Z1mI4vbDi2s
👉 Please donate to Suzanne and all the incredible participants taking part at www.justgiving.com/campaign/breathbeyondborders -
The Pulmonary Vascular Research Institute
@PVRI
Missed our #communitycall on Friday? Here is a sneak peek... Guest authors Grazyna Kwapiszewska, Slaven Crnkovic & Athiththan Yogeswaran discussed:
👉 Adventitial fibroblasts direct smooth muscle cell-state transition in pulmonary vascular disease
👉 Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis
Watch the full recording: pvrinstitute.org/learning-hub/material/september-2025-pvr… -
The Pulmonary Vascular Research Institute
@PVRI
Meet the Living Legend: Lewis Rubin, University of California San Diego
9 October 2025, 16:00 BST
👉 Register: pvrinstitute.org/learning-hub/events/living-legend-lewis-…
This webinar is part of the PVRI Digital Webinar Series, 'Living Legends in Pulmonary Hypertension: History & Personal Perspectives' sessions. Each session features remarkable people who have made major contributions to the field of #pulmonaryhypertension (#ph), bringing their science and personal stories to the worldwide PH community.
Senior Facilitator: Jason Yuan, University of Florida
Junior Facilitator: Jose Gomez-Arroyo, University of Cincinnati
See you there! -
The Pulmonary Vascular Research Institute
@PVRI
Today at 15:00 BST, we look forward to welcoming guest speakers Grazyna Kwapiszewska, Slaven Crnkovic and Athiththan Yogeswaran. Hope to see you there! Register here: pvrinstitute.org/learning-hub/events/pvri-community-call-…
The Pulmonary Vascular Research Institute
@PVRI
🗓️ Happening tomorrow - 19 September, 15H00 BST
Join us for our informal #pulmonaryhypertension #communitycall as we welcome guest authors Grazyna Kwapiszewska, Slaven Crnkovic and Athiththan Yogeswaran to share insights on 'Adventitial fibroblasts direct smooth muscle cell-state transition in pulmonary vascular disease' and 'Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis'. Everyone welcome (and it's free!). Register:
pvrinstitute.org/learning-hub/events/pvri-community-call-… -
The Pulmonary Vascular Research Institute
@PVRI
🗓️ Happening tomorrow - 19 September, 15H00 BST
Join us for our informal #pulmonaryhypertension #communitycall as we welcome guest authors Grazyna Kwapiszewska, Slaven Crnkovic and Athiththan Yogeswaran to share insights on 'Adventitial fibroblasts direct smooth muscle cell-state transition in pulmonary vascular disease' and 'Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis'. Everyone welcome (and it's free!). Register:
pvrinstitute.org/learning-hub/events/pvri-community-call-… -
The Pulmonary Vascular Research Institute
@PVRI
🌎 Did you know…?
...74% (1,513 out of 2,045 respondents) of adult patients with #pulmonaryhypertension have had their employment or education negatively impacted to some degree! Read the full #phgps paper to explore more findings 👉 doi.org/10.1183/23120541.00297-2025 -
The Pulmonary Vascular Research Institute
@PVRI
Our Women's Health & #pulmonaryvasculardisease webinar (brought to you by the #pvri Women's Health Task Force) includes research presentations on sex differences and sex hormone treatments in pulmonary arterial hypertension (#pah). Studies show that this disease primarily affects women, but men have worse survival. There has been significant research on the role of sex hormones in this disparity including the phase 3 trial of anastrozole that was presented. The Task Force aims to improve knowledge, encourage research, and optimise delivery of clinical care to women with #pvd, with future events planned to foster global collaboration on women's health and pulmonary hypertension. Watch the full webinar here: pvrinstitute.org/learning-hub/material/womens-health-and-…
-
The Pulmonary Vascular Research Institute
@PVRI
#pvri2026 includes sessions on promising novel targets & pathways in #pah, along with real-world data of #sotatercept. A major focus will be on the right heart, the role of #ph in chronic lung diseases, & the promise of precision medicine & AI in PH. The meeting will be rounded out by pro-con debates addressing critical & controversial aspects in PH clinical management. Additional highlights include the Shark's Den, the Career Catalyst Mentoring Luncheon, the Women in PH Luncheon & exciting poster discussions - making PVRI 2026 an unmissable event for every researcher and clinician in #pvd!
🗓️ Get your #abstract in before the closing date of 01 October!
🎟️ Register soon to secure a place in one of the PVRI reserved hotels!
pvrinstitute.org/pvri2026 -
The Pulmonary Vascular Research Institute
@PVRI
Missed our #pvridigital Webinar: #sotatercept: New Concepts & Clinical Use? PVRI members can watch it on demand: pvrinstitute.org/learning-and-research - this webinar is part of the 'Cutting Edge Innovation in Clinical & Experimental PH' sessions. Talks include:
▶️ Sotatercept – eligibility, dosing, results by Luke Howard, Imperial College London
▶️ Pulmonary vascular and right heart remodeling: what cardiac imaging and exercise tell us about Sotatercept by Franz Rischard, University of Arizona
▶️ Genetic background: differential response to Sotatercept? by David Montani, Universite Paris-Saclay
▶️ Complications of Sotatercept byRahul Argula, Medical University of South Carolina
#pvri -
The Pulmonary Vascular Research Institute
@PVRI
Join us on 19 September 2025, 15H00 BST for our next PVRI Community Call as we welcome guest authors, Grazyna Kwapiszewska, Slaven Crnkovic and Athiththan Yogeswaran to share insights on 'Adventitial fibroblasts direct smooth muscle cell-state transition in pulmonary vascular disease' and on 'Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry Analysis'.
Our monthly Community Calls are informal, free, and open to everyone. Join the conversation and connect with the PH community! Register now: pvrinstitute.org/learning-hub/events/pvri-community-call-… -
The Pulmonary Vascular Research Institute
@PVRI
Happening today! With nearly 500 attendees registered, we can't wait to see you there!
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Join live at 16:00 BST, all welcome 👉 pvrinstitute.org/learning-hub/events/sotatercept-new-conc…
The Pulmonary Vascular Research Institute
@PVRI
📢 NEW PVRI Digital Webinar happening next week! 'Sotatercept: New Concepts and Clinical Use' is part of the 'Cutting Edge Innovation in Clinical & Experimental PH' sessions, which takes place bi-monthly on the second Thursday at 16:00 GMT/BST.
Presentations
🔹 Sotatercept – eligibility, dosing, results Luke Howard, Imperial College London
🔹 Pulmonary vascular and right heart remodeling: what cardiac imaging and exercise tell us about Sotatercept Franz Rischard, University of Arizona
🔹 Genetic background: differential response to Sotatercept? David Montani, Universite Paris-Saclay
🔹 Complications of Sotatercept Rahul Argula, Medical University of South Carolina
Moderated by David Badesch, University of Colorado, and Ardeschir Ghofrani, Justis-Liebig University Giessen.
Register for free 👉 us02web.zoom.us/webinar/register/WN_aEP-gFhvQkK09qpMOL1LRA -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Join live at 16:00 BST, all welcome 👉 pvrinstitute.org/learning-hub/events/sotatercept-new-conc…
The Pulmonary Vascular Research Institute
@PVRI
📢 NEW PVRI Digital Webinar happening next week! 'Sotatercept: New Concepts and Clinical Use' is part of the 'Cutting Edge Innovation in Clinical & Experimental PH' sessions, which takes place bi-monthly on the second Thursday at 16:00 GMT/BST.
Presentations
🔹 Sotatercept – eligibility, dosing, results Luke Howard, Imperial College London
🔹 Pulmonary vascular and right heart remodeling: what cardiac imaging and exercise tell us about Sotatercept Franz Rischard, University of Arizona
🔹 Genetic background: differential response to Sotatercept? David Montani, Universite Paris-Saclay
🔹 Complications of Sotatercept Rahul Argula, Medical University of South Carolina
Moderated by David Badesch, University of Colorado, and Ardeschir Ghofrani, Justis-Liebig University Giessen.
Register for free 👉 us02web.zoom.us/webinar/register/WN_aEP-gFhvQkK09qpMOL1LRA -
The Pulmonary Vascular Research Institute
@PVRI
Happening today 15:00 BST - Join to explore women's health and #pvd > Register here: us02web.zoom.us/webinar/register/WN_eFeUdkx3RZG3NCzZlW56Gw
The Pulmonary Vascular Research Institute
@PVRI
🚨 Women’s Health and Pulmonary Vascular Disease free webinar tomorrow! Join us 9 September 15:00 BST to explore women’s health and pulmonary vascular disease, hear from experts, and help shape the Task Force’s direction:
🔹 Background and PHANTOM trial results Steven Kawut, University of Pennsylvania School of Medicine
🔹Pregnancy and PAH and/or PHAR data on sex disparities Jacqueline DesJardin, MD, UCSF Health
🔹Proposed aims and objectives for the Task Force, incorporating participant input and discussion Jessica Badlam, University of Vermont Medical Center and Meghan Cirulis, Intermountain Health Intermountain Medical Center
Everyone is welcome, and we encourage you to get involved! Register for free us02web.zoom.us/webinar/register/WN_eFeUdkx3RZG3NCzZlW56Gw
#womenshealth #pulmonaryhypertension #pulmonaryvasculardisease #pvriwebinar -
The Pulmonary Vascular Research Institute
@PVRI
🚨 Women’s Health and Pulmonary Vascular Disease free webinar tomorrow! Join us 9 September 15:00 BST to explore women’s health and pulmonary vascular disease, hear from experts, and help shape the Task Force’s direction:
🔹 Background and PHANTOM trial results Steven Kawut, University of Pennsylvania School of Medicine
🔹Pregnancy and PAH and/or PHAR data on sex disparities Jacqueline DesJardin, MD, UCSF Health
🔹Proposed aims and objectives for the Task Force, incorporating participant input and discussion Jessica Badlam, University of Vermont Medical Center and Meghan Cirulis, Intermountain Health Intermountain Medical Center
Everyone is welcome, and we encourage you to get involved! Register for free us02web.zoom.us/webinar/register/WN_eFeUdkx3RZG3NCzZlW56Gw
#womenshealth #pulmonaryhypertension #pulmonaryvasculardisease #pvriwebinar -
The Pulmonary Vascular Research Institute
@PVRI
📢 NEW PVRI Digital Webinar happening next week! 'Sotatercept: New Concepts and Clinical Use' is part of the 'Cutting Edge Innovation in Clinical & Experimental PH' sessions, which takes place bi-monthly on the second Thursday at 16:00 GMT/BST.
Presentations
🔹 Sotatercept – eligibility, dosing, results Luke Howard, Imperial College London
🔹 Pulmonary vascular and right heart remodeling: what cardiac imaging and exercise tell us about Sotatercept Franz Rischard, University of Arizona
🔹 Genetic background: differential response to Sotatercept? David Montani, Universite Paris-Saclay
🔹 Complications of Sotatercept Rahul Argula, Medical University of South Carolina
Moderated by David Badesch, University of Colorado, and Ardeschir Ghofrani, Justis-Liebig University Giessen.
Register for free 👉 us02web.zoom.us/webinar/register/WN_aEP-gFhvQkK09qpMOL1LRA -
The Pulmonary Vascular Research Institute
@PVRI
New publication: How Is Pulmonary Hypertension Characterised and Treated in Children With Trisomy 21? Observations From the TOPP Registry (Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension) by Tilman Humpl Et al. Read the full research article➡️
-
The Pulmonary Vascular Research Institute
@PVRI
The wait is over… the preliminary programme for #pvri2026 Dublin is here! From sotatercept and translational science to AI, biomarkers, and global PH challenges, PVRI 2026 will showcase innovation shaping the next 20 years of pulmonary hypertension.
Here’s a first look at what’s in store:
29 January - 20 years of progress in PAH
🔹 Sotatercept: from clinical trials to emerging insights
🔹Translational insights into promising targets and pathways
🔹Two organs, one mission: The RV-lung alliance
30 January - 20 years advances in all-cause PH
🔹PH associated with lung diseases: hope or hype?
🔹Global aspects of PH
🔹20 years of progress in CTEPH
🔹Translating innovation into PH therapies
31 January - The next 20 years of PH
🔹Precision medicine and artificial intelligence in PH
🔹Sharks Den: new targets, biomarkers, devices in PH
🔹Innovative concepts for future thinking in PH
🔹The future hope of living life to the full with PH
📍 Explore the full programme 👉 pvrinstitute.org/learning-hub/events/pvri-2026-dublin
Join us in Dublin, 28 January - 1 February 2026, to shape the future of PH therapies & drive progress together.
#pvri2026 #pulmonaryhypertension #pulmonaryvasculardisease -
The Pulmonary Vascular Research Institute
@PVRI
🎥 From Patient Voices to Action: Understanding the PH Global Survey - Webinar Recording Now Available On-Demand!
Did you miss our live session on the Pulmonary Hypertension Global Patient Survey (PHGPS)? You can now catch up and watch the full discussion anytime.
In this patient-focused webinar, Hall Skaara & Wendy Gin-Sing unpacked the European adult findings, covering:
🔹 Time to diagnosis
🔹 Quality of life
🔹 Access to care
🔹 Understanding the 10 Calls to Action
▶️ Watch on-demand here pvrinstitute.org/learning-hub/material/patient-voices-act…
#phgps #pulmonaryhypertension #patientwebinar #patientcare @EuropePHA @EuropeanLung -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Pulmonary Vascular Compromise Is Associated With Survival in Pediatric Pulmonary Hypertension: A New Computational Model by Maria Niccum Et al. Read the full research article➡️
doi.org/10.1002/pul2.70156 -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Join live at 13:00 BST 👉 register for free us02web.zoom.us/webinar/register/WN_6EdhvmqHROKrX0Q3xXIDJw
The Pulmonary Vascular Research Institute
@PVRI
Next in our High Altitude Webinar Series: Hypoxia in Pulmonary Vascular Research – Altitude and Beyond🗻
📅 2 September 2025 | 13:00 BST
🎙️ A Matter of Degrees. The remarkable life of Mabel Purefoy FitzGerald, a pioneer in hypoxia acclimatization
Expert speaker & moderators include Martha Tissot van Patot, Aastha Mishra & Ulrich Silvia
Free & open to all – join live and be part of the discussion! Register here: us02web.zoom.us/webinar/register/WN_6EdhvmqHROKrX0Q3xXIDJw
#highaltitude #phresearch #hypoxia #webinar #pulmonaryhypertension -
The Pulmonary Vascular Research Institute reposted
PHAEUROPE
@EuropePHA
Today, Hall Skaara the pleasure of co-presenting a webinar on the PH Global Patient Survey (PH GPS) with Wendy Gin-Sing (UK nurse). It was a great combo - patient + nursing perspectives - sharing findings from nearly 4,000 patients and carers worldwide. We also had 90+ live ⤵️
-
The Pulmonary Vascular Research Institute
@PVRI
New publication: Renal Outcomes After Lung or Combined Heart-Lung Transplantation in Pulmonary Hypertension by Laura Hardy Et al. Read the full research article➡️
onlinelibrary.wiley.com/doi/10.1002/pul2.70136 -
The Pulmonary Vascular Research Institute
@PVRI
Join at 11:00 BST today for a live webinar on the European findings from the #phgps survey. This session will discuss time to diagnosis, quality of life, access to care and the 10 Calls to Action us02web.zoom.us/webinar/register/WN_bp1yMKqhRvOLNQWWoziLJw
@EuropePHA @EuropeanLung -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Analysis of Clinical Characteristics of 54 Dead Pregnant Patients With Pulmonary Hypertension by Lishi Chen Et al. Read the full research article➡️
onlinelibrary.wiley.com/doi/10.1002/pul2.70123 -
The Pulmonary Vascular Research Institute
@PVRI
⏰ Happening THIS Friday! Don’t miss our free webinar on the European findings from the PH Global Patient Survey (PHGPS).
📅 29 August | 11:00 BST | Online via Zoom
Hear from Hall Skaara & Frances Varian on diagnosis, quality of life, access to care + the 10 Calls to Action.
🌍 With live Q&A and multi-language captions.
👉 Register now before it’s too late: us02web.zoom.us/webinar/register/WN_bp1yMKqhRvOLNQWWoziLJw
#phgps #pulmonaryhypertension #patientcare
The Pulmonary Vascular Research Institute
@PVRI
📢 From Patient Voices to Action: Understanding the PH Global Survey - A Webinar for Patients and Carers on PHGPS European Findings
📅 Friday, 29 August | 🕚 11:00 BST | 💻 Online via Zoom
We’re excited to invite you to a free, patient-focused webinar that unpacks key findings from the Pulmonary Hypertension Global Patient Survey (PHGPS) — with a spotlight on European adult data. Hall Skaara & @VarianFrances will be discussing:
- Time to diagnosis
- Quality of life
- Access to care
- Understanding the 10 Calls to Action
🗣 Live Q&A + discussion forum
🌍 Multi-language captions via Zoom
🤝 In partnership with @EuropePHA & @EuropeanLung
Register for free: us02web.zoom.us/webinar/register/WN_bp1yMKqhRvOLNQWWoziLJw
#phgps #pulmonaryhypertension #patientwebinar #patientcare -
The Pulmonary Vascular Research Institute reposted
Vumedi Pulmonology
@Pulm_Vumedi
From @PVRI Drug Discovery & Development Symposium 2025 — Dr. @SudarRajagopal (@DukeMedSchool) discusses the power & limits of imaging in proving disease-modifying effects in PH drug trials.
Watch on Vumedi: www.vumedi.com/video/the-role-of-imaging-in-establishing-…
#pulmonaryhypertension #pvri #vumedi #drugdevelopment #imaging @Cardio_Vumedi -
The Pulmonary Vascular Research Institute
@PVRI
⏰ Happening tomorrow! Don’t miss this free session in the iPVD Virtual Symposium Series. Join Dr Prashant Bobhate as he explores ‘Pulmonary Hypertension in the Shadow of Infections: Challenges in Indian Practice’ — a vital discussion you won’t want to miss.
🗓️ 27 August 2025
⏰ 3PM BST
Moderated by Navneet Dhillon. Register now us02web.zoom.us/webinar/register/WN_NL30X0OcQsGyWFacwVuGBQ
#pvd #pulmonaryhypertension #infection #inflammation #webinar -
The Pulmonary Vascular Research Institute reposted
Vumedi Pulmonology
@Pulm_Vumedi
At @PVRI Congress 2025, Dr. Anna Hemnes (@VUMCDiscoveries) explores treating Group 1 PH in patients with comorbidities—balancing risks, benefits, and personalization.
📺 Watch now on #vumedi: www.vumedi.com/video/approach-to-the-treatment-of-group-1…
#pvri2025 #pah #pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Global, Regional, and National Burden of Pulmonary Arterial Hypertension Among Women of Childbearing Age, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021 by Junjun Liu Et al. Read the full research article➡️
doi.org/10.1002/pul2.70154 -
The Pulmonary Vascular Research Institute
@PVRI
Happening next week! Register for free & join the discussion 🎦 us02web.zoom.us/webinar/register/WN_NL30X0OcQsGyWFacwVuGBQ
The Pulmonary Vascular Research Institute
@PVRI
🌍 Upcoming webinar – free & open to all! Join us for the next session in the iPVD Virtual Symposium Series, where Prashant Bobhate will be discussing 'Pulmonary Hypertension in the Shadow of Infections: Challenges in Indian Practice'.
🗓️ 27 August 2025
⏰ 3PM BST
Moderated by Navneet Dhillon - register for free us02web.zoom.us/webinar/register/WN_NL30X0OcQsGyWFacwVuGBQ
#pvd #pulmonaryhypertension #infection #inflammation #webinar -
The Pulmonary Vascular Research Institute
@PVRI
Heading to #pvri2026 Dublin? Don’t miss our satellite meetings (28 Jan & 1 Feb)—free & open to all!
✔ Imaging
✔ Paediatric
✔ Latin America
✔ iPVD
✔ IDDI
✔ High Altitude
✔ PAH-ICON
Be part of the global PVD conversation🌍
👉 Register now: pvrinstitute.org/learning-hub/events/pvri-2026-dublin -
The Pulmonary Vascular Research Institute
@PVRI
🌍 Breath Beyond Borders Challenge – November 2025 🌍
This #phawarenessmonth, PVRI members and friends around the world are uniting to push their limits — running, walking, cycling, swimming, even playing the piano — all in support of PH research and innovation.
Here’s where we stand so far:
- 24 participants already signed up
- Together pledging 3,901 km / 2,438 miles
- That’s further than the journey from Athens to Dublin — virtually crossing 12 countries along the way
And we’re just getting started. Want to be part of it? 👉 Simply tell us your chosen activity and distance goal, and get ready for November. Every step, mile, or note helps raise awareness for #pulmonaryhypertension worldwide. pvrinstitute.org/breathbeyondborders -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Relationship Between Phenotypical and Echocardiographic Findings With Pulmonary Hypertension in COPD Patients by Sayyed Gholamreza Mortazavi Moghaddam Et al. Read the full research article doi.org/10.1002/pul2.70153
-
The Pulmonary Vascular Research Institute reposted
PHAEUROPE
@EuropePHA
📣 PHAEUROPE invites you to a free, patient-focused webinar unpacking key findings from the Pulmonary Hypertension Global Patient Survey (PHGPS), with a focus on European adult data. Hall Skaara and Dr. Frances Varian will discuss⤵️
-
The Pulmonary Vascular Research Institute
@PVRI
📢 From Patient Voices to Action: Understanding the PH Global Survey - A Webinar for Patients and Carers on PHGPS European Findings
📅 Friday, 29 August | 🕚 11:00 BST | 💻 Online via Zoom
We’re excited to invite you to a free, patient-focused webinar that unpacks key findings from the Pulmonary Hypertension Global Patient Survey (PHGPS) — with a spotlight on European adult data. Hall Skaara & @VarianFrances will be discussing:
- Time to diagnosis
- Quality of life
- Access to care
- Understanding the 10 Calls to Action
🗣 Live Q&A + discussion forum
🌍 Multi-language captions via Zoom
🤝 In partnership with @EuropePHA & @EuropeanLung
Register for free: us02web.zoom.us/webinar/register/WN_bp1yMKqhRvOLNQWWoziLJw
#phgps #pulmonaryhypertension #patientwebinar #patientcare -
The Pulmonary Vascular Research Institute reposted
Kurt Prins
@kurt_prins
Alternative link: Microbiota Transplant Therapy Is Safe and Feasible in Pulmonary Arterial Hypertension | JACC: Basic to Translational Science.
Kurt Prins
@kurt_prins
Proud to see this out. I played a small role and all the credit goes to Dr. Moutsoglou and @thenappanMD for doing the first clinical trial of microbiome transplant in PAH! miniurl.com/t474uow6. @PVRI @ATS_PC @JACCJournals @3CPRCouncil @PHAssociation
-
The Pulmonary Vascular Research Institute
@PVRI
New publication: Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies by James R. Klinger Et al. Read the full research article 👉
onlinelibrary.wiley.com/doi/10.1002/pul2.70140 -
The Pulmonary Vascular Research Institute
@PVRI
🌍Did you know?
...in 2023/4 over 3000 patients or their loved ones responded to the Pulmonary Hypertension Global Patient Survey, providing a unique insight to their lived experience with the disease. Read the full #phgps paper to explore the key findings 👉 -
The Pulmonary Vascular Research Institute reposted
Yogesh Reddy
@yreddyhf
With inflammation being associated with HFpEF, MPO inhibitors are testing inflammation suppression in HFpEF. However with acute administration we saw acute worsening HFpEF hemodynamics in this RCT. Will it overcome this to work chronically? @MayoClinicCV
authors.elsevier.com/c/1lY-a5qq8fS9w -
The Pulmonary Vascular Research Institute
@PVRI
Next in our High Altitude Webinar Series: Hypoxia in Pulmonary Vascular Research – Altitude and Beyond🗻
📅 2 September 2025 | 13:00 BST
🎙️ A Matter of Degrees. The remarkable life of Mabel Purefoy FitzGerald, a pioneer in hypoxia acclimatization
Expert speaker & moderators include Martha Tissot van Patot, Aastha Mishra & Ulrich Silvia
Free & open to all – join live and be part of the discussion! Register here: us02web.zoom.us/webinar/register/WN_6EdhvmqHROKrX0Q3xXIDJw
#highaltitude #phresearch #hypoxia #webinar #pulmonaryhypertension -
The Pulmonary Vascular Research Institute reposted
ATS PC Assembly
@ATS_PC
We continue to learn more about sotatercept as its use extends beyond clinical trials. Check out these two new reports on pericardial effusions associated with sotatercept use!
doi.org/10.1183/13993003.01040-2025
doi.org/10.1002/pul2.70141
@rjbernardoMD @PVRI @EuroRespSoc @ERSpublications -
The Pulmonary Vascular Research Institute reposted
Sandeep Sahay, MD, MSc
@SandeepSahayMD
Pericardial Effusions And Sotatercept Therapy in Pulmonary Arterial Hypertension: A Multicenter Real-World Experience publications.ersnet.org/content/erj/early/2025/07/17/1399… @ATS_PC @ERSpublications @AssociationWsph @PVRI
-
The Pulmonary Vascular Research Institute
@PVRI
🌍 Upcoming webinar – free & open to all! Join us for the next session in the iPVD Virtual Symposium Series, where Prashant Bobhate will be discussing 'Pulmonary Hypertension in the Shadow of Infections: Challenges in Indian Practice'.
🗓️ 27 August 2025
⏰ 3PM BST
Moderated by Navneet Dhillon - register for free us02web.zoom.us/webinar/register/WN_NL30X0OcQsGyWFacwVuGBQ
#pvd #pulmonaryhypertension #infection #inflammation #webinar -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Effect of Regulating FUNDC1 Mitophagy-Mediated cGAS/STING Pathway in Oleic Acid-Induced Acute Lung Injury Model by Liangyu Mi Et al. Read the full research article
onlinelibrary.wiley.com/doi/10.1002/pul2.70137 -
The Pulmonary Vascular Research Institute
@PVRI
What is #breathbeyondborders? A global fundraising challenge to raise awareness about the importance of research and innovation in #pulmonaryhypertension, and show the strength of the global #ph community🌍
Whether it’s walking, swimming, or doing yoga, you can take part wherever you are — throughout November for #phawareness Month.
Follow our journey, support the PVRI Breath Beyond Borders team, and help spread the word. Together, we will make every mile count.
👉 Sign up & find out more pvrinstitute.org/breathbeyondborders
#phresearch #pvri2026This media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Characterization of the Population With Intermediate-Risk Status in Pulmonary Arterial Hypertension: Patients in a Latin American Country: The CAPRI Registry by R. Conde-Camacho Et al. Read the full research article
onlinelibrary.wiley.com/doi/10.1002/pul2.70145 -
The Pulmonary Vascular Research Institute
@PVRI
🎥 Missed the webinar? Catch the recording on demand!
The PVRI Lung Transplantation in Pulmonary Hypertension Workstream brought together leading experts for a powerful session on bridging paediatric patients to lung transplant—from infancy through adolescence.
💡 Watch now to gain insights into evolving mechanical support strategies and hear real-world case discussions from top clinicians in the field.
🎙️ Featuring: Ryan Coleman, Pirooz Eghtesady, Darren Freed, Rebecca Johnson Kameny, and Melinda Solomon.
Available on demand now — don’t miss this expert-led deep dive into paediatric transplant medicine! pvrinstitute.org/learning-hub/material/paediatric-bridge-…
#paediatrictransplant #lungtransplant #pulmonaryhypertension #webinar -
The Pulmonary Vascular Research Institute
@PVRI
📢 Happening Tomorrow: Paediatric Bridge to Transplant Webinar
📅 29 July 2025, 16:00 BST
Our Lung Transplantation in Pulmonary Hypertension Workstream will be presenting a webinar on expert strategies for bridging paediatric patients to lung transplant. Expert speakers & moderators include: Ryan Coleman, Pirooz Eghtesady, Darren Freed, Rebecca Johnson Kameny, and Melinda Solomon.
Don’t miss this opportunity to gain insights from leaders at the forefront of paediatric transplant medicine! Register for free 👉 us02web.zoom.us/webinar/register/WN_eqCdTw_3TPiUDYSWlYdBaw
#lungtransplant #pulmonaryhypertension #webinar #paediatricpatients -
The Pulmonary Vascular Research Institute
@PVRI
🚨 Women’s Health Task Force is back — and we want you to be part of it!
Join us for a dedicated webinar on 9 September (3PM BST) to explore women’s health and pulmonary vascular disease, hear from experts, and help shape the Task Force’s direction:
· Background and PHANTOM trial results Steve Kawut, University of Pennsylvania School of Medicine
· Pregnancy and PAH and/or PHAR data on sex disparities Jackie DesJardin, UCSF Health
· Proposed aims and objectives for the Task Force, incorporating participant input and discussion Jessica Badlam, University of Vermont Medical Center and Meghan Cirulis, Intermountain Health Intermountain Medical Center
Everyone is welcome, and we encourage you to get involved!
Learn more pvrinstitute.org/learning-hub/events/womens-health-and-pu…
#womenshealth #pulmonaryhypertension #pulmonaryvasculardisease #pvriwebinar -
The Pulmonary Vascular Research Institute
@PVRI
Catch up on Martin Wilkins’ presentation from #ddds2025, where he explored the limitations of relying on single reading averages from traditional clinical trials and made the case for n-of-1 studies in PAH:
🔹 Valuable for assessing novel treatments in rare conditions like PAH
🔹 Remote monitoring helps address concerns around treatment ‘washout’ periods
🔹 Provides deeper insights into individual treatment response over time
🎥Full recording available on demand: pvrinstitute.org/learning-hub/material/n-1-trials-and-ran…
#pah #clinicaltrials #drugdevelopment #ddds2025 -
The Pulmonary Vascular Research Institute
@PVRI
📢Call for Abstracts
Submit your research for #pvri2026 by 1 October 2025 🗓️
We’re inviting abstracts across four exciting themes:
1. Basic & Translational Science
2. Clinical Science
3. International & Global Health
4. Mind the Gap: Cases that Highlight Gaps in Evidence
Best abstracts will be eligible for our prestigious awards, including the Butrous Foundation Young Investigator Award, Rupert Swift Award, and three Early Career Abstract Awards — with winners invited to present at the Congress! Accepted abstracts (with your permission) will be published in Pulmonary Circulation.
🔗 Get full abstract guidelines, T&Cs, and submit here: pvrinstitute.org/learning-hub/events/pvri-2026-dublin
#pvri2026 #callforabstracts #phresearch #pulmonaryhypertension #phcommunity #globalhealth -
The Pulmonary Vascular Research Institute
@PVRI
🌍 Ready to take on a fitness challenge with global impact for pulmonary hypertension? Join #breathbeyondborders this November for #phawarenessmonth. PVRI members and friends around the world are invited to take on personal challenges — walking, running, cycling, yoga-ing, speed skating, or even playing the piano — to shine a light on PH research and innovation, and raise vital funds for PVRI along the way.
👉 Sign up & find out more pvrinstitute.org/breathbeyondborders
#phcommunity #pulmonaryhypertension #pvrichallengeThis media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Risk Assessment Models and Event-Free Survival in Pulmonary Arterial Hypertension by Clara Hjalmarsson Et al. Read the full research article 👉onlinelibrary.wiley.com/doi/10.1002/pul2.70132
-
The Pulmonary Vascular Research Institute
@PVRI
🎉 Our #pvridigital Webinar Series is back this September! Join us on the 2nd Thursday of each month at 16:00 BST/GMT for inspiring keynote talks from global PH experts — alternating between:
🔬 Cutting Edge Innovation in Clinical & Experimental PH
🎙️ Living Legends in PH: History & Personal Perspectives
✨ Free. Global. Open to all.
Can’t make it live? Recordings will be available for PVRI members to watch on demand.
A huge thank you to our organising committee for an incredible programme ahead! Patricia Thistlethwaite, Franz Rischard, Andrew Sweatt, Micheala Aldred, Stephen Chan, Ke Yuan, Corey Ventetuolo.
Find out more pvrinstitute.org/PVRIDigital
#pvridigital #phwebinar #phresearch #pulmonaryhypertension #phcommunity -
The Pulmonary Vascular Research Institute reposted
PHAEUROPE
@EuropePHA
📢Big news for the PH community! Findings from the global PH GPS adult survey (3,300+ patients, 90 countries) are now published. PHAEUROPE’s Eva Otter & Gery Fischer are among co-authors. ⤵️
www.facebook.com/phaeurope/posts/1177941574368658 -
The Pulmonary Vascular Research Institute
@PVRI
📢 New publication from our Paediatric Clinical Trial Design & Endpoints Workstream: Enhancing Drug Development for Paediatric Pulmonary Hypertension—An Integrative Perspective. Congrats Steven Abman, Sylvia Nikkho, Rolf Berger, Maria Jesus del Cerro, Eric Austin, Maurice Beghetti, Dunbar Ivy, Megan Griffiths, Anne Hilgendorff, Steven Kawut, Usha Krishnan, Mary Mullen, Shahin Moledina, Bernard Thébaud, Norman Stockbridge. Read the full review article onlinelibrary.wiley.com/doi/10.1002/pul2.70126
-
The Pulmonary Vascular Research Institute
@PVRI
📢 NEW Webinar: Paediatric Bridge to Transplant
📅 29 July 2025, 16:00 BST
Our Lung Transplantation in Pulmonary Hypertension Workstream will be presenting a webinar on expert strategies for bridging paediatric patients to lung transplant. Expert speakers & moderators include: Ryan Coleman, Pirooz Eghtesady, Darren Freed, Rebecca Kameny & Melinda Solomon.
Don’t miss this opportunity to gain insights from leaders at the forefront of paediatric transplant medicine! Register for free 👉 pvrinstitute.org/learning-hub/events/paediatric-bridge-tr…
#lungtransplant #pulmonaryhypertension #webinar #paediatricpatients -
The Pulmonary Vascular Research Institute
@PVRI
📢 Good news! 📢Our #phgps, the largest global survey exploring the perspectives of #pulmonaryhypertension patients, has identified 10 key global priorities for improving #pulmonaryhypertension care in adult patients. These 10 calls to action aim to enhance equitable access to care and research opportunities, particularly across areas of geographical disparities:
1. Patients should be investigated rapidly to reduce the time to PH diagnosis
2. Patients should have access to a specialist PH centre with diagnostics and therapeutics including genetic testing, parenteral prostacyclins and mechanical interventions for management of CTEPH
3. Patient Reported Outcomes Measures (PROMs) should be used to evaluate quality of life and guide holistic care, including psychological and rehabilitative services
4. Patients should be empowered to engage in shared-decision making in partnership with their clinicians, including managing side effects
5. Patients with PH should be encouraged to access PH associations by their healthcare professionals for education and other resources
6. Patients with PH should be assisted in applying to make adjustments to employment or applying for disability support
7. Patients with PH should be empowered to engage with digital and remote healthcare, where appropriate
8. Patients with Groups 2, 3 and 5 PH should be better represented in research and specialist clinical care
9. Patients with PH should be offered the opportunity to participate in clinical research trials and registries, that have ideally been co-designed with patients
10. Patients and their carers should be invited to participate in PHGPS-2 to evaluate progress over time and further widen representation geographically and in Groups 2 and 3
Read more 👉 doi.org/10.1002/pul2.70130
Congratualtions Joseph Newman, Hakim Ghani, Shiv Munagala, Eva Otter, Gerald Fischer, Marcin Kurzyna, Gergely Meszaros, Millicent Stone, Lynsay MacDonald, Shahin Moledina, Luke Howard, Wendy Gin-Sing, Pisana Ferrari, Maurice Beghetti, Katherine Bunclark, Mark Toshner, Matt Granato, The PHGPS Consortium, and Joanna Pepke-Zaba! -
The Pulmonary Vascular Research Institute
@PVRI
How to define or prove disease modification - catch up on @mark_toshner's thought-provoking talk from #ddds2025 as he explores:
🔹 Regulators definition of disease modification
🔹 Biomarkers of disease activity
🔹 Can we use high dimension ‘feel & function’ data to define disease modification
🔹 Is Imatinib disease modifying?
🔹 The importance of patient perspectives in defining disease modification
🎥 Full recording available on demand: pvrinstitute.org/learning-hub/material/how-define-or-prov…
#pah #bmp #imatinib #sotatercept #diseasemodification -
The Pulmonary Vascular Research Institute reposted
Pullamsetti Lab
@PullamsettiL
Thanks to the collaborative efforts of @CRC1213
New in Nature Cardiovascular Research:
We uncover molecular signaling of reversible ECM and cytoskeletal remodeling in the RV of CTEPH patients before and after PEA surgery🫀
@PVRI @AHAScience @3CPRCouncil
www.nature.com/articles/s44161-025-00672-8 -
The Pulmonary Vascular Research Institute
@PVRI
📢 New publication: Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-Registry by Arun Jose, Athiththan Yogeswaran, Khodr Tello, @ElwingJean, Werner Seeger, Meike Fünderich Et al. Read the full research article
-
The Pulmonary Vascular Research Institute
@PVRI
Registration & abstract submissions for #pvri2026 are now open! Join us in Dublin for world-class science, global collaboration, and exciting satellite meetings.
📢 Submit your abstract
🎟️ Secure your place
🔗 pvrinstitute.org/pvri2026
#pulmonaryhypertension #callforabstracts #globalhealth #medicalresearch #phcommunity
The Pulmonary Vascular Research Institute
@PVRI
🚨 The wait is over — registration and abstract submissions are officially open for #pvri2026
With the theme of Celebrating 20 Years of Progress & Innovation, join us in Dublin from 28 January – 1 February for world-class science, dynamic discussions, and impactful networking with leaders in pulmonary vascular research and care.
📢 Call for abstracts
We welcome submissions across four key themes:
🔬 Basic & Translational Science
🩺 Clinical Science
🌍 International & Global Health
❗ Mind the Gap: Cases that Highlight Gaps in Evidence
Whether you're an early career researcher or experienced investigator, your contributions will help shape critical conversations in pulmonary vascular disease.
🗓 Satellite meetings
Don't miss our exciting line-up of free, open-access satellite meetings, including:
· Task Force & IDDI sessions (28 January)
· Early Career Catalyst Luncheon (29 January)
· Women in PH Luncheon (30 January)
· History of PVRI & PH (31 January)
· PAH-ICON (1 February)
Register your place and find out more about abstract submissions here pvrinstitute.org/pvri2026
#pvri2026 #pulmonaryhypertension #medicalresearch #globalhealth #phcommunity #callforabstracts -
The Pulmonary Vascular Research Institute
@PVRI
Great news! Key findings just published in the ERJ Open Research from our Pulmonary Hypertension Global Patient Survey #phgps adult cohort of 3,329 patients highlight the achievements, shortcomings & regional disparities of #ph clinical care & research globally.
Findings in the 'The Pulmonary Hypertension Global Patient Survey: understanding the experiences and perspectives of patients' early view paper include:
🏥 most patients with pulmonary arterial hypertension (#pah) reported a diagnosis within 12 months of symptom onset
💉 33.9% of eligible patients reported genetic testing
📋 20.6% of patients with #pulmonaryhypertension completed Patient Reported Outcome Measures (PROMs), with 7% feeling they changed management
💊 19.1% of patients participated in research; however, 72.2% who have not participated would be willing if invited.
Read the full paper -> doi.org/10.1183/23120541.00297-2025
A huge congratulations to Joe Newman, Hakim Ghani, Shiv Munagala, Eva Otter, Gerald Fischer, Marcin Kurzyna, MD, PhD, FESC, Gergely Meszaros JD, MSc, Millicent Stone, Lynsay MacDonald, Shahin Moledina, Luke Howard, Wendy Gin-Sing, Pisana Ferrari, Maurice Beghetti, Katherine Bunclark, Mark Toshner, Matt J. Granato, The PHGPS consortium, and Joanna Pepke-Zaba on your findings!
#pvri #patientcare -
The Pulmonary Vascular Research Institute
@PVRI
How to use imaging endpoints reflecting the pulmonary circulation & RV - catch up on David Kiely's insightful talk from #ddds2025 as he explores:
🔹 Why do we need to consider using an imaging end-point in PH trials?
🔹 What imaging can we use to assess the cardiopulmonary circulation
🔹 How do we incorporate imaging into a platform to elevate PH treatments?
🎥 Full recording available on demand: pvrinstitute.org/learning-hub/material/how-use-imaging-en… #imaging #pulmonaryhypertension #phtrialsThis media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
Missed it? Catch up on @DrRahulKumarPhD presentation on the role of inflammatory immune cells in hypoxic pulmonary hypertension. 🎥 Now available to watch on demand — free to access:
pvrinstitute.org/learning-hub/material/role-inflammatory-…
#highaltitude #hypoxia #pulmonaryhypertension #webinar
The Pulmonary Vascular Research Institute
@PVRI
Next in our High Altitude webinar series 'Hypoxia in Pulmonary Vascular Research – Altitude and Beyond'🗻
📅 1 July 2025 | 1PM BST
🎙️ Join @DrRahulKumarPhD as he explores the role of inflammatory immune cells in hypoxic pulmonary hypertension.
Moderated by @aastha_mishra06 & @SilviaUlrich6. Free and open to all — register now and be part of the discussion pvrinstitute.org/learning-hub/events/role-inflammatory-im…
#ph #pulmonaryhypertension #highaltitude #hypoxia #phresearch #pvriwebinars -
The Pulmonary Vascular Research Institute
@PVRI
🚨 The wait is over — registration and abstract submissions are officially open for #pvri2026
With the theme of Celebrating 20 Years of Progress & Innovation, join us in Dublin from 28 January – 1 February for world-class science, dynamic discussions, and impactful networking with leaders in pulmonary vascular research and care.
📢 Call for abstracts
We welcome submissions across four key themes:
🔬 Basic & Translational Science
🩺 Clinical Science
🌍 International & Global Health
❗ Mind the Gap: Cases that Highlight Gaps in Evidence
Whether you're an early career researcher or experienced investigator, your contributions will help shape critical conversations in pulmonary vascular disease.
🗓 Satellite meetings
Don't miss our exciting line-up of free, open-access satellite meetings, including:
· Task Force & IDDI sessions (28 January)
· Early Career Catalyst Luncheon (29 January)
· Women in PH Luncheon (30 January)
· History of PVRI & PH (31 January)
· PAH-ICON (1 February)
Register your place and find out more about abstract submissions here pvrinstitute.org/pvri2026
#pvri2026 #pulmonaryhypertension #medicalresearch #globalhealth #phcommunity #callforabstracts -
The Pulmonary Vascular Research Institute reposted
PHAEUROPE
@EuropePHA
PHA Europe was proud to be represented by Hall Skaara at the PVRI Drug Discovery & Development Symposium 2025 in Amsterdam. The event gathered global experts to explore breakthroughs in PH, including sotatercept (Winrevair), now approved in the US and EU, and emerging therapies
-
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Register & join for free us02web.zoom.us/webinar/register/WN_9PH0ReJqQU2oyvC2SxFLKg
The Pulmonary Vascular Research Institute
@PVRI
Next in our High Altitude webinar series 'Hypoxia in Pulmonary Vascular Research – Altitude and Beyond'🗻
📅 1 July 2025 | 1PM BST
🎙️ Join @DrRahulKumarPhD as he explores the role of inflammatory immune cells in hypoxic pulmonary hypertension.
Moderated by @aastha_mishra06 & @SilviaUlrich6. Free and open to all — register now and be part of the discussion pvrinstitute.org/learning-hub/events/role-inflammatory-im…
#ph #pulmonaryhypertension #highaltitude #hypoxia #phresearch #pvriwebinars -
The Pulmonary Vascular Research Institute
@PVRI
📝 Hall Skaara shares his reflections on #ddds2025
We loved reading this brilliant write-up by Hall Skaara from @EuropePHA, capturing key moments and takeaways from our Drug Discovery & Development Symposium 2025 in Amsterdam.
From global collaboration to patient access and the future of PH drug development — Hall’s piece highlights the heart of what made this meeting so impactful.
📖 Take a look at the full article here:
🔗 www.phaeurope.org/news/pvri-symposium-report-2025/
A huge thank you to Hall for sharing your perspective and helping amplify the voice of the patient community.
#ddds2025 #phresearch #pulmonaryhypertension #phaeurope #pvri -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Hypopituitarism Induced by Continuous Infusion of PGI2 Analogues: A Case Series and the Role of ACTH Screening and Hydrocortisone Treatment by Taijyu Satoh Et al. Read the full research article onlinelibrary.wiley.com/doi/10.1002/pul2.70116
-
The Pulmonary Vascular Research Institute
@PVRI
🎥 Missed #ddds2025 in Amsterdam?
Catch Luke Howard’s talk: How Sotatercept will change the treatment algorithm 💊
▶️ Full recording: pvrinstitute.org/learning-hub/material/how-sotatercept-wi…
@HelpMyBreathing
#phresearch #drugdevelopment #sotatercept #pvriThis media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
Next in our High Altitude webinar series 'Hypoxia in Pulmonary Vascular Research – Altitude and Beyond'🗻
📅 1 July 2025 | 1PM BST
🎙️ Join @DrRahulKumarPhD as he explores the role of inflammatory immune cells in hypoxic pulmonary hypertension.
Moderated by @aastha_mishra06 & @SilviaUlrich6. Free and open to all — register now and be part of the discussion pvrinstitute.org/learning-hub/events/role-inflammatory-im…
#ph #pulmonaryhypertension #highaltitude #hypoxia #phresearch #pvriwebinars -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Melatonin Improves Quality of Life, Oxidative Stress, and Cardiovascular Function in Pulmonary Arterial Hypertension by Alicia de la Fuente Et al. Read the full research article onlinelibrary.wiley.com/doi/10.1002/pul2.70109
-
The Pulmonary Vascular Research Institute reposted
Sebastien « Seb » Bonnet
@sbonnet2
Our latest review on Anti-remodeling therapies in pulmonary arterial hypertension: Trends in Pharmacological Sciences www.cell.com/trends/pharmacological-sciences/fulltext/S01… @3CPRCouncil @ATS_PC @PVRI @IUCPQ
-
The Pulmonary Vascular Research Institute
@PVRI
That’s a wrap! A huge thank you to all our delegates & speakers who joined us in this amazing city. We are so grateful to you all and we hope you have taken away some valuable insights and meaningful connections that will continue to drive our shared vision forward. #ddds2025 #drugdevelopment #pah
-
The Pulmonary Vascular Research Institute
@PVRI
Fantastic panel discussion this afternoon for our 'Global aspects of drug development & availability' session. Thank you to our wonderful moderators & speakers, Anton Vonk Noordegraaf, Deimante Hoppenot, Werner Seeger, Anna Hemnes, Ardeschir Ghofrani #ddds2025
-
The Pulmonary Vascular Research Institute
@PVRI
Werner Seeger is kicking off the afternoon presentations with a talk on using the GoDeep registry to prioritise & facilitate global drug trials. PVRI GoDeep is a global meta-registry of #pulmonaryhypertension patients, including currently nearly 40,000 patients from 47 PH referral centres worldwide. Its rich data set allows assessment of regional differences impacting drug trials, as well as in silico trial simulation. #ddds2025
-
The Pulmonary Vascular Research Institute
@PVRI
What a morning at #ddds2025! Great to hear so many insightful presentations already on new standards of care and disease modification.
Here’s some highlights:
🔬 After Anna Hemnes’s welcome, Mitchell Psotka (FDA) and Illiana Meurs (CBG-MEB) opened with a presentation on global perspective on regulatory approval of Sotatercept
🔬 Luke Howard discussed how Sotatercept will change the treatment algorithm
🔬 Implications of a new background therapy for drug development was the next talk led by Marion Delcroix
🔬 Mark Toshner presented a talk on how to define or prove disease modification
🔬 Followed by Sudarshan Rajagopal’s presentation on the role of imaging in establishing disease modifying effects of a trial drug
Looking forward to an afternoon of networking and sharing the latest drug developments in #ph! -
The Pulmonary Vascular Research Institute reposted
Pulmonary Hypertension at Penn
@PennMedPH
🚨 Now accepting applications for the 2026–2027 Penn Pulmonary Hypertension Fellowship!
Physicians who’ve completed Cardiology or PCCM fellowships are eligible. Apply by July 11 with CV, cover letter & 3 LORs to: Denice.Susini@pennmedicine.upenn.edu
@ATS_PC @PVRI @ACCP @ISHLT -
The Pulmonary Vascular Research Institute
@PVRI
Hallo! We’ve just arrived in Amsterdam, and we can’t wait to welcome the PH community to our Drug Discovery and Development Symposium 2025. We are all set up for registrations, so if you'd like to collect your name badge and check in, we’ll be here until 18:30! #ddds2025 #drugdevelopment #pah
-
The Pulmonary Vascular Research Institute reposted
Frankie
@VarianFrances
Looking forward to #ddds2025 @PVRI tomorrow… I’ll be explaining how to carbon footprint a clinical trial in five easy steps… with only a set of weighing scales required…. ⚖️🌍
-
The Pulmonary Vascular Research Institute
@PVRI
📣Exciting news! We’re thrilled to announce a new chapter in the leadership of PVRI’s Innovative Drug Discovery Initiative (IDDI). We warmly welcome industry reps, Gil Golden (UTC) and @SidraHoffman (Gossamer Bio), to the IDDI Leadership Team. They’ll be joining @SandeepSahayMD and Luke Howard @HelpMyBreathing, who remain on as IDDI Leaders.
Our heartfelt thanks to Peter Fernandes and Sylvia Nikkho, who are stepping down from their roles. Their dedication has laid a strong foundation for the future of the IDDI, and we are very grateful that Sylvia will remain active in several Workstreams.
See their profiles: pvrinstitute.org/iddi-workstreams-task-forces
Together, we’re building the future of pulmonary vascular drug discovery. 💊💡
#pulmonaryhypertension #drugdiscovery #clinicalresearch #phcommunity -
The Pulmonary Vascular Research Institute reposted
PHAEUROPE
@EuropePHA
📢Pulmonary arterial hypertension (PAH) is a rare, progressive disease. About 55% of people survive 5 years after diagnosis. Sotatercept (Winrevair), a newly approved treatment, targets “activin signaling,” a pathway involved in PAH. #pulmonaryhypertension⤵️
-
The Pulmonary Vascular Research Institute
@PVRI
📢 Get ready to submit your abstract to PVRI 2026 Dublin — registrations & the abstract portal will open on 1 July!
Join us in the historic city of Dublin, 28 January – 1 February 2026, for cutting-edge science, global collaboration, and inspiring conversations. Stay tuned for full details on how to register and submit your abstract! pvrinstitute.org/pvri2026
The abstract portal will close on 1 October. #pvri2026 #pulmonaryhypertension #globalscience #congress -
The Pulmonary Vascular Research Institute
@PVRI
New publication: The Role of Telehealth in PAH Management: Benefits, Barriers, and Solutions by Susanne McDevitt Et al. Read the full research article onlinelibrary.wiley.com/doi/10.1002/pul2.70079
-
The Pulmonary Vascular Research Institute
@PVRI
Missed this month's #pulmonaryhypertension Community Call? Full recording now available on demand ⏯️ pvrinstitute.org/learning-hub/material/june-2025-pvri-com…
Catch up on the discussion:
🔬 Epicardial adipose tissue as an independent risk factor for mortality in PAH
🌍 Morbidity and mortality associated with PAH in a schistosomiasis‐endemic region of Brazil -
The Pulmonary Vascular Research Institute
@PVRI
Our Community Call is live now! Join us for a discussion on all things PH: us02web.zoom.us/webinar/register/WN_GGO3t84nRmSHngXry1o9bA
-
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow🎙️Free and open to all — don’t miss it! us02web.zoom.us/webinar/register/WN_GGO3t84nRmSHngXry1o9bA #communitycall #pulmonaryhypertension #pah
The Pulmonary Vascular Research Institute
@PVRI
Join us for our June PVRI Community Call! We’re excited to welcome guest authors @DoctorBreanne, @AlNaamani_N, and Ricardo Amorim Corrêa as they share insights on:
🔬 Epicardial adipose tissue as an independent risk factor for mortality in PAH
🌍 Morbidity and mortality associated with PAH in a schistosomiasis‐endemic region of Brazil
Moderated by Joel James, Katrina Barry, and @SandeepSahayMD.
🗓️ 6 June 2025
🕒 3PM BST
Our monthly Community Calls are informal, free, and open to all. Join the conversation and connect with the PH community! Register now: us02web.zoom.us/webinar/register/WN_GGO3t84nRmSHngXry1o9bA -
The Pulmonary Vascular Research Institute
@PVRI
Final countdown⌛️ Less than 2 weeks to go until #ddds2025 in Amsterdam! From therapeutic targets to trial innovation and regulatory perspectives, join the PH community and register your place today pvrinstitute.org/DDDS2025
The Pulmonary Vascular Research Institute
@PVRI
📆 1 month to go – are you joining us in Amsterdam?
Our Drug Discovery & Development Symposium 2025 is just a month away, and we’re counting down the days! From big conversations on the future of PH drug development to brilliant networking and an incredible speaker line-up, it’s shaping up to be two unmissable days.
Be part of the conversation shaping the future of therapeutic targets, trial innovation, and global collaboration in PH research.
🎟️ Secure your spot today: pvrinstitute.org/DDDS2025 #ddds2025 #drugdevelopment #phresearch #pahThis media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
🎥 Watch the preview: La Rinconada Expedition 5300 – Scientific Highlights
Samuel Verges shares how the body adapts at the world’s highest city. Part of our 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar series by the High Altitude Task Force.
▶️ Snippet below – full webinar here: pvrinstitute.org/learning-hub/material/la-rinconada-exped… -
The Pulmonary Vascular Research Institute reposted
Pulmonary Hypertension at Penn
@PennMedPH
Join the @PVRI community call this Friday to hear from our very own @DoctorBreanne and @AlNaamani_N
The Pulmonary Vascular Research Institute
@PVRI
Join us for our June PVRI Community Call! We’re excited to welcome guest authors @DoctorBreanne, @AlNaamani_N, and Ricardo Amorim Corrêa as they share insights on:
🔬 Epicardial adipose tissue as an independent risk factor for mortality in PAH
🌍 Morbidity and mortality associated with PAH in a schistosomiasis‐endemic region of Brazil
Moderated by Joel James, Katrina Barry, and @SandeepSahayMD.
🗓️ 6 June 2025
🕒 3PM BST
Our monthly Community Calls are informal, free, and open to all. Join the conversation and connect with the PH community! Register now: us02web.zoom.us/webinar/register/WN_GGO3t84nRmSHngXry1o9bA -
The Pulmonary Vascular Research Institute reposted
Sebastien « Seb » Bonnet
@sbonnet2
Exploratory study of prognostic plasma biomarkers in patients with PAH. ajp.amjpathol.org/article/S0002-9440(25)00181-6/fulltext latest paper from our group bravo to Yukimitsu and Olivier boucherat😎 @IUCPQ @universitelaval @facmedUL @ATS_PC @3CPRCouncil @PVRI
-
The Pulmonary Vascular Research Institute
@PVRI
New PAH treatment offers hope for patients in advanced stage of disease🫁Read the groundbreaking study in @NEJM www.nejm.org/doi/full/10.1056/NEJMe2503944
University of Maryland School of Medicine
@UMmedschool
🫁 Big news in pulmonary hypertension:
A new study shows sotatercept cuts risk of death/hospitalization by 76% in advanced PAH patients.
Dr. Bradley Maron calls the results “staggering” in @NEJM. A potential game-changer.
🔗shorturl.at/pJiIU
#nejm #medtwitter -
The Pulmonary Vascular Research Institute reposted
Liquidia Corporation
@Liquidia_Corp
Liquidia is proud to announce that the U.S. FDA has approved YUTREPIA™ (treprostinil) inhalation powder for patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). See today’s press release here:
-
The Pulmonary Vascular Research Institute
@PVRI
Join us for our June PVRI Community Call! We’re excited to welcome guest authors @DoctorBreanne, @AlNaamani_N, and Ricardo Amorim Corrêa as they share insights on:
🔬 Epicardial adipose tissue as an independent risk factor for mortality in PAH
🌍 Morbidity and mortality associated with PAH in a schistosomiasis‐endemic region of Brazil
Moderated by Joel James, Katrina Barry, and @SandeepSahayMD.
🗓️ 6 June 2025
🕒 3PM BST
Our monthly Community Calls are informal, free, and open to all. Join the conversation and connect with the PH community! Register now: us02web.zoom.us/webinar/register/WN_GGO3t84nRmSHngXry1o9bA -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Arteriovenous Oxygen Content Difference: A Diagnostic Predictor for Preselecting Invasive Treatment in Congenital Heart Disease-Related Pulmonary Arterial Hypertension by Ashfaq Ahmad Et al. Read the full research article➡️
onlinelibrary.wiley.com/doi/10.1002/pul2.70091 -
The Pulmonary Vascular Research Institute
@PVRI
Happening today! 🌍 Join us for this free webinar in the iPVD Virtual Symposium Series, where Yassine Sassi will discuss Environmental Determinants and PVDs.
🗓️ 28 May | ⏰ 3PM BST
🎤 Moderated by Rudolf Oliveira
🔗 Register here: us02web.zoom.us/webinar/register/WN_rM54YWA-RMeBHbmYrWfPdw
The Pulmonary Vascular Research Institute
@PVRI
🌍 Upcoming webinar – free & open to all! Join us for the next session in the iPVD Virtual Symposium Series, where Yassine Sassi will be discussing 'Environmental determinants and PVDs'.
🗓️ 28 May 2025
⏰ 3PM BST
Moderated by Rudolf Oliveira - register for free us02web.zoom.us/webinar/register/WN_rM54YWA-RMeBHbmYrWfPdw
#pvd #pulmonaryhypertension #ipvd #inflammation -
The Pulmonary Vascular Research Institute reposted
Jose Carlos Rivas Ferreira
@jcrivasferr
Could reduced levels of #prmt1 and #pecam1 be #biomarkers for #early #detection and prevent the development and progression of COPD? 🫰🧬🐁
Could treatment with BAY-11-7082 be the #drug of choice for COPD in the future by inhibiting the NF-κB #pathway, thereby preventing the development of #senescence and #endothelial #dysfunction?🫰🔬🧬
Could BAY-11-7082 be effective in preventing endothelial dysfunction in non-pulmonary #vessels?🐁🔬🐁🐁🧬
@atvbahajournals @gkolost @LungCancerEu @HyperAHA @IEEEembs
@PVRI @The_MCSociety @CirVascularAND @CircRes @ajpheartcirc @HaoYin20 @CMPLPUCCHILE @LuisSobrevia2 @JCVPOnline @CTRC_UofSCSOM @CNIC_CARDIO @WashUDeptMed @WashUCardiology @SocFisiolChile @IFPA_Official @ResearchGermany @IJMS_MDPI @ESC_Journals @NatRevCardiol @hopkinsheart @escardio @HypertensionAus @SAC_54 @isth 👇🧵👇
Endothelial Cell News
@endothelialnews
How does PRMT1 affect #endothelial cells in the context of #copd? 🤔
Researchers show that by suppressing NF-κB activation and preventing inflammatory shifts, PRMT1 protects against endothelial dysfunction, inflammation, and senescence in COPD.
advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202411514 -
The Pulmonary Vascular Research Institute
@PVRI
We are now live! Still time to join us02web.zoom.us/webinar/register/WN_tcODpxY8Q7-_imOjyeIZBw
The Pulmonary Vascular Research Institute
@PVRI
🚨 Happening Tomorrow! Next in our High Altitude webinar series: La Rinconada Expedition 5300 – an overview of scientific results🏔️
Join Samuel Vergès, Grenoble Alpes University, and our moderators @aastha_mishra06, CSIR-Institute of Genomics & Integrative Biology & @SilviaUlrich6, University Hospital Zurich at 1PM BST tomorrow.
🎟️ Free to attend – don’t miss out us02web.zoom.us/webinar/register/WN_tcODpxY8Q7-_imOjyeIZBw -
The Pulmonary Vascular Research Institute
@PVRI
🚨 Happening Tomorrow! Next in our High Altitude webinar series: La Rinconada Expedition 5300 – an overview of scientific results🏔️
Join Samuel Vergès, Grenoble Alpes University, and our moderators @aastha_mishra06, CSIR-Institute of Genomics & Integrative Biology & @SilviaUlrich6, University Hospital Zurich at 1PM BST tomorrow.
🎟️ Free to attend – don’t miss out us02web.zoom.us/webinar/register/WN_tcODpxY8Q7-_imOjyeIZBw -
The Pulmonary Vascular Research Institute
@PVRI
🚨 Exciting speaker update! We’re thrilled to welcome @Illianameurs from the Dutch Medicines Evaluation Board (CBG-MEB) to the #ddds2025 scientific programme. Illiana will be joining @mpsotka (FDA representative, speaking virtually) to share a global perspective on the regulatory approval of Sotatercept.
Join us in Amsterdam next month as we bring together global experts to shape the future of #pah drug discovery.
📍 Mercure Hotel Amsterdam City
📅16 – 17 June 2025
🎟️ Don’t miss it → pvrinstitute.org/DDDS2025
#pvri #ddds2025 #pulmonaryhypertension #drugdevelopment -
The Pulmonary Vascular Research Institute
@PVRI
Don’t miss this upcoming iPVD webinar with Yassine Sassi on 'Environmental determinants and PVDs', moderated by Rudolf Oliveira. Free and open to all! us02web.zoom.us/webinar/register/WN_rM54YWA-RMeBHbmYrWfPdw #pulmonaryhypertension #ipvd #pvd
The Pulmonary Vascular Research Institute
@PVRI
🌍 Upcoming webinar – free & open to all! Join us for the next session in the iPVD Virtual Symposium Series, where Yassine Sassi will be discussing 'Environmental determinants and PVDs'.
🗓️ 28 May 2025
⏰ 3PM BST
Moderated by Rudolf Oliveira - register for free us02web.zoom.us/webinar/register/WN_rM54YWA-RMeBHbmYrWfPdw
#pvd #pulmonaryhypertension #ipvd #inflammation -
The Pulmonary Vascular Research Institute reposted
Sasha Prisco, MD, PhD
@SashaPrisco
Thank you @CircHF for the opportunity to share our work on how modulating the gut microbiome may be an approach to enhance RV function in PAH. Grateful to the entire research team for their help on this project. @ATS_PC @3CPRCouncil @PVRI @GiessenPh @RyanTedfordMD @GMFHx
Circ: Heart Failure
@CircHF
Lactobacillus supplementation combats inflammation and augments RV function in PAH via the GP130-microtubule axis @SashaPrisco @jenna_mendelson @MadelynJBlak @kurt_prins @LilleheiHrt @UMN_DCVM #ahajournals ahajrnls.org/3SfzPpD
-
The Pulmonary Vascular Research Institute
@PVRI
New publication: Endothelial Features Along the Pulmonary Vascular Tree in Chronic Thromboembolic Pulmonary Hypertension: Distinctive or Shared Facets? by Janne Verhaegen Et al. Read the full research article➡️onlinelibrary.wiley.com/doi/10.1002/pul2.70096
-
The Pulmonary Vascular Research Institute
@PVRI
Happening next week! Register for free us02web.zoom.us/webinar/register/WN_tcODpxY8Q7-_imOjyeIZBw
The Pulmonary Vascular Research Institute
@PVRI
Next up in our High Altitude webinar series:
🚀 "Hypoxia in Pulmonary Vascular Research – Altitude and Beyond"
Join Samuel Vergès for a presentation on La Rinconada Expedition 5300 – an overview of scientific results 🗻
🗓️ 27 May 2025
🕐 1PM BST
Free to attend – register now and join the discussion! us02web.zoom.us/webinar/register/WN_tcODpxY8Q7-_imOjyeIZBw -
The Pulmonary Vascular Research Institute
@PVRI
Huge congratulations to @SandeepSahayMD on receiving the ATS Outstanding Clinician Award — so well deserved! 👏site.thoracic.org/membership/awards/ats-respiratory-healt…
Houston Methodist MD
@HMethodistMD
Congratulations to our Director of the Pulmonary Hypertension Program Dr. @SandeepSahayMD on being awarded the Outstanding Clinician Award from the @atscommunity! site.thoracic.org/membership/awards/ats-respiratory-healt…
-
The Pulmonary Vascular Research Institute reposted
Kurt Prins
@kurt_prins
www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.124.012524. @SashaPrisco shows Lactobacillus treatment alters the micro/mycobiome improves RV function via an inflammatory-microtubule axis in @CircHF! @3CPRCouncil @PVRI @ATS_PC @metagenomics @RyanTedfordMD #microtubules
-
The Pulmonary Vascular Research Institute
@PVRI
📆 1 month to go – are you joining us in Amsterdam?
Our Drug Discovery & Development Symposium 2025 is just a month away, and we’re counting down the days! From big conversations on the future of PH drug development to brilliant networking and an incredible speaker line-up, it’s shaping up to be two unmissable days.
Be part of the conversation shaping the future of therapeutic targets, trial innovation, and global collaboration in PH research.
🎟️ Secure your spot today: pvrinstitute.org/DDDS2025 #ddds2025 #drugdevelopment #phresearch #pahThis media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Automated Bi-Ventricular Segmentation and Regional Cardiac Wall Motion Analysis for Rat Models of Pulmonary Hypertension by Marili Niglas Et al. Read the full research article➡️ onlinelibrary.wiley.com/doi/full/10.1002/pul2.70092
-
The Pulmonary Vascular Research Institute
@PVRI
📢 Announcing the PVRI 2026 Scientific Organising Committee!
We’re excited to introduce our fantastic team shaping the scientific programme for #pvri2026, taking place 28–31 January 2026 in Dublin. This global group of experts will bring together diverse perspectives across basic research, clinical practice, and innovation in pulmonary hypertension:
🔹Seán Gaine, Mater Misericordiae University Hospital, Dublin
🔹William Oldham, Brigham and Women's Hospital, North America
🔹Katarina Zeder, Medical University of Graz, Austria
🔹@AlbertaPHdoc, University of Alberta, Canada
🔹Soni Pullamsetti, Max Planck Institute, Germany
🔹@mark_toshner, University of Cambridge, UK
🔹Catherine Simpson, Johns Hopkins University, North America
🔹Shahin Moledina, Great Ormond Street Hospital, UK
🔹@SarahKCullivan, Mater Misericordiae University Hospital, Dublin
With their leadership, we’re building an agenda filled with cutting-edge science, global collaboration, and transformative conversations.
📍 Join us in Dublin next January — more details coming soon!
🔗 pvrinstitute.org/pvri2026
#pvri2026 #pulmonaryhypertension #congress -
The Pulmonary Vascular Research Institute
@PVRI
Next up in our High Altitude webinar series:
🚀 "Hypoxia in Pulmonary Vascular Research – Altitude and Beyond"
Join Samuel Vergès for a presentation on La Rinconada Expedition 5300 – an overview of scientific results 🗻
🗓️ 27 May 2025
🕐 1PM BST
Free to attend – register now and join the discussion! us02web.zoom.us/webinar/register/WN_tcODpxY8Q7-_imOjyeIZBw -
The Pulmonary Vascular Research Institute
@PVRI
Missed Pietro Nardelli's talk at #pvri2025? Now's your time to catch up!🎦
🔹CT-derived machine-learning approach to distinguish CTEPH patients from controls & acute PE cases
🔹The model leverages radiomic analysis of intraparenchymal vessels to identify key markers distinguishing CTEPH
🔹Promising potential to improve CTEPH diagnosis & patient management
Watch the full talk on demand now ➡️ pvrinstitute.org/learning-hub/material/ct-based-discrimin…
#pvri2025 #cteph #machinelearning #pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
🌍 Upcoming webinar – free & open to all! Join us for the next session in the iPVD Virtual Symposium Series, where Yassine Sassi will be discussing 'Environmental determinants and PVDs'.
🗓️ 28 May 2025
⏰ 3PM BST
Moderated by Rudolf Oliveira - register for free us02web.zoom.us/webinar/register/WN_rM54YWA-RMeBHbmYrWfPdw
#pvd #pulmonaryhypertension #ipvd #inflammation -
The Pulmonary Vascular Research Institute
@PVRI
🚨 Just over 1 month to go! We're counting down to our Drug Discovery & Development Symposium 2025, taking place 16–17 June in Amsterdam — and the excitement is building!
Here’s what previous attendees had to say...
💬‘Outstanding meeting, thank you’ Allan Lawrie, University of Sheffield
💬‘A wonderful meeting and fantastically run’ Alexander Rothman, University of Sheffield
💬‘One of the best meetings of the year’
Haven’t registered yet? Now’s the time! Secure your spot and be part of this exciting gathering discussing the latest drug developments in PH pvrinstitute.org/DDDS2025
#ddds2025 #drugdevelopment #pulmonaryhypertension #pah -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Role of MiR-542-3p/Integrin-Linked Kinase/Myocardin Signaling Axis in Hypoxic Pulmonary Hypertension by Linqing Li Et al. Read the full research article➡️ onlinelibrary.wiley.com/doi/full/10.1002/pul2.70094
-
The Pulmonary Vascular Research Institute
@PVRI
💜 Today is World PH Day — a moment to raise awareness, honour patients and families, and spotlight the global effort to advance PH care and research.
At PVRI, we’re proud to be part of that effort — and we’re continuing the momentum this June at the Drug Discovery & Development Symposium 2025 in Amsterdam.
🌍 Join global experts for two days of innovation, collaboration, and insightful conversations on the future of PH drug development.
📅 16–17 June 2025 | 📍 Amsterdam
🔗Learn more & register: pvrinstitute.org/DDDS2025
#worldphday #ddds2025 #pulmonaryhypertension #phawareness #pvri #globalhealthThis media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
NEW editorial just published: PVRI International Conference 2025: Embracing Heterogeneity by our #pvri2025 scientific organising committee members Katarina Zeder & @navneetsinghmd. Not to be missed! Read the full article ➡️ onlinelibrary.wiley.com/doi/full/10.1002/pul2.70093
-
The Pulmonary Vascular Research Institute
@PVRI
🎥 Missed @DunbarIvy's presentation at #pvri2025? Catch this snippet & dive into the complexities of paediatric pulmonary vascular disease, from the latest classification updates to the critical role of echocardiography, altitude, & tailored treatment strategies in children.
📺 Watch the full recording now → pvrinstitute.org/learning-hub/material/classification-dia…
#pvri2025 #paediatricph #pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
Missed our April Community call? Here's a snippet from guest author @LloydDHarvey's presentation on lysosomal dysfunction & inflammatory sterol metabolism in PAH📽️ Watch the full recording on our website for free⏯️ pvrinstitute.org/learning-hub/material/april-2025-pvri-co…
-
The Pulmonary Vascular Research Institute
@PVRI
New publication: Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension) by Pavel Jansa Et al. Read the full research article
-
The Pulmonary Vascular Research Institute
@PVRI
🎤 Let the debate begin! 🧠💥
At #ddds2025 in Amsterdam, we’re diving into global aspects of drug development & availability – featuring a pro/con debate with Anna Hemnes and Ardeschir Ghofrani.
🔬 Pro/con debate: It is Big Pharma’s responsibility to prioritise drug availability over drug discovery
Expect a lively discussion, compelling science, and some friendly sparks 💥—this is a session you won’t want to miss.
📍 Join us in Amsterdam, 16–17 June 2025
🔗 pvrinstitute.org/DDDS2025 -
The Pulmonary Vascular Research Institute reposted
Ghazwan Butrous
@gbutrous
Over the past few months, I've been writing two review articles on the global aspects of pulmonary hypertension and the role of infectious diseases. Both have just been published. Still, we don’t know about the global burden, and further research is needed. @PVRI for links 👇
-
The Pulmonary Vascular Research Institute
@PVRI
🎥 Catch a snippet from yesterday's Community Call!
Dive into the latest on the #zenith trial & a long-term follow-up study of Sotatercept for treatment of Pulmonary Arterial Hypertension: Interim results of SOTERIA with Aaron Waxman, featuring Community Call host Katrina Barry, participant in the long-term follow-up study of #soteria.
Watch the full recording here ➡️ pvrinstitute.org/learning-hub/material/april-2025-pvri-co…This media couldn't be displayed. See it on the original post. -
The Pulmonary Vascular Research Institute
@PVRI
📰New publication from our Lung Transplantation in Pulmonary Hypertension Workstream: Approach to Lung Transplantation in Pulmonary Arterial Hypertension: A Delphi Consensus on Behalf of the Transplant Task Force of the Pulmonary Vascular Research Institute by Nicholas A. Kolaitis Et al. Read the full research article onlinelibrary.wiley.com/doi/full/10.1002/pul2.70088
-
The Pulmonary Vascular Research Institute reposted
Nicholas Kolaitis, MD MAS
@LungTxptMD
Just in time for the @ISHLT conference, our @PVRI Delphi Project on Lung Transplant for PAH is now published.
onlinelibrary.wiley.com/doi/full/10.1002/pul2.70088
Come hear about our work at the #ishlt2025 conference.
Symposium 23, in Ballroom C on 4/28/2025 1:15-2:31 pm EST.
www.abstractsonline.com/pp8/ -
The Pulmonary Vascular Research Institute
@PVRI
Our Community Call is live now! Join us for a discussion on all things PH!
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Register for free & join the discussion➡️ pvrinstitute.org/learning-hub/events/pvri-community-call-… #webinar #zenith #soteria #pah
The Pulmonary Vascular Research Institute
@PVRI
Join us next week for our April Community Call with guest authors Aaron Waxman, @LloydDHarvey, and
@chansteve73. We’ll be diving into:
- ZENITH trial & a long-term follow-up study of Sotatercept for PAH: Interim results of SOTERIA – with insights from study participant Katrina Barry, who will also answer audience questions from a patient perspective
- Lysosomal dysfunction & inflammatory sterol metabolism in PAH
Moderated by @AlbertaPHdoc, Katrina Barry, Joel James, @SandeepSahayMD, and @Tatiana_PVRI.
📍Free to attend – all welcome!
📆24 April 2025, 16:00 BST
🔗pvrinstitute.org/learning-hub/events/pvri-community-call-… -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Register for free & join the discussion➡️ pvrinstitute.org/learning-hub/events/pvri-community-call-… #webinar #zenith #soteria #pah
The Pulmonary Vascular Research Institute
@PVRI
Join us next week for our April Community Call with guest authors Aaron Waxman, @LloydDHarvey, and
@chansteve73. We’ll be diving into:
- ZENITH trial & a long-term follow-up study of Sotatercept for PAH: Interim results of SOTERIA – with insights from study participant Katrina Barry, who will also answer audience questions from a patient perspective
- Lysosomal dysfunction & inflammatory sterol metabolism in PAH
Moderated by @AlbertaPHdoc, Katrina Barry, Joel James, @SandeepSahayMD, and @Tatiana_PVRI.
📍Free to attend – all welcome!
📆24 April 2025, 16:00 BST
🔗pvrinstitute.org/learning-hub/events/pvri-community-call-… -
The Pulmonary Vascular Research Institute
@PVRI
⭐️Meet the speaker⭐️
We’re delighted to have @mark_toshner joining #ddds2025, who will be speaking on 'How to define or prove disease modification'.
Here’s a sneak peek...
“Dr Toshner will outline the challenges defining what might constitute modification of disease in the context of pulmonary hypertension before considering if any therapy passes the bar and what the implications are for future trials and clinical practice.”
Register to join us in Amsterdam! pvrinstitute.org/DDDS2025 -
The Pulmonary Vascular Research Institute
@PVRI
🎥 Missed it live? If you couldn’t make it to last week’s webinar, you can now watch the full recording anytime on our website⏯️pvrinstitute.org/learning-hub/material/acute-altitude-ill… #copd #pulmonary #vascular #highaltitude
The Pulmonary Vascular Research Institute
@PVRI
Happening today! Join us at 1PM BST for the next session in the 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar series by the #pvri High Altitude Task Force 🗻 Michael Furian will be discussing acute altitude illnesses in COPD patients and healthy individuals at high altitude us02web.zoom.us/webinar/register/WN_oC6pzfeBT72F7IxkFonYdg
-
The Pulmonary Vascular Research Institute
@PVRI
🐰Our office will be closed from Friday 18 to Monday 21 April, but we’ll be back and ready to catch up on Tuesday. Wishing you a lovely weekend - whatever you're up to, we hope it's a good one!
-
The Pulmonary Vascular Research Institute
@PVRI
New publication: Physical Activity, Sleep, and Quality of Life in Pulmonary Arterial Hypertension: Novel Insights From Wearable Devices by Andrew M. Hughes Et al. Read the full research article onlinelibrary.wiley.com/doi/full/10.1002/pul2.70069
-
The Pulmonary Vascular Research Institute
@PVRI
Join us next week for our April Community Call with guest authors Aaron Waxman, @LloydDHarvey, and
@chansteve73. We’ll be diving into:
- ZENITH trial & a long-term follow-up study of Sotatercept for PAH: Interim results of SOTERIA – with insights from study participant Katrina Barry, who will also answer audience questions from a patient perspective
- Lysosomal dysfunction & inflammatory sterol metabolism in PAH
Moderated by @AlbertaPHdoc, Katrina Barry, Joel James, @SandeepSahayMD, and @Tatiana_PVRI.
📍Free to attend – all welcome!
📆24 April 2025, 16:00 BST
🔗pvrinstitute.org/learning-hub/events/pvri-community-call-… -
The Pulmonary Vascular Research Institute
@PVRI
⏳ Just 2 months to go until #ddds2025 kicks off in Amsterdam (16–17 June)!
Join us for two days of insightful conversations, fresh perspectives, & global collaboration as we dive into the future of PH drug development, therapeutic innovation, and evolving regulatory pathways.
🎤Speakers include:
Mitchel Psotka · @bmprii · @catibrownjohns · Ardeshir Ghofrani · @AthenaisBoucly · Pilar Escribano Subías · @alex_rothman · @VarianFrances · Marc Pritzker & more
🎟️ Secure your spot today pvrinstitute.org/DDDS2025
#ddds2025 #pvri #pulmonaryhypertension #drugdevelopment #pah -
The Pulmonary Vascular Research Institute reposted
The Pulmonary Hypertension Association
@PHAssociation
In the latest episode of PH Insights, Navneet Singh and Christopher Mullin, pulmonologists at Rhode Island Hospital, discuss risk factors for pulmonary embolisms and #cteph.
Learn more about the diagnosis process and treatment options. phassociation.org/events-and-resources/online-education/p… -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Importance of age at diagnosis of pulmonary hypertension in children living at high altitude: Longitudinal follow-up of 86 patients by Gabriel F. Diaz Et al. Read the full research article onlinelibrary.wiley.com/doi/full/10.1002/pul2.70017
-
The Pulmonary Vascular Research Institute
@PVRI
Happening today! Join us at 1PM BST for the next session in the 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar series by the #pvri High Altitude Task Force 🗻 Michael Furian will be discussing acute altitude illnesses in COPD patients and healthy individuals at high altitude us02web.zoom.us/webinar/register/WN_oC6pzfeBT72F7IxkFonYdg
-
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Register for free & join 1PM BST us02web.zoom.us/webinar/register/WN_oC6pzfeBT72F7IxkFonYdg #highaltitude #copd #webinars
The Pulmonary Vascular Research Institute
@PVRI
Happening next week! Join us for the next session in the 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar series by the #pvri High Altitude Task Force 🗻 Michael Furian will be discussing acute altitude illnesses in COPD patients and healthy individuals at high altitude.
📅 15 April 2025, 1pm BST
🔗Register for free pvrinstitute.org/learning-hub/events/acute-altitude-illne…
#copd #pulmonary #vascular #webinar -
The Pulmonary Vascular Research Institute
@PVRI
🗓️ Upcoming webinar – April Community Call
Join us for our next online discussion with guest authors Aaron Waxman, @LloydDHarvey, and @chansteve73. We’ll be diving into:
- A long-term follow-up study of Sotatercept for PAH: Interim results of SOTERIA – with insights from Community Call host and study participant Katrina Barry, who will also answer audience questions from a patient perspective
- Lysosomal dysfunction & inflammatory sterol metabolism in PAH
Moderated by @AlbertaPHdoc, Katrina Barry, Joel James, @SandeepSahayMD, and @Tatiana_PVRI.
📍 Free to attend – all welcome!
📅 24 April 2025, 16:00 BST
🔗 pvrinstitute.org/learning-hub/events/pvri-community-call-… -
The Pulmonary Vascular Research Institute
@PVRI
Let the debate begin!💥
At #ddds2025 in Amsterdam, we’re diving into disease modification – featuring a pro/con debate with @mardigomberg and @docroham.
⚡ Pro/con debate: Drug development in the post vasodilator era - including a demonstration of disease modification
Expect a lively discussion, compelling science, and some friendly sparks 💥—this is a session you won’t want to miss.
📍 Join us in Amsterdam, 16–17 June 2025
🔗 pvrinstitute.org/DDDS2025
#pulmonaryhypertension #pah #drugdevelopment #ddds2025 #pvri -
The Pulmonary Vascular Research Institute
@PVRI
Missed Khodr Tello's talk on cardiopulmonary exercise testing in the diagnosis & phenotyping of PH patients at #pvri2025? Now’s your chance to catch up!🎦
🔹 Current guidelines in regard of cardiopulmonary exercise testing
🔹 Current data in regard of phenotyping PH with exercise
🔹 Outlook to knowledge gaps
Watch the full talk on demand now➡️ pvrinstitute.org/learning-hub/material/cardiopulmonary-ex… #pulmonaryhypertension #cardiopulmonary #exercisetesting -
The Pulmonary Vascular Research Institute
@PVRI
🚨 Exciting speaker update! We’re thrilled to welcome Luke Howard @HelpMyBreathing , Marc Pritzker, and @Jing_ZhiCheng to the scientific programme for our Drug Discovery & Development Symposium 2025!
Join us in Amsterdam this June as we bring together global experts to shape the future of #pah drug discovery.
📍 Mercure Hotel Amsterdam City
📅16 – 17 June 2025
🎟️ Don’t miss it → pvrinstitute.org/DDDS2025 #pvri #ddds2025 #pulmonaryhypertension #drugdevelopment -
The Pulmonary Vascular Research Institute
@PVRI
New publication: Pediatric Pulmonary Hypertension is Associated With Increased Circulating Levels of BMP 7 and CHIP by Edward C. Kirkpatrick Et al. Read the full research article doi.org/10.1002/pul2.70068
-
The Pulmonary Vascular Research Institute
@PVRI
Happening next week! Join us for the next session in the 'Hypoxia in pulmonary vascular research – altitude and beyond' webinar series by the #pvri High Altitude Task Force 🗻 Michael Furian will be discussing acute altitude illnesses in COPD patients and healthy individuals at high altitude.
📅 15 April 2025, 1pm BST
🔗Register for free pvrinstitute.org/learning-hub/events/acute-altitude-illne…
#copd #pulmonary #vascular #webinar -
The Pulmonary Vascular Research Institute
@PVRI
🗞️New research article has just been published in Pulmonary Circulation, exploring ‘Cellular Communication Network Protein 2 in the Right Ventricle of Pulmonary Arterial Hypertension’, authored by Carly E. Byrd Et al. Read the full article onlinelibrary.wiley.com/doi/full/10.1002/pul2.70067
-
The Pulmonary Vascular Research Institute
@PVRI
Missed Ravikumar Sitapara's talk on the combination of seralutinib & sotatercept in preclinical models at #pvri2025? Now’s your chance to catch up! 🎦
Highlights:
✅ improvements in pulmonary hemodynamics and RV hypertrophy
✅reduction of pro-fibrotic markers in vitro
✅clinical potential of combination therapy
Watch the full talk on demand now pvrinstitute.org/learning-hub/material/preclinical-models… #pah #seralutinib #sotatercept -
The Pulmonary Vascular Research Institute
@PVRI
🚀 We’ve joined Bluesky! Come follow us! 🌟
Exciting news! We’re expanding our community and bringing the latest updates, insights, and discussions to Bluesky. Join us for ground-breaking research, expert perspectives, and meaningful conversations on #pulmonaryhypertension. 🔗Follow us on Bluesky: bsky.app/profile/pvrinstitute.bsky.social -
The Pulmonary Vascular Research Institute
@PVRI
🎥 Watch the latest Community Call recording!
Missed our recent discussion? Here’s a snippet from our latest #ph Community Call, where guest authors Alex Rothman, Maki Niihori, and Olga Rafikova explored:
💊Positioning Imatinib for pulmonary arterial hypertension: A dose finding phase 2 study
🔬Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension
Catch up on the full discussion pvrinstitute.org/learning-hub/material/march-2025-pvri-co… #phcommunity #pulmonaryhypertension #phwebinar #pah -
The Pulmonary Vascular Research Institute
@PVRI
Just published! 📰 New research article has just been published in Pulmonary Circulation, exploring ‘High Altitude May Protect Against the Early Development of Irreversible Pulmonary Hypertension in Patients With Congenital Heart Disease’, authored by Inge von Alvensleben Et al.
-
The Pulmonary Vascular Research Institute
@PVRI
⭐️Meet the speaker⭐️
We’re delighted to have @VarianFrances joining #ddds2025, who will be speaking on 'Climate impact of drug development'.
Here’s a sneak peek...
“Clinical trials generate an estimated 100 million tonnes of CO2 equivalent emissions annually, representing around 5% of the total healthcare-related CO2 emissions worldwide. For context, this is roughly equivalent to the annual emissions of Belgium. However, innovative clinical trial designs, such as decentralised trials with remote monitoring, offer significant potential for reducing this environmental impact. A carbon modeling example of a decentralised trial is presented, exploring the integration of sustainable value in drug development processes.”
Register to join us in Amsterdam! pvrinstitute.org/DDDS2025 -
The Pulmonary Vascular Research Institute
@PVRI
Have you registered your place for our Drug Discovery & Development Symposium? With the theme of 'Inclusive and sustainable drug development for PAH’, #ddds2025 is a unique opportunity for regulatory, industry, and academic bodies in the field to unite in Amsterdam for in-depth discussions, knowledge exchange, and collaboration on the latest drug advancements in #pah.
20+ expert speakers will be speaking on:
🫁 New standards of care
🫁 Disease modification
🫁 Diversity & inclusion
🫁 Global aspects of drug development & availability
🫁 Innovations in trial design
🫁 Novel drug & device therapies
Join the community 16 – 17 June in Amsterdam and help shape the future of PAH drug discovery and development.
Register today: pvrinstitute.org/DDDS2025 -
The Pulmonary Vascular Research Institute
@PVRI
Our Community Call is live now! Join us for a discussion on all things #ph: us02web.zoom.us/webinar/register/WN_CsC1ch88TXGzrh7QGTnIYw
-
The Pulmonary Vascular Research Institute
@PVRI
Join us for tomorrow’s Community Call! 🎙️
This month we're joined by Maki Niihori, Olga Rafikova, and @alex_rothman who will dive into:
🔬 Mitochondria’s role in angiogenesis in PAH
💊 Imatinib for PAH – insights from a Phase 2 study
Moderated by @AlbertaPHdoc, Katrina Barry, Joel James, @SandeepSahayMD, and @Tatiana_PVRI.
Don’t miss this opportunity to connect, learn, and discuss! Join the discussion at 13:00 GMT us02web.zoom.us/webinar/register/WN_CsC1ch88TXGzrh7QGTnIYw
#phcommunity #pulmonaryhypertension -
The Pulmonary Vascular Research Institute reposted
Anjali Vaidya MD 🫀
@anjalivaidyaMD
Pls RT: 📢🚨 Announcing: Accepting apps @TempleHealth @TempleCards Advanced #pulmonaryhypertension / Pulmonary Vascular Disease 1-yr Fellowship‼️ '26-27
✅Apply: 📧 PHFellowship@TempleHealth.org
🔗medicine.temple.edu/departments-centers/clinical-departme…
🫀🫁@PForfiaPHDOC @pravinp8 @RiyazBashir @VladLakhter -
The Pulmonary Vascular Research Institute reposted
Kurt Prins
@kurt_prins
Our latest attack on right heart failure. Here we performed a multi-omic analysis of dysfunctional right atrial tissue to determine what therapeutic targets could be. www.biorxiv.org/content/10.1101/2025.03.22.644722v1 @mark_toshner @RyanTedfordMD @3CPRCouncil @PVRI @ATS_PC
-
The Pulmonary Vascular Research Institute
@PVRI
Missed the last #pvridigital series? Here’s a snippet from "PAH Risk Calculators – State of the Art Assessment" webinar, where expert speakers explored the latest advancements in PAH prognosis:
📈 Raymond Benza – REVEAL 2.0 & beyond: improving prognostic accuracy
🧬 Eric Austin – Integrating mutational profiles into PAH risk assessment
🧪 Anna Hemnes – The role of biomarkers in refining risk calculators
Watch the full recording here: pvrinstitute.org/learning-hub/material/pah-risk-calculato…
Stay tuned for the 2025-26 PVRI Digital series - more cutting-edge discussions coming soon!
#pah #pvridigital #webinar -
The Pulmonary Vascular Research Institute
@PVRI
Happening next week! Join the discussion on Wednesday 26 March 17:30 CET ➡️www.linkedin.com/events/what-snewinpulmonaryhypertensio73…
The Pulmonary Vascular Research Institute
@PVRI
Join us for the "What's New in PH" Quarterly Webinar Series 2025! Explore the latest PAH breakthroughs for 2026, insights into the PVRI Rio Congress, the impact of novel agents on PH treatment, findings from the PH Global Patient Survey, and updates on the GoDeep PH International Registry — offering a comprehensive view of the evolving PH landscape.
📅 Date: 26 March 2025
🕠 Time: 17:30 - 19:30 CET
📍 Online – Register Now!
www.linkedin.com/uas/login?session_redirect=https%3A%2F%2… #pulmonaryhypertension #phupdates #phwebinar #phcommunity #whatsnewinph -
The Pulmonary Vascular Research Institute
@PVRI
Join us next week for our March Community Call to discuss 'Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension' with guests Maki Niihori and Olga Rafikova🎙️Taking place 1PM GMT, register online for free pvrinstitute.org/learning-hub/events/pvri-community-call-… See you there!
-
The Pulmonary Vascular Research Institute
@PVRI
⭐️Meet the speaker⭐️
We’re delighted to have Werner Seeger joining #ddds2025, who will be speaking on 'Using the GoDeep Registry to prioritise & facilitate global drug trials'.
Here’s a sneak peek...
“PVRI GoDeep is a global meta-registry of pulmonary hypertension (PH) patients, including currently nearly 40,000 patients from 42 PH referral centers worldwide. Its rich data set allows assessment of regional differences impacting drug trials, as well as in silico trial simulation.”
See you in Amsterdam! pvrinstitute.org/DDDS2025 -
The Pulmonary Vascular Research Institute
@PVRI
🔬 Exciting opportunity for #ph researchers!
The @PHAssociation's Innovation Research Award will support new areas of PH research that couldn’t have been explored without dedicated funding. This grant welcomes all innovative #pulmonaryhypertension research proposals, offering up to $60,000 per year for two years to drive progress.
📅 Deadline: May 7, 11:59 p.m. EDT
🔗 Apply now: phassociation.org/research/innovation-research-award/
The Pulmonary Hypertension Association
@PHAssociation
PHA’s Innovation Research Award supports groundbreaking #ph research that introduces innovative approaches or challenges current paradigms in PH research. The grant offers up to $60,000 per year for a two-year project. Apply by May 7, 11:59 p.m. EDT. phassociation.org/ph-professionals/research-programs/gran…
-
The Pulmonary Vascular Research Institute
@PVRI
Missed @SashaPrisco's deep dive into the microbiome's role in PAH at #pvri2025? Now’s your chance to catch up! 🎥
🔬 Key takeaways from the talk:
✅ How inflammation drives pulmonary arterial hypertension (PAH)
✅ The gut-lung connection & unique bacterial compositions in PAH patients
✅ Intermittent fasting & lactobacillus supplementation – promising ways to improve heart function
✅ Exciting research on fungal species & fluconazole treatment in reducing disease severity
The microbiome is reshaping how we understand and treat PAH - watch the full talk on demand now pvrinstitute.org/learning-hub/material/microbiome-pulmona…
#pah #microbiome #pulmonaryhypertension #pvri2025 -
The Pulmonary Vascular Research Institute
@PVRI
☘️ Happy St. Patrick’s Day from PVRI! ☘️ Is anyone else as excited as we are to head to Dublin for #pvri2026?!
📍 Dublin Royal Convention Centre, Ireland
📅 28 – 31 January 2026
#pvri2026 is gearing up to be an unforgettable event…
🔹Sean Gaine, Mater Misericordiae University Hospital, leading the Scientific Organising Committee
🔹4* Hotel rooms reserved a stone’s throw away from the Convention Centre
🔹Gala Dinner to be hosted at the Guinness Storehouse, Friday 30 January
Find out more… pvrinstitute.org/pvri2026 🍀
#stpatricksday #pulmonaryhypertension #ph -
The Pulmonary Vascular Research Institute
@PVRI
Join us for the "What's New in PH" Quarterly Webinar Series 2025! Explore the latest PAH breakthroughs for 2026, insights into the PVRI Rio Congress, the impact of novel agents on PH treatment, findings from the PH Global Patient Survey, and updates on the GoDeep PH International Registry — offering a comprehensive view of the evolving PH landscape.
📅 Date: 26 March 2025
🕠 Time: 17:30 - 19:30 CET
📍 Online – Register Now!
www.linkedin.com/uas/login?session_redirect=https%3A%2F%2… #pulmonaryhypertension #phupdates #phwebinar #phcommunity #whatsnewinph -
The Pulmonary Vascular Research Institute
@PVRI
🎥Can digital twins transform Pulmonary Hypertension care?
At #pvri2025, Steven Niederer explored how computational models can simulate patient responses to treatments, paving the way for personalised medicine.
🔹 Enhancing patient care with digital models
🔹Regulatory challenges & validation frameworks
🔹Diversity in clinical trials & model drift in digital health
📺 Watch the full talk on demand now pvrinstitute.org/learning-hub/material/building-and-testi… #pulmonaryhypertension #pvri2025 -
The Pulmonary Vascular Research Institute
@PVRI
Have you seen the programme yet for our Drug Discovery and Development Symposium 2025? 20+ expert speakers will be discussing new standards of care, diversity & inclusion, innovations in trial design, and more!
📍 Amsterdam | 16-17 June 2025
🔗 Explore the full programme: pvrinstitute.org/DDDS2025
Looking forward to insightful discussions and collaborations at #ddds2025 🫁
The Pulmonary Vascular Research Institute
@PVRI
We’re thrilled to announce that the full scientific programme for our Drug Discovery and Development Symposium 2025, ‘Inclusive and sustainable drug development for PAH’, is live! pvrinstitute.org/DDDS2025
Programme overview:
🫁 New standards of care
🫁 Disease modification
🫁 Diversity & inclusion
🫁 Global aspects of drug development & availability
🫁 Innovations in trial design
🫁 Novel drug & device therapies
Join us on 16-17 June 2025 in Amsterdam, where we will bring together regulatory bodies, industry leaders, and academic experts to discuss the latest advancements in #pulmonaryhypertension drug development. #ddds2025 -
The Pulmonary Vascular Research Institute
@PVRI
Happy International Women's Day!💜
At PVRI we are committed to gender equality across our leadership, events and research. We are inspired by women in PH and are proud to share women’s experiences, challenges & achievements in the field. Join us in celebrating all the wonderful women in PH this International Women's Day 🎉#internationalwomensday #iwd2025 #womeninph -
The Pulmonary Vascular Research Institute
@PVRI
The UN Secretary-General has issued a red alert on noncommunicable diseases, the leading cause of death and disability worldwide🚨
At PVRI we support this urgent call to action. As a global family working towards a world without pulmonary vascular disease, we stand with the push for stronger policies and better healthcare to prevent and manage NCDs. Read the analysis by NCDA's Policy and Advocacy Director @AlisonDDCox
#ncds #healthforall #globalhealth
NCD Alliance
@ncdalliance
📚A new report from the UN Secretary-General confirms that the world is massively off track & urgently calls to #actonncds
The report is the key document informing the upcoming #hlm on NCDs & #mentalhealth
Read the analysis by our @AlisonDDCox 👇actonncds.org/stories/blogs/20250303-red-alert-ncds-unsgs… -
The Pulmonary Vascular Research Institute
@PVRI
📢 Exciting news! 🚀 The Pulmonary Hypertension Global Patient Survey (#phgps) is evolving! To allow the Patient Engagement & Empowerment Workstream to focus on new initiatives, PHGPS is becoming a stand-alone #pvri Task Force. This ensures the Workstream can tackle other unmet patient needs and the new PHGPS Task Force can focus on advancing their work plan.
This transition also brings leadership changes:
💜 After 7 years of dedicated service, Joanna Pepke-Zaba is stepping down as Co-chair of the Workstream—huge thanks for her incredible contributions!
💜 Matt Granato steps down as Co-chair of the Workstream to take on the new role of Chair of the PHGPS Task Force
💜 Wendy Gin-Sing & Hall Skaara are welcomed as our new Co-chairs of the Patient Engagement & Empowerment Workstream, bringing invaluable experience and advocacy
Read more ➡️pvrinstitute.org/learning-hub/news/ph-global-patient-surv…
#ph #pulmonaryhypertension #patientengagement -
The Pulmonary Vascular Research Institute
@PVRI
Thank you to all those who participated at #pvri2025 in Rio. With attendees from 25 countries across 5 continents 🌎, our congress provided a unique opportunity to explore the latest global advancements in understanding #ph, driving progress and enhancing the lives of those affected by the condition. Curious about the highlights? Check out the full report for a snapshot of the meeting pvrinstitute.org/learning-hub/news/pvri-2025-rio-embracin…. We can’t wait to see you at PVRI 2026 Dublin!
-
The Pulmonary Vascular Research Institute
@PVRI
Missed it? You can now watch February's Community Call replay here ⏯️pvrinstitute.org/learning-hub/material/february-2025-pvri… #pulmonaryhypertension
The Pulmonary Vascular Research Institute
@PVRI
Our Community Call is live now! Join us for a discussion on all things PH: us02web.zoom.us/webinar/register/WN_niCMkDOLSbS52vbPaxZ9bg
-
The Pulmonary Vascular Research Institute
@PVRI
We’re thrilled to announce that the full scientific programme for our Drug Discovery and Development Symposium 2025, ‘Inclusive and sustainable drug development for PAH’, is live! pvrinstitute.org/DDDS2025
Programme overview:
🫁 New standards of care
🫁 Disease modification
🫁 Diversity & inclusion
🫁 Global aspects of drug development & availability
🫁 Innovations in trial design
🫁 Novel drug & device therapies
Join us on 16-17 June 2025 in Amsterdam, where we will bring together regulatory bodies, industry leaders, and academic experts to discuss the latest advancements in #pulmonaryhypertension drug development. #ddds2025 -
The Pulmonary Vascular Research Institute
@PVRI
Missed it? Watch the replay of @iPVDc 'Perspectives on global epidemiology challenges' here⏯️ pvrinstitute.org/learning-hub/material/perspectives-globa…
-
The Pulmonary Vascular Research Institute
@PVRI
Today is #rarediseaseday, and at PVRI, we stand with the global community in raising awareness for the millions of individuals and families affected by rare diseases. Our vision is to reduce the global burden of pulmonary vascular disease and our mission is to see it acknowledged as a major global condition.
Every day is an opportunity to educate, advocate, and support research for those who face these challenges. Together, we can make a difference 💜 🌎 -
The Pulmonary Vascular Research Institute
@PVRI
Our Community Call is live now! Join us for a discussion on all things PH: us02web.zoom.us/webinar/register/WN_niCMkDOLSbS52vbPaxZ9bg
-
The Pulmonary Vascular Research Institute
@PVRI
Join our February Community Call tomorrow to discuss 'Defining echocardiographic degrees of right heart size and function in pulmonary vascular disease from the PVDOMICS study' and 'Skeletal muscle SIRT3 deficiency contributes to pulmonary vascular remodeling in pulmonary hypertension due to heart failure with preserved ejection fraction'.
See you there! us02web.zoom.us/webinar/register/WN_niCMkDOLSbS52vbPaxZ9bg
The Pulmonary Vascular Research Institute
@PVRI
Happening next week! Join our February Community Call🎙️for an informal discussion on the latest developments in #pulmonaryhypertension. Guest authors include @MMukherjeeMD, Charly Lai, and Eliza Jheng. Register for free pvrinstitute.org/learning-hub/events/pvri-community-call-…
-
The Pulmonary Vascular Research Institute
@PVRI
We are delighted to invite our members to submit suggestions for the next #pvridigital series, which is scheduled to start in September 2025 and will run for 18 months.
#pvridigital is a monthly webinar series with keynote talks from senior experts in the field of #ph as well as young investigators. We invite you to share your innovative ideas and proposals - your insights could shape the topics that inspire and engage our community!
Find out more and submit your proposals here pvrinstitute.org/learning-hub/news/pvri-digital-2025-26-s… -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Register for free us02web.zoom.us/webinar/register/WN_XcVi5x5MSGC8LERmB300uQ #pulmonaryhypertension
The Pulmonary Vascular Research Institute
@PVRI
Join us next week for a new @iPVDc webinar on "Perspectives on Global Epidemiology Challenges"🌍Speakers and moderators include Simon Stewart, Judith Namuyonga, and Ana Mocumbi.
Taking place 26 February 7AM GMT, register for free to join: pvrinstitute.org/learning-hub/events/perspectives-global-… #pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
PVRI latest news📰
After many years and two sessions as Chair of our Board of Trustees, Paul Corris stood down at the #pvri2025 Board meeting. We owe Paul a huge debt of gratitude: the role of Chair isn’t an easy one, and we’re hugely grateful for the skills and knowledge he’s so generously shared, and for his energetic leadership and wise counsel. Thank you Paul! We’re also delighted to share the news that Martin Wilkins has accepted the role of Chair, and we look forward to working with him in this new role.
Find out more about our people pvrinstitute.org/about-us/our-people -
The Pulmonary Vascular Research Institute
@PVRI
Happening next week! Join our February Community Call🎙️for an informal discussion on the latest developments in #pulmonaryhypertension. Guest authors include @MMukherjeeMD, Charly Lai, and Eliza Jheng. Register for free pvrinstitute.org/learning-hub/events/pvri-community-call-…
-
The Pulmonary Vascular Research Institute
@PVRI
Missed it? Watch the replay here ⏯️pvrinstitute.org/learning-hub/material/phenotypes-and-tre… Speakers & moderators included @LucillaPiccari, Oksana Shlobin, John Wort, Steven Nathan, and Sylvia Nikkho #pulmonaryhypertension #ph
-
The Pulmonary Vascular Research Institute
@PVRI
Join us next week for a new @iPVDc webinar on "Perspectives on Global Epidemiology Challenges"🌍Speakers and moderators include Simon Stewart, Judith Namuyonga, and Ana Mocumbi.
Taking place 26 February 7AM GMT, register for free to join: pvrinstitute.org/learning-hub/events/perspectives-global-… #pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
Missed it? Watch #pvri2025 on demand! We are delighted to announce that many of the talks presented in Rio are now available to PVRI members to watch on demand through our website ⏯️ pvrinstitute.org/learning-and-research?field_publication_…
-
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Register for free us02web.zoom.us/webinar/register/WN_aPSOn0uFTjuV-8AgDlyBIg
The Pulmonary Vascular Research Institute
@PVRI
NEW PH Group III webinar happening next week! 📢
Presentations include 'Is there evidence for different phenotypes of PH in ILD?' @LucillaPiccari, Oksana Shlobin and 'Treatment of pulmonary vascular disease in ILD: as early as possible or only in severe PH?' John Wort, Steven Nathan. Moderated by Sylvia Nikkho & Steven Nathan.
Register for free and join us 20 February 3PM GMT➡️pvrinstitute.org/learning-hub/events/phenotypes-and-treat… -
The Pulmonary Vascular Research Institute reposted
Caio de Assis Moura Tavares
@caiodeamtavares
Great to have discussed innovative and digital trials at @PVRI in Rio! Grateful to have @OtavioBerwanger as a mentor—a true leader in this field!
-
The Pulmonary Vascular Research Institute
@PVRI
Huge congratulations to all our #pvri2025 award winners and a big thank you to all our members who submitted their nominations🎉The gala dinner was a night to remember, and a fantastic opportunity to recognise the outstanding contributions to the field of PH.
A special congratulations to PVRI 2025 Lifetime Achievement Award winner, Rubin Tuder @LungScholar, a trailblazer in the field of pulmonary vascular biology and a driving force in PH research. Read the full article📰pvrinstitute.org/learning-hub/news/pvri-2025-lifetime-ach… -
The Pulmonary Vascular Research Institute reposted
Northwestern Radiology
@NURadiology
Mohammed Elbaz was in Rio de Janeiro, Brazil last week as part of the Imaging Task Force of the Pulmonary Vascular Research Institute (PVRI). Attendees from 25 countries shared insights on PVDs. @PVRI
-
The Pulmonary Vascular Research Institute
@PVRI
NEW PH Group III webinar happening next week! 📢
Presentations include 'Is there evidence for different phenotypes of PH in ILD?' @LucillaPiccari, Oksana Shlobin and 'Treatment of pulmonary vascular disease in ILD: as early as possible or only in severe PH?' John Wort, Steven Nathan. Moderated by Sylvia Nikkho & Steven Nathan.
Register for free and join us 20 February 3PM GMT➡️pvrinstitute.org/learning-hub/events/phenotypes-and-treat… -
The Pulmonary Vascular Research Institute
@PVRI
A huge thank you to everyone who travelled to Rio from all corners of the world to be part of our meeting. We couldn’t have done it without your support! 💜
And now, it’s time to reveal the location for our 2026 Annual Congress🎉 We hope you’re just as excited as we are!
Stay tuned for more details…#pvri2026 -
The Pulmonary Vascular Research Institute reposted
Pulmonary Hypertension at Penn
@PennMedPH
🚨 Exciting Announcement
Join us for the 7th Alfred P. Fishman Symposium as we dive into new scientific discoveries and their impact on patients with PVD
📅 April 11-12 (Fri-Sat)
📍 Where: in person or virtual
🔗 Sign up now: upenn.cloud-cme.com/Fishman2025
@PennMedicine @ATS_PC @PVRI -
The Pulmonary Vascular Research Institute reposted
Sebastien « Seb » Bonnet
@sbonnet2
The new baby of Québec www.cell.com/cell-reports-medicine/fulltext/S2666-3791(25… bravo @SarahEve_Lemay Manon and Mélanie for the beautiful working, Thank you to her majesty Queen @PullamsettiL and Bravo Olivier for the leadership. @IUCPQ @facmedUL @PVRI @ATS_PC @3CPRCouncil
-
The Pulmonary Vascular Research Institute reposted
Shameek Gayen
@GayenShameek
How does the reduced PVR cutoff for precapillary #pulmonaryhypertension affect #lungtransplant waitlist outcomes in patients with #ipf and PH? See our work led by @TemplePCCM fellows @DhananiZehra @DrMikeNicks doi.org/10.1002/pul2.70046 @PVRI @SRTRNews
-
The Pulmonary Vascular Research Institute reposted
Pullamsetti Lab
@PullamsettiL
Our lab had such a great time at the #pvri2025 in Brazil!
Amazing talks, great presentations and very cool posters! We got to exchange some brilliant ideas and really had some insightful discussions! @PVRI @UKGM_Presse @CPI_ExStra @sbonnet2 @dzlacademy -
The Pulmonary Vascular Research Institute
@PVRI
That’s a wrap! Thank you to all our attendees, speakers, sponsors and exhibitors who have travelled to this great city to support our meeting. We are so grateful to you all and we hope you have taken away some valuable insights and lasting connections that will advance our shared mission. #pvri2025 #embracingheterogeneity #pulmonaryhypertension
-
The Pulmonary Vascular Research Institute reposted
Golnaz Hesami
@GolnazHesami
Honored to present my talk at #pvri2025 and truly thankful to receive the Butrous Foundation Young Investigator Award! Grateful to my mentor, Prof. Pullamsetti and my wonderful collaboration partners at @Savai_Lab , @RajkumarSavai , and @siavash668, for their invaluable support.
-
The Pulmonary Vascular Research Institute
@PVRI
Brilliant talk this afternoon from Frances Varian on ‘Patient reported outcomes’, and learning more about implementing valid patient-reported outcome measures (PROMs) for assessing health-related quality of life (HRQoL) in pulmonary arterial hypertension #pvri2025
Frankie
@VarianFrances
Delighted to present @PVRI in Rio on patient reported outcomes as a joint talk with @PHAssociation
-
The Pulmonary Vascular Research Institute reposted
Anjali Vaidya MD 🫀
@anjalivaidyaMD
TY @PVRI #pvri2025 & Rio 🇧🇷❗️
🧵 Honored to share our #pah #womenshealth international 🌎 collaborative - Drs.
@ValMcLaughlinMD, Ioana Preston, Marion Delcroix
👏🏼 global PH discussions - improving recognition (#vestph 👇🏼)& access @prashantbobhate @PulmonaryHIndia, AnaMocumbi -
The Pulmonary Vascular Research Institute reposted
Ghazwan Butrous
@gbutrous
It is always a pleasure and an honour to work with young scientists—the future leaders of our field. Standing with Soni @PullamsettiL and her current mentees, @GolnazHesami and @Sandribiopio, whose PhD work I had the privilege of co-supervising.
-
The Pulmonary Vascular Research Institute reposted
Ghazwan Butrous
@gbutrous
Congratulations to @GolnazHesami on receiving the Butrous Foundation Young Investigator Award at #pvri2025!
The Butrous Foundation @Butrousfound supports young scientists by fostering scientific creativity and communication skills, inspiring the next generation of researchers👇 -
The Pulmonary Vascular Research Institute
@PVRI
Hot topics from PVRI GoDeep is now live! Kicking off the function with an overview of the GoDeep meta-registry from Werner Seeger, we’re looking forward learning more about the data and hearing talks from Athiththan Yogeswaran, Arun Jose, Khodr Tello, and Evan Brittain. Thank you to our chairs Martin Wilkins, Paul Hassoun, Werner Seeger #pvri2025
-
The Pulmonary Vascular Research Institute
@PVRI
Huge congratulations to our #pvri2025 Lifetime Achievement Award winner @LungScholar! 🎉 Rubin was nominated for this prestigious award for his significant contribution to the field of PVD and to PVRI.
-
The Pulmonary Vascular Research Institute
@PVRI
What an empowering event welcoming women from around the world who shared their journeys and what it means to them to be a woman in #pulmonaryhypertension. Our Women in PH Luncheon included guest speakers Ana Olga Mocumbi, Karin Tran-Lundmark and Jill Maron. Thank you for shining a light on women in #ph and sharing such inspiring personal stories. Thank you to @UTHRMed for sponsoring this Luncheon. #womeninph
#womeninscience -
The Pulmonary Vascular Research Institute
@PVRI
Good morning from Rio! We have a jam-packed day ahead with sessions on vascular heterogeneity in chronic lung disease and heterogeneity in PH associated with heart disease, as well as our Women in PH Luncheon and Gala Dinner & Award Presentations! #pvri2025
-
The Pulmonary Vascular Research Institute reposted
Rodolfo A. Estrada, MD FCCP
@REstradaMD
What an exciting day full of great sessions, exchanging ideas during our poster presentation and catching up with friends at #pvri in Rio de Janeiro! 🇧🇷 Looking forward to today’s topics!
@PVRI @UTHealthSA @UTHSA_PCCM -
The Pulmonary Vascular Research Institute
@PVRI
At PVRI, we’re committed to addressing #ph on a global level, and to close the scientific talks today we had a stimulating panel discussion on the realities and challenges of applying PH guidelines for diagnosis & treatment in LMIC. Thank you to our fantastic panel @Viniciodjperez, Werner Seeger, Ana Mocumbi, @DrMaarman, and @mauorozcolevi #pvri2025
-
The Pulmonary Vascular Research Institute
@PVRI
Our #ph Career Catalyst Luncheon was a great success! New for #pvri2025, early career professionals had the opportunity to connect with globally renowned senior and mid-career PH professionals during a speed networking lunch. Thank you to @UTHRMed for sponsoring this Luncheon, and thank you to our mentors for delivering a fantastic session!
-
The Pulmonary Vascular Research Institute
@PVRI
What a morning at #pvri2025! Great to hear such captivating talks on establishing the framework for the classification & diagnosis of PH worldwide 🫁
Here’s some highlights:
🌎After Anna Hemnes’s welcome, Rogerio Souza opened with an insightful talk on PH care in Brazil
🌎Gabor Kovacs discussed Classification & diagnosis of PH: Updates from the 7th WSPH
🌎 Omics-based & data-driven approaches to early disease diagnosis was the next talk led by Catherine Simpson
🌎 Ioana Preston presented a talk on CIPHER & CIPHER-MRI studies for early diagnosis of PH
🌎 Followed by Andy Swifts’ presentation on advanced medical imaging & AI in PH diagnosis & classification
🌎After a break, we moved onto cardiopulmonary exercise testing in the diagnosis & phenotyping of PH patients with a presentation from Khodr Tello
🌎 Dunbar Ivy discussed classification & diagnosis of paediatric PH: Updates from the 7th WSPH
🌎 And final presentations for the morning included CTEPH & CTED approach to early diagnosis & treatment and how pre-clinical models can be used to improve clinical phenotyping & early diagnosis with speakers Mark Toshner, Vineet Agrawal
Looking forward to another afternoon of science and networking! #pvri2025 -
The Pulmonary Vascular Research Institute
@PVRI
Day 1 of #pvri2025 main congress has officially kicked off! We are grateful for all the participants who have travelled to this great city and support our meeting.
🌎We welcome attendees from 25 countries
🌎50+ speakers will be sharing groundbreaking insights
🌎 We look forward to 3 days of content, networking and fostering collaboration with the PH community -
The Pulmonary Vascular Research Institute reposted
Cheng-Yu Wu
@danielchengyuwu
Looking forward to the latest research on pulmonary vascular diseases #pvd and exchanging ideas with fellow scientists at #pvri2025
@PVRI @CPI_ExStra @UKGM_Presse
Stefan Hadzic
@hstefan991
Day 1 #pvri2025 in beautiful Rio de Janeiro
@danielchengyuwu @PVRI -
The Pulmonary Vascular Research Institute
@PVRI
We’re so happy to see so many faces in our #ph community at today’s pre-meetings! We have attendees joining from 25 countries, all uniting to share groundbreaking insights, foster collaborations and advance our collective mission towards conquering PVDs.
-
The Pulmonary Vascular Research Institute
@PVRI
Our Pulmonary Vascular Disease (iPVD) Consortium Task Force delivered fantastic talks during todays pre-meetings, with sessions on current updates on infection associated PVDs, Schistosomiasis associated PVD in Latin America and second hit phenomenon in infection associated PVDs #pvri2025
@nadhillon @gbutrous @Viniciodjperez @PeterNyasulu -
The Pulmonary Vascular Research Institute reposted
University of Minnesota PH Program
@UMNPHProgram
Dr. Marc Pritzker giving an outstanding presentation at the international @PVRI meeting in Rio de Janeiro. @UMN_DCVM @umn_dom
-
The Pulmonary Vascular Research Institute reposted
-
The Pulmonary Vascular Research Institute reposted
Sasha Prisco, MD, PhD
@SashaPrisco
Thrilled to be at one of my favorite pulmonary hypertension meetings #pvri2025 in beautiful Rio and to be immersed in several days of learning! @PVRI
-
The Pulmonary Vascular Research Institute reposted
United Therapeutics Medical
@UTHRMed
We are also honored to support the Women in PH Luncheon and the Career Catalyst Luncheon: Speed Mentoring for Early Career PH Professionals at @PVRI #pvri2025! 8/8 #pulmonaryhypertension
-
The Pulmonary Vascular Research Institute reposted
United Therapeutics Medical
@UTHRMed
We are looking forward to connecting with our colleagues at @PVRI Annual Congress #pvri2025. We will present several scientific posters and participate in or support additional events. #pulmonaryhypertension 1/8
-
The Pulmonary Vascular Research Institute
@PVRI
We are delighted to introduce our #pvri2025 exhibitors and sponsors, @UTHRMed, @MSDInvents, @ChiesiGroup, and Pulmovant.
We can't wait to see you at PVRI 2025 Rio.
Find out more pvrinstitute.org/pvri-2025-exhibitors-sponsors -
The Pulmonary Vascular Research Institute
@PVRI
There is just over 1 week to go until our annual congress, hosted in the vibrant and captivating city of Rio de Janeiro. With delegates and speakers coming from 25 different countries, it is shaping up to be a truly global event! 🌎#pvri2025
And there's still time to join▶️pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute reposted
Sebastien « Seb » Bonnet
@sbonnet2
Amazing work by @SarahEve_Lemay proposing integrine a5b1 as a new therapeutic target for PAH that can boost Sotatercept effects. @3CPRCouncil @IUCPQ @facmedUL @ATS_PC @ErsPvd @UKGM_Presse @vascularbiology @bmprii @HTaPFrance @PHAssociation @PVRI www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.124.07…
-
The Pulmonary Vascular Research Institute
@PVRI
Hot off the printing press!! #pvri2025 delegate bags are ready. With only 2 weeks to go, we can’t wait to see you all in Rio soon! #pulmonaryhypertension
-
The Pulmonary Vascular Research Institute reposted
United Therapeutics Medical
@UTHRMed
A @PVRI consensus statement on real-world evidence in #pulmonaryarterialhypertension recently overviewed contemporary #pulmonaryhypertension registries and compiled them into a table. 4/4 pubmed.ncbi.nlm.nih.gov/38144948/
-
The Pulmonary Vascular Research Institute
@PVRI
Take a look at the latest articles published in the Pulmonary Circulation NEW January issue, including a recent paper on 'Differences in Pulmonary Artery Flow Hemodynamics Between PAH and PH-HFpEF: Insights From 4D-Flow CMR' by Bong-Joon Kim Et al onlinelibrary.wiley.com/journal/20458940
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
Missed it? Watch the replay⏯️pvrinstitute.org/learning-hub/material/session-4-young-in… #pvridigital
The Pulmonary Vascular Research Institute
@PVRI
Less than 1 week to go until the 4th session of the #pvridigital 'Young Investigators Series'. Speakers & moderators include @ArcSuellen, Neil Goldenberg, @ImadAlGhouleh, @SobanUmar, @ElinoffJason, @Tatiana_PVRI, @TimLahm, and @Viniciodjperez.
Join 8 January 3PM GMT: pvrinstitute.org/learning-hub/events/session-4-young-inve…
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute reposted
Suellen D`Arc Oliveira
@ArcSuellen
Thanks to @PVRI and the amazing moderators & mentors @Viniciodjperez @TimLahm - much more to do & always more to say, but saving it for #2025pvri in #riodejaneiro #brazil
The Pulmonary Vascular Research Institute
@PVRI
We are now live! Still time to join today’s #pvridigital webinar: us02web.zoom.us/webinar/register/WN_IQpmbOXBRdmSgWkx0dpXpw
-
The Pulmonary Vascular Research Institute
@PVRI
We are now live! Still time to join today’s #pvridigital webinar: us02web.zoom.us/webinar/register/WN_IQpmbOXBRdmSgWkx0dpXpw
-
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Register for free: us02web.zoom.us/webinar/register/WN_IQpmbOXBRdmSgWkx0dpXpw
The Pulmonary Vascular Research Institute
@PVRI
Less than 1 week to go until the 4th session of the #pvridigital 'Young Investigators Series'. Speakers & moderators include @ArcSuellen, Neil Goldenberg, @ImadAlGhouleh, @SobanUmar, @ElinoffJason, @Tatiana_PVRI, @TimLahm, and @Viniciodjperez.
Join 8 January 3PM GMT: pvrinstitute.org/learning-hub/events/session-4-young-inve…
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
Just over 3 weeks to go until #pvri2025! Hosted in the vibrant and captivating city of Rio de Janeiro, we can’t wait to see you there.
Here’s a reminder of the programme overview
💜29 January: Pre-meetings (IDDI, iPVD Consortium, Paediatric Task Force, PAH-ICON, High Altitude Task Force)
💜30 January: Heterogeneity in the presentation of PH
💜31 January: Heterogeneity in the pathobiology of PH
💜1 February: Learning from heterogeneity to improve outcomes in PH
There are now limited spaces remaining for our Career Catalyst Luncheon: Speed Mentoring for Early Career PH Professionals event. If you are interested in joining, please book asap pvrinstitute.org/pvri2025rio
See you in Rio! -
The Pulmonary Vascular Research Institute
@PVRI
Less than 1 week to go until the 4th session of the #pvridigital 'Young Investigators Series'. Speakers & moderators include @ArcSuellen, Neil Goldenberg, @ImadAlGhouleh, @SobanUmar, @ElinoffJason, @Tatiana_PVRI, @TimLahm, and @Viniciodjperez.
Join 8 January 3PM GMT: pvrinstitute.org/learning-hub/events/session-4-young-inve…
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
Wishing everyone a Happy New Year! 🎆A heartfelt thank you to each of you for your support throughout 2024.
As we begin the new year, take a look at our upcoming events and webinars where you can connect with the PH community, share new research, and advance our collective mission towards conquering PVDs: pvrinstitute.org/upcoming-events -
The Pulmonary Vascular Research Institute
@PVRI
Season's greetings from PVRI!🎄
Happy holidays and have a wonderful start to the new year! From all of the PVRI team, we wish you a safe and festive holiday season. -
The Pulmonary Vascular Research Institute
@PVRI
⭐️Meet the speaker⭐️
We’re delighted to have Karin Tran-Lundmark joining #pvri2025, who will be speaking on 'Developing imaging surrogates of vascular histology to quantify reverse remodeling' Saturday 1 February.
Here’s a sneak peek...
"How can novel high-resolution 3D-imaging techniques be used for understanding pulmonary vascular remodeling in pulmonary hypertension? Is it possible to connect imaging of explanted tissue with clinical imaging to increase our understanding of what is seen in a clinical CT scan? And can we use this to visualize therapeutic effects on remodeling?"
See you in Rio! pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute reposted
Pulmonary Hypertension India
@PulmonaryHIndia
🎉 Dr. Sahay was at the #phsymposium!
We were thrilled to have you with us for our 🇮🇳 PHight @SandeepSahayMD!
@PVRI -
The Pulmonary Vascular Research Institute reposted
Pulmonary Hypertension India
@PulmonaryHIndia
What an absolutely incredible Townhall we had with our beloved PHighters and their amazing families!
A heartfelt thank you to everyone who joined us and opened up to share your beautiful and inspiring stories 💜💜
#phsymposium -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow at 1PM GMT! Register for free us02web.zoom.us/webinar/register/WN_ZVYYOBaLT5CFvEqpVPikEw #webinar #pulmonaryvascular #highaltitude
The Pulmonary Vascular Research Institute
@PVRI
1 week to go! Join Professor Norbert Weissmann for a presentation on ‘The role of hypoxia on the pulmonary vasculature’ 17 December 2024 1PM GMT 🗻Organised by the High Altitude Task Force, this #webinar is part of the 'Hypoxia in pulmonary vascular research – altitude and beyond' series. Moderated by @aastha_mishra06 & Silvia Ulrich. Register for free: pvrinstitute.org/learning-hub/events/role-hypoxia-pulmona…
-
The Pulmonary Vascular Research Institute
@PVRI
Limited places remaining for Women in PH Luncheon!
The #pvri2025 Women in PH Luncheon is a way to support educational opportunities for women in #ph and strengthen their professional network, to build a more inclusive and diverse community. The event is proving very popular, and we now have very limited places remaining for this function. If you are interested in joining, please book soon pvrinstitute.org/pvri2025rio
The Pulmonary Vascular Research Institute
@PVRI
Following our successful Luncheon in PVRI 2024 London, we are delighted to bring to you the Women in PH Luncheon at #pvri2025. We look forward to another exhilarating event welcoming women from around the world who share their journeys and what it means to them to be a woman in #pulmonaryhypertension. Thank you to United Therapeutics Corporation for sponsoring this Luncheon pvrinstitute.org/pvri2025rio
-
The Pulmonary Vascular Research Institute reposted
Navneet Singh, MD, ScM
@navneetsinghmd
This is going to be so unique and fascinating. Can’t wait! Register below 👇🏽
@PHAssociation @PVRI @atsearlycareer @ATS_PC
ATS_Assemblies
@ATS_Assemblies
On Dec. 17 at 3pm Eastern join our @ATS_PC for a webinar on Industry Partnerships and how partnering with industry has the potential to accelerate research as well as the transition from academics to industry!
Register here: thoracic.zoom.us/meeting/register/tZYtd-CtrT8pHdSJGaJfK_I… -
The Pulmonary Vascular Research Institute
@PVRI
Missed it? Watch the replay here➡️pvrinstitute.org/learning-hub/material/session-3-young-in… (members only) #pvridigital
Speakers & moderators included @rjbernardoMD, @YongnengZhang,
@AlNaamani_N, Andrew J Sweatt, Zhiyu Dai and @James_West_PhD -
The Pulmonary Vascular Research Institute reposted
Sebastien « Seb » Bonnet
@sbonnet2
Finally the latest baby of the Quebec PAH and vascular biology research group is out 😎. Congrats Dr Grobs @Grobs4
@3CPRCouncil @PVRI @ATS_PC @PullamsettiL @Savai_Lab @facmedUL
www.science.org/doi/10.1126/scitranslmed.ado7824 -
The Pulmonary Vascular Research Institute
@PVRI
Now live! Join our #pvridigital webinar us02web.zoom.us/webinar/register/WN_9rA2yBn5QWeeszJ3jjdNhw
-
The Pulmonary Vascular Research Institute
@PVRI
NEW Pulmonary Hypertension Group III Workstream review article just published: 'Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative—group 3 pulmonary hypertension' by P. Vitulo MD Et al. Read the full article: pvrinstitute.org/learning-hub/material/screening-and-diag…
-
The Pulmonary Vascular Research Institute
@PVRI
Happening at 3PM GMT today! Still time to join us02web.zoom.us/webinar/register/WN_9rA2yBn5QWeeszJ3jjdNhw
The Pulmonary Vascular Research Institute
@PVRI
1 week to go until the 3rd session of the #pvridigital 'Young Investigators Series'. Speakers & moderators include @rjbernardoMD, @YongnengZhang, @AlNaamani_N, Andrew J Sweatt, Zhiyu Dai and @James_West_PhD
Join 11 December 3PM GMT: pvrinstitute.org/learning-hub/events/session-3-young-inve…
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
1 week to go! Join Professor Norbert Weissmann for a presentation on ‘The role of hypoxia on the pulmonary vasculature’ 17 December 2024 1PM GMT 🗻Organised by the High Altitude Task Force, this #webinar is part of the 'Hypoxia in pulmonary vascular research – altitude and beyond' series. Moderated by @aastha_mishra06 & Silvia Ulrich. Register for free: pvrinstitute.org/learning-hub/events/role-hypoxia-pulmona…
-
The Pulmonary Vascular Research Institute
@PVRI
Registrations are now open for the PVRI Drug Discovery and Development Symposium 2025! Sessions include new standards of care, disease modification, diversity & inclusion, global aspects of drug development & availability and more. Register your place pvrinstitute.org/DDDS2025
#ddds2025
The Pulmonary Vascular Research Institute
@PVRI
We are excited to announce that registrations are now open for #ddds2025! Taking place in Amsterdam 16-17 June, the #pvri Drug Discovery and Development Symposium promises to be an excellent opportunity for regulatory, industry, and academic bodies to discuss the latest drug developments in #pulmonaryhypertension.
Find out more pvrinstitute.org/DDDS2025 -
The Pulmonary Vascular Research Institute
@PVRI
NEW research article just published: 'THBS1 mediates hypoxia driven EndMT in pulmonary hypertension' by Bingming Peng Et al.
Read the full article: pvrinstitute.org/learning-hub/material/thbs1-mediates-hyp… -
The Pulmonary Vascular Research Institute
@PVRI
⭐️Meet the speaker⭐️
We’re delighted to have Steven Abman joining #pvri2025, who will be speaking on 'Vascular changes in paediatric chronic lung disease' Friday 31 January.
Here’s a sneak peek...
"Recent studies have demonstrated that nearly half of paediatric PH subjects enrolled in a large multicenter registry study were classified as Group 3 disease, which was predominantly due to children with bronchopulmonary dysplasia (BPD) and congenital diaphragmatic hernia, as well as other rare developmental lung disorders. Despite high mortality in infants with Group 3 disease, current diagnostic and therapeutic strategies targeting pulmonary vascular disease remain poorly defined and are based largely on small case series and clinical experience."
See you in Rio! pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute
@PVRI
1 week to go until the 3rd session of the #pvridigital 'Young Investigators Series'. Speakers & moderators include @rjbernardoMD, @YongnengZhang, @AlNaamani_N, Andrew J Sweatt, Zhiyu Dai and @James_West_PhD
Join 11 December 3PM GMT: pvrinstitute.org/learning-hub/events/session-3-young-inve…
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
PVRI is delighted to support our successful PVRI India group in running what we know will be another successful scientific meeting. We look forward to meeting faculty, patients and industry supporters in Mumbai in December. Register pvrinstitute.org/learning-hub/events/indian-national-ph-s…
Pulmonary Hypertension India
@PulmonaryHIndia
🌟 Join us at The PH Symposium 2024! 🌟
🗓️ 14th Dec, 9:30 AM
📍 Kokilaben Dhirubhai Ambani Hospital, Mumbai
A Townhall for #pulmonaryhypertension patients, caregivers & doctors in India.
💬 Let’s connect, share, & support!
#phsymposium2024 #phindia #phcommunity #phwarriors -
The Pulmonary Vascular Research Institute
@PVRI
Interested in accessing the PH GPS data? 📊
We’re excited to unlock new insights from the phase 1 of the #phgps survey. Nearly 4,000 PH patients and caregivers from over 85 countries participated. The findings have the potential to improve patient care, guide future research and help us address unmet needs.
“I'm particularly interested in the quality-of-life data. Pulmonary hypertension patient associations in Europe will likely play a role in Health Technology Assessment (HTA) processes as part of the approval for new PH medications. The PH GPS quality of life data would support them in this process.” Hall Skaara, PHA Europe
If you're interested, we would love to hear from you. Find out more: pvrinstitute.org/phgps -
The Pulmonary Vascular Research Institute
@PVRI
We are excited to announce that registrations are now open for #ddds2025! Taking place in Amsterdam 16-17 June, the #pvri Drug Discovery and Development Symposium promises to be an excellent opportunity for regulatory, industry, and academic bodies to discuss the latest drug developments in #pulmonaryhypertension.
Find out more pvrinstitute.org/DDDS2025 -
The Pulmonary Vascular Research Institute
@PVRI
Missed it? You can now watch a replay of @iPVDc 'Co-Infection and Pulmonary Vascular Disease' webinar⏯️pvrinstitute.org/learning-hub/material/co-infection-ipvd-…
-
The Pulmonary Vascular Research Institute
@PVRI
Have you registered for #pvri2025? 🌎With just 2 months to go, time is running out to secure your place! Hear from the Scientific Organising Committee leader, William Oldham, on what you can expect at the Congress. Register today pvrinstitute.org/pvri2025rio
See you in Rio! -
The Pulmonary Vascular Research Institute
@PVRI
Live now! Join here us02web.zoom.us/webinar/register/WN_eOA2k9PaR2G0R__S6hGyQg
The Pulmonary Vascular Research Institute
@PVRI
Happening 3PM GMT today! Hanan Yusuf from Addis Ababa University will be speaking on 'Co-Infection and Pulmonary Vascular Disease' next week. Register for free: us02web.zoom.us/webinar/register/WN_eOA2k9PaR2G0R__S6hGyQg
@iPVDc -
The Pulmonary Vascular Research Institute
@PVRI
Happening 3PM GMT today! Hanan Yusuf from Addis Ababa University will be speaking on 'Co-Infection and Pulmonary Vascular Disease' next week. Register for free: us02web.zoom.us/webinar/register/WN_eOA2k9PaR2G0R__S6hGyQg
@iPVDc -
The Pulmonary Vascular Research Institute
@PVRI
Calling early career professionals in the #pulmonaryhypertension community📢
New for #pvri2025, we will be hosting a PH Career Catalyst Luncheon to support early career professionals and trainees in connecting with globally renowned senior and mid-career PH professionals in a welcoming and informal setting. Find out more pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute
@PVRI
Did you know that Pulmonary Circulation is #pvri's peer-reviewed research journal dedicated exclusively to pulmonary circulation and pulmonary vascular disease? In support of #phawarenessmonth and working towards a future in which #ph is better understood and more effectively treated worldwide, our journal is fully open-access! pvrinstitute.org/learning-and-research/pulmonary-circulation
-
The Pulmonary Vascular Research Institute
@PVRI
Happening this week! Register for free us02web.zoom.us/webinar/register/WN_eOA2k9PaR2G0R__S6hGyQg
The Pulmonary Vascular Research Institute
@PVRI
Hanan Yusuf from Addis Ababa University will be speaking on 'Co-Infection and Pulmonary Vascular Disease' next week. Register to join the @iPVDc webinar▶️ pvrinstitute.org/learning-hub/events/co-infection-ipvd-mi…
-
The Pulmonary Vascular Research Institute
@PVRI
Hear from the #pvri2025 Scientific Organising Committee leader, William Oldham, on what attendees can expect at PVRI 2025 Rio and why this meeting is important for the whole #pulmonaryhypertension community. With 2 months to go, we can't wait to see you there! Watch the full interview and register your place today pvrinstitute.org/pvri2025rio
-
The Pulmonary Vascular Research Institute
@PVRI
Missed it? You can now watch the replay of our #pulmonaryhypertension November Community Call here: pvrinstitute.org/learning-hub/material/november-2024-pvri…
Featuring guests @hilarydubrockMD, Wusheng Xiao, and Community Call hosts @AlbertaPHdoc, Katrina Barry, Joel James, @Tatiana_PVRI
The Pulmonary Vascular Research Institute
@PVRI
Our Community Call is live now! Join us for a discussion on all things PH: us02web.zoom.us/webinar/register/WN_xbVQwba7Tmy2ut3A1XyU9A
-
The Pulmonary Vascular Research Institute reposted
Rodolfo A. Estrada, MD FCCP
@REstradaMD
Check out this "quick read while you walk from the car to the office" update on key takeaways from the latest PH World Symposium we wrote with @rjbernardoMD #chidinmaejikeme for @journal_CHEST. Amazing support from @CHESTPulmCardio team!
@ATS_PC @PVRI @PHAssociation @EuropePHA
CHEST
@accpchest
Members of the Pulmonary Vascular Disease Section of the Pulmonary Vascular and Cardiovascular Network provide a review of the latest updates in #ph research. Read more: www.chestphysician.org
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
Our Community Call is live now! Join us for a discussion on all things PH: us02web.zoom.us/webinar/register/WN_xbVQwba7Tmy2ut3A1XyU9A
-
The Pulmonary Vascular Research Institute
@PVRI
Happening today! Join at 3PM GMT to hear the latest developments in #pulmonaryhypertension Register for free: us02web.zoom.us/webinar/register/WN_xbVQwba7Tmy2ut3A1XyU9A
The Pulmonary Vascular Research Institute
@PVRI
There's still time to join this month's Community Call, happening Thursday 3PM GMT! Guest authors include @hilarydubrockMD and Wusheng Xiao, register for free to join the discussion pvrinstitute.org/learning-hub/events/pvri-community-call-…
@AlbertaPHdoc @Tatiana_PVRI @SandeepSahayMD -
The Pulmonary Vascular Research Institute
@PVRI
Hanan Yusuf from Addis Ababa University will be speaking on 'Co-Infection and Pulmonary Vascular Disease' next week. Register to join the @iPVDc webinar▶️ pvrinstitute.org/learning-hub/events/co-infection-ipvd-mi…
-
The Pulmonary Vascular Research Institute
@PVRI
There's still time to join this month's Community Call, happening Thursday 3PM GMT! Guest authors include @hilarydubrockMD and Wusheng Xiao, register for free to join the discussion pvrinstitute.org/learning-hub/events/pvri-community-call-…
@AlbertaPHdoc @Tatiana_PVRI @SandeepSahayMD -
The Pulmonary Vascular Research Institute
@PVRI
⭐️Meet the speaker⭐️
We’re delighted to have @BobhatePrashant joining #pvri2025, who will be speaking on 'Managing RV dysfunction in resource-limited settings' Friday 31 January.
Here’s a sneak peek...
"Managing right ventricular dysfunction in pulmonary hypertension in a resource-limited setting focuses on optimizing supportive care with available therapies. This includes careful fluid management, the use of affordable medications such as diuretics and calcium channel blockers when appropriate, and maximizing non-pharmacological measures like Potts shunt and atrial septostomy. Key is identifying the patient early and acting before right ventricular dysfunction ensues."
See you in Rio!
pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute
@PVRI
✨Massive congrats to Kurt Stenmark, our previous president, who has been made a distinguished professor at the University of Colorado✨
This high honour recognises exceptional contributions in research, education and service. Kurt Stenmark, Professor of Paediatrics, is an internationally acclaimed expert in pulmonary vascular disease whose pioneering research has revolutionized the understanding and treatment of this complex condition. Congratulations Kurt on this achievement!
connections.cu.edu/spotlights/nine-faculty-members-join-r… -
The Pulmonary Vascular Research Institute
@PVRI
Missed it? Watch the replay⏯️pvrinstitute.org/learning-hub/material/session-2-young-in…
#pvridigital
The Pulmonary Vascular Research Institute
@PVRI
There's still time to register for today's 'Session 2 of Young Investigator Symposium' at 3PM GMT!
Speakers & moderators include Farbod N. Rahaghi, Darlene Kim, Robert Szulcek, @ThomasBertero,
@KeYuan_BCH, @GoncharovaLab and @Hansmann_Lab. Join here ➡️pvrinstitute.org/learning-hub/events/session-2-young-inve…
#pvridigital -
The Pulmonary Vascular Research Institute
@PVRI
Join us for an evening of celebration at our Gala Dinner & Awards Evening at #pvri2025, where excellence will be honoured and memories made🎉 Together, we’ll celebrate the impact each member of our community makes with good food and wine, a DJ, and a Bossa Nova band🥁
Don’t forget, nominations for the PVRI Achievement Awards close 25 November! pvrinstitute.org/membership/pvri-awards/pvri-achievement-… -
The Pulmonary Vascular Research Institute
@PVRI
Less then 2 weeks to go!⏰ Register for free: pvrinstitute.org/learning-hub/events/co-infection-ipvd-mi…
#webinar #pulmonaryvasculardisease
The Pulmonary Vascular Research Institute
@PVRI
Join us 27 November 3pm GMT for the next session in @iPVDc Microbes Virtual Symposium series. Hanan Yusuf from Addis Ababa University will be speaking on 'Co-Infection and Pulmonary Vascular Disease'. Moderated by Dr. Peter Nyasulu from the University of the Witwatersrand. Don't miss out! Register: pvrinstitute.org/learning-hub/events/co-infection-ipvd-mi… @ArcSuellen
-
The Pulmonary Vascular Research Institute
@PVRI
In support of #phawarenessmonth, we invite you to join our monthly Community Call next week to discuss the latest news and advancements in #ph. Our November Community Call features guest authors @hilarydubrockMD and Wusheng Xiao, and hosts @AlbertaPHdoc, Katrina Barry, Joel James, @Tatiana_PVRI, and @SandeepSahayMD.
Join November 21 3PM GMT: pvrinstitute.org/learning-hub/events/pvri-community-call-… -
The Pulmonary Vascular Research Institute
@PVRI
#pvridigital now live! Join here: us02web.zoom.us/webinar/register/WN_CL-w4aP0ROakNeUBWe_TTw
-
The Pulmonary Vascular Research Institute
@PVRI
NEW state of the art review just published: 'Infection and pulmonary vascular diseases consortium: United against a global health challenge' by the @iPVDc.
Read the full review: pvrinstitute.org/learning-hub/material/infection-and-pulm…
@ArcSuellen @gbutrous @nadhillon @Viniciodjperez -
The Pulmonary Vascular Research Institute reposted
PHAEUROPE
@EuropePHA
Today is World CTEPH Awareness Day (#cteph). This type of #pulmonaryhypertension affects up to 3% of those with past pulmonary embolism. Fortunately, it’s the only form of PH that can be treated and cured surgically, with balloon pulmonary angioplasty (#bpa), or pharmacologically
-
The Pulmonary Vascular Research Institute
@PVRI
There's still time to register for today's 'Session 2 of Young Investigator Symposium' at 3PM GMT!
Speakers & moderators include Farbod N. Rahaghi, Darlene Kim, Robert Szulcek, @ThomasBertero,
@KeYuan_BCH, @GoncharovaLab and @Hansmann_Lab. Join here ➡️pvrinstitute.org/learning-hub/events/session-2-young-inve…
#pvridigital -
The Pulmonary Vascular Research Institute
@PVRI
⭐️Meet the speaker⭐️
We’re delighted to have @SashaPrisco joining #pvri2025, who will be speaking on 'The Microbiome in PH' Saturday 1 February.
Here’s a sneak peek...
"Inflammation contributes to the development of pulmonary hypertension and right ventricular dysfunction. Up to 70-80% of our body's immune cells reside in our intestine. Dr. Prisco will present data suggesting that altering the gut microbiome could be an innovative approach to treating pulmonary hypertension and right ventricular failure."
See you in Rio! 🇧🇷
pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute reposted
Andrew Ho
@Tru_Ho
Exploring the impact of comorbidities on patients with PE in Pulmonary Circulation - Analysis of a national database of 561k patients showed up to 5.4 fold increase in mortality in high comorbidity groups
doi.org/10.1002/pul2.70010
@ParthRali @PVRI @PulmCirc @TemplePCCM -
The Pulmonary Vascular Research Institute
@PVRI
#pvridigital webinar happening this Wednesday 13 November! Register for free pvrinstitute.org/learning-hub/events/session-2-young-inve…
The Pulmonary Vascular Research Institute
@PVRI
1 week to go until the 2nd session of the #pvridigital 'Young Investigators Series'🥼🧪Speakers & moderators include Farbod N. Rahaghi, Darlene Kim, Robert Szulcek, @ThomasBertero, @KeYuan_BCH, @GoncharovaLab and @Hansmann_Lab.
Join 13 November 3PM GMT: pvrinstitute.org/learning-hub/events/session-2-young-inve…
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
NEW research article just published: 'Quantitative pulmonary perfusion in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension' by Jacob V. Hansen et al. Read the full article: pvrinstitute.org/learning-hub/material/quantitative-pulmo…
@PulmCirc 📰 #pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
NEW data on PH symptoms, treatments, and patients’ quality of life worldwide 📊
Nearly 4,000 PH patients and caregivers from over 85 countries participated in the first phase of the #phgps (Pulmonary Hypertension Global Patient Survey), and experts are currently analysing the data. The findings have the potential to improve patient care, guide future research and help us address unmet needs.
Interested? Find out more: pvrinstitute.org/phgps
We would love to hear from you. -
The Pulmonary Vascular Research Institute
@PVRI
There's still time to submit your nominations for the PVRI Achievement Awards 2025!🎉
These awards honour outstanding contributions to pulmonary hypertension research. Nominate by 25 November 2024. Winners will be announced at the #pvri2025 Rio Gala Dinner and Awards Ceremony.
Find out more and submit your nominations today! pvrinstitute.org/membership/pvri-awards/pvri-achievement-… -
The Pulmonary Vascular Research Institute
@PVRI
Missed it? You can now watch the replay of
@andrewmurray78's presentation on ‘Human metabolic responses to high altitude hypoxia’ ⏯️ pvrinstitute.org/learning-hub/material/human-metabolic-re…
Organised by the High Altitude Task Force 🗻and moderated by @aastha_mishra06 & Silvia Ulrich. -
The Pulmonary Vascular Research Institute
@PVRI
1 week to go until the 2nd session of the #pvridigital 'Young Investigators Series'🥼🧪Speakers & moderators include Farbod N. Rahaghi, Darlene Kim, Robert Szulcek, @ThomasBertero, @KeYuan_BCH, @GoncharovaLab and @Hansmann_Lab.
Join 13 November 3PM GMT: pvrinstitute.org/learning-hub/events/session-2-young-inve…
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
⭐️Meet the speaker⭐️
We’re delighted to announce a joint talk with @PHAssociation at #pvri2025 Saturday 1 February. @VarianFrances will be speaking on ‘Patient reported outcomes’, and here’s a sneak peek of her talk:
"Are you interested to know more about implementing valid patient-reported outcome measures (PROMs) for assessing health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH)? Systematic analysis shows that only 20 RCTs in PAH have used a valid PROM for HRQoL, with just 8 being adequately powered. This presentation details HRQoL conceptual mapping in PAH, the psychometric validity of existing PROMs, and the future role of PROMs in health economic evaluations, aiming to establish HRQoL as a robust outcome measure in PAH."
See you in Rio! 🇧🇷
pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute
@PVRI
Happening today! Register for free: us02web.zoom.us/webinar/register/WN_YiikA6JFTduMsPkleIXIBA
The Pulmonary Vascular Research Institute
@PVRI
1 week to go! Join @andrewmurray78 for a presentation on ‘Human metabolic responses to high altitude hypoxia’ 5 November 2024 1PM GMT 🗻
Organised by the High Altitude Task Force, this is the second #webinar in the 'Hypoxia in pulmonary vascular research – altitude and beyond' series. Moderated by @aastha_mishra06 & Silvia Ulrich.
Register for free: pvrinstitute.org/learning-hub/events/human-metabolic-resp… -
The Pulmonary Vascular Research Institute
@PVRI
November is #phawarenessmonth! To help spread #ph awareness, the PVRI Lung Transplantation in PH Workstream presented a patient-focused webinar on debunking myths about lung transplantation🫁 We are delighted to announce that a full transcript is now available and can be translated into your preferred language➡️ pvrinstitute.org/learning-hub/material/debunking-myths-ab… @PHAssociation @EuropePHA
-
The Pulmonary Vascular Research Institute reposted
PHAEUROPE
@EuropePHA
💛November is Pulmonary Hypertension Awareness Month! Follow Pulmonary Hypertension Association Europe and Pulmonary Hypertension Association to spread #ph awareness and see how the #pulmonaryhypertension community let their light shine...⤵️
-
The Pulmonary Vascular Research Institute
@PVRI
Today marks the start of #ph Awareness Month!🎇In support of #phdayuk, the #pvri is committed to sharing cutting-edge research, raising awareness of PH, and addressing key challenges. Our goal is to improve diagnosis, treatment, and care for patients all around the world, and we will advocate, collaborate, and educate globally until PH is well-understood and properly resourced.
www.phauk.org/pledge/pulmonary-vascular-research-institut…
@PHA_UK #phdayuk #togetherforph -
The Pulmonary Vascular Research Institute reposted
PHA UK
@PHA_UK
🎉 Today is #phdayuk and we’re celebrating all the amazing individuals in our #pulmonaryhypertension community. Please share this video to remind everyone that patients are people too…
#togetherforph -
The Pulmonary Vascular Research Institute
@PVRI
We are delighted to invite our community members to the 5th Paediatric and 2nd Adult Latin American Symposium on #ph in Sao Paulo, Brazil🇧🇷
Taking place 22 - 23 November 2024, the event is being organised by the leaders of the PVRI LATAM Task Force and aims to address the latest advances in diagnosis and management of adult and paediatric PH.
Register➡️ pvrinstitute.org/learning-hub/events/5th-paediatric-and-2… -
The Pulmonary Vascular Research Institute
@PVRI
We’re two weeks into the nomination period for the prestigious PVRI Lifetime Achievement Award 2025 and PVRI Achievement Awards 2025, and there’s still time to recognise the outstanding contributions of colleagues in the field of PH🎉
If you know someone who deserves this recognition now is the time to submit a nomination! pvrinstitute.org/membership/pvri-awards/pvri-achievement-…
The nomination period will remain open for four more weeks, closing on 25 November 2024. Thank you for helping us celebrate excellence in PH research and clinical care💜
The Pulmonary Vascular Research Institute
@PVRI
🎉Nominations are now open for the PVRI Achievement Awards 2025! 🌎
These awards honour outstanding contributions to pulmonary hypertension research. Nominate by 25 November 2024. Winners will be announced at the #pvri2025 Rio Gala Dinner and Awards Ceremony.
Find out more and submit your nominations today! pvrinstitute.org/membership/pvri-awards/pvri-achievement-… -
The Pulmonary Vascular Research Institute
@PVRI
1 week to go! Join @andrewmurray78 for a presentation on ‘Human metabolic responses to high altitude hypoxia’ 5 November 2024 1PM GMT 🗻
Organised by the High Altitude Task Force, this is the second #webinar in the 'Hypoxia in pulmonary vascular research – altitude and beyond' series. Moderated by @aastha_mishra06 & Silvia Ulrich.
Register for free: pvrinstitute.org/learning-hub/events/human-metabolic-resp… -
The Pulmonary Vascular Research Institute
@PVRI
NEW research article just published: 'Extracorporeal membrane oxygenation (ECMO) support for children with pulmonary hypertension: A single-institutional experience of outcomes' by Christopher Nemeh et al. Read the full article: pvrinstitute.org/learning-hub/material/extracorporeal-mem…
@PulmCirc -
The Pulmonary Vascular Research Institute
@PVRI
Missed it? You can now watch the replay of our #pulmonaryhypertension October Community Call here: pvrinstitute.org/learning-hub/material/october-2024-pvri-…
Featuring guests @EszterNToth
& @GrynblatJ, and Community Call hosts Katrina Barry, Tatiana Kudryashova & Jason Weatherald. -
The Pulmonary Vascular Research Institute
@PVRI
📢Hot topics from PVRI GoDeep
This session will take place on Saturday, 1 February 2025. You can register for the session when you register for the #pvri2025.
Chairs: Martin Wilkins, Paul Hassoun, Werner Seeger
💜Overview of the GoDeep meta-registry, Werner Seeger
💜Risk scores beyond group 1 PH – baseline and follow-up, Athiththan Yogeswaran
💜Survival outcomes and impact of targeted PAH therapy in PoPH, Arun Jose
💜PAH-targeted therapies in group 3 PH – PDE5 inhibitor therapy associated with improved survival, Khodr Tello
💜Male survival disadvantage in PH: independent of etiology, age, disease severity, comorbidities and treatment, but race-dependent, Evan Brittain
Find out more: pvrinstitute.org/learning-hub/news/hot-topics-pvri-godeep… -
The Pulmonary Vascular Research Institute reposted
Team PHenomenal Hope
@teamphhope
#ctephday is Nov 13, & we look forward to sharing a recorded discussion with Dr. Anjali Vaidya of #templeuniversity & CTEPH patient Harry Rozakis. Together, they cover diagnosis, BPA, dangers of off-label meds, & more. Stay tuned on Wed, Nov 13 #pulmonaryhypertension
-
The Pulmonary Vascular Research Institute
@PVRI
Our Community Call is live now! Join us for a discussion on all things PH: us02web.zoom.us/webinar/register/WN_hcRSFtlrTpK7slpw3677gQ
-
The Pulmonary Vascular Research Institute
@PVRI
Join at 3PM BST today to discuss the latest developments in #pulmonaryhypertension us02web.zoom.us/webinar/register/WN_hcRSFtlrTpK7slpw3677gQ
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Join our #pulmonaryhypertension October Community Call🎙️@3PM BST with guests @EszterNToth, @BogaardHarm and @GrynblatJ to discuss:
💜Deep phenotyping of unaffected carriers of pathogenic BMPR2 variants screened for pulmonary arterial hypertension
💜Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation
Register for free: us02web.zoom.us/webinar/register/WN_hcRSFtlrTpK7slpw3677gQ -
The Pulmonary Vascular Research Institute reposted
Jenny Yang
@JennyYangMD
TAPSE/PASP works in #cteph too! 🔔 RV-PA coupling improvement after #bpa can be monitored and trended via TAPSE/PASP @ucsdpccm @UCSDCardiology
onlinelibrary.wiley.com/doi/full/10.1002/pul2.12452 -
The Pulmonary Vascular Research Institute
@PVRI
NEW research article just published: 'Non-invasive surrogates for right Ventricular-Pulmonary arterial coupling: a systematic review and Meta-Analysis' by Jem M. Golbin et al. Read the full article: pvrinstitute.org/learning-hub/material/non-invasive-surro…
@PulmCirc -
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Join our #pulmonaryhypertension October Community Call🎙️@3PM BST with guests @EszterNToth, @BogaardHarm and @GrynblatJ to discuss:
💜Deep phenotyping of unaffected carriers of pathogenic BMPR2 variants screened for pulmonary arterial hypertension
💜Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation
Register for free: us02web.zoom.us/webinar/register/WN_hcRSFtlrTpK7slpw3677gQ -
The Pulmonary Vascular Research Institute
@PVRI
Interested in improving #pulmonaryhypertension patient care? 📊
Data from our #phgps global patient survey is being analysed. This new data will expand our knowledge and understanding of PH symptoms, treatments, and patients’ quality of life worldwide. The findings have the potential to improve patient care, guide future research and help us address unmet needs.
If you're interested, we would love to hear from you. Find out more: pvrinstitute.org/phgps -
The Pulmonary Vascular Research Institute
@PVRI
Closing at midnight! Submit your abstract today: pvrinstitute.org/pvri2025rio
The Pulmonary Vascular Research Institute
@PVRI
📢#pvri2025 abstract submissions closing Monday!
This is your last opportunity to get your abstracts in for PVRI 2025 Rio. The abstract portal will be closing at midnight 21 October, so don't miss your opportunity to showcase your research and share your work📊
Chosen abstract presenters will be notified by 11 November 2024 pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute reposted
Team PHenomenal Hope
@teamphhope
#teamph is at #mounteverest Base Camp! We are so proud of our team members Jessica Ashbaucher, Aaron Waxman, and Manreet Kanwar for representing the #pulmonaryhypertension community on the most difficult climb in the world. Stay tuned for details on their climb! #letmebeyourlungs
-
The Pulmonary Vascular Research Institute
@PVRI
📢#pvri2025 abstract submissions closing Monday!
This is your last opportunity to get your abstracts in for PVRI 2025 Rio. The abstract portal will be closing at midnight 21 October, so don't miss your opportunity to showcase your research and share your work📊
Chosen abstract presenters will be notified by 11 November 2024 pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute reposted
Kurt Prins
@kurt_prins
www.ahajournals.org/doi/10.1161/CIRCRESAHA.123.324138. Excited to share our journey of ferroptosis in PAH. Thanks to generous collaborators @Lab__Williams @VUMC_heart (Evan Brittain), @therealtyrone50 and Christopher Rhodes! @CircRes @LilleheiHrt @UMN_DOMResearch @PVRI @ATS_PC @PHAssociation @SashaPrisco
-
The Pulmonary Vascular Research Institute
@PVRI
1 week to go⌛️Register for our upcoming Community Call to discuss the latest developments in #ph pvrinstitute.org/learning-hub/events/pvri-community-call-…
The Pulmonary Vascular Research Institute
@PVRI
Join us for our October #pulmonaryhypertension Community Call next Thursday 3PM BST. Guest speakers include @EszterNToth, @BogaardHarm , @GrynblatJ and Frédéric Perros.
Registration is free and open to all in the PH community: pvrinstitute.org/learning-hub/events/pvri-community-call-…
@AlbertaPHdoc @Tatiana_PVRI @SandeepSahayMD -
The Pulmonary Vascular Research Institute
@PVRI
Next in the 'Hypoxia in pulmonary vascular research – altitude and beyond' #webinar series 🗻
Join @andrewmurray78 for a presentation on ‘Human metabolic responses to high altitude hypoxia’ 5 November 2024 1PM GMT. Organised by the High Altitude Task Force & moderated by @aastha_mishra06 & Silvia Ulrich, Register here pvrinstitute.org/learning-hub/events/human-metabolic-resp… -
The Pulmonary Vascular Research Institute
@PVRI
NEW research article just published: 'The influence of the NRG1/ERBB4 signaling pathway on pulmonary artery endothelial cells' by Jin-Bo Huang et al. Read the full article: pvrinstitute.org/learning-hub/material/influence-nrg1erbb…
@PulmCirc -
The Pulmonary Vascular Research Institute
@PVRI
Join us for our October #pulmonaryhypertension Community Call next Thursday 3PM BST. Guest speakers include @EszterNToth, @BogaardHarm , @GrynblatJ and Frédéric Perros.
Registration is free and open to all in the PH community: pvrinstitute.org/learning-hub/events/pvri-community-call-…
@AlbertaPHdoc @Tatiana_PVRI @SandeepSahayMD -
The Pulmonary Vascular Research Institute
@PVRI
🎉Nominations are now open for the PVRI Achievement Awards 2025! 🌎
These awards honour outstanding contributions to pulmonary hypertension research. Nominate by 25 November 2024. Winners will be announced at the #pvri2025 Rio Gala Dinner and Awards Ceremony.
Find out more and submit your nominations today! pvrinstitute.org/membership/pvri-awards/pvri-achievement-… -
The Pulmonary Vascular Research Institute reposted
-
The Pulmonary Vascular Research Institute reposted
Ghazwan Butrous
@gbutrous
It is a pleasure to be attending and participating in a seminar at the UNIFESP Medical School, Federal University of Sao Paulo, @Brazil tomorrow. The seminar is dedicated to discussing the role of infectious diseases in @pulmonary #hypertension @iPVDc @PVRI
-
The Pulmonary Vascular Research Institute
@PVRI
Join us 27 November 3pm GMT for the next session in @iPVDc Microbes Virtual Symposium series. Hanan Yusuf from Addis Ababa University will be speaking on 'Co-Infection and Pulmonary Vascular Disease'. Moderated by Dr. Peter Nyasulu from the University of the Witwatersrand. Don't miss out! Register: pvrinstitute.org/learning-hub/events/co-infection-ipvd-mi… @ArcSuellen
-
The Pulmonary Vascular Research Institute
@PVRI
We are so grateful to everyone for contributing to our vision to improve the worldwide patient experience. The findings from Phase 1 of the PH GPS survey will be pivotal in shaping future research and enhancing healthcare to benefit patients globally, and we look forward to sharing them soon, as well as the plans for phase 2.
We particularly thank the PH patients and carers for their participation 💜
pvrinstitute.org/learning-research/pulmonary-hypertension…
PHAEUROPE
@EuropePHA
Thank you to all #pulmonaryhypertension patients in Europe and worldwide! 🙌 PHA Europe is proud to have supported the PH Global Patient Survey by PVRI. With nearly 4,000 responses from 85+ countries, your voices will shape future research and patient care.⤵️
-
The Pulmonary Vascular Research Institute
@PVRI
NEW research article just published: 'Didang decoction attenuates cancer-associated thrombosis by inhibiting PAD4-dependent NET formation in lung cancer' by Xiaoyan Zeng et al.
Read the full article: pvrinstitute.org/learning-hub/material/didang-decoction-a…
@PulmCirc -
The Pulmonary Vascular Research Institute
@PVRI
Missed the first session of our NEW Young Investigators Series? Watch the replay here➡️pvrinstitute.org/learning-hub/material/session-1-young-in… (members only) #pvridigital
Speakers & moderators included Speakers & moderators include
@Daniela_ValdezJ, Jasleen Minhas, @galbamd, @AnFrumpIU,@RRVdpool, @iuc453, @BogaardHarm and Jurjan Aman. -
The Pulmonary Vascular Research Institute
@PVRI
Just in case you missed it - the abstract submission deadline has been extended for #pvri2025! Find out more: pvrinstitute.org/learning-hub/news/abstract-submissions-p…
The Pulmonary Vascular Research Institute
@PVRI
🔊Abstract announcement – submission deadline has been extended!
Thank you to everyone who has submitted their abstract so far for #pvri2025. We have extended the abstract deadline by 2 weeks to ensure you have the opportunity to share your work. The best abstracts will be considered for travel awards and selected for oral presentations in our main programme.
Make sure to submit before 21 October: pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute
@PVRI
3PM BST today! Join the first session of our NEW Young Investigators Series next week! Part of #pvridigital, the Young Investigators Series aims to showcase the groundbreaking research being done by clinicians and scientists that are early in their careers. Register for free:
-
The Pulmonary Vascular Research Institute
@PVRI
Happening tomorrow! Register for free: pvrinstitute.org/learning-hub/events/session-1-young-inve…
The Pulmonary Vascular Research Institute
@PVRI
Join the first session of our NEW Young Investigators Series next week! Part of #pvridigital, the Young Investigators Series aims to showcase the groundbreaking research being done by clinicians and scientists that are early in their careers. Speakers & moderators include @Daniela_ValdezJ, Jasleen Minhas, @galbamd, @AnFrumpIU, @RRVdpool, @iuc453, @PullamsettiL and @BogaardHarm.
Register for free & join 9 October 3PM BST: pvrinstitute.org/learning-hub/events/session-1-young-inve… -
The Pulmonary Vascular Research Institute reposted
ATS PC Assembly
@ATS_PC
Don’t miss this PHenomenal session TOMORROW 10/8 at 2p ET! @atsearlycareer @PVRI @3CPRCouncil
P.S. - We are loving all the 🔥🔥 #ph #pah #pvd #rv #pe #cteph content at #chest2024! @CHESTPulmCardio
ATS_Assemblies
@ATS_Assemblies
Our @ATS_PC Assembly is presenting a webinar on Oct 8⃣ at 2⃣pm ET showcasing some of the great Basic science/Translational Abstracts from #ats2024
Register here: shorturl.at/Onql1 -
The Pulmonary Vascular Research Institute
@PVRI
🔊Abstract announcement – submission deadline has been extended!
Thank you to everyone who has submitted their abstract so far for #pvri2025. We have extended the abstract deadline by 2 weeks to ensure you have the opportunity to share your work. The best abstracts will be considered for travel awards and selected for oral presentations in our main programme.
Make sure to submit before 21 October: pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute
@PVRI
📢Abstract submissions closing
Last chance to submit your abstract for #pvri2025!
Don't miss your opportunity to showcase your research and share your work. Submission details:
💜Abstracts must be submitted through our abstract portal
💜There is no fee for abstract submission, but you must have an active PVRI membership to submit
💜Deadline for submission: 7 October 2024
💜Chosen abstract presenters will be notified by 11 November 2024
Submit your abstract: pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute
@PVRI
Missed it? You can now watch a replay of the first webinar in the NEW High Altitude Task Force series 'Pulmonary hemodynamic acclimatization to high altitude – pathophysiological insights' pvrinstitute.org/learning-hub/material/pulmonary-hemodyna…
-
The Pulmonary Vascular Research Institute reposted
Liquidia Corporation
@Liquidia_Corp
Liquidia and @PharmosaBiopharm announced an expanded collaboration regarding investigational sustained release inhaled #treprostinil (L606). See today's press release for more information - liquidia.com/news-releases/news-release-details/liquidia-…
-
The Pulmonary Vascular Research Institute
@PVRI
Join the first session of our NEW Young Investigators Series next week! Part of #pvridigital, the Young Investigators Series aims to showcase the groundbreaking research being done by clinicians and scientists that are early in their careers. Speakers & moderators include @Daniela_ValdezJ, Jasleen Minhas, @galbamd, @AnFrumpIU, @RRVdpool, @iuc453, @PullamsettiL and @BogaardHarm.
Register for free & join 9 October 3PM BST: pvrinstitute.org/learning-hub/events/session-1-young-inve… -
The Pulmonary Vascular Research Institute reposted
ATS PC Assembly
@ATS_PC
Interested in #ph & #healthdisparities? Don’t miss this great opportunity! Apply by Oct. 23rd!!
@ATS_Assemblies @atsearlycareer @PVRI @CHESTPulmCardio @3CPRCouncil
The Pulmonary Hypertension Association
@PHAssociation
PHA is currently accepting research grant applications for the Health Disparities in PH Research Award, which supports research to improve clinical outcomes and treatments for #pulmonaryhypertension patients affected by health inequities. Apply by Oct. 23. phassociation.org/living-with-ph/managing-your-health/
-
The Pulmonary Vascular Research Institute
@PVRI
Happening today! Join the first webinar in the NEW High Altitude Task Force series 'Pulmonary hemodynamic acclimatization to high altitude – pathophysiological insights' at 1pm BST. Register for free: us02web.zoom.us/webinar/register/WN_JMA0BfuZQEmJb87VkMR1_g
-
The Pulmonary Vascular Research Institute
@PVRI
We’re counting down to #pvri2025 hosted in the vibrant city of Rio de Janeiro, Brazil🇧🇷 Don’t miss your chance to showcase your research - abstract submissions close next week! Submit now pvrinstitute.org/pvri2025rio See you there!
-
The Pulmonary Vascular Research Institute
@PVRI
Missed it? You can now watch a replay of our latest #pulmonaryhypertension Community Call with
@LungScholar and Athiththan Yogeswaran pvrinstitute.org/learning-hub/material/september-2024-pvr…
Thank you to our guests and hosts @LucillaPiccari, Katrina Barry & Joel James💜 -
The Pulmonary Vascular Research Institute
@PVRI
This #worldheartday, PVRI supports the @worldheartfed campaign USE ❤️FOR ACTION to drive meaningful change in advancing healthcare & improving heart health. We call on everyone in the PH community to sign the first global petition prioritising heart health world-heart-federation.org/world-heart-day/
-
The Pulmonary Vascular Research Institute
@PVRI
Missed our 'Debunking myths about lung transplantation for PH' webinar? The replay is now available on our website. Thank you to our expert speakers Corey Ventetuolo, @CDemarest_MDPhD, @LungTxptMD, and inspiring patient representatives Natalia Maeva @EuropePHA & Diane Ramirez @PHAssociation for your insightful talks💜
pvrinstitute.org/learning-hub/material/debunking-myths-ab… -
The Pulmonary Vascular Research Institute reposted
Marcin Kurzyna
@marcin_kurzyna
Phase I of the Global Patients Survey will soon end. Thank you to all PH patients who participated!
-
The Pulmonary Vascular Research Institute
@PVRI
📢Pulmonary Hypertension Global Patient Survey closed
Thank you to the whole #ph community for their participation and contributions to the PH GPS. We’ve had a huge response, with almost 4,000 patients and carers in over 85 countries completing phase 1 of the survey! The PH GPS research team is analysing the results and finalising a report. The findings will be pivotal in shaping future research and enhancing healthcare to benefit patients globally. We are so grateful to everyone for helping to improve the worldwide patient experience. Watch this space!
pvrinstitute.org/learning-hub/news/phase-1-pulmonary-hype… -
The Pulmonary Vascular Research Institute reposted
Kurt Prins
@kurt_prins
Great manuscript on the role of mitochondria and lipoic acid in pulmonary hypertension. rupress.org/jem/article/221/11/e20231568/276992/Mitochond…. @Viniciodjperez @3CPRCouncil @PVRI
-
The Pulmonary Vascular Research Institute
@PVRI
Our Community Call is live now! Join us for a discussion on all things PH: us02web.zoom.us/webinar/register/WN_4ICz7z4sT2SUv2FO6ymX0g
-
The Pulmonary Vascular Research Institute
@PVRI
Join us for the #pulmonaryhypertension Community Call today @ 3PM BST with hosts Katrina Barry, Joel James, @LucillaPiccari, and guests @LungScholar and Athiththan Yogeswaran. Registration is free and open to all in the PH community us02web.zoom.us/webinar/register/WN_4ICz7z4sT2SUv2FO6ymX0g
-
The Pulmonary Vascular Research Institute
@PVRI
Live now! Still time to join our 'Debunking myths about lung transplantation for PH' webinar for patients and caregivers us02web.zoom.us/webinar/register/WN_QFTwfsAfQbyQ9pXJbYrHXQ
-
The Pulmonary Vascular Research Institute reposted
The Pulmonary Hypertension Association
@PHAssociation
Today is #worldlungday! This year’s theme encourages communities and governments to invest in #lunghealth and tackle air pollution. Learn about World Lung Day and how to get involved. www.firsnet.org/world-lung-day-2024
-
The Pulmonary Vascular Research Institute
@PVRI
Happening today! On #worldlungday, join us at 5PM BST for a patient-focused webinar on debunking myths of lung transplantation pvrinstitute.org/learning-hub/events/debunking-myths-abou…
The Pulmonary Hypertension Association
@PHAssociation
Join us for the “Debunking myths about lung transplantation for PH,” webinar hosted by @PVRI tomorrow at noon EDT/4 p.m. UTC. Learn about #lungtransplantation from experts and patients who’ve received a lung transplant. Register now. us02web.zoom.us/webinar/register/WN_QFTwfsAfQbyQ9pXJbYrHXQ
-
The Pulmonary Vascular Research Institute
@PVRI
Happening next week! Join the first webinar in the NEW High Altitude Task Force series 'Pulmonary hemodynamic acclimatization to high altitude – pathophysiological insights' 1 October 1pm BST. Register for free: us02web.zoom.us/webinar/register/WN_JMA0BfuZQEmJb87VkMR1_g
-
The Pulmonary Vascular Research Institute reposted
PHAEUROPE
@EuropePHA
Join us for the “Debunking myths about lung transplantation for PH,” webinar hosted by
@PVRI on Wednesday, Sept. 25 at noon EDT/4 p.m. UTC. Learn about #lungtransplantation from experts and patients who’ve received a lung transplant. Register now. us02web.zoom.us/webinar/register/WN_QFTwfsAfQbyQ9pXJbYrHXQ -
The Pulmonary Vascular Research Institute reposted
Physician's Weekly
@physicianswkly
What are the most significant predictors of mortality in patients undergoing #lungtransplant for #ipah?
Find out what a study published in Pulmonary Circulation of @PVRI by @RedaGirgis of @MSUMD and coauthors discovered here: www.physiciansweekly.com/post/identifying-patients-at-ris…
#medtwitter #somedocs -
The Pulmonary Vascular Research Institute reposted
Anjali Vaidya MD 🫀
@anjalivaidyaMD
📢 Apply now for July 2025:
Advanced #pulmonaryhypertension Fellowship (1 yr) @TempleHealth @TempleCards in Philadelphia, PA
medicine.temple.edu/PH-Fellowship
Email/Apply: PHFellowship@TempleHealth.org
ALL forms of PH, emphasis on hemodynamics, echo-Doppler, iCPET, CTEPH, & more‼️ -
The Pulmonary Vascular Research Institute reposted
The Pulmonary Hypertension Association
@PHAssociation
Join us for the “Debunking myths about lung transplantation for PH,” webinar hosted by @PVRI on Wednesday, Sept. 25 at noon EDT/4 p.m. UTC. Learn about #lungtransplantation from experts and patients who’ve received a lung transplant. Register now. us02web.zoom.us/webinar/register/WN_QFTwfsAfQbyQ9pXJbYrHXQ
-
The Pulmonary Vascular Research Institute
@PVRI
Join our Community Call next week to discuss the latest news and advancements in #pulmonaryhypertension. Our panel and guest authors include @LungScholar, @GiessenPh, Katrina Barry, Joel James and @LucillaPiccari.
26 September @ 3PM BST, register for free pvrinstitute.org/learning-hub/events/pvri-community-call-…
Hope to see you there! #ph -
The Pulmonary Vascular Research Institute reposted
Sebastien « Seb » Bonnet
@sbonnet2
Congratulations fingers crossed for revisions @ATS_PC @SarahEve_Lemay @3CPRCouncil @PVRI @AssociationWsph
-
The Pulmonary Vascular Research Institute
@PVRI
NEW Young Investigators Series🌟 Part of #pvridigital, the Young Investigators Series aims to showcase the groundbreaking research being done by clinicians and scientists that are early in their careers.
Join the first session 9 October 2024 @ 3PM BST pvrinstitute.org/learning-hub/events/session-1-young-inve…
Speakers & moderators include @Daniela_ValdezJ, Jasleen Minhas, @galbamd, @AnFrumpIU, @RRVdpool, @iuc453, @PullamsettiL and @BogaardHarm. -
The Pulmonary Vascular Research Institute
@PVRI
📅Save the date! We are thrilled to announce that our Drug Discovery and Development Symposium is coming to Amsterdam 16-17 June 2025➡️pvrinstitute.org/DDDS2025
The symposium promises to be an excellent opportunity for regulatory, industry, and academic bodies to meet and discuss the latest drug developments in #ph.
Hope to see you there! #ddds2025 -
The Pulmonary Vascular Research Institute reposted
Kurt Prins
@kurt_prins
Data from International CTEPH registry in @CircAHA www.ahajournals.org/doi/epdf/10.1161/CIRCULATIONAHA.124.0…. Fantastic outcomes for CTEPH patients treated PEA or BPA. Please get all your CTEPH patients to expert centers for evaluation for PEA or BPA! @anjalivaidyaMD @PHAssociation @PVRI @ICA_CTEPH
-
The Pulmonary Vascular Research Institute reposted
Brown Medicine Pulmonary Vascular Disease
@BrownPVD
Abstracts now being accepted for the Advances in Right Heart Biology Symposium! We have an exciting lineup of experts on topics from basic science to advanced physiology & more. Please join us! cme-learning.brown.edu/ARHB
@SobanUmar @kurt_prins @RRVdpool @ImadAlGhouleh @GChoudharyMD -
The Pulmonary Vascular Research Institute
@PVRI
🚨Happening next week: 'Debunking myths about lung transplantation for PH - A webinar for patients & caregivers'🫁
Join speakers Corey Ventetuolo, @CDemarest_MDPhD, @LungTxptMD, and patient representatives Natalia Maeva @EuropePHA & Diane Ramirez @PHAssociation next Wednesday 25 September 5PM BST.
Register for free pvrinstitute.org/learning-hub/events/debunking-myths-abou…
#pulmonaryhypertension -
The Pulmonary Vascular Research Institute
@PVRI
📢Abstract submission deadline approaching! Just over two weeks to go until submissions close for #pvri2025. Have you submitted your abstract yet?
pvrinstitute.org/learning-hub/news/abstract-submissions-p…
The best abstracts in the following areas will be selected for oral presentations in our main programme:
💜Establishing the framework for the classification & diagnosis of PH worldwide
💜Risk stratification & treatment in the new era of PH therapeutics
💜Vascular heterogeneity in chronic lung disease
💜Heterogeneity in PH associated with heart disease
💜The individual exposome & it’s contribution to PH heterogeneity
💜Quantifying therapeutic responses
💜Leveraging disease heterogeneity in clinical trial design
Time is running out, so make sure you submit your abstract by 7 October 2024! -
The Pulmonary Vascular Research Institute
@PVRI
The Aristotle Classes on PH & ACHD is a scientific event organised jointly by the Medical School of Aristotle University, the Heart Center at @UniCologne, and @RBandH.
The programme will feature:
• state of the Art interactive plenary sessions
• abstract presentations
• numerous further networking opportunities.
🗓️Save the date: 11-12 October 2024 pvrinstitute.org/learning-hub/news/aristotle-classes-ph-achd
@escardio -
The Pulmonary Vascular Research Institute
@PVRI
The scientific programme for #pvri2025 has just been released! With 4 days of expert PH content, the congress is set to be an invaluable meeting. Hosted in the vibrant and captivating city of Rio de Janeiro from 29 January - 1 February 2025 with the theme of Embracing Heterogeneity, we can’t wait to see you there.
Programme overview:
💜29 January: Pre-meetings (IDDI, iPVD Consortium, Paediatric Task Force, PAH-ICON, High Altitude Task Force)
💜30 January: Heterogeneity in the presentation of PH
💜31 January: Heterogeneity in the pathobiology of PH
💜1 February: Learning from heterogeneity to improve outcomes in PH
See the full scientific programme here➡️pvrinstitute.org/pvri2025rio -
The Pulmonary Vascular Research Institute
@PVRI
Congratulations Jennifer & team for an insightful review on 'Scoping review of post-TB pulmonary vascular disease: Proceedings from the 2nd International Post-Tuberculosis Symposium'. Read the full review article here pvrinstitute.org/learning-hub/material/scoping-review-pos…
Jennifer Van heerden
@JenniferVanhe10
Really excited to see our review on post-TB pulmonary vascular disease recently published online @PulmCirc!
@PVRI @PostTBSymposium
Scoping review of post‐TB pulmonary vascular disease: Proceedings from the 2nd International Post‐Tuberculosis Symposium onlinelibrary.wiley.com/doi/full/10.1002/pul2.12424 -
The Pulmonary Vascular Research Institute reposted
PHAEUROPE
@EuropePHA
PHA Europe remains committed to improving access to care and shared decision-making for PH patients. #ers2024 #ph #patientadvocacy
➡️Read 𝗣𝗛𝗔 𝗘𝘂𝗿𝗼𝗽𝗲'𝘀 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀:
www.facebook.com/phaeurope/posts/935383795291105
⤵️ -
The Pulmonary Vascular Research Institute
@PVRI
Following our successful Luncheon in PVRI 2024 London, we are delighted to bring to you the Women in PH Luncheon at #pvri2025. We look forward to another exhilarating event welcoming women from around the world who share their journeys and what it means to them to be a woman in #pulmonaryhypertension. Thank you to United Therapeutics Corporation for sponsoring this Luncheon pvrinstitute.org/pvri2025rio
-
The Pulmonary Vascular Research Institute reposted
Kurt Prins
@kurt_prins
Excited to share our recent data evaluating the role of ferroptosis in PAH next Wednesday during lunch our. Join in if you can, we love to see a big in-person and online audience! @3CPRCouncil @PVRI @PHAssociation @ATS_PC
Lillehei Heart Institute
@LilleheiHrt
LHI Lecture Sept. 18, noon: Kurt Prins, M.D., Ph.D. “Ferroptosis in Pulmonary Arterial Hypertension.” 1-101 Microbiology Research Facility | More info: med.umn.edu/lhi/news-events/lecture-series | Webcast: umn.zoom.us/j/92384714152 #umnresearch #umnheart
-
The Pulmonary Vascular Research Institute
@PVRI
Happening next month, 'Pulmonary hemodynamic acclimatization to high altitude – pathophysiological insights' is the first webinar in the NEW High Altitude Task Force series.
1 October 1pm BST, register for free us02web.zoom.us/webinar/register/WN_JMA0BfuZQEmJb87VkMR1_g
The Pulmonary Vascular Research Institute
@PVRI
NEW webinar series 📢Organised by the High Altitude Task Force, join Robert Naeije for a presentation on ‘Pulmonary hemodynamic acclimatization to high altitude – pathophysiological insights’ 1 October 2024📅 Moderated by @aastha_mishra06 & Silvia Ulrich, this webinar is the first of the 'Hypoxia in pulmonary vascular research – altitude and beyond' series. Register here pvrinstitute.org/learning-hub/events/pulmonary-hemodynami…
-
The Pulmonary Vascular Research Institute
@PVRI
Thank you to everyone who attended our #pvri Drinks Reception after the #erscongress2024. We really enjoyed catching up with our #pulmonaryhypertension friends and making new ones. We can’t wait to see some of you at #pvri2025 in Rio!
The Pulmonary Vascular Research Institute
@PVRI
-
The Pulmonary Vascular Research Institute
@PVRI
Great to celebrate with @Dr_Joe_Newman one of the award winners at the #erscongress2024! Joe will be presented with the ELF Travel grant 10th September for best abstract in patient centred research entitled “The Pulmonary Hypertension Global Patient Survey (PH GPS): an overview and results”. The PH GPS is the first global survey to assess the impacts of PH on patients and their lived experiences, and is pivotal in shaping future research and enhancing healthcare to benefit patients on a global scale. Almost 4,000 patients and carers in over 85 countries have completed our PH GPS, and we thank the whole #pulmonaryhypertension community for their contributions. Congratulations again Joe on your award, and all the team for their brilliant work. Find out more about the PH GPS pvrinstitute.org/learning-and-research/pulmonary-hyperten…
-
The Pulmonary Vascular Research Institute reposted
Mark Toshner
@mark_toshner
Thé @PVRI and #ers are frankly 2 key global supporters of PH research. Nice to see them together
-
The Pulmonary Vascular Research Institute
@PVRI
Great to chat with Paul and Martin #pvridrinksreception
-
The Pulmonary Vascular Research Institute
@PVRI
Our guests are enjoying a wonderful evening of music, drinks and canapes at our #pvri Drinks Reception! So lovely to chat with @danielchengyuwu @hstefan991 @PullamsettiL @CPI_ExStra @UKGM_Presse @jlugiessen
-
The Pulmonary Vascular Research Institute
@PVRI
NEW webinar series 📢Organised by the High Altitude Task Force, join Robert Naeije for a presentation on ‘Pulmonary hemodynamic acclimatization to high altitude – pathophysiological insights’ 1 October 2024📅 Moderated by @aastha_mishra06 & Silvia Ulrich, this webinar is the first of the 'Hypoxia in pulmonary vascular research – altitude and beyond' series. Register here pvrinstitute.org/learning-hub/events/pulmonary-hemodynami…



































































































































































































































































































































































































































































































































































































































































































































































































































































